Page 1

2O17 On-site Guide

COME SEE WHAT’S NEW IN BOOTH #473.

e t i s On ide Gu

• Booth Descriptions • Daily Passports • Office of the Future

  Bo

 • 017 8, 2 2–2 il 2 Apr

}} Annual Meeting Information }} Exhibits

n sto

AMERICAN ACADEMY OF NEUROLOGY

©2017 EMD Serono, Inc.

All rights reserved.

US/REB/0217/0037e

Printed in USA

03/17


1275 1273 1271 1269

Office of the Future Headshots

1265 1263 1261 1259 1257

1253

1249 1247 1245

1241 1239 1235

1229 1227 1225 1223 1221

Association Neighborhood

Tech Area 1274 1272 1270

1264 1260 1258 1256

1252

1248 1246 1244

1175

1165 1163 1161 1159 1157

1153

1149 1147 1145

1171

1240 1238 1236 1234

1228

1224 1222 1220 1218

1129

1125 1123 1121 1119

Technology Pavilion

Presentation Stage

1174 1172 1170 1168

1164 1162 1160

1075 1073

1065 1063 1061 1059 1057 1055 1053 1051

1069

1156 1154 1152 1150

Charging Hub

1140 1138 1136 1134

1128 1126 1124 1122 1120 1118 1116

1112

1041 1039 1037 1035

1029 1027 1025 1023 1021 1019 1017

1013 1011

Career Fair

981 994

889

895 894 892

Meal Services

984 885

791

969

974

Charging Hub

785

795 793

975

1064 1062 1060 1058 1056 1054 1052 965 963 961

957

955 953

971

858

771

779

945

927

Charging Hub

853

875 873 871

1028 1026 1024 1022 1020 1018 1016

745

751

917

924 922

916

911

825 823 818 816 Publications Row 838

1010 1008 1006 907 906

811

807

836 834

741 739 737 735

721

729

801

1012

715

740 738 736 734

685

559

573

591

925 923 921

547

523

585

501

513

535

To Posters 489

493

483

467

473

426

445

454

409

401

439

417 383

379 377 375 373

369

367

339

337 335

First Time Exhibitors

283

MS1

378 376 374 279 277 275 274

MS2

MS5

MS7

MS3

MS6

MS8

Charging Hub

336 334

241 239 237 235

272 270 268

177 175 173 171 169

MS4

240 238

234

139

137 135

229

324 322

310 308

225 223

209

224 127

201 Charging Hub

Charging Hub

125

116 147

164

MS16

MS9

338

244

260

301

311 329

MS10

MS11

MS12

MS13

145

128

124

112 110

106 104

148 146 144

Exhibit Hall BC

MS14

052B

052A

051

MS15

050

2017 AAN Annual Meeting Exhibit Hall Map

Up

Up


Welcome to the 2017 AAN Annual Meeting The Annual Meeting’s all-inclusive registration rate gives you access to more than 95% of this year’s programming, eliminating the need to pre-register for most courses and providing maximum flexibility and options! • Programs marked $ indicate that an additional fee is required for that program(s); however, you can still add these programs through registration, if space is available • All programs that do not require pre-registration are available on a first-come, first-serve basis—so plan to arrive early to any program(s) of interest. Full program(s) may be overflowed to a second room.

Visit the Exhibit Hall New—open on Sunday! The Exhibit Hall will give you a chance to visit over 200 exhibiting organizations to see the range of cutting-edge, patient-focused products, services, and therapies the industry has to offer the field of neurology.


What's Inside Welcome to the 2017 AAN Annual Meeting . . . . . . . . . . . . . . . . . . . . 1

Schedules & Maps Hotel Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Meeting-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 Hours of Operation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 Schedule . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 Saturday, April 22 . . . . . . . . . . . 30

Wednesday, April 26 . . . . . . . . . 50

Sunday, April 23 . . . . . . . . . . . . 33

Thursday, April 27 . . . . . . . . . . . 55

Monday, April24 . . . . . . . . . . . . 39

Friday, April 28 . . . . . . . . . . . . . 59

Tuesday, April 25 . . . . . . . . . . . . 45

Meetings ICW Meetings / Alumni Reunions . . . . . . . . . . . . . . . . . . . . . . . . . . . 66 Friday, April 21 . . . . . . . . . . . . . 66

Tuesday, April 25 . . . . . . . . . . . . 68

Saturday, April 22 . . . . . . . . . . . 66

Wednesday, April 26 . . . . . . . . . 71

Sunday, April 23 . . . . . . . . . . . . 66

Thursday, April 27 . . . . . . . . . . . 72

Monday, April 24 . . . . . . . . . . . . 67

Emerging Science Emerging Science Program Schedule . . . . . . . . . . . . . . . . . . . . . . . . 73

Exhibitors Exhibitor Listing—Topic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93 Exhibitor Listing—Booth Number . . . . . . . . . . . . . . . . . . . . . . . . . . . 104 Exhibitor Listing—Descriptions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108

Awards 2017 Award Recipients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159

Attendees Annual Meeting Registrants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201

Passport AAN Annual Meeting Passport . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 281

All content is current as of April 13, 2017.


For the adjunctive treatment of seizures associated with LGS in adults and children,

Add BANZEL for powerful, broad spectrum efficacy in total seizure reduction ®

• 32.7% median reduction of total seizures in the ® BANZEL group vs 11.7% for placebo (P<0.002)1,2 * • 42.5% median reduction in tonic-atonic seizures (drop attacks) in the BANZEL® group vs 1.4% increase for placebo (P<0.0001)1,2 *

Learn more at Booth 301 *A 12-week, randomized, double-blind, multicenter, placebo-controlled, parallel-group trial to assess the effectiveness of BANZEL (rufinamide) to reduce inadequately controlled seizures associated with LGS in patients (N=138, intent to treat) being treated with 1-3 concomitant, stable-dose AEDs. These were primary efficacy endpoints in the pivotal trial.1–3

Indication: BANZEL® is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults.

Important Safety Information Contraindication:

BANZEL is contraindicated in patients with Familial Short QT syndrome.

Warnings:

AEDs increase the risk of suicidal thoughts or behavior in patients. Patients, their caregivers, and families should be informed of the risk and advised to monitor and report any emergence or worsening of depression, suicidal thoughts or behavior, or any unusual changes in mood or behavior, or thoughts of self-harm. If these symptoms occur, consider if it may be related to the AED or illness because epilepsy itself can increase these risks. Use of BANZEL has been associated with central nervous system–related adverse reactions, such as somnolence or fatigue, coordination abnormalities, dizziness, gait disturbances, and ataxia.

Precautions:

Formal cardiac ECG studies demonstrated shortening of the QT interval (mean = 20 msec, for doses ≥ 2400 mg twice daily) with BANZEL. Caution should be used when administering BANZEL with other drugs that shorten the QT interval. Multi-organ hypersensitivity syndrome has been reported in association with BANZEL therapy. In clinical trials, hypersensitivity reactions occurred in children

less than 12 years of age and within 4 weeks of starting BANZEL therapy. In addition, rare cases of Drug Reaction with Eosinophilia and Systemic Symptoms and StevensJohnson syndrome have been reported in association with rufinamide therapy post marketing. If any of these reactions are suspected, BANZEL should be discontinued and alternative treatment started. All patients who develop a rash while taking BANZEL must be closely supervised. As with all AEDs, BANZEL should be gradually withdrawn to minimize the risk of increased seizure frequency.

Adverse reactions:

In the pooled, double-blind, adjunctive therapy studies in adults and pediatric patients ages 4 and older, the most commonly observed (≥10%) adverse reactions with BANZEL vs placebo, respectively, were headache (25% vs 20%), dizziness (17% vs 10%), fatigue (15% vs 9%), somnolence (13% vs 9%), and nausea (11% vs 7%). In a multicenter, parallel group, open-label study in pediatric patients (1 year to less than 4 years of age) the most commonly observed (≥10%) adverse reactions and with a higher frequency with BANZEL vs any other AED, respectively, were vomiting (24% vs 9%), somnolence (16% vs 0%), constipation (12% vs 9%), cough (12% vs 9%), bronchitis (12% vs 0%), rash (12% vs 9%), and decreased appetite (12% vs 9%).

The material in this booth is based on the US Prescribing Information and may not be consistent with prescribing information in other countries For more information, please visit www.BANZEL.com/hcp References: 1. Glauser et al. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology. 2008;70(21):1950-1958. 2. BANZEL® (rufinamide) prescribing information, Eisai Inc. 3. Data on file, Eisai Inc.

Please see Brief Summary of full Prescribing Information on the adjacent pages. ©2017 Eisai Inc. All rights reserved. BANZ-US0349(1) March 2017 Distributed and marketed by Eisai Inc., Woodcliff Lake, NJ 07677


BANZEL (rufinamide) BRIEF SUMMARY—See package insert for full Prescribing Information Dosage Information Pediatric patients (1 year to less than 17 years) The recommended starting daily dose of BANZEL in pediatric patients with Lennox-Gastaut Syndrome is approximately 10 mg/kg administered in two equally divided doses. The dose should be increased by approximately 10 mg/kg increments every other day until a maximum daily dose of 45 mg/kg, not to exceed 3200 mg, administered in two equally divided doses, is reached. It is not known whether doses lower than the target doses are effective. Adults (17 years and older) The recommended starting daily dose of BANZEL in adults with Lennox-Gastaut Syndrome is 400 to 800 mg per day administered in two equally divided doses. The dose should be increased by 400-800 mg every other day until a maximum daily dose of 3200 mg, administered in two equally divided doses, is reached. It is not known whether doses lower than 3200 mg are effective. Administration Information Administer BANZEL with food. BANZEL film-coated tablets can be administered whole, as half tablets or crushed. BANZEL oral suspension should be shaken well before every administration. The provided adapter and calibrated oral dosing syringe should be used to administer the oral suspension. The adapter which is supplied in the product carton should be inserted firmly into the neck of the bottle before use and remain in place for the duration of the usage of the bottle. The dosing syringe should be inserted into the adapter and the dose withdrawn from the inverted bottle. The cap should be replaced after each use. The cap fits properly when the adapter is in place. Dosing in Patients Undergoing Hemodialysis Hemodialysis may reduce exposure to a limited (about 30%) extent. Accordingly, adjusting the BANZEL dose during the dialysis process should be considered. Dosing in Patients with Hepatic Disease Use of BANZEL in patients with hepatic impairment has not been studied. Therefore, use in patients with severe hepatic impairment is not recommended. Caution should be exercised in treating patients with mild to moderate hepatic impairment. Dosing in Patients Taking Valproate Patients taking valproate should begin BANZEL at a dose lower than 10 mg/kg per day in pediatric patients or 400 mg per day in adults. CONTRAINDICATIONS BANZEL is contraindicated in patients with Familial Short QT syndrome. WARNINGS AND PRECAUTIONS Suicidal Behavior and Ideation Antiepileptic drugs (AEDs), including BANZEL, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. Patients treated with any AED for any indication should be monitored for the emergence or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior. Pooled analyses of 199 placebo-controlled clinical trials (mono- and adjunctive therapy) of 11 different AEDs showed that patients randomized to one of the AEDs had approximately twice the risk (adjusted Relative Risk 1.8, 95% CI:1.2, 2.7) of suicidal thinking or behavior compared to patients randomized to placebo. In these trials, which had a median treatment duration of 12 weeks, the estimated incidence rate of suicidal behavior or ideation among 27,863 AEDtreated patients was 0.43%, compared to 0.24% among 16,029 placebo-treated patients, representing an increase of approximately one case of suicidal thinking or behavior for every 530 patients treated. There were four suicides in drugtreated patients in the trials and none in placebo-treated patients, but the number is too small to allow any conclusion about drug effect on suicide. The increased risk of suicidal thoughts or behavior with AEDs was observed as early as one week after starting drug treatment with AEDs and persisted for the duration of treatment assessed. Because most trials included in the analysis did not extend beyond 24 weeks, the risk of suicidal thoughts or behavior beyond 24 weeks could not be assessed. The risk of suicidal thoughts or behavior was generally consistent among drugs in the data analyzed. The finding of increased risk with AEDs of varying mechanisms of action and across a range of indications suggests that the risk applies to all AEDs used for any indication. The risk did not vary substantially by age (5-100 years) in the clinical trials analyzed. Table 1 shows absolute and relative risk by indication for all evaluated AEDs. Table 1: Absolute and Relative Risk of Suicidal Behavior and Ideation Indication

Placebo Patients with Events Per 1000 Patients

Drug Patients with Events Per 1000 Patients

Relative Risk: Incidence of Events in Drug Patients/ Incidence in Placebo Patients

Risk Difference: Additional Drug Patients with Events Per 1000 Patients

Epilepsy

1.0

3.4

3.5

2.4

Psychiatric

5.7

8.5

1.5

2.9

Other

1.0

1.8

1.9

0.9

Total 2.4 4.3 1.8 1.9 The relative risk for suicidal thoughts or behavior was higher in clinical trials for epilepsy than in clinical trials for psychiatric or other conditions, but the absolute risk differences were similar for the epilepsy and psychiatric indications. Anyone considering prescribing BANZEL or any other AED must balance the risk of suicidal thoughts or behavior with the risk of untreated illness. Epilepsy and many other illnesses for which AEDs are prescribed are themselves associated with morbidity and mortality and an increased risk of suicidal thoughts and behavior. Should suicidal thoughts and behavior emerge during treatment, consider whether the emergence of these symptoms in any given patient may be related to the illness being treated. Patients, their caregivers, and families should be informed that AEDs increase the risk of suicidal thoughts and behavior and should be advised of the need to be alert for the emergence or worsening of the signs and symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts, behavior, or thoughts about self-harm. Behaviors of concern should be reported immediately to healthcare providers. Central Nervous System Reactions Use of BANZEL has been associated with central nervous system-related adverse reactions in the controlled clinical trial of patients 4 years or older with Lennox-Gastaut Syndrome. The most significant of these can be classified into two general categories: 1) somnolence or fatigue, and 2) coordination abnormalities, dizziness, gait disturbances, and ataxia. Somnolence was reported in 24% of BANZEL-treated patients compared to 13% of patients on placebo, and led to study discontinuation in 3% of BANZEL-treated patients compared to 0% of patients on placebo. Fatigue was reported in 10% of BANZEL-treated patients compared to 8% of patients on placebo patients. It led to study discontinuation in 1% of BANZEL-treated patients and 0% of patients on placebo patients. Dizziness was reported in 2.7% of BANZEL-treated patients compared to 0% of patients on placebo, and did not lead to study discontinuation. Ataxia and gait disturbance were reported in 5.4% and 1.4% of BANZEL-treated patients, respectively, compared to no patient on placebo. None of these reactions led to study discontinuation. Accordingly, patients should be advised not to drive or operate machinery until they have gained sufficient experience on BANZEL to gauge whether it adversely affects their ability to drive or operate machinery.

QT Shortening Formal cardiac ECG studies demonstrated shortening of the QT interval (mean = 20 msec, for doses ≥2400 mg twice daily) with BANZEL. In a placebo-controlled study of the QT interval, a higher percentage of BANZEL-treated subjects (46% at 2400 mg, 46% at 3200 mg, and 65% at 4800 mg) had a QT shortening of greater than 20 msec at Tmax compared to placebo (5-10%). Reductions of the QT interval below 300 msec were not observed in the formal QT studies with doses up to 7200 mg per day. Moreover, there was no signal for drug-induced sudden death or ventricular arrhythmias. The degree of QT shortening induced by BANZEL is without any known clinical risk. Familial Short QT syndrome is associated with an increased risk of sudden death and ventricular arrhythmias, particularly ventricular fibrillation. Such events in this syndrome are believed to occur primarily when the corrected QT interval falls below 300 msec. Non-clinical data also indicate that QT shortening is associated with ventricular fibrillation. Patients with Familial Short QT syndrome should not be treated with BANZEL. Caution should be used when administering BANZEL with other drugs that shorten the QT interval. Multi-organ Hypersensitivity Reactions Multi-organ Hypersensitivity Syndrome, a serious condition sometimes induced by antiepileptic drugs, has occurred in association with BANZEL therapy in clinical trials. One patient experienced rash, urticaria, facial edema, fever, elevated eosinophils, stuperous state, and severe hepatitis, beginning on day 29 of BANZEL therapy and extending over a course of 30 days of continued BANZEL therapy with resolution 11 days after discontinuation. Additional possible cases presented with rash and one or more of the following: fever, elevated liver function studies, hematuria, and lymphadenopathy. These cases occurred in pediatric patients less than 12 years of age, within 4 weeks of treatment initiation, and were noted to resolve and/or improve upon BANZEL discontinuation. This syndrome has been reported with other anticonvulsants and typically, although not exclusively, presents with fever and rash associated with other organ system involvement. Because this disorder is variable in its expression, other organ system signs and symptoms not noted here may occur. If this reaction is suspected, BANZEL should be discontinued and alternative treatment started. In addition, rare cases of DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) and StevensJohnson syndrome have been reported in association with rufinamide therapy post marketing. If an antiepileptic drug hypersensitivity syndrome is suspected, rufinamide should be discontinued and alternative treatment started. All patients who develop a rash while taking BANZEL must be closely supervised. Withdrawal of AEDs As with all antiepileptic drugs, BANZEL should be withdrawn gradually to minimize the risk of precipitating seizures, seizure exacerbation, or status epilepticus. If abrupt discontinuation of the drug is medically necessary, the transition to another AED should be made under close medical supervision. In clinical trials, BANZEL discontinuation was achieved by reducing the dose by approximately 25% every 2 days. Status Epilepticus Estimates of the incidence of treatment emergent status epilepticus among patients treated with BANZEL are difficult because standard definitions were not employed. In a controlled Lennox-Gastaut Syndrome trial, 3 of 74 (4.1%) BANZEL-treated patients had episodes that could be described as status epilepticus in the BANZEL-treated patients compared with none of the 64 patients in the placebo-treated patients. In all controlled trials that included patients with different epilepsies, 11 of 1240 (0.9%) BANZEL-treated patients had episodes that could be described as status epilepticus compared with none of 635 patients in the placebo-treated patients. Leukopenia BANZEL has been shown to reduce white cell count. Leukopenia (white cell count < 3X109 L) was more commonly observed in BANZEL-treated patients 43 of 1171 (3.7%) than placebo-treated patients, 7 of 579 (1.2%) in all controlled trials. ADVERSE REACTIONS The following serious adverse reactions are described below and elsewhere in the labeling: - Suicidal Behavior and Ideation - Central Nervous System Reactions - QT Shortening - Multi-organ Hypersensitivity Reactions - Leukopenia Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. Adverse Reactions in Adult and Pediatric Patients ages 3 to 17 years of age In the pooled, double-blind, adjunctive therapy studies in adult and pediatric patients ages 3 to 17 years of age, the most common (≥10%) adverse reactions in BANZEL-treated patients, in all doses studied (200 to 3200 mg per day) with a higher frequency than in patients on placebo were: headache, dizziness, fatigue, somnolence, and nausea. Table 2 lists adverse reactions that occurred in at least 3% of pediatric patients (ages 3 to less than 17 years) with epilepsy treated with BANZEL in controlled adjunctive studies and were numerically more common in patients treated with BANZEL than in patients on placebo. At the target dose of 45 mg/kg per day for adjunctive therapy in pediatric patients (ages 3 to less than 17 years), the most common (≥3%) adverse reactions with an incidence greater than in placebo for BANZEL were somnolence, vomiting, and headache. Table 2: Adverse Reactions in Pediatric Patients (Ages 3 to less than 17 years) in Pooled Double-Blind Adjunctive Trials Adverse Reaction (BANZEL [N=187] vs Placebo [N=182]) Somnolence (17% vs 9%), Vomiting (17% vs 7%), Headache (16% vs 8%), Fatigue (9% vs 8%), Dizziness (8% vs 6%), Nausea (7% vs 3%), Influenza (5% vs 4%), Nasopharyngitis (5% vs 3%), Decreased appetite (5% vs 2%), Rash (4% vs 2%), Ataxia (4% vs 1%), Diplopia (4% vs 1%), Bronchitis (3% vs 2%), Sinusitis (3% vs 2%), Psychomotor hyperactivity (3% vs 1%), Upper abdominal pain (3% vs 2%), Aggression (3% vs 2%), Ear infection (3% vs 1%), Disturbance in attention (3% vs 1%), and Pruritis (3% vs 0%) Table 3 lists adverse reactions that occurred in at least 3% of adult patients with epilepsy treated with BANZEL (up to 3200 mg/day) in adjunctive controlled studies and were numerically more common in patients treated with BANZEL than in patients on placebo. In these studies, either BANZEL or placebo was added to current AED therapy. At all doses studied of up to 3200 mg per day given as adjunctive therapy in adults, the most common (≥ 3%) adverse reactions, and with the greatest increase in incidence compared to placebo, for BANZEL were dizziness, fatigue, nausea, diplopia, vision blurred, and ataxia. Table 3: Adverse Reactions in Adults in Pooled Double-Blind Adjunctive Trials Adverse Reaction (BANZEL [N=823] vs Placebo [N=376]) Headache (27% vs 26%), Dizziness (19% vs 12%), Fatigue (16% vs 10%), Nausea (12% vs 9%), Somnolence (11% vs 9%), Diplopia (9% vs 3%), Tremor (6% vs 5%), Nystagmus (6% vs 5%), Blurred vision (6% vs 2%), Vomiting (5% vs 4%), Ataxia (4% vs 0%), Upper abdominal pain (3% vs 2%), Anxiety (3% vs 2%), Constipation (3% vs 2%), Dyspepsia (3% vs 2%), Back pain (3% vs 1%), Gait disturbance (3% vs 1%), and Vertigo (3% vs 1%) Discontinuation in Controlled Clinical Studies In controlled, double-blind, adjunctive clinical studies, 9% of pediatric and adult patients receiving BANZEL as adjunctive therapy and 4% receiving placebo discontinued as a result of an adverse reaction. The adverse reactions most commonly leading to discontinuation of BANZEL (>1%) used as adjunctive therapy were generally similar in adults and children. In pediatric patients (ages 4 to less than 17 years) double-blind adjunctive clinical studies, 8% of patients receiving BANZEL as adjunctive therapy (at the recommended dose of 45 mg/kg per day) and 2% receiving placebo discontinued as a result of an adverse reaction. The adverse reactions most commonly leading to discontinuation of BANZEL (>1%) used as adjunctive therapy are presented in Table 4.


Table 4: Most Common Adverse Reactions Leading to Discontinuation in Pediatric Patients (Ages 4 to less than 17 years) in Pooled Double-Blind Adjunctive Trials Adverse Reaction (BANZEL [N=187] vs Placebo [N=182]) Convulsion (2% vs 1%), Rash (2% vs 1%), Fatigue (2% vs 0%), and Vomiting (1% vs 0%) In adult double-blind, adjunctive clinical studies, 10% of patients receiving BANZEL as adjunctive therapy (at doses up to 3200 mg per day) and 6% receiving placebo discontinued as a result of an adverse reaction. The adverse reactions most commonly leading to discontinuation of BANZEL (>1%) used as adjunctive therapy are presented in Table 5. Table 5: Most Common Adverse Reactions Leading to Discontinuation in Adult Patients in Pooled Double-Blind Adjunctive Trials Adverse Reaction (BANZEL [N=823] vs Placebo [N=376]) Dizziness (3% vs 1%), Fatigue (2% vs 1%), Headache (2% vs 1%), Nausea (1% vs 0%), and Ataxia (1% vs 0%) Pediatric Patients ages 1 to less than 4 years In a multicenter, parallel group, open-label study comparing BANZEL (45 mg/kg per day) adjunctive treatment (n=25) to the adjunctive treatment with an AED of the investigator’s choice (n=11) in pediatric patients (1 year to less than 4 years of age) with inadequately controlled Lennox-Gastaut Syndrome, the adverse reaction profile was generally similar to that observed in adults and pediatric patients 4 years of age and older treated with BANZEL. Adverse reactions that occurred in at least 2 (8%) BANZEL-treated patients and with a higher frequency than in the AED comparator group were: vomiting (24%), somnolence (16%), bronchitis (12%), constipation (12%), cough (12%), decreased appetite (12%), rash (12%), otitis media (8%), pneumonia (8%), decreased weight (8%), gastroenteritis (8%), nasal congestion (8%), and pneumonia aspiration (8%). Other Adverse Reactions Observed During Clinical Trials BANZEL has been administered to 1978 individuals during all epilepsy clinical trials (placebo-controlled and open-label). Adverse reactions occurring during these studies were recorded by the investigators using terminology of their own choosing. To provide a meaningful estimate of the proportion of patients having adverse reactions, these events were grouped into standardized categories using the MedDRA dictionary. Adverse events occurring at least three times and considered possibly related to treatment are included in the System Organ Class listings below. Terms not included in the listings are those already included in the tables above, those too general to be informative, those related to procedures, and terms describing events common in the population. Some events occurring fewer than 3 times are also included based on their medical significance. Because the reports include events observed in open-label, uncontrolled observations, the role of BANZEL in their causation cannot be reliably determined. Events are classified by body system and listed in order of decreasing frequency as follows: frequent adverse events— those occurring in at least 1/100 patients; infrequent adverse events—those occurring in 1/100 to 1/1000 patients; rare—those occurring in fewer than 1/1000 patients. Blood and Lymphatic System Disorders: Frequent: anemia. Infrequent: lymphadenopathy, leukopenia, neutropenia, iron deficiency anemia, thrombocytopenia. Cardiac Disorders: Infrequent: bundle branch block right, atrioventricular block first degree. Metabolic and Nutritional Disorders: Frequent: decreased appetite, increased appetite. Renal and Urinary Disorders: Frequent: pollakiuria. Infrequent: urinary incontinence, dysuria, hematuria, nephrolithiasis, polyuria, enuresis, nocturia, incontinence. DRUG INTERACTIONS Effects of BANZEL on Other AEDs Population pharmacokinetic analysis of average concentration at steady state of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, and valproate showed that typical rufinamide Cavss levels had little effect on the pharmacokinetics of other AEDs. Any effects, when they occur, have been more marked in the pediatric population. Table 6 summarizes the drug-drug interactions of BANZEL with other AEDs. Table 6: Summary of drug-drug interactions of BANZEL with other antiepileptic drugs AED Co-administered

Influence of Rufinamide on AED concentrationa)

Influence of AED on Rufinamide concentration

Carbamazepine

Decrease by 7 to 13%b)

Decrease by 19 to 26% Dependent on dose of carbamazepine

No Effect Decrease by 25 to 46%c),d) Independent of dose or concentration of phenobarbital Decrease by 25 to 46%c),d) Phenytoin Increase by 7 to 21%b) Independent of dose or concentration of phenytoin Topiramate No Effect No Effect Increase by <16 to 70%c) Valproate No Effect Dependent on concentration of valproate Decrease by 25 to 46%c),d) Independent of dose or concentration of Primidone Not Investigated primidone Benzodiazepinese) Not Investigated No Effect a) Predictions are based on BANZEL concentrations at the maximum recommended dose of BANZEL. b) Maximum changes predicted to be in pediatric patients and in adult patients who achieve significantly higher levels of BANZEL, as the effect of rufinamide on these AEDs is concentration-dependent. c) Larger effects in pediatric patients at high doses/concentrations of AEDs. d) Phenobarbital, primidone and phenytoin were treated as a single covariate (phenobarbital-type inducers) to examine the effect of these agents on BANZEL clearance. e) All compounds of the benzodiazepine class were pooled to examine for ‘class effect’ on BANZEL clearance. Phenytoin: The decrease in clearance of phenytoin estimated at typical levels of rufinamide (Cavss 15 μg/mL) is predicted to increase plasma levels of phenytoin by 7 to 21%. As phenytoin is known to have non-linear pharmacokinetics (clearance becomes saturated at higher doses), it is possible that exposure will be greater than the model prediction. Effects of Other AEDs on BANZEL Potent cytochrome P450 enzyme inducers, such as carbamazepine, phenytoin, primidone, and phenobarbital, appear to increase the clearance of BANZEL (see Table 6). Given that the majority of clearance of BANZEL is via a non-CYPdependent route, the observed decreases in blood levels seen with carbamazepine, phenytoin, phenobarbital, and primidone are unlikely to be entirely attributable to induction of a P450 enzyme. Other factors explaining this interaction are not understood. Any effects, where they occurred, were likely to be more marked in the pediatric population. Valproate Patients stabilized on BANZEL before being prescribed valproate should begin valproate therapy at a low dose, and titrate to a clinically effective dose. Similarly, patients on valproate should begin at a BANZEL dose lower than 10 mg/kg per day (pediatric patients) or 400 mg per day (adults). Effects of BANZEL on Hormonal Contraceptives Female patients of childbearing age should be warned that the concurrent use of BANZEL with hormonal contraceptives may render this method of contraception less effective. Additional non-hormonal forms of contraception are recommended when using BANZEL. Lamotrigine

Decrease by 7 to 13%b)

Phenobarbital

Increase by 8 to 13%b)

USE IN SPECIFIC POPULATIONS Pregnancy Pregnancy Category C There are no adequate and well-controlled studies in pregnant women. BANZEL should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Rufinamide produced developmental toxicity when administered orally to pregnant animals at clinically relevant doses. Rufinamide was administered orally to rats at doses of 20, 100, and 300 mg/kg per day and to rabbits at doses of 30, 200, and 1000 mg/kg/day during the period of organogenesis (implantation to closure of the hard palate); the high doses are associated with plasma AUCs ≈2 times the human plasma AUC at the maximum recommended human dose (MRHD, 3200 mg per day). Decreased fetal weights and increased incidences of fetal skeletal abnormalities were observed in rats at doses associated with maternal toxicity. In rabbits, embryo-fetal death, decreased fetal body weights, and increased incidences of fetal visceral and skeletal abnormalities occurred at all but the low dose. The highest dose tested in rabbits was associated with abortion. The no-effect doses for adverse effects on rat and rabbit embryo-fetal development (20 and 30 mg/kg per day, respectively) were associated with plasma AUCs ≈ 0.2 times that in humans at the MRHD. In a rat pre- and post-natal development study (dosing from implantation through weaning) conducted at oral doses of 5, 30, and 150 mg/kg per day (associated with plasma AUCs up to ≈1.5 times that in humans at the MRHD), decreased offspring growth and survival were observed at all doses tested. A no-effect dose for adverse effects on pre- and postnatal development was not established. The lowest dose tested was associated with plasma AUC < 0.1 times that in humans at the MRHD. Pregnancy Registry To provide information regarding the effects of in utero exposure to BANZEL, physicians are advised to recommend that pregnant patients taking BANZEL enroll in the North American Antiepileptic Drug Pregnancy Registry. This can be done by calling the toll free number 1-888-233-2334, and must be done by patients themselves. Information on the registry can also be found at the website http://www.aedpregnancyregistry.org/. Nursing Mothers Rufinamide is likely to be excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from BANZEL, a decision should be made whether to discontinue nursing or discontinue the drug taking into account the importance of the drug to the mother. Pediatric Use Safety and effectiveness have been established in pediatric patients 1 to 17 years of age. The effectiveness of BANZEL in pediatric patients 4 years of age and older was based upon an adequate and well-controlled trial of BANZEL that included both adults and pediatric patients, 4 years of age and older, with Lennox-Gastaut Syndrome. The effectiveness in patients 1 to less than 4 years was based upon a bridging pharmacokinetic and safety study. The pharmacokinetics of rufinamide in the pediatric patients, ages 1 to less than 4 years of age is similar to children older than 4 years of age and adults. Safety and effectiveness in pediatric patients below the age of 1 year has not been established. Geriatric Use Clinical studies of BANZEL did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Pharmacokinetics of rufinamide in the elderly are similar to that in the young subjects. Renal Impairment Rufinamide pharmacokinetics in patients with severe renal impairment (creatinine clearance < 30 mL/min) was similar to that of healthy subjects. Dose adjustment in patients undergoing dialysis should be considered. Hepatic Impairment Use of BANZEL in patients with severe hepatic impairment (Child-Pugh score 10 to 15) is not recommended. Caution should be exercised in treating patients with mild (Child-Pugh score 5 to 6) to moderate (Child-Pugh score 7 to 9) hepatic impairment. OVERDOSAGE Because strategies for the management of overdose are continually evolving, it is advisable to contact a Certified Poison Control Center to determine the latest recommendations for the management of an overdose of any drug. One overdose of 7200 mg per day BANZEL was reported in an adult during the clinical trials. The overdose was associated with no major signs or symptoms, no medical intervention was required, and the patient continued in the study at the target dose. Treatment or Management of Overdose: There is no specific antidote for overdose with BANZEL. If clinically indicated, elimination of unabsorbed drug should be attempted by induction of emesis or gastric lavage. Usual precautions should be observed to maintain the airway. General supportive care of the patient is indicated including monitoring of vital signs and observation of the clinical status of the patient. Hemodialysis: Standard hemodialysis procedures may result in limited clearance of rufinamide. Although there is no experience to date in treating overdose with hemodialysis, the procedure may be considered when indicated by the patient’s clinical state. © 2015 Eisai Inc. Printed in U.S.A. BANZ0920


A commitment to patients. A passion for progress. A culture of compassion.

Neurology with spirit Helping to fulfill our human health care (hhc) mission

Visit us at Booth 301 to learn more about Eisai Neurology or visit www.NeurologyWithSpirit.com to learn more about Eisai Neurology.

Š2017 Eisai Inc. All rights reserved. US0888 March 2017


Live Well Taking Care of Your Patients Starts with Taking Care of You

Neurologists have one of the highest rates of burnout and lowest rates of work-life balance among medical specialties. Find practical solutions to revitalize your well-being.

AAN.com/LiveWell


Annual Meeting Mobile App Now Available Tap into the meeting from anywhere and start planning your 2017 experience: • View and customize your program schedule • Access program syllabi and slide materials • Access program evaluations and submit CME • Find room locations • Access information about Boston Available for iPhone®, iPad®, or Android®

AAN.com/view/app Sponsored by:


WE’RE COMMITTED TO HD Join us at Teva’s

Booth #559

© 2017 Teva Neuroscience, Inc. HD-40328 March 2017


Let’s Give Back to Our 2017 Annual Meeting Host City Help prepare young people from Boston Public Schools for health and science careers and contribute to the skilled science workforce of the future! The AAN is proud to partner with The Center for Community Health and Health Equity at Brigham and Women’s Hospital to help give back to the Boston community during the 2017 AAN Annual Meeting. Your support will help send Boston Public School 9th graders through the innovative Summer Science Academy program, exposing them to health care professions in a hospital setting, and providing hands-on science education that links to real-world professional—and personal—application. Donations will provide transportation, equipment, public health curriculum and student funding. To learn more and donate today, visit AAN.com/view/AANGivesBack.

Your Support Makes a Real Difference! A comprehensive evaluation showed that 100% of the 2016 Summer Science Academy students reported experiencing positive change in their academic motivation, and 94% reported a positive change in learning interest and academic perseverance.


Industry Therapeutic Updates

Saturday, April 22, Tuesday, April 25, and Wednesday, April 26 • Starting at 7:00 p.m. Registration is free and open to registered Annual Meeting attendees. Representatives from the following companies invite you to an informational session on therapeutic updates. This program provides you the opportunity to learn about current therapies and projects in the industry pipeline. Saturday, April 22, 2017 Amgen Science of Migraine: Unmet Needs and New Insights into the Role of CGRP in Migraine Location: Renaissance Boston Waterfront Pacific Grand Ballrooms ABCD

Biogen Improving Patient Outcomes in MS: Stepping Together into the Future—The Role of MS Disease Activity Monitoring in Optimizing Future Patient Outcomes Location: Westin Boston Waterfront Grand Ballroom

Tuesday, April 25, 2017 AbbVie, Inc. Live Patient Perspectives and Treatment Team Insights Location: Westin Boston Waterfront Ballroom A ACADIA Pharmaceuticals Inc. Treating Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis: Insights into the Standard of Care Location: Westin Boston Waterfront Ballroom CDE Alnylam Pharmaceuticals Solve the Case: Challenging Cases in Neurology with a Focus on Rare Disease Location: Hyatt Regency Boston Martha’s Vineyard Ballroom Arbor Pharmaceuticals Moving Toward Control: Treating Patients for Relief from Moderate-toSevere Primary RLS Location: Westin Boston Waterfront Ballroom B

Biogen Spinraza: A New Age of Spinal Muscular Atrophy Location: Renaissance Boston Waterfront, Pacific Grand Ballroom GE Healthcare Dopaminergic Neuroimaging: An Interactive Debate on Diagnosis in Movement Disorders Location: Aloft Boston Seaport Hotel Mann Ballroom 3 Genentech Featuring an Expert Panel Discussion Location: Westin Boston Waterfront Marina Ballroom Eli Lilly and Company Translating Alzheimer’s Disease Research to Clinical Practice: How Do We Bridge the Gap? Location: Westin Boston Waterfront Commonwealth Ballroom

MT Pharma America The Race Against Time: Current Understandings, Diagnosis, and Assessment of Amyotrophic Lateral Sclerosis (ALS) Location: Westin Boston Waterfront Harborfront Ballroom 1 Neurocrine Biosciences Tardive Dyskinesia Presentation and Management: A Case-based Approach Location: Aloft Boston Seaport Hotel Mann Ballroom 1 & 2 Novartis Pharma AG The Tightrope of MS: Maintaining Balance on the Disease Continuum Location: Seaport Boston Hotel Plaza Ballroom Sunovion Pharmaceuticals Inc. Changing Tunes: The Modern Patient Experience Location: Westin Boston Waterfront Harborfront Ballroom 2 & 3

Wednesday, April 26, 2017 Eli Lilly and Company Amyvid Reader Training Location: Seaport Boston Hotel Plaza Ballroom

Sanofi Genzyme Understanding Functional Improvement in the RMS Patient: Is There Evidence of Neuropreservation and Repair? Location: Westin Boston Waterfront Grand Ballroom

RSVP is recommended for these events. Please visit AAN.com/view/ITU for more information.

No CME will be given by any accredited organization for the Industry Therapeutic Updates, and the AAN cannot affirm claims pertaining to FDA off-label medication, research use of pre-FDA drugs, or other research information that might be discussed. Industry Therapeutic Updates are industry events.


12

2017 AAN Annual Meeting On-site Guide

10

9

8

7

6

5

4

3

2

Fairmont Copley Plaza 138 St. James Avenue (617) 267-5300

Embassy Suites Boston at Logan Airport 207 Porter Street (617) 567-5000

Element Boston Seaport 391-395 D Street (617) 530-1600

20

19

18

17

16

15

Colonnade Hotel 120 Huntington Avenue (617) 424-7000

DoubleTree by Hilton - Boston Downtown 821 Washington Street (617) 956-7900

14

13

12

Boston Marriott Long Wharf 296 State Street (617) 227-0800

Boston Park Plaza Hotel 50 Park Plaza at Arlington Street (617) 654-1950

Boston Courtyard Downtown 275 Tremont Street (617) 426-1400

Liberty Hotel Boston 215 Charles Street (617) 399-4226

Lenox Hotel 61 Exeter Street at Boylston (617) 536-5300

Langham Hotel 250 Franklin Street (617) 451-1900

InterContinental Boston 510 Atlantic Avenue (617) 747-1000

Hyatt Regency Boston One Avenue de Lafayette (617) 912-1234

Hotel Commonwealth 500 Commonwealth Avenue 1-(866) 784-4000

Hilton Boston Logan Airport 1 Hotel Drive (617) 568-6700

Hilton Boston Downtown / Faneuil Hall 89 Broad Street (617) 348-1203

Hilton Boston Back Bay 40 Dalton Street (617) 236-1100

Four Seasons Hotel Boston 200 Boylston Street (617) 338-4400

Aloft Boston Seaport Hotel 401-403 D Street (617) 530-1600

11

Hotel Name and Address

Hotel Name and Address

29

28

27

26

25

24

23

22

21

Wyndham Boston Beacon Hill 5 Blossom Street (617) 742-7630

Westin Copley Place Boston Hotel 10 Huntington Avenue (617) 262-9600

Westin Boston Waterfront 425 Summer Street (617) 532-4600

Sheraton Boston Hotel 39 Dalton Street (617) 236-2000

Seaport Boston Hotel One Seaport Lane (617) 385-4212

Renaissance Boston Waterfront Hotel 606 Congress Street (617) 338-4111

Omni Parker House 60 School Street (617) 227-8600

Midtown Hotel 220 Huntington Avenue (617) 262-1000

Marriott Copley Place 110 Huntington Avenue (617) 236-5800

Hotel Name and Address

Hotel Locations and Information


26

Belvide re St

6

Av e

t tS on em Tr

M as sa ch us et ts

22

19 21

10 28

e Av ut m aw Sh

St uth mo Dart

St

way Fen

12

Westla nd Av e

g way S t

n to ng hi as W

Blo ss o

St

m

Unio Mald n Park St en S t St ny ba l A

St

Cou rt St

St on rd

Sch ool

W4 th S t

Travele r St

Kne elan dS t

Ave de Lafa yett e

16

Essex St

ha

23

C New

Merr ima c St

St ay ew us Ca

St con Bea

7

Heral d St

3

Boylston St

EB erk ele y

Park Plz

Lom asn

Cambridge St

on St Mt Vern St tnut Ches

11

Nash

29

Pinckney St

4

20

Rd

t nS lsto Boy ve es A am St J St art Stu

St

Ru gg les

n St lsto Boy

15

Park Dr

Dr ow Sorr St con Bea St gh rou rlbo Ma ve hA ealt onw m Com St ury b w Ne

Av e

2 Mi les O ut

Hu nt in gt on

Longfellow Bridge

Av e

Co lu m bu s

Sorro w Dr

Riv er Da m

Tre mo nt S t

Tr em on tS t Harri son Ave

No

Cr os sS t

Com me rcia lS t

Jo hn F

St lin nk Fra

18

St State

rt

h

Ch ar les

Dorchester Ave

E n to ew N

E

Pa rke rS t

on Dalt

Hem en

W am dh De

Av e

St don ren Cla

St Ha rr is on

t ter S Exe

am th al W

W

A

Linco ln S t

Ha no ve rS t

St

Bro ad S t

13 17

7t h

St

Su mm er St

t eS e as v rch ic A Pu lant At

St re et

Ave etts hus sac Mas

St eley Berk W

5

Co ng re ss St

Marginal Rd

Br oa dw ay

S

St don ren Cla St ree t

St eley Berk A

t nS gto Arlin By pa ss

St rles Cha Bo st on

nut Wal W

1s tS t

1

Se ap or tB lvd

Se rvic eR d

Joy St W

Charles St

Po rte rS t

Ch els ea St

9

To ma ha wk Dr

8

2

27

St

24

No rth ern

M as Su sp m or t H a m er St Drydock Ave

Co ng res s

25

E Broadway

E 1st St

Convention Center

Headquarter Hotel

Hotel

Massport Haul Rd

Farragut Rd

William J Day Blvd

Boston Convention and Exhibition Center 415 Summer St, Boston, MA 02210

1 Mile O ut

BS t

St

Bowdoin St W ay

ay W ey St ress Cong Pa pp as

St Rd

 ua St arl Pe

ul

St ton ing ash NW e Rd urfac rald S zge Fit

Ha rb or St

Atlantic Ave St re et

Meridian St

e Av

D

tel Driv e Ho

L Street

y lon Co Old

d or nc Co

e Av

St

St

Charlesgate

St yth Fors

13

14


Visit Booth

#483

MORE OPTIONS

ZERO CO-PAY*

SIMPLE ! ITâ&#x20AC;&#x2122;S THAT


Give Your Topiramate Patients MORE with Qudexy® XR!

Qudexy® XR1

Topamax®

(topiramate) Tablets2

100% Extended-Release Bead Formulation FDA-Approved Sprinkle Administration Option in All Strengths $0 Co-Pay Offer* 5 Dosage Strengths, Including 150 mg

NEW INDICATION Coming Soon! *Eligible Patients Pay $0. Covers $200/Prescription, Maximum Annual Savings of $2,400. Medicare, Medicaid, and other federal and state health care program patients are not eligible.

Visit us at hcp.QudexyXR.com Qudexy is a registered trademark of Upsher-Smith Laboratories, Inc. All other marks are property of their respective owners. References: 1. Qudexy XR [package insert]. Maple Grove, MN: Upsher-Smith Laboratories, Inc.; May 2016. 2. Topamax Tablets [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; December 2014. © 2017 Upsher-Smith Laboratories, Inc., 6701 Evenstad Drive, Maple Grove, MN 55369 112136.01


Experiential Learning Areas  Sat  Sun  Mon  Tue  Wed  Thu

 Fri

We’re taking learning outside the traditional classroom with these interactive areas. Happening each day during the meeting, these areas offer new ways of learning that will engage you intellectually, emotionally, and socially, and offer you fresh ideas to help you personally and professionally.

1 Education and Publication Station: Knowledge Is Power

2 HeadTalks Engage in creative and provocative presentations on some of the timeliest topics in neurology.

Explore the AAN’s host of top-quality e-learning and publications.

3 Research Corner: Moving Neurology Forward Discover new and valuable resources to help you move your research forward.

EAST REGISTRATION

SOUTH WEST LOBBY

4 Advocacy to Action: Empowering Patients and Physicians

NORTH WEST LOBBY

1

2

MAIN ENTRANCE LOBBY

BCEC Meeting Level 1

SOUTH EAST LOBBY

SOUTH WEST LOBBY

NORTH EAST LOBBY

6

NORTH WEST LOBBY

3

4

5

Learn how you can get involved and make your voice heard for you and your patients.

5 Maximize Your Value: Improve Your Neurology Practice Discover the best business practices for neurology to help you grow and sustain your practice.

6 Navigating Your Career: Choose a Track, Stay on Track, Change Tracks Find useful advice for every stage of your career development.

BCEC Meeting Level 2

SOUTH EAST LOBBY

7

NORTH EAST LOBBY

7 Live Well: Taking Care of Your Patients Starts with Taking Care of You Get inspired about the importance of taking care of your mental and physical health.

Visit AAN.com/view/ela for the most up-to-date topics and speakers


Boston Convention and Exhibition Center: Exhibition Level (Level 0)

Boston Convention and Exhibition Center: Meeting Level 2 (level 2)

 2 X Advocacy to Action

30

 3 Closing Party  4 Coat Check

Up

Up

 5 Curbside Consults: Academic

Up

210B

210A

Southwest Lobby

Up

209

208

Down

207 206B 206A

205C

205B

205A

204B 204A 203

Northwest Lobby

201

Exhibit Hall BC

8

Exhibit Hall A

Down Up

20 19

21

 9 Faculty and Trainee Reception

Up

Down Up

Southeast Lobby

11 X Live Well 052A 052B

23

051

050 Up

1

13 Meal Distribution

24

29

Open to Below

Open to Below

10 X HeadTalks 4

Up

261

260

17

22

Down

Northeast Lobby 259B 259A

258C

258B

258A

257B 257A 256

255 254B 254A

253C

253B

253A

252B 252A 251

Down

Down

11

Shuttle Service Pick-up

14 Meeting Administration

Boston Convention and Exhibition Center/Westin Skyway Connector

15 Meeting Information

Boston Convention and Exhibition Center: Meeting Level 1 (Level 1)

18 X Navigating Your Career 19 Neurobowl®

210C

Up

 8 Exhibit Hall

17 Mothers/Family Room

211

202

 7 X Education and Publications Station

16 Mobile App Help Desk

212

13

 6 Curbside Consults: Clinical

12 X Maximize Your Value

Down

Down

213

METI

 1 AAN Welcome Desk

METI

Meeting Space Floor Plans

Southwest Lobby

Northwest Lobby

Southwest Lobby

Northwest Lobby

7

109B 109A 108 107C 107B 107A 106

20 Plenary Sessions

10

Up Up Down

28 105

104C 104B 104A 103 102B 102A

Boston Convention and Exhibition Center: Ballroom Level (Level 3)

101

Up Up Down

Down

Down

 21 Poster Sessions  22 Prayer room Down

 23 Press Room  24 Registration

25 Open to Below

Open to Below

Open to Below

West

Up

14 16 15

North Lobby

North Lobby

Grand Ballroom

9

East

3

2 12 Down

25 X Research Corner

Up

DN

 26 Section Meetings

DN

 27 Skills Workshops (Westin Locations) 28 Speaker Ready 29 Transportation Desk 30 Quiet Zone

Up Down

162B 162A 161 160C 160B 160A 159

6 158

Southeast Lobby

Southeast Lobby

157C 157B 157A 156C 156B 156A

5

Up Down

155 Northeast Lobby

154 153C 153B 152A 152 151B 151B

18

Northeast Lobby

150

Down

Down


Meeting Space Floor Plans

Annual Meeting Shuttle Schedule Westin: Concourse Level

Westin: Concourse Level

Date

Time

Every 30 mins

11:30 a.m.–7:30 p.m.

Every 10–15 mins

6:00 a.m.–10:00 a.m.

Every 10–15 mins

10:00 a.m.–4:00 p.m.

Every 30 mins

Galleria

4:00 p.m. – 10:30 p.m.

Every 10–15 mins

26

6:00 a.m.–10:00 a.m.

Every 10–15 mins

10:00 a.m.–4:00 p.m.

Every 30 mins

4:00 p.m.–7:30 p.m.

Every 10–15 mins

6:00 a.m.–10:00 a.m.

Every 10–15 mins

10:00 a.m.–4:00 p.m.

Every 30 mins

4:00 p.m.–7:30 p.m.

Every 10–15 mins

6:00 a.m.–10:00 a.m.

Every 10–15 mins

10:00 a.m.–4:00 p.m.

Every 30 mins

4:00 p.m.–7:30 p.m.

Every 10–15 mins

6:00 a.m.–10:00 a.m.

Every 10–15 mins

10:00 a.m.–4:00 p.m.

Every 30 mins

4:00 p.m.–7:30 p.m.

Every 10–15 mins

6:00 a.m.–10:00 a.m.

Every 10–15 mins

10:00 a.m.–7:30 p.m.

Every 30 mins

Saturday, April 22 E

Grand Ballroom A

B

C D

27

B

C

A

Sunday, April 23

Commonwealth Commonwealth Ballroom Ballroom

Pavilion

1

Elm 2

Commonwealth Foyer

Grand Ballroom Foyer

Monday, April 24 Tuesday, April 25

Westin: Lobby Level

Webster

Otis

Stone

Quincy

Wednesday, April 26 Hancock

Paine

Revere

Frequency

6:30 a.m.–11:30 a.m.

Thursday, April 27

Lobby

Friday, April 28

Front Desk

General/ Accessible Shuttle Information If you require a wheelchair accessible shuttle, please call (617) 954-2119 24-hours in advance to schedule a ride. All requests made within 24 hours will be assisted on a first call, first served basis.

Marina Prefunction

All buses departing the BCEC will leave from the East Exhibit Level vestibules.

Marina Ballroom

Sauciety

IV

III

II

I

Boston Convention and Exhibition Center/Westin Skyway Connector

Westin: Conference Level

Westin: Mezzanine Level

Harbor Terrace Independence

Frost Adams Alcott

Burroughs

Bulfinch

27

Executive

Hale Boardroom

Lewis

Hotels

Pick-up Locations

Route 1

Embassy Suites Boston Logan Airport, Hilton Boston Logan Airport

Pick-up is at each hotel

Route 2

InterContinental, Langham, Hyatt Regency Boston Downtown, Hilton Boston Downtown

Pick-up is at each hotel

Route 3

Wyndham Boston Beacon Hill, Liberty Hotel, Marriott Long Wharf, Omni Parker House

Pick-up is at each hotel, except the Wyndham. Guests at the Wyndham should walk to the Liberty Hotel

Route 4

Sheraton Boston Hotel, Hilton Boston Back Bay, Marriott Copley Place, Colonnade Hotel, Midtown Hotel, Fairmont Copley Plaza, Westin Copley Place, Lenox Hotel

Pick-up is at the Hynes Convention Center (900 Boylston Street) for all hotels

Route 5

Hotel Commonwealth

Pick-up is at hotel

Route 6

Boston Courtyard Downtown, Boston Park Plaza, Doubletree Boston Downtown, Four Seasons

Pick-up is at each hotel, except the Doubletree. Guests at the Doubletree should walk to the Courtyard

Harbor Prefunction

Douglass Faneuil Faneuil

Griffin

Carlton

Route

Harbor Ballroom III

II

I

WiFi on bus sponsored by:


There’s an important question being asked at the 2017 AAN Annual Meeting

UNCOVERING THE UNMET NEEDS IN MULTIPLE SCLEROSIS Celgene invites you to share your thoughts about the unmet needs in the treatment of MS at BOOTH #779.

To participate: STOP by the Celgene booth • SCAN your badge • SUBMIT a word or phrase that best states a current unmet need in MS •

In addition to an initial $10,000 donation, for every visitor who contributes an unmet need to the discussion, Celgene will donate to the Multiple Sclerosis Association of America (MSAA).

Your voice matters. Come tell us WHAT’S MS’ing. © 2017 Celgene Corporation All rights reserved. 04/17 USII-CELG170019


Meeting-at-a-Glance

Sun April 23

8:00 a.m.– 10:00 a.m.

8:00 a.m.– 12:00 p.m.

8:00 a.m.– 5:00 p.m.

10:00 a.m. 11:00 a.m. 12:00 p.m. 1:00 p.m. 2:00 p.m.

5:00 p.m. 6:00 p.m. 7:00 p.m. 8:00 p.m.

Presidential Plenary Session

Contemporary Clinical Issues Plenary Session

7:00 a.m.–9:00 a.m.

10:30 a.m.– 12:30 p.m.

Education and Science

Education Education & Science & Science 1:00 p.m.– 3:00 p.m.

1:00 p.m.– 5:00 p.m.

Education & Science 2:00 p.m.– 4:00 p.m.

AAN Business Meeting 4:00 p.m.–4:30 p.m.

1:00 p.m.– 3:00 p.m.

Education and Science

9:15 a.m.–11:30 a.m.

3:30 p.m.–5:30 p.m.

Education and Science

1:00 p.m.–3:00 p.m.

Education and Science

3:30 p.m.–5:30 p.m.

Hot Topics Plenary Session 5:00 p.m.–6:30 p.m.

Opening Party

6:00 p.m.–10:00 p.m.

Industry Therapeutic Updates 7:00 p. m.–10:00 p.m.

6:00 p.m.–8:00 p.m.

Neurobowl®

8:30 p.m.–9:15 p.m.

Trinity Irish Dance Company

9:15 p.m.–10:00 p.m.

9:00 p.m. 10:00 p.m.

17AM M@Gspread v912.indd 17

20

7:00 a.m.–9:00 a.m.

9:15 a.m.–12:00 p.m.

Education & Science

3:00 p.m. 4:00 p.m.

Education and Science

Poster Session II 8:30 a.m.–7:00 p.m.

9:00 a.m.

Education Education Education & Science & Science & Science

Education and Science

Poster Session I 8:30 a.m.–5:30 p.m.

8:00 a.m.

Mon April 24

Exhibit Hall 11:30 a.m.–6:00 p.m.

7:00 a.m.

Exhibit Hall 11:30 a.m.–4:00 p.m.

6:00 a.m.

Sat April 22

2017 AAN Annual Meeting On-site Guide

DJ, Music, and Dancing

Faculty and Trainee Reception 6:00 p.m.– 9:00 p.m.

Education and Science 6:00 p.m.– 9:00 p.m.


Tue April 25

Wed April 26

Thur April 27 Fri April 28

Run/Walk for Brain Research Education 6:30 a.m.–8:30 a.m. and Science

Education and Science

Education and Science

Education and Science

Clinical Trials Plenary Session

Frontiers in Neuroscience Plenary Session

Controversies in Neurology Plenary Session

Neurology Year in Review Plenary Session

Education and Science

3:30 p.m.–5:30 p.m.

Education and Science

3:30 p.m.–5:30 p.m.

Education and Science 1:00 p.m.– 3:00 p.m.

Education and Science

3:30 p.m.– 5:30 p.m.

9:15 a.m.–11:30 a.m.

Education and Science 1:00 p.m.– 3:00 p.m.

Poster Session VI 8:30 a.m.–5:30 p.m.

1:00 p.m.– 3:00 p.m.

7:00 a.m.–9:00 a.m.

9:15 a.m.–11:30 a.m.

Poster Session IV 8:30 a.m.–7:00 p.m.

Education and Science

Exhibit Hall 11:30 a.m.–3:00 p.m.

1:00 p.m.–3:00 p.m.

Poster Session III 8:30 a.m.–7:00 p.m.

Education and Science

7:00 a.m.–9:00 a.m.

9:15 a.m.–11:30 a.m.

Exhibit Hall 11:30 a.m.–4:00 p.m.

9:15 a.m.–11:30 a.m.

7:00 a.m.–9:00 a.m.

Poster Session V 8:30 a.m.–7:00 p.m.

7:00 a.m.–9:00 a.m.

Education and Science

3:30 p.m.– 5:30 p.m.

Closing Party Happy Hour

5:30 p.m.–7:00 p.m.

Industry Therapeutic Updates

7:00 p.m.–10:00 p.m.

Commitment Industry to Cures Therapeutic 7:00 p.m.– Updates

9:30 p.m.

7:00 p.m.– 10:00 p.m.

2/20/17 8:57



21


COMMITTED TO MAKING A DIFFERENCE IN MS Please join us for the Industry Therapeutic Update (ITU) from Sanofi Genzyme: UNDERSTANDING FUNCTIONAL IMPROVEMENT IN THE RMS PATIENT

Is There Evidence of Neuropreservation and Repair? WEDNESDAY, APRIL 26, 2017 Buffet Dinner from 7:00–7:30 pm Presentation from 7:30–9:30 pm Westin Waterfront Hotel Ballroom This is not an AAN-endorsed event, nor will any CME be given.


Patient Portrayal

Visit Booth 523 and Meeting Suite MS1 in the exhibit hall to learn more about our commitment to MS.

©2017 Genzyme Corporation. All rights reserved. Sanofi and Genzyme registered in U.S. Patent and Trademark Office SAUS.MS.17.02.0403 Last Updated 03/17


Hours of Operation Important Phone Number Meeting Information ��������������������������������������������������������������������������������������������(617) 954-3418 Meeting Administration������������������������������������������������������������North Lobby Saturday, April 22–Friday, April 28

6:30 a.m.–5:30 p.m.

AAN.com Booth���������������������������������������������������������������������������North Lobby Saturday, April 22–Friday, April 28

7:00 a.m.–5:30 p.m.

American Brain Foundation Donor Booth ����������������������������North Lobby Saturday, April 22–Friday, April 28

7:00 a.m.–5:30 p.m.

Career Center�������������������������������������������������������������������������������North Lobby Saturday, April 22–Friday, April 28

7:00 a.m.–5:30 p.m.

Exhibit Hall ����������������������������������������������������������������������������� Exhibit Hall BC Sunday, April 23 Monday, April 24 Tuesday, April 25 Wednesday, April 26

11:30 a.m.–4:00 p.m. 11:30 a.m.–6:00 p.m. 11:30 a.m.–4:00 p.m. 11:30 a.m.–3:00 p.m.

X Experiential Learning Areas

Saturday, April 22–Friday, April 28 7:00 a.m.–5:30 p.m. Get ready to experience these interactive, and totally flexible, new ways of exploring, engaging, and learning. Happening every day, between 7:00 a.m. and 5:30 p.m., these experiential learning areas offer a variety of real-world experiences that will engage you intellectually, emotionally, and socially and offer you fresh ideas to help you personally and professionally. Advocacy to Action: Empowering Patients and Physicians Education and Publications Station: Knowledge is Power

Northwest Lobby-Level 1

HeadTalks

Northwest Lobby-Level 1

Live Well: Taking Care of Your Patients Starts with Taking Care of You

Southeast Lobby-Level 2

Maximize Your Value: Improve Your Neurology Practice Navigating Your Career: Choose a Track Stay on Track, Change Tracks Research Corner: Moving Neurology Forward

24

North Lobby

2017 AAN Annual Meeting On-site Guide

North Lobby Northeast Lobby-Level 1 North Lobby


Meeting Information�������������������������������������������������������������������North Lobby Saturday, April 22–Friday, April 28

6:30 a.m.–5:30 p.m.

Membership ����������������������������������������������������������������������� East Registration Saturday, April 22–Friday, April 28

6:30 a.m.–5:30 p.m.

Mobile App Support �������������������������������������������������������������������North Lobby Saturday, April 22–Friday, April 28

6:30 a.m.–5:30 p.m.

Press Room������������������������������������������������������������������������������������������������052A Saturday, April 22 Sunday, April 23–Thursday, April 27 Friday, April 28

7:00 a.m.–6:00 p.m. 7:00 a.m.–5:30 p.m. 7:00 a.m.–1:00 p.m.

Registration������������������������������������������������������������������������� East Registration Friday, April 21 Saturday, April 22–Friday, April 28

3:00 p.m.–7:00 p.m. 6:30 a.m.–5:30 p.m.

Speaker Ready Room����������������������������������������������������������������������������������105 Saturday, April 22–Friday, April 28

6:30 a.m.–5:30 p.m.


Page Heads

TR A NSFOR M THE TR E ATM ENT OF PARKINSON’S DISEASE PSYCHOSIS NUPLAZID® (pimavanserin) IS THE FIRST AND ONLY FDA-approved therapy proven to reduce the symptoms of hallucinations and delusions without impacting motor function1

Change your outlook on Parkinson’s disease psychosis. In vitro, NUPLAZID targets 5-HT2A and 5-HT2C receptors while demonstrating no appreciable binding affinity for dopamine, histamine, muscarinic, or adrenergic receptors. With a proven safety profile and no impact on motor function, once-daily NUPLAZID 34 mg can be prescribed with confidence.1

Visit booth #489 to experience the transformation with the Oculus virtual reality headset.

Indication

NUPLAZID is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.

Important Safety Information for NUPLAZID (pimavanserin) 17-mg Tablets

prolongation or in combination with other drugs known to prolong QT interval including Class 1A antiarrhythmics or Class 3 antiarrhythmics, certain antipsychotic medications, and certain antibiotics. NUPLAZID should also be avoided in patients with a history of cardiac arrhythmias, as well as other circumstances that may increase the risk of the occurrence of torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and presence of congenital prolongation of the QT interval.

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIARELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. NUPLAZID is not approved for the treatment of patients with dementia-related psychosis unrelated Adverse Reactions: The most common to the hallucinations and delusions associated adverse reactions (≥2% for NUPLAZID and greater than placebo) were peripheral edema with Parkinson’s disease psychosis. (7% vs 2%), nausea (7% vs 4%), confusional state (6% vs 3%), hallucination (5% vs 3%), QT Interval Prolongation: NUPLAZID prolongs the QT interval. The use of NUPLAZID should be constipation (4% vs 3%), and gait disturbance (2% vs <1%). avoided in patients with known QT

26

2017 AAN Annual Meeting On-site Guide


Drug Interactions: Strong CYP3A4 inhibitors (eg, ketoconazole) increase NUPLAZID concentrations. Reduce the NUPLAZID dose by one-half. Strong CYP3A4 inducers may reduce NUPLAZID exposure, monitor for reduced efficacy. Increase in NUPLAZID dosage may be needed. Renal Impairment: No dosage adjustment for NUPLAZID is needed in patients with mild to moderate renal impairment. Use of NUPLAZID is not recommended in patients with severe renal impairment. Hepatic Impairment: Use of NUPLAZID is not recommended in patients with hepatic impairment. NUPLAZID has not been evaluated in this patient population. Pregnancy: Use of NUPLAZID in pregnant women has not been evaluated and should

therefore be used in pregnancy only if the potential benefit justifies the potential risk to the mother and fetus. Pediatric Use: Safety and efficacy have not been established in pediatric patients.

Dosage and Administration

Recommended dose: 34 mg per day, taken orally as two 17-mg tablets once daily, without titration. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You can also call ACADIA Pharmaceuticals Inc. at 1-844-4ACADIA (1-844-422-2342). See Brief Summary of Prescribing Information on adjacent pages.

Reference: 1. NUPLAZIDŽ (pimavanserin) prescribing information, ACADIA. Š2017 ACADIA Pharmaceuticals Inc. All rights reserved. NU-0585 03/17.


NUPLAZID™ (pimavanserin) tablets, for oral use. Rx only Brief Summary: This information is not comprehensive. Visit www.NUPLAZID.com to obtain the FDA-approved product labeling or call 1-844-422-2342. WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. NUPLAZID is not approved for the treatment of patients with dementiarelated psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis. 1 INDICATIONS AND USAGE NUPLAZID™ is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. 2 DOSAGE AND ADMINISTRATION The recommended dose of NUPLAZID is 34 mg, taken orally as two 17-mg strength tablets once daily, without titration. • Coadministration with Strong CYP3A4 Inhibitors The recommended dose of NUPLAZID when coadministered with strong CYP3A4 inhibitors (e.g., ketoconazole) is 17 mg, taken orally as one tablet once daily. • Coadministration with Strong CYP3A4 Inducers Monitor patients for reduced efficacy if NUPLAZID is used concomitantly with strong CYP3A4 inducers; an increase in NUPLAZID dosage may be needed. 4 CONTRAINDICATIONS None. 5 WARNINGS AND PRECAUTIONS Increased Mortality in Elderly Patients with Dementia- Related Psychosis Antipsychotic drugs increase the all-cause risk of death in elderly patients with dementia-related psychosis. Analyses of 17 dementia-related psychosis placebo-controlled trials (modal duration of 10 weeks and largely in patients taking atypical antipsychotic drugs) revealed a risk of death in the drug-treated patients of between 1.6- to 1.7-times that in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in placebo-treated patients. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. NUPLAZID is not approved for the

treatment of patients with dementia related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis. QT Interval Prolongation NUPLAZID prolongs the QT interval. The use of NUPLAZID should be avoided in patients with known QT prolongation or in combination with other drugs known to prolong QT interval including Class 1A antiarrhythmics (e.g., quinidine, procainamide) or Class 3 antiarrhythmics (e.g., amiodarone, sotalol), certain antipsychotic medications (e.g., ziprasidone, chlorpromazine, thioridazine), and certain antibiotics (e.g., gatifloxacin, moxifloxacin). NUPLAZID should also be avoided in patients with a history of cardiac arrhythmias, as well as other circumstances that may increase the risk of the occurrence of torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and the presence of congenital prolongation of the QT interval. 6 ADVERSE REACTIONS The following serious adverse reactions are discussed elsewhere in the labeling: • Increased Mortality in Elderly Patients with Dementia-Related Psychosis • QT Interval Prolongation Clinical Trial Experience The clinical trial database for NUPLAZID consists of over 1200 subjects and patients exposed to one or more doses of NUPLAZID. Adverse reactions that occurred in 6-week, placebo-controlled studies and that were reported at an incidence of ≥2%, and >placebo are presented in the following table. Adverse Reactions (≥2% and >Placebo) NUPLAZID 34 mg

Placebo

N = 202

N = 231

Nausea

7%

4%

Peripheral edema

7%

2%

Confusional state

6%

3%

Hallucination

5%

3%

Constipation

4%

3%

Gait disturbance

2%

<1%

Preferred Term

Hallucination includes visual, auditory, tactile, and somatic hallucinations

a

7 DRUG INTERACTIONS QT Interval Prolongation Concomitant use of drugs that prolong the QT interval may add to the QT effects of


NUPLAZID and increase the risk of cardiac arrhythmia. Avoid the use of NUPLAZID in combination with other drugs known to prolong QT interval. Strong CYP3A4 Inhibitors Concomitant use of NUPLAZID with a strong CYP3A4 inhibitor increases pimavanserin exposure. If NUPLAZID is used with a strong CYP3A4 inhibitor, reduce the dosage of NUPLAZID. Strong CYP3A4 Inducers Concomitant use of a strong CYP3A4 inducer may reduce pimavanserin exposure resulting in a potential decrease in efficacy. Patients should be monitored for reduced efficacy and an increase in dosage may be needed if NUPLAZID is used concomitantly with strong CYP3A4 inducers. 8 USE IN SPECIFIC POPULATIONS Pregnancy: There are no data on NUPLAZID use in pregnant women that would allow assessment of the drug-associated risk of major congenital malformations or miscarriage. In animal reproduction studies, no adverse developmental effects were seen when pimavanserin was administered orally to rats or rabbits during the period of organogenesis at doses up to 10- or 12-times the maximum recommended human dose (MRHD) of 34 mg/day, respectively. Administration of pimavanserin to pregnant rats during pregnancy and lactation resulted in maternal toxicity and lower pup survival and body weight at doses which are 2-times the MRHD of 34 mg/day. Lactation: There is no information regarding the presence of pimavanserin in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for NUPLAZID and any potential adverse effects on the breastfed infant from NUPLAZID or from the underlying maternal condition. Pediatric Use Safety and effectiveness of NUPLAZID have not been established in pediatric patients. Geriatric Use No dose adjustment is required for elderly patients. Parkinson’s disease is a disorder occurring primarily in individuals over 55 years of age. The mean age of patients enrolled in the 6-week clinical studies with NUPLAZID was 71 years, with 49% 65-75 years old and 31% >75 years old. In the pooled population of patients enrolled in 6-week, placebocontrolled studies (N=614), 27% had MMSE scores from 21 to 24 compared to 73% with scores ≥25. No clinically meaningful differences in safety or effectiveness were noted between these two groups. Renal Impairment No dosage adjustment for NUPLAZID is

needed in patients with mild to moderate (CrCL ≥30 mL/min, Cockcroft-Gault) renal impairment. Use of NUPLAZID is not recommended in patients with severe renal impairment (CrCL <30 mL/min, CockcroftGault). NUPLAZID has not been evaluated in this patient population. Hepatic Impairment Use of NUPLAZID is not recommended in patients with hepatic impairment. NUPLAZID has not been evaluated in this patient population. 9 DRUG ABUSE AND DEPENDENCE Controlled Substance NUPLAZID is not a controlled substance. Abuse NUPLAZID has not been systematically studied in humans for its potential for abuse, tolerance, or physical dependence. While short-term, placebo-controlled and long-term, open-label clinical trials did not reveal increases in drug-seeking behavior, the limited experience from the clinical trials do not predict the extent to which a CNS-active drug will be misused, diverted, and/or abused once marketed. 10 OVERDOSAGE Human Experience The pre-marketing clinical trials involving NUPLAZID in approximately 1200 subjects and patients do not provide information regarding symptoms with overdose. In healthy subject studies, dose limiting nausea and vomiting were observed. Management of Overdose There are no known specific antidotes for NUPLAZID. In managing overdose, cardiovascular monitoring should commence immediately and should include continuous ECG monitoring to detect possible arrhythmias. If antiarrhythmic therapy is administered, disopyramide, procainamide, and quinidine should not be used, as they have the potential for QT-prolonging effects that might be additive to those of NUPLAZID. Consider the long plasma half-life of pimavanserin (about 57 hours) and the possibility of multiple drug involvement. 17 PATIENT COUNSELING INFORMATION Concomitant Medication Advise patients to inform their healthcare providers if there are any changes to their current prescription or over-the-counter medications, since there is a potential for drug interactions. CAUTION: Federal law prohibits dispensing without prescription. NUPLAZID™ is a trademark of ACADIA Pharmaceuticals Inc. Distributed by: ACADIA Pharmaceuticals Inc. San Diego, CA 92130 NU-0381 09/16.


Program Schedule

 Sat  Sun  Mon  Tue  Wed  Thu

 Fri

Saturday, April 22 7:00 a.m.–7:45 a.m.

X Live Well: Yoga (All-Levels Vinyasa) 8:00 a.m.–8:45 a.m.

X Navigating Your Career: What I

Learned About Research: An Early Career Perspective

8:00 a.m.–10:00 a.m. C1 C2 C3 C4

The Neurology of Social Behavior Parkinson’s Disease Update Status Epilepticus Multiple Sclerosis Essentials

8:00 a.m.–12:00 p.m. C5

Resident Basic Science I: Neuroanatomy: All the Lesions

8:00 a.m.–5:00 p.m. C6

C7 C8 C9

Early Career Research Training Symposium: A Roadmap to Academic Success for Residents and Fellows (registration required) Neurology MOC Prep Course $ (registration required) L Clerkship and Program Directors Leadership Academy (registration required) L Women in Leadership $ (registration required)

9:00 a.m.–9:30 a.m.

X Navigating Your Career: Mentorship is Only as Good as the Mentee

10:00 a.m.–10:30 a.m.

X Research Corner: Are You My Basic Research Mentor?

10:00 a.m.–10:45 a.m.

X Live Well: Integrating Management of X

Activity and Exercise in Routine Clinical Practice Navigating Your Career: Career Stories: Nuts and Bolts of Academic Leadership: Strategies I Have Learned in My Career

10:30 a.m.–11:00 a.m.

X Maximize Your Value: Patient-reported Outcomes Scales for Headache

10:30 a.m.–12:30 p.m. C10 Making Sure You Get Paid Under the New Health Care Laws

C11 Neuromyelitis Optica Spectrum Disorders

C12 Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia C13 Neurologic Complications of Medical Disease C14 Concussion: From Mechanisms to Management

11:00 a.m.–11:30 a.m.

X Education and Publications X

Station:Annual Meeting App: Getting the Most Out of It Navigating Your Career: Social Media for Clinicians

11:00 a.m.–11:45 a.m.

X Live Well: Antidote to Burnout: Advocacy X Navigating Your Career: How to get an NIH Grant

11:30 a.m.–12:00 p.m.

X Research Corner: Grantwriting 101: Getting Started

12:00 p.m.–12:30 p.m.

X Navigating Your Career: Participating in Advocacy

12:00 p.m.–4:00 p.m.

X Live Well: Free Chair Massages 12:30 p.m.–2:00 p.m.

X HeadTalks: Work Life Balance in Neurology

1:00 p.m.–1:30 p.m.

X Advocacy to Action: Antidote to Burnout: X X

Advocacy Education and Publications Station: Neurology ® Genetics: Chat with the Editor Maximize Your Value: Using Forms and Clinical Decision Support to Integrate Your Guidelines Into Your EHR

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

30

2017 AAN Annual Meeting On-site Guide


Hot Topics Plenary Session Saturday, April 22â&#x20AC;&#x192;

5:00 p.m.â&#x20AC;&#x201C;6:30 p.m.

This session features translational research related to clinical issues of importance. Four outstanding physician-scientists provide summaries of their recent research findings and describe the clinical implications of the results. Moderator Eric Klawiter, MD Member, Science Committee

University of Virginia Charlottesville, VA

Lysosomal Proteins as a Therapeutic Target in Neurodegeneration

The Role of CNSdraining Lymphatics in Neurological Diseases

Claudia A. Chiriboga, MD

O. Carter Snead, III, MD, FAAN

Antisense Oligonucleotide Treatment (ASO) and SMA: Results of Clinical Trials



Jonathan Kipnis, PhD

Northwestern University, Chicago, IL

Columbia University, New York, NY

SATURDAY

Dimitri Krainc, MD, PhD

Hospital for Sick Children, Toronto, ON, Canada Population-based Comprehensive Epilepsy Care in Ontario, Canada: A Model Network

31


Program Schedule

 Sat  Sun  Mon  Tue  Wed  Thu

X Navigating Your Career: The

X HeadTalks: The Role of Medical

X

Encompassing Value of the Patientphysician Relationship Research Corner: Your Grant Proposal Was Rejected: Now What? Turning Feedback into a Successful Project

1:00 p.m.–3:00 p.m.

X Live Well: Mastering the Art of Practice:

Recapturing the Joy of Neurology: Personal and Professional Balance C15 Practical Training in Injection Techniques in the Treatment of Headache Disorders Skills Workshop $ (registration required)

1:00 p.m.–5:00 p.m.

Illustration in Neurology

2:00 p.m.–4:00 p.m.

C17 How Is Your Patient Really Doing? C18 C19

C20 C21

C16 Resident Basic Science II: Neuropathology

1:30 p.m.–2:00 p.m.

X Maximize Your Value: Ask the Expert

X

Curbside Consults: Movement Disorders

2:00 p.m.–2:30 p.m.

X Advocacy to Action: Neurology and the X

115th Congress Maximize Your Value: The AAN’s Effort to Enhance your EHR Experience

2:00 p.m.–2:45 p.m.

X Live Well: Mastering the Art of Practice: X X

C22

Patient-Reported Scales, Tools, and Shared Decision Making Vascular Cognitive Impairment and Dementia: Current Status and Future Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission Neurologic Complications of Medical and Surgical Therapies Concussion: Evaluation and Management in the Acute and Chronic Phases It’s a Bird, It’s a Plane, It’s the Doctor Who Cured My Benign Paroxysmal Positional Vertigo

Booth: Using Forms and Clinical Decision 2:30 p.m.–3:00 p.m. Support to Integrate Your Guidelines into X Maximize Your Value: Ask the Expert: The Your EHR AAN’s Effort to Enhance Your Research Corner: How to Give a Talk EHR Experience at AAN

1:30 p.m.–3:00 p.m.

Recapturing the Joy of Neurology: Your Organization and Health Care Policy Navigating Your Career: Introduction to the Fascinating World of Movement Disorders Navigating Your Career: Getting Published

2:00 p.m.–3:00 p.m.

X Education and Publications Station: Role of CNS-draining Lymphatics in Neurological Diseases

3:00 p.m.–4:00 p.m.

X HeadTalks: Being a Neurologist in the

Digital Age: Managing Your Professional Personal Digital Profile

3:15 p.m.–3:45 p.m.

X Navigating Your Career: Benefits of

a Semiprivate Practice: Interviewing, Contracts, and Compensation

3:30 p.m.–4:00 p.m.

X Maximize Your Value: Show me the

Money: The AAN Helping Get What You Earned

4:00 p.m.–4:30 p.m.

AAN Business Meeting

4:00 p.m.–4:30 p.m.

X Maximize Your Value: Telemedicine Beyond Tele-stroke

4:00 p.m.–5:00 p.m.

X HeadTalks: Ask Me Anything–Neurology®

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

32

 Fri

2017 AAN Annual Meeting On-site Guide


4:30 p.m.–5:00 p.m.

X Maximize Your Value: Ask the Expert

Booth: Telemedicine Beyond Tele-stroke

4:45 p.m.–5:15 p.m.

X Live Well: Guided Meditation

5:00 p.m.–6:30 p.m.

Hot Topics Plenary Session

7:00 p.m.–10:00 p.m.

Industry Therapeutic Updates

Please see page 11 for more details.

Sunday, April 23 7:00 a.m.–7:45 a.m.

X Live Well: Yoga (All-Levels Vinyasa)

8:00 a.m.–8:45 a.m.

X Live Well: Using intergrative Therapies to Manage Headache and wellness.

7:00 a.m.–8:00 a.m.

X HeadTalks: Empower Your Patients: Self- 8:00 a.m.–9:00 a.m. management for Chronic X Education and Publications Station:

7:00 a.m.–9:00 a.m. C23 Using Sleep Medicine to Help Solve C24 C25 C26 C27 C28 C29 C30 C31 C32

Difficult Neurologic Cases Child Neurology: A Case-based Approach Cerebellar and Afferent Ataxias: Diagnosis and Management Clinical EMG I: Principles and Practice of NCS and Needle EMG Differential Diagnosis of Neurologic Infections Advances in Neurogenetics Clinical Epilepsy I: Basics Cerebrovascular Disease I: Prevention Advanced Neurologic Coding Emergency Room Neuro-ophthalmology

7:30 a.m.–8:00 a.m.

X Navigating Your Career: Finding Your

Niche in Neurology: Perspectives from an Epileptologist and Educator

8:00 a.m.–8:30 a.m.

X Navigating Your Career: Subspecialty X



Sessions: Neuroimmunology and Neurological Infections Research Corner: “I Don’t Feel Like a Researcher": How to Make the Career Work Even if You Aren’t the “Typical” Fit

Navigating the Annual Meeting

SATURDAY/SUNDAY

Neurologic Disease

X HeadTalks: Annual Meeting Orientation S1

“Best Of” Session: Parkinson’s Disease

8:15 a.m.–8:45 a.m.

X Navigating Your Career: Transitioning

From a Clinical Research Career to an Educational and Clinical Focused Career

8:30 a.m.–9:00 a.m.

X Maximize Your Value: Patient-reported Outcomes Scales for Neuropsych

X Research Corner: How to Find Training: The Best Clinical Research and Methodology Training Options

8:30 a.m.–5:30 p.m. P1

Poster Session I

Presenters Stand by Posters 4:00 p.m.–5:30 p.m.

9:00 a.m.–9:30 a.m.

X Education and Publications Station: You

Purchased Annual Meeting On-Demand… Now What?

9:15 a.m.–12:00 p.m.

Presidential Plenary Session

10:00 a.m.–10:45 a.m.

X Navigating Your Career: Academic

Career Panel: Find Out How to Get Your Career Started

33


Program Schedule

 Sat  Sun  Mon  Tue  Wed  Thu

11:00 a.m.–11:30 a.m.

12:00 p.m.–1:00 p.m.

X Research Corner: Small Group Mentoring Session: Statistics: Sample Size

11:00 a.m.–11:45 a.m.

X Navigating Your Career: Child Neurology: Staying On Track

11:30 a.m.–12:00 p.m.

         

 Fri

Autoimmune Neurology Section Meeting Epilepsy Section Meeting Geriatric Neurology Section Meeting Neurohospitalist Section Meeting Neurohealth & Integrative Neurology Section Meeting

X Research Corner: Small Group Mentoring 12:00 p.m.–4:00 p.m. Session: Finding/Working with X Live Well: Free Chair Massages Statisticians on Your Grant

11:30 a.m.–4:00 p.m.

Exhibit Hall

11:30 a.m.–1:30 p.m. NEW! Exhibit Hall Opening Luncheon Attend the opening lunch to mingle with fellow attendees and preview the latest products and services available in the neurologic industry. The exhibits will be open at this time. Sponsored by:

12:30 p.m.–1:00 p.m.

X Research Corner: Celebrating 200 Years

of Essay on the Shaking Palsy: Where Do We Go in the Next 200 Years?

1:00 p.m.–1:30 p.m.

X Education and Publications Station: X X X

Fulfill Your MOC Requirements and Lifelong Learning Needs Navigating Your Career: Writing & Reviewing for the R&F Section of Neurology ® Research Corner: Selecting an AAN Research Program Mentor Research Corner: Small Group Mentor Session: Surviving as a Clinician Researcher

1:00 p.m.–1:45 p.m. 12:00 p.m.–12:30 p.m.

X Live Well: Enhanced Well-being through Mentoring: Session I

X Research Corner: Epidemiology: What It 1:00 p.m.–2:00 p.m. Is and How to Get Started X HeadTalks: Patient Engagement: The

12:00 p.m.–12:45 p.m.

X Navigating Your Career: Choosing an Academic Career in Neurology: The General and Foreign Medical Graduates Perspectives

12:00 p.m.–1:00 p.m.

X HeadTalks: From Member to Leader: How to Engage with the AAN

Good, The Bad, Is There Any Ugly?

1:00 p.m.–3:00 p.m. C33 Non-Alzheimer’s Dementia I:

Frontotemporal Dementias and Chronic Traumatic Encephalopathy C34 Introduction to Primary Headache Disorders I: Migraine and Other Primary Headaches Including Tension-type, Hypnic, Primary Stabbing, and Nummular Headache Syndromes

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

34

2017 AAN Annual Meeting On-site Guide


Presidential Plenary Session Sunday, April 23 

9:15 a.m.–12:00 p.m.

This session features the AAN’s premier lecture awards for clinically relevant research and a presentation by a leading lecturer. Top researchers speak on some of the most significant findings in neurology in 2017. Don’t miss the final presentation from AAN President Terrence L. Cascino, MD, FAAN, before he passes the gavel to President Elect Ralph L. Sacco, MD, MS, FAHA, FAAN. Moderator Natalia Sana Rost, MD, FAAN Vice Chair, AAN Science Committee

Sidney Carter Award in Child Neurology Improving Outcomes in Childhood Epilepsy

Terrence L. Cascino, MD, FAAN

J. Helen Cross, PhD

H. Houston Merritt Lecture Ophthalmoscopy in the 21st Century

Robert Wartenberg Lecture How Early Can We Diagnose Alzheimer’s Disease?

Mayo Clinic, Rochester, MN

Nancy J. Newman, MD, FAAN

Emory University School of Medicine, Atlanta, GA



SUNDAY

Presidential Lecture Burnout, Wellness, and the Future of Our Profession

UCL-Institute of Child Health, London, United Kingdom

Ronald C. Petersen, PhD, MD, FAAN

Mayo Clinic, Rochester, MN

35


Program Schedule C35 Deep Brain Stimulation I: Basic C36 C37 C38 C39

C40 C41 C42 C43 C44 C45 N1

S2 S3

Principles and Programming in Movement Disorders Multiple Sclerosis Therapy: Diseasemodifying Treatment I Clinical EMG II: Neuromuscular Junction Testing and Quantitative EMG Case Studies: Neurologic Consultations in Cancer Patients I So You’ve Diagnosed Your Patient with a Neuroinfectious Disease, Now What? Practical Pearls in the Treatment and Management of Neuroinfectious Diseases Neurology Update I: Epilepsy, Headache, and Neurologic Infections Clinical Epilepsy II: Considerations Across the Age Span Pediatrics, Pregnancy, and Elderly Cerebrovascular Disease II: Hemorrhagic Stroke Introduction to Clinical Research and Methods Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies I Navigating the World of Mobile Health Neuroscience in the Clinic: Neurobiology and Treatmentof Disorders of Language and Action Neuroimaging in MS ALS: Disease Mechanism and Therapeutics yy Presentation of the Sheila Essey Award: An Award for ALS Research

S4 S5

Movement Disorders: Beyond Oral Levodopa in Parkinson’s Disease General Neurology: Pathogenesis, Modulation, and Biomarkers of Complex Neurological Disorders

1:00 p.m.–5:00 p.m. C46 Resident Basic Science III:

Neuropharmacology C47 L Gender Issues in Leadership C48 L Leadership Challenges in Practice

 Sat  Sun  Mon  Tue  Wed  Thu

 Fri

1:00 p.m.–5:30 p.m. C49 Clinical Uses of Botulinum Toxin

for Dystonia Skills Workshop $ (registration required) C50 Neuro-ophthalmology and Neurovestibular Exam Lab Skills Workshop $ (registration required)

1:15 p.m.–1:45 p.m.

X Navigating Your Career: Foreign Medical Graduates Adjustment Skills

1:30 p.m.–2:00 p.m.

X Maximize Your Value: Top 3 Patient Reported Outcomes Tools

X Research Corner: AAN Research Program Alumni Discussion

X Research Corner: Small Group Mentoring Session: Working with an Epidemiologist

1:30 p.m.–3:00 p.m.

Curbside Consults: Neuro-oncology

2:00 p.m.–2:30 p.m.

X Advocacy to Action: AAN Federal Advocacy

X Education and Publications Station: X X X

Extending Your Annual Meeting CME Year Round Navigating Your Career: Subspecialty Sessions: IOM and cEEG—Session 1 Research Corner: Clinical Trials Methodology Course—Information Session Research Corner: Small Group Mentoring Session: Defining and Managing Your Message as an Early Career Scientist

2:00 p.m.–2:45 p.m.

X Live Well: How Social Relationships

Contribute to Healthy Cognitive Aging

X Navigating Your Career: Measuring Success: Quality Improvement 101

2:00 p.m.–3:00 p.m.

X HeadTalks: Stories of Boston Neurology 2:30 p.m.–3:00 p.m.

X Education and Publications Station: How to Get the Most of the Annual Meeting Science Program

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

36

2017 AAN Annual Meeting On-site Guide


OPENING PARTY Sunday, April 23 • 6:00 p.m.–10:00 p.m.

Kick Off the Annual Meeting Everyone’s Talking About with the Party Everyone Will Be Talking About Neurobowl® 6:00 p.m.–8:00 p.m. This popular event, hosted by AAN former president Thomas R. Swift, MD, FAAN, is one of the Annual Meeting’s premier happenings. Neurobowl showcases the best and brightest in neurology competing for the coveted Neurobowl trophy in an entertaining game-show format.

Trinity Irish Dance Company 8:30 p.m.–9:15 p.m. Billed as “everything you expect but nothing you imagine,” Trinity Irish Dance Company quickly dispels whatever notions you may have about Irish dance. The company dazzles audiences with hard-driving percussive power, lightning-fast agility, aerial grace, and the awe-inspiring precision of its dancers that led them to win an unprecedented 17 World Championships for the US and appearances in feature films by Disney, DreamWorks, Touchstone, and Universal and on the Tonight Show.

Live DJ and Dancing 9:15 p.m.–10:00 p.m. Get down with friends and colleagues to some of the most memorable dance tunes spanning the past six decades.

AAN.com/view/AM17


Program Schedule X Research Corner: Nuts and Bolts of AAN

Research Program: Explanations of How Much Funding Is Available and What Kind of Research Is Accepted

3:00 p.m.–3:30 p.m.

X Advocacy to Action: How to: Obtain a Grant

X Maximize Your Value: Data You Need to X

Improve Care Navigating Your Career: Being a Great Chief Resident

3:00 p.m.–3:45 p.m.

X Live Well: Mind over Matter: Meditation for the Practicing Neurologist

 Sat  Sun  Mon  Tue  Wed  Thu C55 Clinical EMG III: Nerve Conduction C56 C57 C58 C59 C60 C61

X Navigating Your Career: Teleneurology: Is this for Me? Pre-hospital and Nontraditional Uses of Teleneurology

N2

3:00 p.m.–4:00 p.m.

X Education and Publications Station: X X

Sleep and the Practicing Neurologist: Mechanisms and Management HeadTalks: Ask us Anything: Expert Panel on Stroke Research Corner: Transitioning from an AAN Research Program Grant to NIH Funding

3:30 p.m.–4:00 p.m.

S6 S7

3:30 p.m.–5:30 p.m. C51 Non-Alzheimer’s Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias C52 Introduction to Primary Headache Disorders II: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Primary Thunderclap Headaches C53 Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders C54 Multiple Sclerosis Therapy: Diseasemodifying Treatment II

Criteria and Electrodiagnostic Approaches Case Studies: Neurologic Consultations in Cancer Patients II Neurology Update II: Movement, Spine, and Autonomic Neurology Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) Cerebrovascular Disease III: Acute Ischemic Stroke Precision Neurology: The Promise and Perils of Personalized Medicine in the Genomic Era Genomic Neurology Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies II Neuroscience in the Clinic: Child Neurology: Neurologic Disorder Through a Lifespan–A Focus on MS Research Methodology and Education: Education Research Aging and Dementia: Clinical and Translational Studies in Neurodegenerative Diseases yy Presentation of the Potamkin Prize for Research in Pick’s, Alzheimer’s, and Related Diseases

S8

X Maximize Your Value: Ask the Expert Booth: Data You Need to Improve Your Care

S9

Cerebrovascular Disease and Interventional Neurology: Acute Stroke Treatment Neuro Trauma and Sports Neurology

3:45 p.m.–4:15 p.m.

X Navigating Your Career: So You Want to Be a Residency Program Director?

4:00 p.m.–4:30 p.m.

X Maximize Your Value: Patient Reported Outcomes Scales for Dementia

X Research Corner: Writing a Great AAN Research Program Proposal

4:00 p.m.–5:00 p.m.

X Education and Publications Station: Navigating the Annual Meeting

X HeadTalks: Caring for Your Neurologic Patient for $500 or Less

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

38

2017 AAN Annual Meeting On-site Guide

 Fri


4:15 p.m.–5:00 p.m.

X Navigating Your Career: Fellowship Panel 4:30 p.m.–5:00 p.m.

X Research Corner: Congratulations! Your Research Training Application Was Accepted! Now Make the Most of It!

4:45 p.m.–5:15 p.m.

X Live Well: Guided Meditation 5:00 p.m.–5:30 p.m.

X Research Corner: Current Research

Program Recipients Panel Discussion

5:00 p.m.–6:00 p.m.   Business Administration Section Meeting   Neurogenetics Section Meeting   Stroke & Vascular Neurology Section Meeting

6:00 p.m.–10:00 p.m.

Opening Party Neurobowl

6:00 p.m.–8:00 p.m.

Trinity Irish Dance Company 8:30 p.m.–9:15 p.m.

DJ Music and Dancing 9:15 p.m.–10:00 p.m.

7:00 a.m.–7:45 a.m.

X Live Well: Yoga (All-Levels Vinyasa) 7:00 a.m.–8:00 a.m.

X HeadTalks: Burnout in an Academic General Neurology Group

7:00 a.m.–8:00 a.m.   Neuromuscular Section Meeting

C72 Gender-specific Care for Neurological Disorders

C73 Current Management of Incidental and

Asymptomatic Cerebrovascular Lesions

C74 Annual A.B. Baker Program: Focus on Professionalism

7:30 a.m.–8:00 a.m.

X Navigating Your Career: Sleep Health

7:00 a.m.–9:00 a.m. C62 Mild Cognitive Impairment: Implications C63 C64 C65 C66 C67 C68 C69 C70 C71 

for Clinicians CNS Toxicities ICD-10-CM: How to Optimize for Accurate Diagnosis and Reimbursement Child Neurology I: Pediatric Stroke, MS/ Autoimmune Neuro-oncologic Emergencies Infections of the Nervous System I: Diagnostic Testing of Neurological Infections Approach to the Shaky Patient Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis Sports Neurology: Enhancing Athletic Performance Hot Topics in Sleep Neurology

SUNDAY/MONDAY

Monday, April 24

X

Matters in Neurology—Why We are Losing Sleep Navigating Your Career: Teaching During a Busy Clinic

8:00 a.m.–8:45 a.m.

X Live Well: Enhanced Well-being through Mentoring: Session II

8:00 a.m.–9:00 a.m.

X Education and Publications Station:

Writing Better Papers by Sharpening Your Reviewing Skills X HeadTalks: Publication Editors Tell All: Hits, Misses, and Tips S10 “Best Of” Session: MS and CNS Inflammatory Disease

8:15 a.m.–8:45 a.m.

X Navigating Your Career: Career Stories: Challenges for the Physician Scientist

39


Program Schedule X Navigating Your Career: Autoimmune Neurology

8:30 a.m.–9:00 a.m.

X Maximize Your Value: Opioid Use in Neurology

X Research Corner: Why Study the History

 Sat  Sun  Mon  Tue  Wed  Thu        

 Fri

Clinical Neurophysiology Section Meeting Child Neurology Section Meeting Neuroendocrinology Section Meeting Neuroepidemiology Section Meeting

12:00 p.m.–2:00 p.m.

X HeadTalks: Neurological Exam Tips of Neurology? A Panel Discussion and Tricks Featuring the Lawrence C. McHenry Award and Roland P. Mackay Medical 12:00 p.m.–4:00 p.m. Student Essay Award Winners X Live Well: Free Chair Massages X Research Corner: Small Group Mentoring 12:00 p.m.–5:30 p.m. Session: Careers in Industry C75 Clerkship and Program Directors 8:30 a.m.–7:00 p.m. Conference: Wellness and Burnout P2 Poster Session II During Training Presenters Stand by Posters 5:30 p.m.–7:00 p.m.

9:00 a.m.–9:45 a.m.

X Navigating Your career: Giving and

Receiving Feedback for Medical Students and Residents

9:00 a.m.–10:00 a.m.

X Education and Publications Station: Tips

1:00 p.m.–1:30 p.m.

X Advocacy to Action: Advocacy at Home X Research Corner: Small Group Mentoring Session: Neurologic Disparities

1:00 p.m.–1:45 p.m.

X Live Well: Physical Exercise and

for Successful Submission to Neurology: Clinical Practice®

9:15 a.m.–11:30 a.m.

Contemporary Clinical Issues Plenary Session

10:00 a.m.–10:30 a.m.

X Navigating Your Career: Up Your Game as a Medical Educator in Neurology

11:00 a.m.–11:45 a.m.

X Navigating Your Career: Research in Residency: How to Choose the Right Project

11:30 a.m.–6:00 p.m.

Exhibit Hall

12:00 p.m.–12:45 p.m.

X Navigating Your Career: How Educating Can Improve Productivity During Clinical Activities

12:00 p.m.–1:00 p.m.   Autonomic Nervous System Section Meeting

X

Cognitive Training in Neurology: Application in Aging and Neurodegenerative Disease Navigating Your Career: Audiencespecific Teaching

1:00 p.m.–2:00 p.m.

X Education and Publications Station:

Oral Anticoagulation After Intracerebral Hemorrhage S11 Research Corner: Autonomic Disorders: Synucleinopathies yy Presentation of the Irwin Schatz Award for Autonomic Disorders

1:00 p.m.–3:00 p.m.

X Maximize Your Value: Ethics Course C76 L Mentoring…Growing the

Next Generation of Neurologist $ (registration required) C77 Behavioral Neurology I: Network Anatomy of Behavior and Language C78 Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I C79 Neuroimaging for the General Neurologist I: Brain and Spine

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

40

2017 AAN Annual Meeting On-site Guide


Contemporary Clinical Issues Plenary Session Monday, April 24 

9:15 a.m.–11:30 a.m.

This session highlights issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments. Commentary and discussion follow each presentation. Moderator: Natalia Sana Rost, MD, FAAN Vice Chair, AAN Science Committee

Nusinersen in Infants Diagnosed with Spinal Muscular Atrophy (SMA): Study Design and Initial Interim Efficacy and Safety Findings from the Phase 3 International ENDEAR Study

Discussant: Charlotte J. Sumner, MD Johns Hopkins Medicine, Baltimore, MD

Presenter: Alessandro Biffi, MD Massachusetts General Hospital, Boston, MA Resumption of Oral Anticoagulation After Intracerebral Hemorrhage Is Associated with Decreased Mortality and Favorable Functional Outcome

Discussant: Daniel F. Hanley, MD, FAAN Johns Hopkins Medicine, Baltimore, MD

Targeting Neuronal Activity-regulated Neuroligin-3 Secretion for Glioma Therapy

Presenter: Michelle Monje, MD, PhD Stanford University, Stanford, CA Discussant: Tracy T. Batchelor, MD, MPH Massachusetts General Hospital, Boston, MA

MONDAY

Presenter: Nancy L. Kuntz, MD Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL

Invited Speakers Louise D. McCullough, MD, PhD The University of Texas Health Science Center at Houston, Houston, TX A Woman “Found Down” Amaal J. Starling, MD Mayo Clinic, Phoenix, AZ The Era of Targeted Preventive Treatment for Migraine: CGRP Monoclonal Antibodies Dennis N. Bourdette, MD, FAAN Oregon Health & Science University, Portland, OR High Drug Prices: The Elephant in the Clinic



41


Program Schedule

 Sat  Sun  Mon  Tue  Wed  Thu

 Fri

C80 Child Neurology II: Epilepsy C81 C82 C83 C84 C85 C86 C87

N3 S12 S13 S14

X Research Corner: Your CV is Talking and Neuromuscular About You Behind Your Back, and Your LORs, are too! Common Spine Disorders I: Evaluation Infections of the Nervous System II: 2:00 p.m.–2:45 p.m. Neuro-ID Emergencies X Live Well: Acupuncture Demonstration Hot Topics and Controversies in X Navigating Your Career: Successful APPParkinson’s Disease physician Team Models Panel Clinical Approach to Muscle Disease I: 2:00 p.m.–3:00 p.m. Muscle Disorders and Rhabdomyolysis Boston City Hospital: The Cradle of X HeadTalks: Neurology and Art American Neurology Part I X Education and Publications Station: Practice Current: Share Your Best Neuro-otology I: The Common Peripheral Practices and Compare in Real-time with Vestibular Disorders International Peers and Experts How to Run a Practice: Business Strategies for Neurology Private 3:00 p.m.–3:30 p.m. Practices, Academic Centers, and X Advocacy to Action: Neurology and the the Future 115th Congress Neuroscience in the Clinic: Cutting Edge X Maximize Your Value: Coding and Concussion Data from the NCAA-DoD Reimbursement for APPs Grand Alliance X Navigating Your Career: Using The MS Therapeutics and MRI Outcomes R&F Section of Neurology ® for Your Motor Neuron Diseases: Biomarkers, Residents and Residency Outcome Measures, and Therapeutics Research Corner: Q&A with the 2017 X Highlights in Sleep Science Sheila Essey Award: An Award for ALS yy Presentation of the Sleep Research Recipient Science Award yy Presentation of the Wayne A. Hening Sleep Medicine Investigator Award

1:00 p.m.–5:00 p.m. C88 L Improving Your Leadership Skills: A Practical Approach (registration required)

1:00 p.m.–5:30 p.m. C89 Neurophysiologic Intraoperative Monitoring Skills Workshop $ (registration required)

1:30 p.m.–2:00 p.m.

3:00 p.m.–3:45 p.m.

X Live Well: Introduction to Acupuncture I: X

Conceptual Framework and Mechanism of Action Navigating Your Career: Utilization of APPs in Neurology Practice Panel

3:00 p.m.–4:00 p.m.

X Education and Publications Station:

Efficient Use of Online Education Resources and Information: RSS Feeds

3:00 p.m.–5:00 p.m.

X Research Corner: Small Group Mentoring X HeadTalks: Hot Topics En Españo

Session: Creating Bridge Funding—How 3:30 p.m.–4:00 p.m. to Use Non-NIH Funding X Advocacy to Action: State 1:30 p.m.–3:00 p.m. Neurosocieties + State Advocacy = Curbside Consults: Alzheimer’s Disease Victory Maximize Your Value: Patient-reported X 2:00 p.m.–2:30 p.m. Outcomes Scales for Parkinson’s Disease X Advocacy to Action: Painting in Twighlight: an Artist's Escape from Alzheimer’s $  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

42

2017 AAN Annual Meeting On-site Guide


Let’s All Commit To Outsmarting Brain Disease. The American Brain Foundation is the central driving force behind bringing all neurologists, researchers, patients, and caregivers together to help generate funding for and awareness of brain disease. Come learn what is new with the Foundation as we celebrate our 25th anniversary. JOIN US AT COMMITMENT TO CURES a fundraising event for the American Brain Foundation held on Wednesday, April 26 at the Boston Westin Waterfront Hotel. For event details and tickets please visit the American Brain Foundation’s booth located in the North Lobby.

B. Smith & Dan Gasby Public Leadership in Neurology Award Recipients

Francis I. Kittredge, Jr. MD, FAAN Board Chair’s Recipient

Delfeayo Marsalis Jazz Quartet

VISIT OUR BOOTH located in the North Lobby to learn about our new crowdfunding platform, take a break and play giant jenga, and make a contribution. Gifts of $25 and over receive a t-shirt. CONNECT THROUGH CROWDFUNDING with the American Brain Foundation’s unique platform that allows individuals to search for and contribute to scientifically-vetted projects posted by researchers. Stop by the Foundation’s booth in the North Lobby for a demonstration of how the platform works. Celebrating Our 25th Anniversary

Mission: The American Brain Foundation brings researchers and donors together to defeat brain disease. For more information, visit www.AmericanBrainFoundation.org 

43


Program Schedule

 Sat  Sun  Mon  Tue  Wed  Thu

3:30 p.m.–5:30 p.m.

4:00 p.m.–4:30 p.m.

 Fri

C90 Behavioral Neurology II: Memory

X Maximize Your Value: New Codes for 2017:

C91

X Research Corner: How do Awards and

C92 C93 C94 C95 C96 C97 C98

and Praxis Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II Neuroimaging for the General Neurologist II: Brain and Spine Boston City Hospital: The Cradle of American Neurology Part II Child Neurology III: Headache, TBI/Post-concussion Common Spine Disorders II: Treatment Infections of the Nervous System III: Advanced Topics in Infectious Neurology The Dystonias: Diagnosis, Treatment, and Update on Causes Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology

C99 Therapeutic Temperature Modulation in  

C100 C101 C102 S15

the ICU Invited Science: Headache Neuro-otology II: Diagnosis and Treatment of Nuanced Causes of Dizziness Drug-induced Neurologic Emergencies Business Strategies for Payer Negotiations and/or How to Go off the Grid Neuroepidemiology

Are You Leaving Money on the Table?

Research Fit Into Your Career Path?—A Panel Discussion Featuring Current and Former Potamkin Prize and Founders Award Winners

4:00 p.m.–4:45 p.m.

X Live Well: StrengthsFinder™ Social Hour 4:00 p.m.–5:00 p.m.

X Education and Publications Station:

Tips for Successful Submission to Neurology ® Resident & Fellows Section

4:30 p.m.–5:00 p.m.

X Maximize Your Value: Ask the Expert:

New Codes for 2017: Are You Leaving Money on the Table?

4:30 p.m.–5:15 p.m.

X Navigating Your Career: Choosing a Career in Clinical Practice

4:30 p.m.–6:00 p.m. NEW! Exhibit Hall Networking Reception Open to all Annual Meeting attendees, this new event extends hall hours to give attendees an opportunity to mingle with exhibitors. Light snacks and beverages will be served. Sponsored by:

yy Presentation of the Bruce S. Schoenberg International Award in Neuroepidemiology

S16 MS Characterizations and Tools for Measurement

S17 Movement Disorders: Ataxia and the Cerebellum

S18 Behavioral and Cognitive Neurology

yy Presentation of the Alliance Awards: S. Weir Mitchell yy Presentation of the Norman Geschwind Prize in Behavioral Neurology

4:45 p.m.–5:15 p.m.

X Navigating Your Career: How to be

"Useful" on Rotations: Tips for Medical Students

5:00 p.m.–5:30 p.m.

X Live Well: Guided Meditation

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

44

2017 AAN Annual Meeting On-site Guide


5:30 p.m.–6:30 p.m.   Movement Disorders Section Meeting   A.B. Baker Section on Neurological Education Meeting   Government Service Section Meeting   Neuro-ophthalmology/Neuro-otology Section Meeting

6:00 p.m.–9:00 p.m.   Advanced Practice Provider Networking Reception

6:00 p.m.–9:00 p.m. C103 Case Studies: Dementia C104 Case Studies: Multiple Sclerosis

C105 Test Your Knowledge: A Case-based Approach to Neuroimaging

C106 Case Studies: Unusual Movement Disorders

C107 Case Studies: Unusual Diagnostic

and Management of Cases in Neuromuscular Disease C108 Case Studies in the ICU C109 Case Studies: How to Analyze Spells by Video-EEG C110 Case Studies: Challenging Headache Cases

6:00 p.m.–9:00 p.m.

Faculty and Trainee Reception

6:30 a.m.–8:30 a.m.

2017 AAN Run/Walk for Brain Research Join your colleagues for a friendly run/walk. All proceeds will help support brain research. $ (registration required) Sponsored by:

7:00 a.m.–8:00 a.m.   Ethics Section Meeting   General Neurology Section Meeting   Neuro-infectious Disease Section Meeting

7:00 a.m.–9:00 a.m. C111 Principles of Genomic Medicine: C112 C113 C114 C115 C116 C117

7:00 a.m.–7:45 a.m.

X Live Well: Yoga (All-Levels Vinyasa) 7:00 a.m.–8:00 a.m.

X HeadTalks: Need for Comprehensive Neuroscience Centers

C118 C119 C120



MONDAY/TUESDAY

Tuesday, April 25

Clinical Exome Sequencing in Neurologic Disease Stroke in Young Adults and Women Neuroimaging Biomarkers Across the Dementia Spectrum Therapy of Movement Disorders: A Case-based Approach The Burden of Epilepsy: Managing Comorbidities and Quality of Life Multiple Sclerosis Therapy: Symptom Management The Palliative Care Guide in Neurology: Best Practice Guidelines in Communication, Symptom Management, and End of Life Care of Patients with Brain Tumors and Other Life Limiting Neurological Disorders Nystagmus and Saccadic Intrusions Made Simple Management of Migraine and Psychiatric Comorbidities Mastering EMG Waveform Recognition Skills in Just Two Hours!

45


Program Schedule

 Sat  Sun  Mon  Tue  Wed  Thu

7:30 a.m.–8:00 a.m.

11:30 a.m.–4:00 p.m.

 Fri

X Navigating Your Career: From Member to Exhibit Hall Leader: How to Engage with the AAN

X Navigating Your Career: SIGN up for a Career in Neurology

7:30 a.m.–8:30 a.m.

X Education and Publications Station:

Patient Quality and Safety—Using NeuroLearn for Practice Improvement

8:00 a.m.–8:30 a.m.

X Research Corner: Learn About

Opportunities to Work with the NIH Intramural Program

8:00 a.m.–8:45 a.m.

X Live Well: Complementary Therapies in Parkinson’s Disease

8:00 a.m.–9:00 a.m. S19 “Best Of” Session: Cerebrovascular

11:45 a.m.–12:30 p.m.

X Navigating Your Career: Choosing Teleneurology as a Career

12:00 p.m.–1:00 p.m.   Endovascular & Interventional Neurology Section Meeting   Headache & Facial Pain Section Meeting   Neuroimaging Section Meeting   Women’s Issues in Neurology Section Meeting

12:00 p.m.–12:30 p.m.

X Live Well: Neuropathy X Navigating Your Career: AAN Resident & Fellow Members: Meet and Greet

X Research Corner: Small Group Mentoring Session: How to Bridge to Careers in Industry

Disease and Interventional Neurology

8:15 a.m.–8:45 a.m.

X Navigating Your Career: Teaching History 12:00 p.m.–1:00 p.m. X HeadTalks: How Does Your Practice Fare and Exam with Teleneurology when Compared to International Peers and Experts?

8:30 a.m.–9:00 a.m.

X Maximize Your Value: Axon Registry ® X Research Corner: NIH Funding and

Professional Development Opportunities for Diverse Researchers

8:30 a.m.–9:30 a.m.

X

X Live Well: Free Chair Massages 12:30 p.m.–1:00 p.m.

X Research Corner: Introduction to the 2017-2019 TRANSCENDS Scholars Education and Publications Station: How to Write Multiple Choice Questions: 12:45 p.m.–1:15 p.m. Making “Fair” and “Balanced” X Navigating Your Career: Transitioning Mean Something from Private Practice to Academics

8:30 a.m.–7:00 p.m. P3

12:00 p.m.–4:00 p.m.

Poster Session III

Presenters Stand by Posters 5:30 p.m.–7:00 p.m.

9:00 a.m.–9:30 a.m.

X Navigating Your Career: Being a Great Chief Resident

9:15 a.m.–11:30 a.m.

Clinical Trials Plenary Session

11:00 a.m.–11:45 a.m.

1:00 p.m.–1:30 p.m.

X Advocacy to Action: How to: Organize a Charity 5k

X Navigating Your Career: Subspecialty Sessions: IOM and cEEG—Session 2

X Research Corner: Small Group Mentoring X

Session: Bridge Funding Research Corner: Introduction and Overview of NIH Funding

X Navigating Your Career: Career as a

MuDPhuD: Choosing NOT to Choose

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

46

2017 AAN Annual Meeting On-site Guide


Clinical Trials Plenary Session Tuesday, April 25 

9:15 a.m.–11:30 a.m.

This session covers important clinical topics identified from other society meetings that affect patient care. The latest updates within several clinical trials conducted over the course of the last year will be presented Moderators: Natalia Sana Rost, MD, FAAN Vice Chair AAN Science Committee

Petra Kaufmann, MD, FAAN Member AAN Science Committee

Miia Kivipelta, MD Kaolinska Institute Solna, Sweeden

E ffect of Intensive Systolic Blood Pressure Lowering on Hematoma Expansion in Patients with Intracerebral Hemorrhage: Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II Trial

 2-year Multidomain Intervention of A Diet, Exercise, Cognitive Training, and Vascular Risk Monitoring Versus Control to Prevent Cognitive Decline in At-risk Elderly People (FINGER): A Randomized Controlled Trial

Jerry R. Mendell, MD, FAAN The Research Institute at Nationwide Children’s Hospital, Columbus, OH

Jerry R. Mendell, MD, FAAN The Research Institute at Nationwide Children’s Hospital, Columbus, OH

L ongitudinal Effect of Eteplirsen Versus Historical Control on Ambulation in Duchenne Muscular Dystrophy

 VXS-101 Phase 1 Gene Therapy A Clinical Trial in SMA Type 1: Event Free Survival and Achievement of Developmental Milestones

K ids Are Not Just Little Adults: The Childhood and Adolescent Migraine Prevention Trial (CHAMP)

TUESDAY

Joshua N. Goldstein, MD, PhD Massachusetts General Hospital, Boston, MA

Scott Powers, PhD Cincinnati Children’s Hospital, Cincinnati, OH



Deborah Hall, MD, PhD, FAAN Member AAN Science Committee

J. Helen Cross, PhD UCL-Institute of Child Health, London, United Kingdom C annabidiol (CBD) Reduces Convulsive Seizure Frequency in Dravet Syndrome: Results of a Multi-center, Randomized, Controlled Trial (GWPCARE 1)

Ludwig Kappos, MD University Hospital Basel Basel, Switzerland

Gil I. Wolfe, MD, FAAN University at Buffalo Buffalo, NY

E fficacy of Siponimod in Secondary Progressive Multiple Sclerosis: Results of the Phase 3 Study

 GTX: Results of the Multinational M Thymectomy Trial in Non-thymomatous Myasthenia Gravis

47


Program Schedule

 Sat  Sun  Mon  Tue  Wed  Thu

1:00 p.m.–1:45 p.m.

S21 Epilepsy and Clinical Neurophysiology

X Live Well: Guts & Glory: The Importance of Diet & Exercise in Managing Persons with Multiple Sclerosis

1:00 p.m.–2:00 p.m.

X Education and Publications Station: The

 Fri

(EEG) I

S22 Parkinson’s Disease: Observational Studies

yy Presentation of the Jon Stolk Award in Movement Disorders for Young Investigators yy Presentation of the Movement Disorders Research Award

Gamification of Neurology Education X HeadTalks: Telemovement: Using Telemedicine in an Outpatient 1:00 p.m.–5:00 p.m. Neurology Setting C133 L The Most Important Tool in Your X Maximize Your Value: Improving Patients Black Bag: Gallup StrengthsFinder™ and Family Satisfaction Education Workshop $ (registration required) 1:00 p.m.–3:00 p.m. C134 L Advanced Leadership Training: LifeC121 Small Fiber Neuropathies: Sensory, after-the-Limelights Autonomic, and Both I: Focus on Autonomic Nervous System 1:00 p.m.–5:30 p.m. C122 Neurology Update III: Neuromuscular, C135 Neuromuscular Ultrasound Skills Dementia, and Stroke Workshop $ (registration required) C123 Myelopathies I: Inflammatory and Vascular Etiologies 1:30 p.m.–2:00 p.m. C124 Unilateral Neglect and Anosognosia: X Advocacy to Action: AAN Chalk Talk Federal Advocacy C125 Nonmotor Manifestations of Parkinson’s Navigating Your Career: The Teaching X Disease I Environment C126 Critical Care EEG Monitoring X Research Corner: Panel of K Awardees C127 Neuroendocrine Update: Nuts and Bolts X Research Corner: Small Group of What You Need to Know Mentoring Session: Clinical Research C128 Sleep Apnea and Related Disorders Over Recommendations for Residents the Lifecycle: What Neurologists Need and Fellows to Know X Research Corner: Small Group Mentoring C129 Pediatric Neuro-ophthalmology Update Session: VA Funding Mechanisms C130 Eponymous Women in Neurology I 1:30 p.m.–3:00 p.m. C131 Hot Topics in Headaches and Related Curbside Consults: Academic Disorders I: Migraine Pathophysiology, Curbside Consults: Multiple Sclerosis Brain Imaging, and Therapeutic Advances 2:00 p.m.–2:30 p.m. C132 Developing the Treatments of Tomorrow X Advocacy to Action: How to: Make the I: Taking Molecules from Lab to Man Media Your Friend N4 Neuroscience in the Clinic: Zika Virus: X Maximize Your Value: MACRA Overview The Global Outbreak of a X Navigating Your Career: Why Choose a Neurotropic Virus Career in Neuro-oncology?   Invited Science: Neuro-oncology X Research Corner: Q&A with an NIH S20 Neuromyelitis Optica and Other BRAIN Initiative Grantee Autoimmune Disorders

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

48

2017 AAN Annual Meeting On-site Guide


2:00 p.m.–2:45 p.m.

X Live Well: Nutrition and Neurology: General Principles for Physicians

2:00 p.m.–3:00 p.m.

X Education and Publications Station: X

Writing for Publication: Challenges and Pitfalls HeadTalks: Ask Us Anything: Expert Panel on Parkinson Disease and Dementia

3:30 p.m.–5:00 p.m.

3:30 p.m.–5:30 p.m. C136 Small Fiber Neuropathies: Sensory, C137

2:15 p.m.–2:45 p.m.

X Navigating Your Career: How to Give Effective Feedback

2:30 p.m.–3:00 p.m.

X Maximize Your Value: Ask the Expert: MACRA Overview

2:30 p.m.–3:30 p.m.

X Research Corner: Panel of NIH Grant Review Committees

C138 C139 C140 C141 C142 C143

X Advocacy to Action: Follow the Dollar: X X X

BrainPAC Donation to Candidate Contribution Maximize Your Value: MIPS: What is MIPS and How Do I Participate Navigating Your Career: Everything You Wanted to Know About the R&F Section of Neurology Navigating Your Career: Neurohospitalists 2.0, How to Craft a Satisfying and Sustainable Career

3:00 p.m.–3:45 p.m.

X Live Well: Nutrition and Neurology: Treating Neurological Conditions with Food

3:00 p.m.–4:00 p.m.

X Education and Publications Station:

X

Neurology, Neuroimmunology and Neuroinflammation: A Chat with the Editor HeadTalks: Hall of Presidents: Neurology Through the Years

3:30 p.m.–4:00 p.m.



C144 C145 C146 C147 C148 S23 S24 S25

Autonomic, and Both II: Focus on Sensory Nervous System Neurology Update IV: Multiple Sclerosis, Dizziness, and Autoimmune Encephalopathies Myelopathies II: Symptom Management and Rehabilitation Behavioral Neurology: A Case-based Approach Nonmotor Manifestations of Parkinson’s Disease II Acute and Chronic Clinical Epilepsy Update Explained in 6 Cases Pediatric MS: Diagnosis and Treatment Non-Neuro-oncology: Case-based Palliative Care Throughout the Continuum® of Disease Approaching the Management of Common Sleep Disorders: Case-based Review for the Non-sleep Specialist Hot Topics in Neurologic Practice: Managing the Patient Experience in 2017 and Beyond Eponymous Women in Neurology II Hot Topics in Headaches and Related Disorders II: Unusual Headaches, Childhood Headaches, and Head Trauma Developing the Treatments of Tomorrow II: Clinical Trials in Neurology Neurocritical Care: Neurological Intensive Care MS Therapeutics and Clinical Research I Cerebrovascular Disease and Interventional Neurology: Prehospital and Emergency Department Ischemic Stroke Care yy Presentation of the Michael S. Pessin Stroke Leadership Prize

S26 Neuro-opthalmology/Neuro-otology

4:00 p.m.–4:30 p.m.

X Maximize Your Value: Ask the

X Advocacy to Action: Global Advocacy:

X

X Maximize Your Value: AAN’s APMs:

Expert: MIPS Research Corner: NIH Clinical Trials Recruitment

TUESDAY

3:00 p.m.–3:30 p.m.

Section Topic Controversies: Stem Cells for Treatment of Neurological Diseases: The Ecstasy and the Agony

National Dementia Plans in Europe Management and Participation

49


Program Schedule

 Sat  Sun  Mon  Tue  Wed  Thu

4:00 p.m.–4:45 p.m.

5:00 p.m.–5:30 p.m.

X Live Well: Striking the Balance: A X X

Neurologist’s Personal Wellness Story Navigating Your Career: How to Start a Career in Neurology Education Navigating Your Career: The Accreditation Council of Graduate Medical Education and You

4:00 p.m.–5:00 p.m.

X HeadTalks: Ask Us Anything: Expert Panel on Headache and Pain

4:30 p.m.–5:00 p.m.

X Advocacy to Action: How to: Collaborate Across Specialities

X Education and Publications Station: X

Annual Meeting App: Getting the Most Out of It Maximize Your Value: Patient-reported Outcomes Scales for Epilepsy

4:45 p.m.–5:15 p.m.

 Fri

X Maximize Your Value: Axon Registry® X Navigating Your Career: Staying on

Track: A Career as a Clinical Researcher

5:30 p.m.–6:00 p.m.

X Maximize Your Value: Ask The Expert: Axon Registry

5:30 p.m.–6:30 p.m.        

Behavioral Neurology Section Meeting Global Health Section Meeting Multiple Sclerosis Section Meeting Sleep Medicine Section Meeting

5:45 p.m.–7:15 p.m.   Emerging Science Session

7:00 p.m.–10:00 p.m.

Industry Therapeutic Updates

Please see page 11 for more details.

X Live Well: Guided Meditation

Wednesday, April 26 7:00 a.m.–7:45 a.m.

X Live Well: Yoga (All-Levels Vinyasa) 7:00 a.m.–8:00 a.m.

X HeadTalks: Annual Meeting Orientation 7:00 a.m.–9:00 a.m. C149 Low and High Pressure Headache: C150 C151 C152 C153 C154

Clinical Presentation and Approach to Evaluation and Management Neurological Intensive Care: The Essentials Neuro-ophthalmology I: Visual Loss, Optic Neuropathies, and Papilledema Clinical Pearls: Learning from Complex Cases Simple Lessons that Apply to Everyday Problems Alzheimer’s Dementia: Diagnosis and Treatment Autism Spectrum Disorders What We Know and Where We Are Going

C155 Controversies in Stroke Therapy C156 Rehabilitation in Neurology C157 Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low Back Pain, and Failed Back Syndrome

7:30 a.m.–8:00 a.m.

X Navigating Your Career: Involving

Students Through a SIGN Chapter

8:00 a.m.–8:30 a.m.

X HeadTalks: Blended Learning X Research Corner: Women in Basic Science

8:00 a.m.–8:45 a.m.

X Live Well: The Sleep Mythbuster!: Illuminating the Facts and Fiction Towards Achieving the Sleep Healthy Neurologist

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

50

2017 AAN Annual Meeting On-site Guide


Frontiers in Neuroscience Plenary Session Wednesday, April 26 

9:15 a.m.–11:30 a.m.

This plenary session features basic and translational research related to clinical issues of importance. Six outstanding physician-scientists provide summaries of their recent research findings and describe the clinical implications of the results. Moderator Randolph S. Marshall, MD, FAAN Member, AAN Science Committee

Xandra O. Breakefield, PhD

Duke Center for Genomic and Computational Biology Durham, NC Genome and Epigenome Editing for Gene Therapy and Cell Programming

Massachusetts General Hospital Charlestown, MA Vesicle Communication in the Tumor-bearing Brain

Mary Reilly, MD, FRCP, FRCPI National Hospital for Neurology and Neurosurgery London, United Kingdom Axonopathies: What Next? Amy R. Brooks-Kayal, MD, FAAN Children’s Hospital Colorado Aurora, CO



Epilepsy at the Cutting Edge: Using Novel Models for Therapeutic Advances

TUESDAY/WEDNESDAY

Charles Gersbach, PhD

M. Elizabeth Ross, MD, PhD Cornell University New York, NY The Lives of a Gene: Diverse Roles in Diseases of Developing and Mature Brain Eliezer Masliah, MD National Institute on Aging Bethesda, MD The Promise of Immunotherapy for Neurodegenerative Disorders: Progress and Challenges

51


Program Schedule

 Sat  Sun  Mon  Tue  Wed  Thu

8:00 a.m.–9:00 a.m.

12:00 p.m.–12:30 p.m.

S27 “Best Of” Session: Neuromuscular Disease Therapeutics

8:15 a.m.–8:45 a.m.

X Navigating Your Career: Patientcentered Teaching

X Navigating Your Career: Interviewing

Skills: Medical Students and Residents

8:30 a.m.–9:00 a.m.

X Research Corner: Income Disparity in X

Research Careers Research Corner: Small Group Mentoring Session: Making the Transition from Research Fellow to Clinical Research Faculty

8:30 a.m.–9:30 a.m.

X Education and Publications Station: Using Continuum® for Resident Education

8:30 a.m.–7:00 p.m. P4

Poster Session IV

Presenters Stand by Posters 5:30 p.m.–7:00 p.m.

9:00 a.m.–9:45 a.m.

X Navigating Your Career: Choosing a Career in Neurocritical Care

9:15 a.m.–11:30 a.m.

Frontiers in Neuroscience Plenary Session

10:00 a.m.–10:30 a.m.

X Navigating Your Career: How to Evaluate a Practice

11:30 a.m.–12:15 p.m.

X Navigating Your Career: Recruiting, Developing and Retaining Faculty

X Navigating Your Career: Choosing a Neurohospitalist Career

11:30 a.m.–12:30 p.m.

Advanced Practice Provider Bring-YourOwn-Lunch Networking

11:30 a.m.–3:00 p.m.

Exhibit Hall

X Research Corner: FDA Introductory

Seminar on Navigating the Regulatory landscape for Neurological Devices to Move Neurotechnologies to Patients and Caregivers

12:00 p.m.–1:00 p.m.

X HeadTalks: The Purpose Checkup: Find Meaning, Live Longer, Better

12:00 p.m.–1:00 p.m.   LGBTQI Section Meeting   Neural Repair & Rehabilitation Section Meeting   Pain & Palliative Care Section Meeting   Spine Section Meeting

12:00 p.m.–4:00 p.m.

X Live Well: Free Chair Massages 12:30 p.m.–1:00 p.m.

X Research Corner: Small Group Mentoring Session: FDA Introduction Continued

12:30 p.m.–1:15 p.m.

X Navigating Your Career: What to Expect: A General Overview of How to Pick the Right Career Path

1:00 p.m.–1:30 p.m.

X Maximize Your Value: Hot Topics in Guidelines Development

X Research Corner: Small Group Mentoring Session: Mentor-mentee Relationships

1:00 p.m.–1:45 p.m.

X Live Well: Communication in Neurology Practice

1:00 p.m.–2:00 p.m.

X Education and Publications Station:

Adding a New Nurse Practitioner or Physician Assistant to Your Practice: Our Method of Getting Started X HeadTalks: Health Care Disparities Amongst Underserved Populations S28 Research Corner: History of Neurology yy Presentation of the Lawrence C. McHenry Award: An Award for the History of Neurology

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

52

2017 AAN Annual Meeting On-site Guide

 Fri


1:00 p.m.–2:30 p.m.

Section Topic Controversies: Neurologists Should Take a Position Regarding the Cost of Neurological Treatments

1:00 p.m.–3:00 p.m. C158 Comprehensive Migraine Education C159 C160 C161 C162 C163

C165 C166 C167

C168 C169

C170 N5



Interventional Neurology: Critical Care and Hemorrhage S30 Infectious Disease: HIV, Syphilis, Borrelia, TB, Cysticercosis, and Other Infections S31 MS Therapeutics and Clinical Research II

1:00 p.m.–5:00 p.m. C171 L The Most Important Tool in Your

Black Bag: Gallup StrengthsFinder™ Assessment: Advanced Workshop $ (registration required)

1:00 p.m.–5:30 p.m. C172 EMG Skills Workshop: Basic

$ (registration required)

1:30 p.m.–2:00 p.m.

X Maximize Your Value: Ask the Expert:

Hot Topics in Guidelines Development

WEDNESDAY

C164

Program I: Diagnosis, Risk Factors and Neurobiology Neurological Intensive Care II: From the Brain to the Muscles Neuro-ophthalmology II: Optic Neuritis, Visual Fields, and Anisocoria Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients I Continuum® Test Your Knowledge: A Multiple-choice Question Review I An Introduction to Research in Medical Education Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies Clinical Neurology for Advanced Practice Providers I Circadian Rhythm Disorders: Implications for Neurology Autoimmune Neurology I Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS Neuroimaging for the General Neurologist I: Spine and Peripheral Nerve Core Concepts in Pain Management I: Refractory Neuropathic Pain Practical Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids Sports Concussion Skills Workshop I: Event Coverage Skills $ (registration required) Neuroscience in the Clinic: Stress and Neurologic Diseases: What Is It, and What Is The Provider To Do?

S29 Cerebrovascular Disease and

X Navigating Your Career: Career

Development for Clinician Educators

1:30 p.m.–3:00 p.m.

Curbside Consults: Academic Curbside Consults: Headache

2:00 p.m.–2:30 p.m.

X Advocacy to Action: Barrow Brainbook: X

Concussion Education for Student Athletes Navigating Your Career: Staying on an Academic Clinical Track

2:00 p.m.–2:45 p.m.

X Live Well: Physical Exercise and Cognitive Training After Stroke

2:00 p.m.–3:00 p.m.

X Education and Publications Station: How Early Can We Diagnose Alzheimers?

2:15 p.m.–2:45 p.m.

X Navigating Your Career: Interviewing Skills: Negotiation

2:30 p.m.–3:00 p.m.

X Maximize Your Value: Patient-reported Outcomes Scales for Sleep

53


Program Schedule

 Sat  Sun  Mon  Tue  Wed  Thu

2:30 p.m.–3:30 p.m.

C182 Autoimmune Neurology II Advanced:

X Advocacy to Action: How to: Be a X

Lobbyist for a Day HeadTalks: Is There a Neurologist on This Flight?

3:00 p.m.–3:30 p.m.

X Advocacy to Action: Drug Prices in

C183 C184

Academic Practice: A Growing Problem

X Maximize Your Value: Hospital Patient Coding

3:00 p.m.–3:45 p.m.

X Live Well: Introduction to Acupuncture

X

II: Evidence-based Applications for Acupuncture in the Treatment of Neurologic Conditions Navigating Your Career: Career Development for Medical Educators

3:30 p.m.–4:15 p.m.

S32 Research Corner: Global Health

3:30 p.m.–5:30 p.m.

X HeadTalks: Paint And Wine Hour C173

C174 C175 C176 C177 C178 C179 C180

C181

(limited seating to 25) Comprehensive Migraine Education Program II: Behavioral and Psychological Aspects, Preventative Pharmacology, and Treatment Advances Neurological Intensive Care III: Vascular Diseases Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus Bedside Evidence-based Medicine: How to Find and Deconstruct Articles in Order to Take Care of Patients II Continuum® Test Your Knowledge: A Multiple-choice Question Review II Biomarkers in Dementia Treatments for Drug-resistant Epilepsy: An Update Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia Clinical Neurology for Advanced Practice Providers II

C185 N6 S33

Autoimmune Encephalitis at the Frontiers of Neuroscience Neuroimaging for the General Neurologist II: Spine and Peripheral Nerve Core Concepts in Pain Management II: Safe Opioid Prescribing Practical Considerations, Unintended Consequences, and Legal Issues Sports Concussion Skills Workshop II: Office-based Skills $ (registration required) Neuroscience in the Clinic: Functional Recovery in Neurology and Neuroscience Progressive MS Therapeutics yy Presentation of the John Dystel Prize for Multiple Sclerosis Research

S34 Epilepsy and Clinical Neurophysiology (EEG) II

yy Presentation of the Dreifuss-Penry Epilepsy Award

S35 Aging and Dementia: Neuroimaging in Neurodegenerative Diseases yy Presentation of the Alliance Awards: Founders

S36 Cerebrovascular Disease and

Interventional Neurology: Epidemiology

4:00 p.m.–4:30 p.m.

X Live Well: Physician Resiliency in the Face of Patient Death

X Navigating Your Career: Participating in Advocacy

4:30 p.m.–5:00 p.m.

X Research Corner: American Brain Foundation Crowdfunding

4:45 p.m.–5:15 p.m.

X Live Well: Guided Meditation 5:00 p.m.–5:30 p.m.

X Navigating Your Career: Negotiation Skills: You Do Not Get What You Deserve, You Get What You Negotiate for

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

54

2017 AAN Annual Meeting On-site Guide

 Fri


5:30 p.m.–6:30 p.m.   Critical Care & Emergency Neurology Section Meeting   History of Neurology Section Meeting   Neuro-oncology Section Meeting   Sports Neurology Section Meeting

7:00 p.m.–9:30 p.m.

Commitment to Cures $ (registration required)

7:00 p.m.–10:00 p.m.

Industry Therapeutic Updates

Please see page 11 for more details.

Thursday, April 27 7:00 a.m.–7:45 a.m.

X Live Well: Yoga (All-Levels Vinyasa) C186 Chronic Traumatic C187 C188 C189 C190 C191 C192 C193 C194 C195 C196 C197

Encephalopathy: Update Mitochondrial Disorders in Neurology Clinical EEG I: Normal EEG, Normal Variants, and How to Avoid Over-reading EEGs Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors? Multiple Sclerosis Overview: Basic and Translational Science A Case-Based Approach to Neuroophthalmology: What Went Wrong? Paroxysmal Movement Disorders Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies Basic Principles of Brain Tumors: For Practice and for Certification Stroke Team Action Therapy (STAT): Current State of the Art an New Frontiers Emergency and Inpatient Management of Migraine and Other Headache Disorders Interpreting Sleep Study Procedure(s), Data, and Reports: What the Non-sleep Specialist Needs to Know

8:00 a.m.–8:30 a.m.

X

Research Corner: PCORI: What’s All the Fuss?

X Live Well: The Mindful Practice

Curriculum at the University of Rochester

X Navigating Your Career: Navigating

WEDNESDAY/THURSDAY

7:00 a.m.–9:00 a.m.

8:00 a.m.–8:45 a.m.

Fellowship in Neurology

8:00 a.m.–9:00 a.m.

X HeadTalks: Learn the Neurological Exam en Español

S37 “Best Of” Session: Epilepsy

8:30 a.m.–9:00 a.m.

X Maximize Your Value: Axon Registry ® X Research Corner: Small Group Mentoring Session: How to Get a K-Award

X Research Corner: Live Demonstration X

of the American Brain Foundation Crowdfunding Site Research Corner: Small Group Mentoring Session: Retaining Difficult Populations in Research

8:30 a.m.–7:00 p.m. P5

Poster Session V

Presenters Stand by Posters 5:30 p.m.–7:00 p.m

9:00 a.m.–9:30 a.m.

X Research Corner: Small Group Mentoring Session Funding Clinically Oriented/ Translational Research Before the R01/Consortium and Foundation Opportunities

9:15 a.m.–11:30 a.m.

Controversies in Neurology Plenary Session

11:30 a.m.–12:00 p.m.

X Navigating Your Career: International Resident & Fellow Roundtable



55


Program Schedule

 Sat  Sun  Mon  Tue  Wed  Thu

11:45 a.m.–12:30 p.m.

C202 Higher Cortical Visual Disorders: Case-

X Navigating Your Career: Industry Panel 12:00 p.m.–12:30 p.m.

X Research Corner: Grant Applications:

Working with Your Chair and/or Grant Team from Application to Conclusion

12:00 p.m.–1:00 p.m.

X HeadTalks: Neurology Pictionary Challenge

12:00 p.m.–4:00 p.m.

X Live Well: Free Chair Massages 12:15 p.m.–12:45 p.m.

X Navigating Your Career: How to Become

and Get Promoted as a Clinician Educator

12:30 p.m.–1:00 p.m.

X Research Corner: The Pathway to Become a Clinical Trialist

1:00 p.m.–1:45 p.m.

X Live Well: Integrative Approach to the X

Management of Chronic Pain Syndromes Navigating Your Career: An Interview with Stanley B. Prusiner, MD, FAAN, for the Oral History Archive Project

based Review

C203 Hyperkinetic Movement Disorders: Videodiagnosis and Treatment

C204 Peripheral Neuropathy II: Diabetic and Inherited Neuropathies

C205 Neurologic Complications in Adults with Down Syndrome

C206 Neurologic Case Studies in Pregnancy I: Stroke and Headache

C207 Severe TBI: From ICU to Rehabilitation C208 A Case-based Approach to Acute CNS Infections

C209 Clinical Usefulness of Botulinum

Toxin for Spasticity Skills Workshop $ (registration required) N7 Neuroscience in the Clinic: Dopamine Transporter (DaT) Imaging S39 Movement Disorders: Functional and Structural Imaging in Parkinson’s Disease S40 Infectious Disease: The Neurology of Zika, Chikungunya, and Acute Flaccid Myelitis S41 Neuro-oncology yy Presentation of the Neuro-oncology Investigator Award yy Presentation of the Neuro-oncology Scientific Award

1:00 p.m.–2:00 p.m.

X Education and Publications Station: AAN Online MOC Exam Prep Course X HeadTalks: Stuff No One Tells You Regarding the Mentor-mentee Relationship S38 Research Corner: Pain and Palliative Care yy Presentation of the Mitchell B. Max Award for Neuropathic Pain

1:00 p.m.–3:00 p.m. C198 Functional Neurologic Disorders I:

Movement, Non-epileptic Seizures, and MS-like Disorders C199 Clinical EEG II: Focal, Diffuse, and Epileptiform Abnormalities in Adults C200 Therapy in Neurology I: Multiple Sclerosis and Headache C201 Multiple Sclerosis Overview I: Clinical Pearls

S42 Update in Muscular Dystrophy

Section Topic Controversies: Chemo Brain: Neuro-cognitive Impact of Anticancer Therapies

1:00 p.m.–5:00 p.m. C210 L Being a Resilient Leader: How Do You Lead the Change?

1:30 p.m.–2:00 p.m.

X Maximize Your Value: Ask The Expert: APPs

1:30 p.m.–3:00 p.m.

Curbside Consults: Academic Curbside Consults: Stroke

2:00 p.m.–2:30 p.m.

X Advocacy to Action: Follow the Dollar: BrainPAC Donation to Candidate Contribution

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

56

2017 AAN Annual Meeting On-site Guide

 Fri


Controversies in Neurology Plenary Session Thursday, April 27 

9:15 a.m.–11:30 a.m.

This session features experts discussing the most current and controversial issues in neuroscience. It is set up as a debate format in which two speakers argue one side of a single topic, followed by a rebuttal. Moderators: Joseph Jankovic, MD, FAAN Member, AAN Science Committee Aleksandar Videnovic, MD, MSc, FAAN Member, AAN Science Committee

THURSDAY

Is Focused Ultrasound Better Than Deep Brain Stimulation? Yes: Paul S. Fishman, MD, PhD University of Maryland School of Medicine Baltimore, MD No: Michael S. Okun, MD, FAAN University of Florida Gainesville, FL Should Disease-modifying Therapies Be Stopped in Progressive MS? Yes: John Corboy, MD, FAAN University of Colorado School of Medicine Aurora, CO No: Robert T. Naismith, MD Washington University St. Louis, MO Does Removal of Amyloid Improve Cognition in Alzheimer’s Disease? Yes: Reisa A. Sperling, MD Brigham and Women’s Hospital Boston, MA No: George Perry, PhD The University of Texas at San Antonio San Antonio, TX 

57


Sat  Sun  Mon  Tue  Wed  Thu 2:00 p.m.–2:45 p.m.

C221 Emerging Approaches to Biosensing

X Live Well: Diets and Supplements in MS: X

What’s the Evidence Thus Far? Navigating Your Career: Training in Neurology While On a Visa: Challenges and Possible Solutions for Foreign Medical Graduates

2:00 p.m.–3:00 p.m.

X HeadTalks: Rural Neurology 3:00 p.m.–3:30 p.m.

N8

S44 S45 S46

X Navigating Your Career: Interviewing Skills S47 X Research Corner: Small Group Mentoring S48 Session: Finding Collaborators

3:00 p.m.–3:45 p.m.

X Live Well: Cultivating Resilience in the Practice of Neurology

3:00 p.m.–4:00 p.m.

X HeadTalks: Globalization and Neurology 3:30 p.m.–4:00 p.m.

X Maximize Your Value: Drug Pricing 3:30 p.m.–4:30 p.m. S43 Research Corner: Exciting New Results in Neuro-rehabilitation

3:30 p.m.–5:30 p.m.

C214 C215 C216 C217 C218 C219 C220

for the Diagnosis and Management of Neurological Disease Neuroscience in the Clinic: Novel Therapeutic Targets in Critical Care Neurology: Intracerebral and Intraventricular Hemorrhage MS Risk Factors and Modifications Peripheral Nerve Disorders Child Neurology: Molecular Biology to Clinical Trials Headache: Basic and Clinical Science Practice, Policy, and Ethics

3:45 p.m.–4:15 p.m.

X Navigating Your Career: Choosing

Neurology as a Career? Choosing the Right Residency Program

3:45 p.m.–4:30 p.m.

X Navigating Your Career: Pursuing a

Career in Health Care Administration

4:00 p.m.–4:30 p.m.

X Maximize Your Value: Using Forms and Clinical Decision Support to Integrate Your Guidelines into Your EHR

4:00 p.m.–5:00 p.m.

X HeadTalks: A National Inpatient

Rehabilitation Research Network for Right Brain Recovery Management, CBT, and Inpatient Therapeutic Strategies 4:30 p.m.–5:00 p.m. Clinical EEG III: Pediatric and Neonatal X Maximize Your Value: Patient-reported Therapy in Neurology II: Epilepsy and Outcomes Scales for MS Neuro-oncology 4:45 p.m.–5:15 p.m. Multiple Sclerosis Overview II: Live Well: Guided Meditation Clinical Advances X Canalith Repositioning for Benign X Navigating Your Career: Navigating Fellowship Choices Amidst the Pressure of Paroxysmal Positional Vertigo Choosing a Fellowship Early Balance and Gait Disorders Peripheral Neuropathy III: Genetic 4:45 p.m.–5:30 p.m. Testing and Next Generation Sequencing X Navigating Your Career: Effective Cutting Edge Neuro-oncology Neurology Residency Program Understanding Current Trends Neurologic Case Studies in Pregnancy II: Epilepsy and Neuro-ophthalmology Memory Disorders: A Case-based Approach

C211 Functional Neurologic Disorders II: C212 C213

$  Additional Fee Required  L  AAN Leadership University  X  Experiential Learning Area session C  Course · N  Neuroscience in the Clinic Session · P  Poster Session · S  Scientific Platform Session

58

 Fri

2017 AAN Annual Meeting On-site Guide


Friday, April 28 7:00 a.m.–9:00 a.m. C222 The Global Burden of C223 C224 C225 C226 C227

C229 C230

7:30 a.m.–8:00 a.m.

Neurology Year in Review Plenary Session

11:45 a.m.–12:30 p.m.

X Navigating Your Career: Advancing Your

Leadership Skills: Tips forthe Successful Chief Resident

12:00 p.m.–1:00 p.m.

X HeadTalks: Improvisation and the Brain… At the Piano

1:00 p.m.–1:30 p.m.

X Advocacy to Action: Neurology and the X

1:00 p.m.–1:45 p.m.

X Live Well: Outsmart Stress X Navigating Your Career: Clinical

Research in the Area of Practice, Quality, and Patient Safety

X Navigating Your Career: Neurology is Cool—SIGN up!

8:00 a.m.–8:30 a.m.

1:00 p.m.–2:00 p.m.

X Education and Publications Station:

X Education and Publications Station: Fulfill Your MOC Requirements and Lifelong Learning Needs

8:00 a.m.–8:45 a.m.

X Live Well: Experiential Breathing Practicums

8:00 a.m.–9:00 a.m. S49 “Best Of” Session: Aging and Dementia

8:30 a.m.–5:30 p.m. P6

Poster Session VI

Presenters Stand by Posters 4:00 p.m.–5:30 p.m.

9:00 a.m.–9:45 a.m.

X Navigating Your Career: Choosing a Research Path



115th Congress Research Corner: Defining and Managing Your Message as an Early Career Scientist

THURSDAY/FRIDAY

C228

Neurologic Diseases Movement Disorders for the General Neurologist I: Diagnosis and Management of Parkinsonian Disorders Controversies in Multiple Sclerosis Therapy Update on Medical Management of Stroke How to Integrate Sleep Medicine into Your Child Neurology Practice Borderlands of Neurology and Internal Medicine: Chalk Talk Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders Emerging Therapies in Epilepsy Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia

9:15 a.m.–11:30 a.m.

X

Amyloid Removal and Cognition in Alzheimer's Disease HeadTalks: Quality Improvement Registry for Epilepsy Centers

1:00 p.m.–3:00 p.m. C231 Therapy in Neurology III: Neuromuscular

Disease and Neurological Infectious Diseases C232 Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia C233 Multiple Sclerosis: A Case-based Approach C234 Sleep for the Practicing Neurologist I: Is it Narcolepsy or Something Else? Diagnostic and Management Challenges in the Central Disorders of Hypersomnolence

59


Program Schedule C235 Neck Pain, Cervical Spinal Stenosis,

 Sat  Sun  Mon  Tue  Wed  Thu 2:00 p.m.–3:00 p.m.

 Fri

Cervical Radiculopathy, and Cervical X HeadTalks: Bullying and Cyberbullying Spondylotic Myelopathy Prevention C236 Assessment of Rapidly Progressive 3:00 p.m.–3:30 p.m. Dementias I: Overview, Prion Diseases, Maximize Your Value: Ask the Expert: X and Neurodegenerative Rapidly Opioids Progressive Dementia 3:30 p.m.–5:30 p.m. C237 Emergency Neurology I: Evaluation of Coma, Meningitis, and Viral Encephalitis C239 Therapy in Neurology IV: Movement in the Emergency Room Disorders and Cerebrovascular Disease N9 Neuroscience in the Clinic: Afferent and C240 Movement Disorders for the General Efferent Visual Pathway Manifestations Neurologist III: Chorea, Dystonia, of Neurodegenerative Diseases: Myoclonus, Stereotypes, and Tics Implications for Diagnosis and Treatment C241 Update on Endovascular Treatment S50 MS Novel Therapeutics and of Acute Stroke and Cerebrovascular Animal Models Diseases S51 Cerebrovascular Disease and C242 Sleep for the Practicing Neurologist Interventional Neurology: Stroke II: Night Fighting: Sleep Related Prevention and Translation Hypermotor Epilepsy, Sleepwalking, and Dream Enactment S52 Headache: Clinical Trials and Disease Burden C243 Assessment of Rapidly Progressive yy Presentation of the Harold WolffDementias II: Autoimmune John Graham Award: An Award for Encephalopathies and Infections Headache/Facial Pain Research Presenting as Rapidly Progressive S53 General Neurology: Mechanisms and Dementia Diagnosis in Overlapping Medical and C244 Emergency Neurology II: Consultations in Neurological Diseases the General ICU 1:00 p.m.–5:30 p.m. C245 Now You See It, Now You Know It C238 Epilepsy Skills Workshop Pathognomonic Neuro-ophthalmology Findings $ (registration required) S54 Motor Neuron Disease and Myopathies 1:30 p.m.–2:00 p.m. X Research Corner: Invasive/Intraoperative S55 Epilepsy and Clinical Neurophysiology (EEG) III Research S56 Movement Disorders: Huntington’s 1:30 p.m.–3:00 p.m. Disease and Drug-Induced Dyskinesias Curbside Consults: Academic 5:30 p.m.–7:00 p.m. Curbside Consults: Nueromuscular Disorders Closing Party Happy Hour

2:00 p.m.–2:30 p.m.

X Advocacy to Action: Slow and Steady: Building your Advocacy Over Time

X Research Corner: Transitioning from an AAN Research Program Grant to NIH Funding

60

2017 AAN Annual Meeting On-site Guide


Neurology Year in Review Plenary Session Friday, April 28â&#x20AC;&#x192;

9:15 a.m.â&#x20AC;&#x201C;11:30 a.m.

This session will feature six speakers, each focusing on the latest research that has happened in the last year within a specific subspecialty topic

Moderator: Shafali Jeste, MD Member, Science Committee

Peter A. Calabresi, MD, FAAN Johns Hopkins University Baltimore, MD Multiple Sclerosis

Erika Fullwood Augustine, MD, FAAN University of Rochester Medical Center Rochester, NY Pediatric Neurology

Paul Vespa, MD University of California Los Angeles, Los Angeles, CA Neurocritical Care

Brett M. Kissela, MD, MS, FAAN University of Cincinnati Hospital Cincinnati, OH Stroke

Cynthia L. Hardan, MD Mount Sinai Health System New York, NY

FRIDAY



Susan Fox, MD Toronto Western Hospital Toronto, ON, Canada Movement Disorders

Epilepsy

61


NEW! Exhibit Hall

NEW DATES, Sunday, April 23–Wednesday, April 26

The Exhibit Hall is your destination for enjoying good food, socializing, networking, and learning in a fun and relaxed environment. Plan your Exhibit Hall visit today! Exhibit Hall Opening Luncheon

Sunday, April 23, 11:30 a.m.–1:30 p.m. Sponsored by Attend the opening lunch to mingle with fellow attendees and preview the latest products and services available in the neurologic industry.

Office of the Future

Sunday, April 23–Wednesday, April 26 Sponsored by

Ricoh Company, Ltd., and Sunovion Pharmaceuticals

Showcasing recent technological advancements that help physicians streamline their processes, which allows for better patient care. Come explore!

Headshot Lounge

Sunday, April 23–Wednesday, April 26 Sponsored by Visit the Headshot Lounge, located in the Office of the Future pavilion, for your complimentary professional headshot—perfect for updating company bios or social media pages!

Exhibit Hall Networking Reception Monday, April 24, 4:30 p.m.–6:00 p.m.

Sponsored by Network and socialize with fellow attendees in a fun and relaxed environment.

Charging Hubs

Sunday, April 23–Wednesday, April 26 Charge your devices while mingling with other attendees, catching up on work, or simply relaxing in style!

the te in a p i c i Part

to sport s a P ll it Ha Exhib

s! prize y l i a win d


CLOSING PARTY! DON’T MISS THE

Friday, April 28

5:30 p.m.–7:00 p.m.

Celebrate the end of a great meeting at a special early-evening happy hour event! • Enjoy drinks and socializing with colleagues • Swing out to your favorite jazz standards with a live performance by NEURO JAZZ, a four-piece ensemble led by AAN member Phillip Pearl, MD, FAAN • Make plans to explore beautiful, historic Boston afterwards


Industry Therapeutic Update from ACADIA Pharmaceuticals Inc. Tuesday, April 25, 2017 7:00 PM – 10:00 PM Dinner will be served

Treatment Advances in Parkinson's Disease Psychosis: Transforming the Standard of Care for Hallucinations and Delusions Stuart Isaacson, MD

Director Parkinson’s Disease and Movement Disorders Center of Boca Raton Associate Professor of Neurology Florida International University Herbert Wertheim College of Medicine, Miami, FL

L O C AT I O N The Westin Boston Waterfront 425 Summer Street, Boston, MA 02210 Grand Ballroom CDE

Dr. Daniel Kremens, MD, JD

Associate Professor of Neurology, Co-Director, Parkinson's Disease and Movement Disorders Department of Neurology, Sidney Kimmel Medical College, Thomas Jefferson University

LEARNING OBJECTIVES •

This is not an AAN endorsed event. No CME will be given by any accredited organization for the Industry Therapeutic Updates, and the AAN cannot affirm claims pertaining to FDA off-label medication, research use of pre-FDA drugs, or other research information that might be discussed. Industry Therapeutic Updates are industry events. Important Safety Information for NUPLAZID (pimavanserin) 17-mg Tablets WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. NUPLAZID is not approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis.

QT Interval Prolongation: NUPLAZID prolongs the QT interval. The use of NUPLAZID should be avoided in patients with known QT prolongation or in combination with other drugs known to prolong QT interval including Class 1A antiarrhythmics or Class 3 antiarrhythmics, certain antipsychotic medications, and certain antibiotics. NUPLAZID should also be avoided in patients with a history of cardiac arrhythmias, as well as other circumstances that may increase the risk of the occurrence of torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and presence of congenital prolongation of the QT interval. Adverse Reactions: The most common adverse reactions (≥2% for NUPLAZID and greater than placebo) were peripheral edema (7% vs 2%), nausea (7% vs 4%), confusional state (6% vs 3%), hallucination (5% vs 3%), constipation (4% vs 3%), and gait disturbance (2% vs <1%). Drug Interactions: Strong CYP3A4 inhibitors (eg, ketoconazole) increase

Understand the symptoms, diagnosis, and impact of Parkinson’s disease psychosis (PDP) Explore the selective targeting of key serotonin receptors by NUPLAZID® (pimavanserin) Discuss the efficacy, safety, and administration of NUPLAZID, the first and only FDA-approved treatment for hallucinations and delusions associated with PDP

SEATING IS AVAILABLE ON A FIRST-COME, FIRST-SERVED BASIS; NO PRE-REGISTRATION REQUIRED NUPLAZID concentrations. Reduce the NUPLAZID dose by one-half. Strong CYP3A4 inducers may reduce NUPLAZID exposure, monitor for reduced efficacy. Increase in NUPLAZID dosage may be needed. Renal Impairment: No dosage adjustment for NUPLAZID is needed in patients with mild to moderate renal impairment. Use of NUPLAZID is not recommended in patients with severe renal impairment. Hepatic Impairment: Use of NUPLAZID is not recommended in patients with hepatic impairment. NUPLAZID has not been evaluated in this patient population. Pregnancy: Use of NUPLAZID in pregnant women has not been evaluated and should therefore be used in pregnancy only if the potential benefit justifies the potential risk to the mother and fetus. Pediatric Use: Safety and efficacy have not been established in pediatric patients. Dosage and Administration Recommended dose: 34 mg per day, taken orally as two 17-mg tablets once daily, without titration. Indication NUPLAZID is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.

For full Prescribing Information, please visit www.NUPLAZIDhcp.com. ©2017 ACADIA Pharmaceuticals Inc. All rights reserved. NU-0523 03/17


NUPLAZID™ (pimavanserin) tablets, for oral use. Rx only Brief Summary: This information is not comprehensive. Visit www.NUPLAZID.com to obtain the FDA-approved product labeling or call 1-844-422-2342. WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIARELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. NUPLAZID is not approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis.

1 INDICATIONS AND USAGE NUPLAZID™ is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. 2 DOSAGE AND ADMINISTRATION The recommended dose of NUPLAZID is 34 mg, taken orally as two 17-mg strength tablets once daily, without titration. • Coadministration with Strong CYP3A4 Inhibitors The recommended dose of NUPLAZID when coadministered with strong CYP3A4 inhibitors (e.g., ketoconazole) is 17 mg, taken orally as one tablet once daily. • Coadministration with Strong CYP3A4 Inducers Monitor patients for reduced efficacy if NUPLAZID is used concomitantly with strong CYP3A4 inducers; an increase in NUPLAZID dosage may be needed. 4 CONTRAINDICATIONS None. 5 WARNINGS AND PRECAUTIONS Increased Mortality in Elderly Patients with Dementia-Related Psychosis Antipsychotic drugs increase the all-cause risk of death in elderly patients with dementia-related psychosis. Analyses of 17 dementia-related psychosis placebo-controlled trials (modal duration of 10 weeks and largely in patients taking atypical antipsychotic drugs) revealed a risk of death in the drug-treated patients of between 1.6- to 1.7-times that in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in placebo-treated patients. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. NUPLAZID is not approved for the treatment of patients with dementia related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis. QT Interval Prolongation NUPLAZID prolongs the QT interval. The use of NUPLAZID should be avoided in patients with known QT prolongation or in combination with other drugs known to prolong QT interval including Class 1A antiarrhythmics (e.g., quinidine, procainamide) or Class 3 antiarrhythmics (e.g., amiodarone, sotalol), certain antipsychotic medications (e.g., ziprasidone, chlorpromazine, thioridazine), and certain antibiotics (e.g., gatifloxacin, moxifloxacin). NUPLAZID should also be avoided in patients with a history of cardiac

arrhythmias, as well as other circumstances that may increase the risk of the occurrence of torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and the presence of congenital prolongation of the QT interval. 6 ADVERSE REACTIONS The following serious adverse reactions are discussed elsewhere in the labeling: • Increased Mortality in Elderly Patients with Dementia-Related Psychosis • QT Interval Prolongation Clinical Trial Experience The clinical trial database for NUPLAZID consists of over 1200 subjects and patients exposed to one or more doses of NUPLAZID. Adverse reactions that occurred in 6-week, placebocontrolled studies and that were reported at an incidence of ≥2%, and >placebo are presented in the following table. Adverse Reactions (≥2% and >Placebo) Preferred NUPLAZID 34 Placebo Term mg N = 202 N = 231 Nausea 7% 4% Peripheral edema 7% 2% Confusional 6% 3% state Hallucination 5% 3% Constipation 4% 3% Gait disturbance 2% <1% a

Hallucination includes visual, auditory, tactile, and somatic hallucinations

7 DRUG INTERACTIONS QT Interval Prolongation Concomitant use of drugs that prolong the QT interval may add to the QT effects of NUPLAZID and increase the risk of cardiac arrhythmia. Avoid the use of NUPLAZID in combination with other drugs known to prolong QT interval. Strong CYP3A4 Inhibitors Concomitant use of NUPLAZID with a strong CYP3A4 inhibitor increases pimavanserin exposure. If NUPLAZID is used with a strong CYP3A4 inhibitor, reduce the dosage of NUPLAZID. Strong CYP3A4 Inducers Concomitant use of a strong CYP3A4 inducer may reduce pimavanserin exposure resulting in a potential decrease in efficacy. Patients should be monitored for reduced efficacy and an increase in dosage may be needed if NUPLAZID is used concomitantly with strong CYP3A4 inducers. 8 USE IN SPECIFIC POPULATIONS Pregnancy: There are no data on NUPLAZID use in pregnant women that would allow assessment of the drug-associated risk of major congenital malformations or miscarriage. In animal reproduction studies, no adverse developmental effects were seen when pimavanserin was administered orally to rats or rabbits during the period of organogenesis at doses up to 10- or 12times the maximum recommended human dose (MRHD) of 34 mg/day, respectively. Administration of pimavanserin to pregnant rats during pregnancy and lactation resulted in maternal toxicity and lower pup survival and body weight at doses which are 2times the MRHD of 34 mg/day. Lactation: There is no information regarding the presence of pimavanserin in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with

the mother’s clinical need for NUPLAZID and any potential adverse effects on the breastfed infant from NUPLAZID or from the underlying maternal condition. Pediatric Use Safety and effectiveness of NUPLAZID have not been established in pediatric patients. Geriatric Use No dose adjustment is required for elderly patients. Parkinson’s disease is a disorder occurring primarily in individuals over 55 years of age. The mean age of patients enrolled in the 6-week clinical studies with NUPLAZID was 71 years, with 49% 65-75 years old and 31% >75 years old. In the pooled population of patients enrolled in 6-week, placebo-controlled studies (N=614), 27% had MMSE scores from 21 to 24 compared to 73% with scores ≥25. No clinically meaningful differences in safety or effectiveness were noted between these two groups. Renal Impairment No dosage adjustment for NUPLAZID is needed in patients with mild to moderate (CrCL ≥30 mL/min, Cockcroft-Gault) renal impairment. Use of NUPLAZID is not recommended in patients with severe renal impairment (CrCL <30 mL/min, Cockcroft-Gault). NUPLAZID has not been evaluated in this patient population. Hepatic Impairment Use of NUPLAZID is not recommended in patients with hepatic impairment. NUPLAZID has not been evaluated in this patient population. 9 DRUG ABUSE AND DEPENDENCE Controlled Substance NUPLAZID is not a controlled substance. Abuse NUPLAZID has not been systematically studied in humans for its potential for abuse, tolerance, or physical dependence. While short-term, placebocontrolled and long-term, open-label clinical trials did not reveal increases in drug-seeking behavior, the limited experience from the clinical trials do not predict the extent to which a CNS-active drug will be misused, diverted, and/or abused once marketed. 10 OVERDOSAGE Human Experience The pre-marketing clinical trials involving NUPLAZID in approximately 1200 subjects and patients do not provide information regarding symptoms with overdose. In healthy subject studies, dose limiting nausea and vomiting were observed. Management of Overdose There are no known specific antidotes for NUPLAZID. In managing overdose, cardiovascular monitoring should commence immediately and should include continuous ECG monitoring to detect possible arrhythmias. If antiarrhythmic therapy is administered, disopyramide, procainamide, and quinidine should not be used, as they have the potential for QT-prolonging effects that might be additive to those of NUPLAZID. Consider the long plasma half-life of pimavanserin (about 57 hours) and the possibility of multiple drug involvement. 17 PATIENT COUNSELING INFORMATION Concomitant Medication Advise patients to inform their healthcare providers if there are any changes to their current prescription or over-the-counter medications, since there is a potential for drug interactions. CAUTION: Federal law prohibits dispensing without prescription. NUPLAZID™ is a trademark of ACADIA Pharmaceuticals Inc. Distributed by: ACADIA Pharmaceuticals Inc. San Diego, CA 92130


ICW Meetings and Alumni Reunions Friday, April 21 AAN Meetings Diversity Leadership Program Meeting

12:00 p.m.–5:00 p.m.

BCEC 160 C

Enhanced Resident/Medical Student Diversity Reception

5:00 p.m.–7:00 p.m.

Transforming Leaders Program Meeting

12:00 p.m.–5:00 p.m.

BCEC 162 A

Diversity Leadership Program Meeting

12:00 p.m.–4:00 p.m.

BCEC 160 C

Section Leadership Summit

2:30 p.m.–4:00 p.m.

BCEC 259 AB

Transforming Leaders Program Meeting

12:00 p.m.–4:00 p.m.

BCEC 162 A

BCEC 203

Saturday, April 22 AAN Meetings

External Meetings 8:00 a.m.–5:00 p.m.

WEST Webster

Autoimmune Neurology Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Business Administration Section Meeting

5:00 p.m.–6:00 p.m.

WEST Galleria

Careers in Child Neurology Networking Reception

5:30 p.m.–6:00 p.m.

BCEC 157 AB

Consortium of Neurology Clerkship Directors Business Meeting

8:00 a.m.–9:00 a.m.

BCEC 107 ABC

Consortium of Neurology Program Directors Business Meeting

1:00 p.m.–3:00 p.m.

BCEC 107 ABC

Epilepsy Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Geriatric Neurology Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Medical Student Diversity Program Breakfast

7:00 a.m.–9:00 a.m.

BCEC 203

Neurogenetics Section Meeting

5:00 p.m.–6:00 p.m.

WEST Galleria

Neurohealth & Integrative Neurology Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Neurohospitalist Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

World Federation of Neurology

Sunday, April 23 AAN Meetings

66

2017 AAN Annual Meeting On-site Guide


Program Coordinators Business Meeting

3:30 p.m.–5:30 p.m.

BCEC 107 ABC

Publications Committee Meeting

12:00 p.m.–3:00 p.m.

Stroke & Vascular Neurology Section Meeting

5:00 p.m.–6:00 p.m.

WEST Galleria

AUPN Clerkship Directors Course

12:15 p.m.–2:30 p.m.

WEST Hancock

AUPN New Chair Luncheon

12:15 p.m.–1:45 p.m.

WEST Paine

A.B. Baker Section on Neurological Education Meeting

5:30 p.m.–6:30 p.m.

WEST Galleria

ABPN Maintenance of Certification Informational Session

2:00 p.m.–3:00 p.m.

BCEC 259 A

Advanced Practice Provider Networking Reception

6:00 p.m.–9:00 p.m.

WEST Webster

American Brain Foundation Board Meeting

7:30 a.m.–9:30 a.m.

BCEC 102 B

Autonomic Nervous System Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Child Neurology Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Clinical Neurophysiology Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Data Governance Subcommittee Meeting

12:00 p.m.–1:00 p.m.

BCEC 103

Diversity Leadership Program Alumni Reception

4:00 p.m.–6:00 p.m.

REN Atlantic Junior Ballroom Salon 3

Emerging Leaders Forum Alumni Work Group Meeting

7:30 a.m.–9:00 a.m.

BCEC 203

Government Service Section Meeting

5:30 p.m.–6:30 p.m.

WEST Galleria

Industry Roundtable Breakfast

6:30 a.m.–9:00 a.m.

BCEC 259 AB

BCEC 103

External Meetings

ICW Meetings and Alumni Reunions

Monday, April 24 AAN Meetings

BCEC—Boston Convention and Exhibition Center WEST—Westin Boston Waterfront

ALOFT—Aloft Boston Seaport Hotel SHER—Sheraton Boston Hotel

REN—Renaissance Boston Waterfront Hotel 

Locations subject to change • Current as of March 27, 2017

67


ICW Meetings and Alumni Reunions Member Research Subcommittee Meeting

11:30 a.m.–1:00 p.m.

BCEC 107 A

Movement Disorders Section Meeting

5:30 p.m.–6:30 p.m.

WEST Galleria

Neuro-ophthalmology/Neuro-otology Section Meeting

5:30 p.m.–6:30 p.m.

WEST Galleria

Neuroendocrinology Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Neuroepidemiology Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Neurology: Clinical Practice® Editorial Board Meeting

6:45 a.m.–8:45 a.m.

BCEC 254 A

Neuromuscular Section Meeting

7:00 a.m.–8:00 a.m.

WEST Galleria

AUPN Chairs Spring Session

12:15 p.m.–2:15 p.m.

WEST Otis

International ALS Clinical Trials Guidelines Publication Committee Meeting

3:00 p.m.–6:00 p.m.

SHER Berkeley

MedStar Georgetown University Hospital Alumni & Friends Reception

6:00 p.m.–10:00 p.m.

Stanford Neurology Alumni Reunion

5:00 p.m.–8:30 p.m.

ALOFT Mann Ballroom 3

University Hospitals Cleveland Medical Center/Case Western Reserve University Alumni Reunion

6:30 p.m.–8:30 p.m.

SHER Dalton

University of Iowa Alumni Reunion

6:00 p.m.–7:30 p.m.

ALOFT Smoot

UPMC Alumni & Friends Cocktail Reception

7:00 p.m.–9:00 p.m.

WEST Sauciety Restaurant

WVU Neurology Alumni Reunion

6:30 p.m.–9:00 p.m.

WEST Hancock

American Brain Foundation Research Advisory Committee Meeting

7:45 a.m.–8:45 a.m.

BCEC 103

Behavioral Neurology Section Meeting

5:30 p.m.–6:30 p.m.

WEST Galleria

Endovascular & Interventional Neurology Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Enhanced Resident Leadership Program Breakfast

7:00 a.m.–9:00 a.m.

BCEC 203

External Meetings

ALOFT Mahoney Ex:Change

Tuesday, April 25 AAN Meetings

68

2017 AAN Annual Meeting On-site Guide


Ethics Section Meeting

7:00 a.m.–8:00 a.m.

Ethics, Law, and Humanities Committee Meeting

11:30 a.m.–5:00 p.m.

WEST Galleria BCEC 107 A

Guideline Development, Dissemination, and Implementation Subcommittee

12:00 p.m.–4:30 p.m.

General Neurology Section Meeting

7:00 a.m.–8:00 a.m.

WEST Galleria

Global Health Section Meeting

5:30 p.m.–6:30 p.m.

WEST Galleria

Headache & Facial Pain Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

International Subcommittee Meeting

7:30 a.m.–8:30 a.m.

BCEC 107 A

Leadership for Women Subcommittee Meeting

7:30 a.m.–9:00 a.m.

BCEC 259 A

Multiple Sclerosis Section Meeting

5:30 p.m.–6:30 p.m.

WEST Galleria

N2/NG Editorial Board Meeting

11:30 a.m.–1:00 p.m.

BCEC 259 B

Neuro-infectious Disease Section Meeting

7:00 a.m.–8:00 a.m.

WEST Galleria

Neuroimaging Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Neurology® Editorial Board Meeting

6:45 a.m.–8:45 a.m.

REN Atlantic Junior Ballroom

Neuroscience is Critical Work Group Meeting

4:00 p.m.–5:00 p.m.

BCEC 107 C

Sleep Medicine Section Meeting

5:30 p.m.–6:30 p.m.

WEST Galleria

Undergraduate Education Subcommittee Meeting

12:00 p.m.–2:00 p.m.

BCEC 107 C

Women’s Issues in Neurology Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

BCEC 259 A

ICW Meetings and Alumni Reunions

BCEC—Boston Convention and Exhibition Center WEST—Westin Boston Waterfront

Meeting

ALOFT—Aloft Boston Seaport Hotel SHER—Sheraton Boston Hotel

REN—Renaissance Boston Waterfront Hotel 

Locations subject to change • Current as of March 27, 2017

69


ICW Meetings and Alumni Reunions External Meetings

70

ABPN Reception

6:00 p.m.–8:00 p.m.

REN Atlantic Junior Ballroom Salon 3

Alzheimer's Association Reception

6:00 p.m.–8:00 p.m.

Del Frisco's Steakhouse Boston

Association of Indian Neurologists in America Annual Meeting

6:00 p.m.–10:00 p.m.

SHER Commonwealth

Baylor College of Medicine Neurology Alumni Reception

6:00 p.m.–8:30 p.m.

SHER Public Garden

Cleveland Clinic AAN Alumni Reception

6:00 p.m.–7:30 p.m.

WEST Hancock

Columbia University, Neurological Institute of New York 2017 Alumni Reception

6:00 p.m.–8:00 p.m.

REN Atlantic Junior Ballroom Salon 2

Cornell Neurology Reunion

6:30 p.m.–8:30 p.m.

SHER Riverway

Duke University Neurology Alumni Meeting

5:00 p.m.–7:00 p.m.

ALOFT Mahoney Ex:Change

Harvard Neurology Alumni Reception

5:30 p.m.–7:30 p.m.

ALOFT Summer Ballroom

Mayo Clinic Alumni Association Reception

6:00 p.m.–8:00 p.m.

SHER Fairfax

MedLink Neurology Editorial Board Meeting

7:30 a.m.–9:00 a.m.

WEST Paine

Northwestern Alumni Reception

5:30 p.m.–7:30 p.m.

WEST Otis

Pak American Neurology Society Meeting

6:00 p.m.–9:00 p.m.

SHER Berkeley

Society for Behavioral and Cognitive Neurology

6:00 p.m.–9:00 p.m.

WEST Lewis

Thomas Jefferson University Alumni Reception

5:30 p.m.–7:30 p.m.

SHER Beacon A

UCLA Neurology Alumni Reception

6:30 p.m.–10:00 p.m.

University of Chicago Neurology Alumni Reception

6:00 p.m.–7:30 p.m.

SHER The Fens

University of Cincinnati Alumni and Friends Reception

6:00 p.m.–7:30 p.m.

WEST Paine

2017 AAN Annual Meeting On-site Guide

Seaport Hotel and World Trade Center


6:30 p.m.–9:30 p.m.

SHER Clarendon A

University of Massachusetts Alumni Reunion

5:00 p.m.–8:00 p.m.

Top Catch at Joe's Waterfront

University of Miami Alumni Association Reception

5:30 p.m.–8:30 p.m.

WEST Webster

University of Rochester Alumni Reunion

6:00 p.m.–8:00 p.m.

SHER Gardner

UNMC Department of Neurological Sciences Faculty and Alumni Reception

6:00 p.m.–8:00 p.m.

SHER Boston Common

UVA Alumni Reception

7:00 p.m.–9:30 p.m.

SHER Back Bay A

Wake Forest Baptist Alumni, Faculty and Friends Reception

6:00 p.m.–8:30 p.m.

REN Atlantic Junior Ballroom Salon 1

AAN/CNS/CNF Child Neurology Work Group Meeting

12:00 p.m.–1:00 p.m.

BCEC 107 C

Advanced Practice Provider Bring-YourOwn-Lunch Networking

11:30 a.m.–12:30 p.m.

BCEC 259 B

Critical Care & Emergency Neurology Section Meeting

5:30 p.m.–6:30 p.m.

WEST Galleria

History of Neurology Section Meeting

5:30 p.m.–6:30 p.m.

WEST Galleria

LGBTQI Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Neural Repair & Rehabilitation Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Neuro-oncology Section Meeting

5:30 p.m.–6:30 p.m.

WEST Galleria

Pain & Palliative Care Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Spine Section Meeting

12:00 p.m.–1:00 p.m.

WEST Galleria

Sports Neurology Section Meeting

5:30 p.m.–6:30 p.m.

WEST Galleria

ICW Meetings and Alumni Reunions

University of Maryland School of Medicine Neurology Alumni Reception

Wednesday, April 26 AAN Meetings

BCEC—Boston Convention and Exhibition Center WEST—Westin Boston Waterfront

ALOFT—Aloft Boston Seaport Hotel SHER—Sheraton Boston Hotel

REN—Renaissance Boston Waterfront Hotel 

Locations subject to change • Current as of March 27, 2017

71


ICW Meetings and Alumni Reunions External Meetings Boston University School of Medicine Department of Neurology Alumni Reception

7:00 p.m.–9:00 p.m.

ALOFT Mann Ballroom 3

American Brain Foundation: Commitment to Cures

7:00 p.m.–9:30 p.m.

WEST Marina Ballroom

Fusion Clinical Multimedia Dual Discipline BostonInteractive Medicine Society

7:00 p.m.–9:00 p.m.

WEST Hancock

NEALS Consortium

7:15 a.m.–8:15 a.m.

SHER Commonwealth

NeuroNEXT Reception

5:30 p.m.–7:30 p.m.

ALOFT Mahoney Ex: Change

Thursday, April 27 External Meetings Transitioning Peds/Adult IDD Care Roundtable

8:00 a.m.–11:00 a.m.

BCEC—Boston Convention and Exhibition Center WEST—Westin Boston Waterfront

ALOFT—Aloft Boston Seaport Hotel SHER—Sheraton Boston Hotel

REN—Renaissance Boston Waterfront Hotel

72

Locations subject to change • Current as of March 27, 2017

2017 AAN Annual Meeting On-site Guide

WEST Otis


dule e h c S ram g o r P e ienc c S g n i erg m E 7 1 20

F

ollowing is the schedule of Emerging Science abstracts to be presented at the 2017 AAN Annual Meeting. Abstracts qualify for Emerging Science presentations by having key aspects of research conducted after the October 24 abstract submission deadline and must be new and of sufficient scientific importance to warrant expedited presentation and publication.

The Science Committee is committed to presenting the best neuroscientific research at the Annual Meeting so we are excited to announce that we are presenting 23 abstracts as part of the Emerging Science program. 14 dual presentation abstracts will be featured in data blitz format during the first 45 minutes of the Emerging Science Platform session on Tuesday, April 25, from 5:45 p.m. to 6:30 p.m., followed by poster presentations in the same room from 6:30 p.m. to 7:15 p.m. In addition, four poster presentations will be included in Poster Session IV on Wednesday, April 26, from 8:30 a.m. to 7:00 p.m. and four poster presentations will be included in Poster Session V on Thursday, April 27, from 8:30 a.m. to 7:00 p.m. And finally, one abstract will be presented during the Clinical Trials Plenary Session on Tuesday, April 25, from 9:15 a.m. to 11:00 a.m. The 2017 Emerging Science abstracts are embargoed until 12:01 a.m. Eastern time on Friday, April 21.


Emerging Science Emerging Science Platform Session Tuesday, April 25, 2017, 5:45 p.m.–7:15 p.m.

001 A Phase 3, Randomized,

005 Motor effects and safety

002 Non-invasive Vagus Nerve

006 Results of a Phase 1 Study

Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Erenumab in Migraine Prevention: Primary Results of the ARISE Trial David W. Dodick, MD, FAAN Phoenix, AZ

Stimulation for the Acute Treatment of Episodic and Chronic Cluster Headache: Findings From the Randomized, Double-blind, ShamControlled ACT2 Study Peter Goadsby, MD, PhD San Francisco, CA

003 Double-blind, randomized,

placebo-controlled, Phase III study (TOLEDO) to evaluate the efficacy of apomorphine subcutaneous infusion in reducing OFF time in Parkinson’s disease patients with motor fluctuations not well controlled on optimized medical treatment Regina Katzenschlager, MD Vienna, Austria

004 Intraputaminal AADC gene

therapy for advanced Parkinson's disease: Interim Results of a Phase 1b Trial Chadwick W. Christine, MD San Francisco, CA

of IPX203, an investigational extended-release formulation of carbidopa-levodopa, in advanced Parkinson’s disease: A single-dose Phase 2 study Mark Stacy, MD, FAAN Durham, NC

of ABBV-8E12 in Patients with Progressive Supranuclear Palsy and Phase 2 Study Design in Alzheimer’s Disease and PSP Hana Florian North Chicago, IL

007 Sustained seizure reduction

with adjunctive everolimus for treatment-refractory seizures associated with tuberous sclerosis complex (TSC): Long-term results from the phase 3 EXIST-3 study David N. Franz, MD Cincinnati, OH

008 Cannabidiol (CBD)

significantly reduces drop seizure frequency in Lennox-Gastaut syndrome (LGS): results of a doseranging, multi-center, randomized, double-blind, placebo-controlled trial (GWPCARE3) Anup D. Patel, MD Columbus, OH

009 Efficacy and safety of

nusinersen in children with lateronset spinal muscular atrophy (SMA): interim results of the phase 3 CHERISH study Richard S. Finkel, MD Orlando, FL

74

2017 AAN Annual Meeting On-site Guide

010 Subcutaneous

immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: the PATH Study Ivo N. Van Schaik, MD Amsterdam, Netherlands

011 Results of a Phase 1b/2

Study of ATYR1940 in Adult Patients with Limb Girdle Muscular Dystrophy Type 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD) (ATYR1940-C-004) John Vissing, MD Copenhagen, Denmark

012 Dual Responder Analyses of

Both Muscle Strength and Activities of Daily Living, Eculizumab Versus Placebo, in Refractory Generalized Myasthenia Gravis (gMG) Patients: Results from the REGAIN Study James F. Howard, Jr., MD FAAN, Chapel Hill, NC

013 Comparison of protein-coding and long, non-coding RNA gene expression signatures to classify multiple sclerosis Charles Spurlock, III, PhD Nashville, TN

014 A ‘surface-in’ gradient

of thalamic damage is an early and disease-specific process in pediatric-onset multiple sclerosis Giulia Fadda, MD Montreal, QC, Canada


Poster Session IV

Wednesday, April 26, 2017, 8:30 a.m.–7:00 p.m.

P4.406 Delayed-release Dimethyl Fumarate

Reduces the Formation of T2 Lesions in Pediatric Patients with Relapsing-Remitting MS: Results From FOCUS, the First Clinical Trial to Evaluate the Neuroradiological Efficacy of an MS Disease-Modifying Therapy in Pediatric Patients Satish Eraly, MD, PhD Cambridge, MA

P4.407 Patients Who Received Alemtuzumab in

CARE-MS I or II Show a Low Rate of Conversion From Relapsing-Remitting MS to Secondary Progressive MS Through 6 Years Dana Horakova, MD, PhD Prague, Czech Republic

P4.408 Symptomatic and objective clinical

improvement in progressive multiple sclerosis patients treated with autologous Epstein–Barr virus-specific T cell therapy: Interim results of a phase I trial Michael Pender, MD, PhD Brisbane, Australia

P4.409 Radiological Evidence for the Long-Term Effect of Fingolimod Treatment in Patients with Relapsing-Remitting Multiple Sclerosis Jeffrey Allan Cohen, MD Cleveland, OH

EMERGING SCIENCE



Emerging Science Poster Presentations

Poster Session V Thursday, April 27, 2017, 8:30 a.m.–7:00 p.m.

P5.409 3D Mathematical modeling of glioblastoma P5.411 Seizures are locked to long time-scale suggests that transdifferentiated vascular endothelial cells promote resistance to current standard-of-care therapy Daniela Bota, MD Orange, CA

rhythms in epilepsy Maxime Baud, MD, PhD San Francisco, CA

P5.412 The differential effects of eicosapentaenoic

P5.410 Cholinesterase Inhibitor Use and Cognitive Decline in Mild Cognitive Impairment and Mild Dementia due to Alzheimer Disease Jee-young Han St. Louis, MO

(EPA) and docosahexaenoic (DHA) acids on seizure frequency in patients with drug-resistant epilepsy – A Randomized, double-blind, placebo-controlled trial Ahmed Daak, MD, PhD Riviera Beach, FL

Clinical Trials Plenary Session Tuesday, April 25, 2017, 9:15 a.m.–11:30 a.m Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention: Primary Results of the STRIVE Trial Peter Goadsby, MD, PhD San Francisco, CA

75


Emerging Science 001 

5:45 p.m.–5:48 p.m..

EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 A Phase 3, Randomized, Double-Blind, PlaceboControlled Study to Evaluate the Efficacy and Safety of Erenumab in Migraine Prevention: Primary Results of the ARISE Trial David Dodick, MD, FAAN; Messoud Ashina, MD, PhD; David Kudrow, MD; Michel Lanteri-Minet, MD; Vera Osipova; Kerry Paler; Hernan Picard; Daniel Mikol; Robert Lenz Objective: Efficacy and safety of erenumab, a human anti-calcitonin gene-related peptide (CGRP) receptor monoclonal antibody, were evaluated in patients with episodic migraine (EM) in a phase 3 trial (NCT02483585). Background: CGRP plays an important role in migraine pathophysiology. Erenumab is a fully human monoclonal antibody that inhibits the CGRP receptor and is being evaluated as a prophylactic treatment for migraine. Design/Methods: 577 adults with EM were randomized 1:1 to subcutaneous, monthly placebo or erenumab (70mg). Primary endpoint was change in monthly migraine days (MMDs) from baseline to weeks 9-12 of a 12-week double-blind phase. Secondary endpoints were achievement of ≥50% reduction in MMDs, change in acute migraine-specific medication use, and ≥5-point reduction in Physical Impairment (PI) and Impact on Everyday Activities (EA) measured by the Migraine Physical Function Impact Diary. Statistical significance was determined after adjustment for multiple comparisons. Results: Patients reported a

76

2017 AAN Annual Meeting On-site Guide

mean 8.3 MMDs at baseline. Those receiving erenumab experienced a mean -2.9-day change (reduction) from baseline in MMDs, compared to a ?1.8-day reduction for placebo (p<0.001). A ≥50% reduction in MMDs was achieved by 40% and 30% in erenumab and placebo groups (odds ratio: 1.6; p=0.010). Monthly acute migrainespecific medication use was reduced by mean -1.2 and -0.6 days (p=0.002). Respective ≥5-point reductions (improvement) in PI were achieved by 33% and 27% of patients (p=0.13) and in EA by 40% and 36% (p=0.26). The safety profile of erenumab was similar to placebo. Most frequently reported AEs across both groups were upper respiratory tract infection, injection site pain, and nasopharyngitis. Conclusions: Erenumab statistically significantly reduced migraine frequency, acute migraine-specific medication use, and a greater proportion of patients achieved ≥50% reduction in MMDs compared to placebo in this phase 3 trial in EM. Study Supported By: Study funded by Amgen Inc.

002 

5:48 p.m.–5:51 p.m.

EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 Non-invasive Vagus Nerve Stimulation for the Acute Treatment of Episodic and Chronic Cluster Headache: Findings From the Randomized, Double-blind, Sham-Controlled ACT2 Study Peter Goadsby, MD, PhD; Ilse de Coo; Nicholas Silver, MBBS, PhD; Alok Tyagi, MD; Fayyaz Ahmed, MD; Charly Gaul; Rigmor Jensen, MD; H.


Objective: Evaluate non-invasive vagus nerve stimulation (nVNS; gammaCore®) as acute treatment in episodic or chronic cluster headache (eCH, cCH). Background: Clinical observations and recent studies support nVNS use in CH. Design/Methods: Adults with CH received nVNS or sham therapy during a 2-week double-blind period.At attack onset, subjects self-administered three consecutive 120-second stimulations to the vagus nerve (cervical branch). If the attack was not aborted within 9 minutes, three additional stimulations were permitted. Subjects were to refrain from using rescue treatments for 15 minutes after treatment initiation; efficacy end points were assessed at this time. The primary end point was the proportion of attacks that achieved pain-free status (pain score=0). Additional end points included change in pain intensity (0-4 point scale) and proportions of subjects with responder status (pain score=0-1) for ≥50% of attacks. Results: Efficacy evaluations included 48 nVNS-treated (14 eCH, 34 cCH) and 44 sham-treated (13 eCH, 31 cCH) subjects. In the total cohort, proportions of attacks with pain-free status did not differ significantly between treatments (nVNS, 14%; sham, 12%); in the eCH subgroup, nVNS (48%) was superior to sham (6%; PP=0.01); the cCH subgroup showed no significant treatment difference (nVNS, 1.2; sham, 1.0).Proportions of subjects with responder status for 50% of attacks were significantly higher with nVNS in the total cohort (nVNS, 40%; sham, 14%; PP Conclusions: This study supports the acute use of nVNS in patients with eCH but not cCH. Study Supported By: This study was sponsored by electroCore, LLC

003 

5:51 p.m.–5:54 p.m.

EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 Double-blind, randomized, placebo-controlled, Phase III study (TOLEDO) to evaluate the efficacy of apomorphine subcutaneous infusion in

reducing OFF time in Parkinson’s disease patients with motor fluctuations not well controlled on optimized medical treatment Regina Katzenschlager, MD; Werner Poewe, MD; Olivier Rascol, MD, PhD; Claudia Trenkwalder; Guenther Deuschl, MD, FAAN; Kallol Chaudhuri, MD,FRCP; Tove Henriksen; Teus Van Laar, MD, PhD; Kevin Spivey; Senthil Vel; Andrew Lees MD, FRCP Objective: TOLEDO (NCT02006121) is the first prospective, randomized, multicenter, double-blind study to investigate the efficacy of apomorphine subcutaneous infusion (APO) versus placebo in Parkinson’s disease (PD) patients with motor fluctuations not well controlled on optimized medical treatment. Background: Although extensive data from open-label studies with APO demonstrate its efficacy in reducing OFF time, dyskinesias and oral levodopa dose in patients with severe motor fluctuations that are poorly controlled by conventional therapy, evidence from randomized, blinded studies has been lacking. Design/Methods: Patients from 23 centers in 7 countries were randomized to receive APO during their waking time (16±2 hours; ≤8 mg/ hour), or placebo saline infusion using the same pump system. Based on efficacy and tolerability, the hourly flow rate of the infusion and dose of concomitant antiparkinsonian medication were adjusted during the first 4 weeks. The primary endpoint was the absolute change in OFF time from baseline to Week 12 based on patient diaries. Results: Compared with placebo (n=53), APO (n=53) provided significantly greater reduction (improvement) in OFF time between baseline and Week 12 (-0.58 hours versus -2.47 hours, respectively), a difference between treatment groups of -1.89 hours (95% CI: -3.16, -0.62; p=0.0025). The reduction in OFF time with APO was observed within the first week of treatment and sustained over 12 weeks, and was associated with a significantly greater increase in ON time without troublesome dyskinesia. The beneficial effects of APO were reflected in higher scores for Patient Global Impression of Change versus placebo at Week 12 (p<0.001). APO was generally well tolerated and no unexpected adverse events were observed. Conclusions:

EMERGING SCIENCE



Diener, MD, FAAN; Andreas Straube; Eric Liebler; Juana Marin, MD; Michel Ferrari, MD, PhD

77


Emerging Science These results show Level 1 evidence that APO provides a significant and clinically meaningful reduction in OFF time without increasing dyskinesias in patients whose motor fluctuations cannot be controlled with current standard of care, filling an important knowledge gap. Study Supported By: Britannia Pharmaceuticals Ltd.

004 

5:54 p.m.–5:57 p.m.

EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 Intraputaminal AADC gene therapy for advanced Parkinson's disease: Interim Results of a Phase 1b Trial Chadwick Christine, MD; Krzysztoffs Bankiewicz, MD; Amber Van Laar, MD; Mark Richardson, MD, PhD; Bernard Ravina, MD, MSCE; Adreian Kells, PhD; Brendon Boot, MD, MBBS; Alastair Martin, PhD; Marin Thompson, MS; Paul Larson Objective: This trial was designed to evaluate the safety of gene therapy with human aromatic L-amino acid decarboxylase (AADC) AAV-hAADC using large infusion volumes and intraoperative MRI to improve delivery. Background: Levodopa therapy for Parkinson’s disease (PD) becomes less effective over time, possibly due to progressive loss of aromatic L-amino acid decarboxylase (AADC) which converts levodopa into dopamine. In a prior study of AAV-hAADC using low volume (100µl) infusions into bilateral putamen, we obtained limited anatomical coverage. Design/ Methods: Ten subjects with advanced PD received bilateral infusion of AAV-hAADC vector (0.83 x 1012 vg/ml) co-infused with gadoteridol. Five subjects in cohort 1 received up to 450 μl/ putamen and 5 subjects in cohort 2 received up to 900 μl/putamen. 18F-dopa PET was obtained at baseline and 6 months post-procedure to assess gene expression. Results: Twenty one percent of the putamen was covered by vector in cohort 1 and 34% in cohort 2. Treatment was well tolerated with no vector related SAEs. There was one post-procedure pulmonary embolus which resolved. Enzyme activity increased on 18F-dopa PET by 13% in cohort 1 and 56% in cohort 2.

78

2017 AAN Annual Meeting On-site Guide

Five subjects in cohort 1 and 3 in cohort 2 have completed the 12-month evaluation. At 12 months, mean off-medication UPDRS motor scores fell by 16.4 points in cohort 1 and 14.3 in cohort 2. On-medication scores increased 1.8 points in cohort 1, but fell 9.3 in cohort 2. Due to improved motor function, daily levodopa equivalents were reduced an average of 10% for cohort 1 and 35% for cohort 2. On-time without troublesome dyskinesias, measured by motor diaries, increased by 1.6 hours in cohort 1 and 4.1 hrs in cohort 2 at 12 months. Conclusions: These interim results show that AAV-hAADC gene therapy using intraoperative MRI is well-tolerated, provides dose-dependent gene expression and potential clinical efficacy. Study Supported By: The Michael J. Fox Foundation for Parkinson’s Research (Grant # 7266) and Voyager Therapeutics ClinicalTrials.gov Identifier: NCT01973543

005 

5:57 p.m.–6:00 p.m.

EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 Motor effects and safety of IPX203, an investigational extended-release formulation of carbidopa-levodopa, in advanced Parkinson’s disease: A single-dose Phase 2 study Mark Stacy, MD, FAAN; Victor Biton, MD, FAAN; Jason Aldred, MD, FAAN; Aaron Ellenbogen, DO; Robert Rubens, MD, MBA; Nishit Modi; Aravind Mittur; Sarita Khanna; Suneel Gupta, PhD Objective: Evaluate the efficacy and safety of IPX203 vs. immediate-release (IR) carbidopalevodopa (CD-LD) and vs. extended-release (ER) CD-LD (IPX066, RYTARY®) in patients with advanced Parkinson’s disease (PD). Background: Motor fluctuations and dyskinesias often accompany treatment with IR CD-LD in advanced PD. ER reduces “off” time and improves “on” time without troublesome dyskinesia vs. IR. IPX203 is an investigational extended-release capsule formulation of CD-LD aimed at further improving the clinical response over that from


Mueller; Diana Kerwin; Adam Boxer, MD, PhD; David Holtzman, MD, FAAN

Objective: To present the results of a phase 1 study of ABBV-8E12 in patients with Progressive Supranuclear Palsy (PSP) and phase 2 study designs. Background: ABBV-8E12 is a humanized anti-tau monoclonal antibody being developed for the treatment of PSP and Alzheimer’s disease (AD). Design/Methods: The phase 1 study was a double-blind, placebocontrolled, single dose study assessing the safety, tolerability, and pharmacokinetics of ABBV-8E12 in PSP patients (NCT02494024). Patients were randomized 3:1 to drug or placebo and received an intravenous dose of ABBV-8E12 (2.5, 7.5, 15, 25, 50 mg/kg) or placebo. Safety was monitored for 84 days post-dosing. Results: Thirty patients were enrolled/randomized. At screening, the mean (SD) patient age was 69.4 (7.4) years and the mean PSP Rating Scale score was 35.6 (7.6). Twenty-seven patients completed the 84-day follow-up and 1 (3.3%) patient withdrew from the study due to AE. AEs occurred in 21 of the 30 (70%) participants. AEs with the highest incidence were dermatitis (n=5) and fall (n=5). Noncompartmental analysis based on the complete pharmacokinetic dataset indicates dose-proportional increases in AUC and Cmax. A phase 2 study evaluating the 52-week efficacy and safety of ABBV-8E12 in PSP patients is currently recruiting (NCT02985879). Eligible patients (n=180) will meet criteria for possible/ Study Supported By: probable PSP and have symptoms for <5 years. A Impax Laboratories, Inc. separate phase 2 study is designed to evaluate the safety and efficacy of ABBV-8E12 in patients (n=400) with early Alzheimer’s disease (AD) for 006  6:00 p.m.–6:03 p.m. up to 96 weeks (NCT02880956). Conclusions: EMBARGOED FOR RELEASE UNTIL 12:01 When administered as a single dose up to 50 AM FRIDAY, APRIL 21, 2017 mg/kg in PSP patients, ABBV-8E12 exhibited Results of a Phase 1 Study of ABBV-8E12 in an acceptable safety and tolerability profile to Patients with Progressive Supranuclear Palsy and support repeat-dose testing in patients Phase 2 Study Design in Alzheimer’s Disease with tauopathies. and PSP Study Supported By: Hana Florian; Tim West; Joel Braunstein; Ilana This work was funded by C2N Diagnostics and Fogelman; Yvette Bordelon, MD; Irene Litvan, AbbVie Inc. C2N and AbbVie participated in the MD, FAAN; Erik Roberson, MD, PhD; Helen Hu; study design, research, data collection, analysis Philip Verghese; Randall Bateman, MD; Nuno and interpretation of data, writing, reviewing, and Mendonca; Deli Wang; Davis Ryman, MD, PhD; approving the publication.Amy M. Spiegel, PhD, of Laura Gault; Kumar Budur; Beatrice Rendenbach- AbbVie Inc., provided medical writing assistance.

EMERGING SCIENCE



ER. Design/Methods: An open-label, raterblinded, randomized, crossover study compared the response of advanced PD patients to single doses of IR, ER, and IPX203. Patients on a stable IR regimen (≥400 mg LD/day, given ≥4x/day) were rated by trained personnel as “off” or as “on” with or without troublesome dyskinesia every 30 min after dosing. The Unified PD Rating Scale (MDS-UPDRS) Part III was completed hourly for 10 hours after dosing. Adverse events (AEs) were also recorded. Results: Twenty-five of 26 patients completed all 3 periods. The proportion of patients turning “on” by hour 1 was similar between IR, ER, and IPX203. IPX203 decreased mean (±SD) “off” time (4.5±2.0 hr) vs. IR (7.2±1.3 hr, p<.0001) and vs. ER (5.4±1.9 hr, p<.05). IPX203 correspondingly increased “on” time vs. both comparators without significantly increasing troublesome dyskinesia. IPX203 increased the duration of both a 4-point improvement [IPX203: 6.1 hr; IR: 3.7 hr (p<.0001); ER: 5.2 hr (p<.05)] and a 13-point improvement [IPX203: 4.8 hr; IR: 2.2 hr (p<.0001); ER: 3.6 hr (p<.05)] in the MDS-UPDRS Part III. AEs were reported by 28.0% (IR), 8.0% (ER), and 19.2% (IPX203) of patients. AEs reported by ≥2 patients in any treatment were nausea, dizziness, and hypertension; no serious AEs were reported. Conclusions: IPX203 significantly increased the duration of motor symptom improvement compared to both IR and ER CD-LD, without increasing troublesome dyskinesia.

79


Emerging Science years, confirming sustained benefit over time. No increase in emergence of treatment-related adverse events (AEs) over time was observed EMBARGOED FOR RELEASE UNTIL 12:01 (<6 months, 77.8%; 6-12 months, 46.2%; AM FRIDAY, APRIL 21, 2017 2nd year, 45.5%). Grade 3/4 AEs (any cause) Sustained seizure reduction with adjunctive occurred in 40.2% of patients. Forty-seven everolimus for treatment-refractory seizures patients (13%) discontinued due to AEs, primarily associated with tuberous sclerosis complex (TSC): pneumonia (1.7%) and stomatitis (1.4%). Two Long-term results from the phase 3 EXIST-3 study deaths (pneumonia, SUDEP) were reported. Conclusions: Sustained reductions in TSCDavid Franz, MD; John Lawson; Zuhal Yapici; Hiroko Ikeda; Tilman Polster; Rima Nabbout; Paolo associated treatment-refractory seizures over time were achieved with adjunctive everolimus. Curatolo; Petrus de Vries; Dennis Dlugos, MD; Maurizio Voi; Jenna Fan; Severine Peyrard; Diana Safety profile was consistent with the core phase; AE emergence frequency did not increase Pelov; Jacqueline French, MD, FAAN over time. Objective: Assess long-term efficacy and Study Supported By: safety of everolimus as adjunctive therapy Novartis Pharmaceutical Corporation for TSC-associated treatment-refractory seizures. Background: Epilepsy occurs in 85% of patients with TSC; ~60% become 008  6:06 p.m.–6:09 p.m. refractory to antiepileptic drugs (AEDs). EXIST-3 (NCT01713946) demonstrated significantly EMBARGOED FOR RELEASE UNTIL 12:01 reduced seizure frequency with everolimus versus AM FRIDAY, APRIL 21, 2017 placebo. Design/Methods: Patients (2-65 Cannabidiol (CBD) significantly reduces drop years) with TSC-associated refractory seizures seizure frequency in Lennox-Gastaut syndrome receiving 1-3 AEDs were included. Following (LGS): results of a dose-ranging, multi-center, the 18-week core phase, patients could enter randomized, double-blind, placebo-controlled the extension phase and receive everolimus trial (GWPCARE3) (target exposure=3-15 ng/mL) until ≥48 weeks. Anup Patel, MD; Orrin Devinsky, MD, FAAN; J. Efficacy endpoints included change from Helen Cross; Vicente Villanueva; Elaine Wirrell, baseline in average weekly seizure frequency (response rate [RR], ≥50% reduction), and median MD; Kevan VanLandingham, MD, PhD; Claire Roberts; Daniel Checketts; Sameer Zuberi percentage reduction (PR) in seizure frequency. Results: 361/366 patients received everolimus Objective: Evaluate efficacy of add-on CBD for in core or extension phases. RR at week 18 was the treatment of drop seizures associated with 31% (95%CI:26.2-36.1; N=352) versus 46.6% LGS. Background: Class 1 evidence of efficacy (95%CI:40.9-52.5; N=298) at 1 year and 57.7% with CBD in epilepsy is needed. This is the second (95%CI:49.7-65.4; N=163) at 2 years. Greater controlled trial of CBD oral solution in LGS. benefit was observed in younger patients at 1 Design/Methods: Eligible patients were 2–55 year of follow-up. Median PR in seizure frequency years old with a clinical diagnosis of LGS, ≥8 drop was 31.7% (95%CI:28.5-36.1) at week 18 versus seizures during 4-week baseline, and documented 46.7% (95%CI:40.2-54) at 1 year and 56.9% failures on ≥1 antiepileptic drug (AED). Patients (95%CI:50-68.4) at 2 years. Ninety-five patients were randomized (1:1:1) to receive CBD 20mg/kg/ discontinued everolimus before 2 years; 103 day, CBD 10mg/kg/day, or placebo for 14 weeks patients had <2 years of follow up at study (2-week titration; 12-week dose maintenance). cut-off. Sensitivity analysis (early discontinued The primary efficacy endpoint was percentage patients considered non-responders) showed change from baseline in drop seizures/month over RR of 30.2% (95%CI:25.5-35.2; N=361) at week the 14-week treatment period for CBD vs placebo. 18 versus 38.8% (95%CI:33.7-44.1; N=358) at Results: 225 patients were randomized (76 CBD 1 year and 41% (95%CI:34.6-47.7; N=229) at 2

007 

80

6:03 p.m.–6:06 p.m.

2017 AAN Annual Meeting On-site Guide


oligonucleotide for the treatment of SMA that alters SMN2 gene splicing to promote the production of full-length SMN protein. Design/ Methods: Children with symptomatic SMA aged 2-12 years were randomized 2:1 (stratified based on screening age <6 versus ≥6 years) to receive 4 doses of intrathecal nusinersen (12mg non-scaled) or sham procedure over 15 months. Key inclusion criteria include confirmed 5q SMA and onset of SMA clinical symptoms at age >6 months. The primary endpoint was change in the Hammersmith Functional Motor Scale–Expanded (HFMSE) score at month 15. Secondary endpoints included proportion of children with ≥3-point increase in HFMSE score, proportion with achievement of new WHO motor milestones, and change in revised Upper Limb Module (RULM) test at month 15. Safety/ tolerability were also assessed. Results: At the time of this pre-specified interim analysis (August 31, 2016), CHERISH enrolled 126 children. A highly clinically and statistically significant difference in motor function as assessed by mean HFMSE score at 15 months was observed between the nusinersen and sham-control group (least square mean treatment difference [95% CI]=5.9 [3.7,8.1] Study Supported By: points; P=0.0000002). HFMSE scores increased GW Research, Ltd ≥3 points in 57.3% of nusinersen-treated versus 20.5% of sham-treated children; 17.1% versus 10.5% achieved new WHO motor milestones, 009  6:09 p.m.–6:12 p.m. respectively. Greater improvement in RULM score was observed in the nusinersen versus EMBARGOED FOR RELEASE UNTIL 12:01 sham-control group (least square mean treatment AM FRIDAY, APRIL 21, 2017 difference=3.4 points). Nusinersen demonstrated Efficacy and safety of nusinersen in children with a favorable safety profile consistent with other later-onset spinal muscular atrophy (SMA): interim published results, and no children discontinued results of the phase 3 CHERISH study the study or treatment. Additional secondary endpoints will be reported. Conclusions: Richard Finkel, MD; Eugenio Mercuri; Jan Significant improvements in motor function were Kirschner; Claudia A. Chiriboga; Nancy Kuntz; observed in nusinersen- versus sham-treated Basil T. Darras; Perry B. Shieh; Kayoko Saito; children. Nusinersen demonstrated a favorable Darryl De Vivo, MD, FAAN; John W. Day; Elena S. Mazzone; Jacqueline Montes; Qingqing Yang; safety profile. Children from CHERISH will be transitioned into the SHINE (NCT02594124) Zhenshao John Zhong; Sarah Gheuens; C. Frank open-label extension study. Bennett; Eugene Schneider; Wildon Farwell

EMERGING SCIENCE



20mg/kg, 73 CBD 10mg/kg, 76 placebo); 9 CBD 20mg/kg, 2 CBD 10mg/kg, and 2 placebo patients withdrew early. Groups were similar at baseline; mean age was 16 years (30% of patients ≥18 years) and median monthly drop seizure frequency was 85 (IQR: 44, 168). Patients had previously failed a median of 6 and were taking a median of 3 AEDs. Reduction in drop seizure frequency was significantly greater for CBD 20mg/kg (42%) and CBD 10mg/kg (37%) than placebo (17%; p=0.0047 and p=0.0016). Adverse events (AEs) occurred in 94% of CBD 20mg/kg, 84% of CBD 10mg/ kg, and 72% of placebo patients, and most were mild or moderate; the two most common were somnolence and decreased appetite. Treatmentrelated serious AEs were reported in 5 CBD 20mg/kg, 2 CBD 10mg/kg, and 0 placebo patients. Some elevations in transaminases were seen. There were no deaths. Of the 212 completers, 99% entered the open-label extension study. Conclusions: Results suggest that CBD addon therapy for the treatment of drop seizures associated with LGS may be efficacious, with more adverse events than placebo but generally well-tolerated. (NCT02224560)

Objective: The phase 3, multicenter, randomized, Study Supported By: double-blind, sham-procedure controlled CHERISH Ionis Pharmaceuticals, Inc. and Biogen study (NCT02292537) assessed the efficacy and safety of nusinersen in children with later-onset SMA. Background: Nusinersen is an antisense

81


Emerging Science 010 

6:12 p.m.–6:15 p.m.

EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: the PATH Study Ivo Van Schaik, MD; Vera Bril, MD; Nan van Geloven; Hans-Peter Hartung, MD, FAAN; Richard Lewis, MD, FAAN; Gen Sobue, MD; John-Philip Lawo, PhD; Orell Mielke, MD; Billie L Durn; David R Cornblath; Ingemar Merkies, MD; on behalf of the PATH study group Objective: To determine efficacy of IgPro20 for CIDP Background: Approximately two-thirds of CIDP subjects need long-term corticosteroids or intravenous immunoglobulins (IVIg), with IVIg being slightly preferred based on safety profiles. Subcutaneous Ig (SCIg) is an alternative option for Ig delivery but has not previously been investigated in a large-scale clinical trial in CIDP. Design/Methods: Randomized, doubleblind trial in CIDP investigating 0.2 and 0.4 g/ kg weekly doses of SCIg IgPro20 (Hizentra®, CSL Behring) versus placebo in 172 subjects for maintenance treatment. IVIg-dependent adults with definite or probable CIDP according to EFNS/ PNS criteria were eligible. The primary outcome was the percentage of subjects with a CIDP relapse (1-point deterioration on adjusted INCAT disability score) or who were withdrawn for any other reason during the 24-week SCIg-treatment period. Multiple secondary endpoints were assessed. Superiority of at least one IgPro20 dose over placebo was tested one-sided using the Cochran-Armitage trend test for the primary outcome and the Jonckheere-Terpstra tests for secondary outcomes. Results: The primary outcome occurred in 33% of high-dose SCIg, 39% of low-dose SCIg, and 63% of placebo subjects (p < 0.001); CIDP relapse occurred in 19% of high-dose SCIg, 33% of low-dose SCIg and 56% of placebo subjects (p < 0.001), respectively. Both SCIg doses were superior to placebo (low-dose vs placebo p = 0.007; high dose vs placebo p < 0.001). Median INCAT score, MRC sum score, and grip

82

2017 AAN Annual Meeting On-site Guide

strength remained stable in SCIg subjects. Highdose SCIg prevented the R-ODS decline seen with low-dose SCIg and placebo (p < 0.001). All placebo subjects deteriorated on measures of strength and disability. Causally related adverse events occurred in 47 (27%) subjects (18% placebo, 30% low dose, and 35% high dose). Conclusions: SCIg IgPro20 was efficacious and safe as maintenance treatment. High-dose and low-dose SCIg were both superior to placebo, with the high dose potentially showing better efficacy. Study Supported By: Funding: CSL Behring sponsored the study Trial Registration: Clinicaltrials.gov, number NCT01545076

011 

6:15 p.m.–6:18 p.m.

EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 Results of a Phase 1b/2 Study of ATYR1940 in Adult Patients with Limb Girdle Muscular Dystrophy Type 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD) (ATYR1940-C-004) John Vissing, MD; Shahram Attarian, MD, PhD; Teresa Gidaro, MD, PhD; Tahseen Mozaffar, MD, FAAN; Stanley Iyadurai, MD, PhD; Gennyne Walker, PhD; Sanjay Shukla, MD; Laurent Servais, MD, PhD; Kathryn Wagner, MD, PhD Objective: To evaluate the safety, tolerability, and pharmacodynamic activity of ATYR1940 in patients with LGMD2B and FSHD. Background: LGMD2B and FSHD are debilitating genetic myopathies associated with an immune component and dystrophic changes in muscle. ATYR1940 is a Physiocrine-based protein that is substantially identical to human histidyl-tRNA synthetase and has been shown in preclinical studies to modulate immune responses in skeletal muscle. Design/Methods: This multicenter, open-label study evaluated intra-patient dose escalations of intravenous ATYR1940 from weekly to twice weekly (biw) infusions in patients with genetically confirmed disease and STIR-positive muscles on MRI (FSHD/LGMD2B) or elevated creatine kinase (LGMD2B). Eighteen


Study Supported By: aTyr Pharma, Inc.

012 

6:18 p.m.–6:21 p.m.

EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017

Myasthenia Gravis (QMG) tool is a clinicianreported measure of muscle strength. The objective of this analysis was to evaluate the proportion of refractory gMG patients from the REGAIN study treated with eculizumab who responded on both the QMG and the MGADL, compared with placebo. Background: REGAIN was a phase 3, multicenter, randomized, double-blind, placebo-controlled study of the efficacy and safety of eculizumab in patients with AChR+-refractory gMG over 26 weeks. Design/ Methods: Refractory gMG patients continued to receive a stable dose of immunosuppressive therapy (IST) throughout the study and were randomized to receive eculizumab (n=62) or placebo (n=63). In this ad hoc dual responder analysis, a clinically meaningful response was defined as a reduction of ≥3 points from baseline in the MG-ADL total score, and a reduction of ≥5 points from baseline in the QMG total score, both with no rescue therapy. Results: More patients receiving eculizumab versus placebo achieved clinically meaningful responses at week 26 on both the MG-ADL and QMG scales (Week 26: eculizumab 40% vs placebo 13%, nominal P=0.0004). The benefit of eculizumab treatment was apparent within the first 2 weeks (Week 2: eculizumab 19% vs placebo 6% dual responders, nominal P=0.0297). Improvement with eculizumab was generally observed by week 8 (eculizumab 36% vs placebo 14%, nominal P=0.0060). Conclusions: Three times as many of refractory gMG patients treated with eculizumab experienced improvements in muscle strength that benefited patients’ ADLs compared to the placebo group by week 26. Improvement in the eculizumab-treated patient group was observed early compared with placebo and continued to improve over the course of the study.

EMERGING SCIENCE



patients were assigned to Group A or B for one week of placebo, then 12 weeks of ATYR1940. In Group A, 4 FSHD patients received ATYR1940 titrated to 1.0 mg/kg biw; in Group B, 10 LGMD2B and 4 FSHD patients received ATYR1940 titrated to 3.0 mg/kg biw. Safety assessments included: incidence of adverse events, laboratory tests, ECGs, and pulmonary function tests. Exploratory assessments included: manual muscle testing (MMT), the Individualized Neuromuscular Quality of Life (INQoL) questionnaire, targeted MRI, and circulating biomarkers. Results: ATYR1940 was well-tolerated at all doses tested. Adverse events were mild or moderate in intensity. There were no clinically significant changes in other safety assessments. One patient had a reversible infusion-related reaction. Mean change from baseline to Week 14 for MMT was -7.1% for FSHD Group A, 0% for FSHD Group B, and +6.2% for LGMD2B Group B. No consistent changes over time were observed for INQoL scores, circulating biomarkers or MRI. Conclusions: In this pilot, open-label study, ATYR1940 administered up to 3 mg/kg biw was safe and well-tolerated in patients with LGMD2B and FSHD. A mean increase in MMT of 6.2% was observed in the LGMD2B group after 12 weeks of treatment. These data support further evaluation of ATYR1940 for LGMD2B and FSHD.

Dual Responder Analyses of Both Muscle Strength and Activities of Daily Living, Eculizumab Versus Placebo, in Refractory Generalized Study Supported By: Myasthenia Gravis (gMG) Patients Alexion Pharmaceuticals, Inc. Results from the REGAIN Study James Howard, MD, FAAN; Fanny O'Brien; Jing Jing Wang, MD; Renato Mantegazza

013 

Objective: The Myasthenia Gravis Activities of Daily Living (MG-ADL) is a physician-directed, patient-reported measure of symptom severity related to MG-specific ADLs. The Quantitative

EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017

6:21 p.m.–6:24 p.m.

Comparison of protein-coding and long, noncoding RNA gene expression signatures to

83


Emerging Science classify multiple sclerosis

Study Supported By: NIH R43 AI124766 and IQuity, Inc. Charles Spurlock, PhD; John Tossberg; Subramaniam Sriram, MD; Phillip Crooke; Thomas Aune, PhD 014  6:24 p.m.–6:27 p.m. Objective: Develop machine learning classifiers EMBARGOED FOR RELEASE UNTIL 12:01 using messenger RNA (mRNA) and long, nonAM FRIDAY, APRIL 21, 2017 coding RNA (lncRNA) expression data obtained A ‘surface-in’ gradient of thalamic damage is an from whole blood to accurately classify multiple early and disease-specific process in pediatricsclerosis (MS). Background: lncRNAs are a onset multiple sclerosis relatively new class of RNA that play pivotal roles in the regulation of a variety of biological Giulia Fadda, MD; Robert Brown; Brenda Banwell, processes including innate and adaptive MD, FAAN; Louis Collins; Douglas Arnold, MD; immune responses. Compared to mRNAs, our Amit Bar-Or, MD, FRCPC understanding of the functional role of lncRNAs in human diseases, including MS, is in its infancy. Objective: To examine whether the distribution of thalamic damage in pediatric multiple sclerosis To date, no blood-based biomarkers have been (MS) reflects a disease-specific ‘surface-in’ made commercially available to aid in the process of injury, compared to children with diagnosis of MS. Design/Methods: Whole blood collected into PAXgene tubes was obtained non-MS acquired demyelinating syndromes (non-MS ADS). Background: Subpial cortical from healthy subjects (n=346), patients with a pathology in MS is now considered an important clinically isolated syndrome who transitioned contributor to progressive disease. This subpial to clinically definite MS (n=84), diagnosed MS injury reportedly exhibits a ‘surface-in’ gradient patients prior to treatment (n=90), established of damage, implicating a distinct disease MS patients receiving therapies (n=212), and other inflammatory (n=132) and non-inflammatory mechanism (potentially involving soluble CSF (n=115) neurologic diseases. RNA sequencing was factors). However, it remains unknown when performed using a small subset of healthy control during disease course such a process may begin. and MS patient samples to derive two sets of 48 Reduced thalamic volume has been noted in both adult-onset and pediatric-onset MS. Since the highly differentially expressed gene candidates thalamus has both CSF and white matter (WM) using mRNA and lncRNA gene targets. RT-PCR interfaces, we considered whether examination was performed on all patients recruited (n=979) of thalamic injury in pediatric-onset MS would and a portion of the datasets generated were demonstrate an MS-specific ‘surface in’ pattern used to train and independently validate multiof injury. Design/Methods: 100 children (27 MS; category machine learning classifiers capable 73 non-MS ADS) were prospectively followed of distinguishing MS. Results: We found that from incident attack with yearly brain MRI (mean differences in expression of annotated lncRNAs follow-up 4.6 years). 282 healthy children with ranged in magnitude from 4-fold to 32-fold serial MRIs were included as controls. Jacobian across our study cohorts while differences in determinants, calculated in the thalamus from expression of mRNAs were typically less than non-linear registration of scans to the baseline, 4-fold. Compared to mRNAs, lncRNAs exhibit were averaged over each isodistant surface greater discriminatory power and confidence from CSF, then analyzed using non-linear mixed of machine learning predictions with sensitivity effect modeling. Results: While the thalamus and specificity exceeding 90% across case/ control comparisons. Conclusions: Use of gene in both MS and non-MS ADS children failed to exhibit normal growth in thalamic regions expression data obtained from whole blood and analyzed with machine learning methods delivers adjacent to the WM, only children with MS exhibited an additional and striking ventricular a highly accurate, actionable tool for providers ‘surface-in’ gradient of injury. This MS-specific who suspect MS. distance-related abnormality of the thalamic CSF

84

2017 AAN Annual Meeting On-site Guide


P4.406

Poster Session IV, 8:30 a.m.–7:00 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 Delayed-release Dimethyl Fumarate Reduces the Formation of T2 Lesions in Pediatric Patients with Relapsing-Remitting MS: Results From FOCUS, the First Clinical Trial to Evaluate the Neuroradiological Efficacy of an MS DiseaseModifying Therapy in Pediatric Patients

enrolled (12 sites, 10 countries). The mean change in the number of new/newly enlarging T2 hyperintense lesions was -7.9 (90% confidence interval [-8.0, -1.5], p=0.009). The geometric mean Cmax and AUC0-12 of DMF following the morning dose were 1.6 μg/mL and 3.3 h*μg/ mL, respectively. The most common adverse events were gastrointestinal events, flushing, and MS relapse, occurring in 55%, 45%, and 32% of patients, respectively. Lymphopenia, alanine aminotransferase elevation, and aspartate aminotransferase elevation occurred in 23%, 15%, and 10% of patients, respectively. There were no serious adverse events considered by the investigators to be related to DMF treatment. All 20 patients completing the study enrolled in a 2-year extension study (NCT02555215). Conclusions: In this study, the first clinical trial to examine the neuroradiological efficacy of a DMT in pediatric MS patients, the efficacy, safety, and pharmacokinetics of DMF were consistent with those observed in adult RRMS patients.

Satish Eraly, MD, PhD; Rajiv Das, MD; Natalia Penner; Joe Pultz; Catherine Taylor Raed Alroughani

Study Supported By: Biogen

Objective: To evaluate the effect of delayedrelease dimethyl fumarate (DMF) on the formation of T2 lesions, and the safety and pharmacokinetics of DMF, in pediatric relapsingremitting MS (RRMS) patients. Background: No disease-modifying therapy (DMT) has been demonstrated safe and effective in an interventional trial in pediatric MS patients. Design/Methods: FOCUS (NCT02410200) was a single arm, open-label study in RRMS patients aged 10–17 years. The study comprised an 8-week, off-treatment baseline period, followed by a 24-week treatment period during which patients received oral DMF 240 mg twice daily. Brain MRI scans were obtained at the beginning and at the end of the baseline period, and at weeks 16 and 24 of the treatment period. The primary endpoint was the change in the number of new/newly enlarging T2 hyperintense lesions during the 8-week baseline versus the final 8-week treatment period. Results: Twentytwo patients (14 [64%] female; mean age 15.8 [range: 13–17] years; mean weight 66 kg) were

P4.407

EMERGING SCIENCE



interface was already detectable from the first year of disease (p = 0.0002) and became more severe with time (p = 0.0021). Conclusions: We identified two distinct patterns of thalamic damage in pediatric demyelinating disease: one pattern, occurring distant from the ventricular surface, is shared by both children with MS and non-MS ADS; the second pattern, unique to MS, suggests that a distinct ‘surface-in’ process occurs in the very earliest MS disease stages.

Poster Session IV, 8:30 a.m.–7:00 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 Patients Who Received Alemtuzumab in CARE-MS I or II Show a Low Rate of Conversion From Relapsing-Remitting MS to Secondary Progressive MS Through 6 Years Dana Horakova, MD, PhD; Aaron Boster, MD; Tjalf Ziemssen, MD; Antonio Bertolotto, MD; Susan Goelz; Isabel Firmino, MD; Steven Cavalier, MD, FAAN; Karthinathan Thangavelu, PhD; Mark Freedman, MD, FAAN Objective: To determine the rate of conversion from relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS) through 6 years among CARE-MS I and II alemtuzumab-treated patients. Background: Delaying conversion to SPMS is an important treatment goal in MS. In an MSBase patient cohort (17,356 MS patients; median

85


Emerging Science baseline disease duration 3.8 years; median 5.8-year follow-up), 18% of all patients converted to SPMS using a recently developed SPMS definition based on EDSS scores and relapses. In the CARE-MS studies, EDSS scores were stable/improved with alemtuzumab over 6 years in >75% of patients with active RRMS who were treatment-naive (CARE-MS I; NCT00530348) or had inadequate response (≥1 relapse) to prior therapy (CARE-MS II; NCT00548405), in the absence of continuous treatment (extension study: NCT00930553). Design/Methods: Patients with active RRMS received 2 courses of alemtuzumab 12 mg (baseline: 5 consecutive days; 12 months later: 3 consecutive days) in CARE-MS I or II, and in the extension as-needed alemtuzumab for relapse or MRI activity, or another disease-modifying therapy (DMT) per investigator discretion. The definition of SPMS onset was as published by Lorscheider et al. (Brain 2016;139:2395-405). Results: Median disease duration at baseline was 1.7 years in CAREMS I and 3.8 years in CARE-MS II (2.8 pooled). 325/376 (86%) and 344/435 (79%) alemtuzumabtreated patients, respectively, remained on study through Year 6 (669/811 [82%] pooled). Many patients (CARE-MS I: 63%; CARE-MS II: 50%) received no additional treatment in the extension (either alemtuzumab or other DMT). Among alemtuzumab-treated CARE-MS I or II patients, the SPMS definition was met by 4 (1.1%) and 16 (3.7%) patients, respectively, through 6 years (20 [2.5%] pooled). Conclusions: Utilizing an objective definition of SPMS based on the EDSS and relapse data, a very low proportion of alemtuzumab-treated patients from the CARE-MS studies progressed to SPMS. Study Supported By: Sanofi and Bayer HealthCare Pharmaceuticals.

P4.408

Poster Session IV  8:30 a.m.–7:00 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 Symptomatic and objective clinical improvement in progressive multiple sclerosis patients treated

86

2017 AAN Annual Meeting On-site Guide

with autologous Epstein–Barr virus-specific T cell therapy: Interim results of a phase I trial Michael Pender, MD, PhD; Peter Csurhes; Corey Smith; Nanette Douglas; Michelle Neller, PhD; Leone Beagley, PhD; Sweera Rehan, PhD; Tracey Hopkins, PhD; Kate Thompson, PhD; Stefan Blum, MD; Kerryn Green, MBBS; Zara Ioannides, MD; Alan Coulthard, PhD; Kaye Hooper, PhD; Scott Burrows, PhD; Rajiv Khanna, PhD Objective: To determine the safety of treating progressive multiple sclerosis (MS) patients with autologous Epstein–Barr virus (EBV)-specific T cells. Background: Mounting evidence indicates a role for EBV in MS pathogenesis. EBV-infected autoreactive B cells might accumulate in the CNS because of defective cytotoxic CD8+ T-cell immunity. Design/Methods: In this trial we administer autologous EBV-specific T cells to patients with progressive MS (EDSS 5.0–8.0). Each patient receives their own T cells stimulated ex vivo to enhance reactivity to EBV nuclear antigen-1, latent membrane protein 1 (LMP1) and LMP2A, and is followed through 26 weeks. Four escalating dose infusions are administered biweekly. Results: To date, four SPMS patients and one PPMS patient have been treated. No significant adverse events have been observed. Three patients experienced symptomatic and objective clinical improvement, which commenced 2–8 weeks after the first infusion and was most marked in the two patients receiving T cells with the highest EBV reactivity. Striking improvement occurred in one SPMS patient, with normalization of lower extremity tone and plantar (Babinski) responses for the first time in 16 years, increased walking distance with walker from 100 meters at baseline and for the previous 5 years to 1200 meters, marked reduction in fatigue, increased manual dexterity, and improvements in lower extremity power, reflexes and sensation. A second SPMS patient had reduced fatigue, increased productivity and improved balance. The third responder (PPMS) had improved color vision, visual acuity and manual dexterity and reduced fatigue, lower extremity spasms and urinary urgency. These data are consistent with prior data from the first patient ever treated (SPMS compassionate use) who experienced


EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017

(Gd+) T1 lesions until the end of the study as evaluated by Kaplan-Meier analysis. ARneT2 was evaluated through Month 96. Results: Overall, 3167 patients were included (women, 71.2%; age [mean±SD], 38.0±9.1 years). Median exposure to fingolimod was 526 days (range, 75-3619). At baseline, mean (±SD) duration of MS since diagnosis was 6.2±5.6 years and mean (±SD) Expanded Disability Status Scale was 2.4±1.5. In the full analysis set (N=3127), ARneT2 gradually decreased from 1.362 at Month 12 to 1.011 at Year 3, 0.915 at Year 5, and 0.801 at Year 8, suggesting continued radiological stability. Of the 924 evaluable patients, 48.3% (SE: 14.2) remained free from Gd+ T1 lesions throughout the study. Conclusions: Radiological evidence suggests a continuous long-term effect of fingolimod on disease activity in patients with RRMS.

Radiological Evidence for the Long-Term Effect of Fingolimod Treatment in Patients with RelapsingRemitting Multiple Sclerosis

Study Supported By: This study was funded by Novartis Pharma AG, Basel, Switzerland.

Study Supported By: Multiple Sclerosis Society of Queensland, Multiple Sclerosis Research Australia and Perpetual Trustee Company Limited

P4.409

Poster Session IV, 8:30 a.m.–7:00 p.m.

Jeffrey Cohen, MD; Nadia Tenenbaum, MD; Alit Bhatt; Ron Pimentel; Ludwig Kappos, MD Objective: To assess disease activity based on radiological evidence in patients with relapsingremitting multiple sclerosis (RRMS) treated with fingolimod for up to 96 months. Background: Efficacy of fingolimod as assessed by clinical and radiological disease activity measures has been well-established in Phase 2 and 3 trials as well as its generally good tolerability in patients with RRMS. Over 180,000 patients have been treated with Gilenya® (fingolimod), with more than 395,000 patient-years of total exposure in clinical trials and post-marketing setting worldwide. Assessment of the long-term effect of disease modifying therapies is important for managing MS in clinical practice. Design/Methods: LONGTERMS is an open-label, single-arm, extension study evaluating the long-term efficacy, safety, and tolerability of fingolimod in patients who previously participated in phase 2/3/3b fingolimod trials. The fingolimod full analysis set included all patients randomized to the approved dose of fingolimod 0.5 mg. The selected MRI endpoints were annualized rate of new or newly enlarging T2 lesions (ARneT2) and the proportion of patients free from gadolinium-enhancing

EMERGING SCIENCE



reduced fatigue and lower extremity spasms, and improved cognition, hand function and productivity. Conclusions: This is the first report of clinical improvement in a prospective trial of autologous EBV-specific T cells to treat progressive MS patients. Further studies are planned.

P5.409

Poster Session V, 8:30 a.m.–7:00 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 3D Mathematical modeling of glioblastoma suggests that transdifferentiated vascular endothelial cells promote resistance to current standard-of-care therapy Daniela Bota, MD; Huaming Yan; Monica RomeroLópez; Lesly Benitez; Kaijun Di; Hermann Frieboes; Christopher Hughes; John Lowengrub Objective: Glioblastoma (GBM), the most aggressive brain tumor in human patients, is highly heterogeneous and intensively vascularized. Here, we use 3D mathematical modeling to investigate GBM progression and identify novel treatment strategies. Background: Glioma stem/initiating cells (GSC) are found to play a crucial role by increasing cancer aggressiveness and by promoting resistance to therapy. Recently, crosstalk between GSCs and vascular endothelial cells that line capillaries has been shown to considerably promote GSC self-renewal and tumor progression. GSCs have been shown to

87


Emerging Science also transdifferentiate into bona-fide vascular endothelial cells (GEC). GECs inherit mutations present in GSCs and are resistant to traditional anti-angiogenic therapies. Design/Methods: We develop a multispecies mathematical model to investigate the 3D spatiotemporal dynamics of vascularized GBM progression and response to cancer therapies. Results: The model predicts GSCs drive invasive fingering and that GECs spontaneously form a network within the hypoxic core, consistent with published experimental findings. We demonstrate that standard-ofcare treatments using DNA-targeted therapy (radiation/chemo) together with anti-angiogenic therapies reduce GBM tumor sizes but increase invasiveness. Anti-GEC treatments block the GEC support of GSCs and reduce tumor sizes but can lead to increased invasiveness. Anti-GSC therapies that promote differentiation or disturb the stem cell niche effectively reduce tumor invasiveness and sizes, but are ultimately limited in reducing tumor sizes because GECs can maintain GSCs. Anti-GEC therapies are required to remove the tumor completely. Conclusions: Our results suggest that a combinatorial regimen targeting the vasculature, GSCs and GECs, using drugs already approved by the FDA, can reduce both tumor sizes and invasiveness and could lead to tumor eradication without recurrence when the treatment is stopped. Study Supported By: This work is supported in part by the National Science Foundation Division of Mathematical Sciences (HY, JSL), a UC-MEXUS fellowship (MRL), a Miguel Velez fellowship at UCI (MRL), the National Institutes of Health through grants U54CA143907 (HBF), R01HL60067 (CCWH), P50GM76516 for the Center of Excellence in Systems Biology at the University of California, Irvine, and the National Institute for Neurological Diseases and Stroke Award (NINDS/NIH) NS072234 (DB). JSL, DB and CCWH receive support from the Chao Family Comprehensive Cancer Center at University of California, Irvine through an NCI Center Grant Award, P30CA062203.

88

2017 AAN Annual Meeting On-site Guide

P5.410

Poster Session V, 8:30 a.m.â&#x20AC;&#x201C;7:00 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 Cholinesterase Inhibitor Use and Cognitive Decline in Mild Cognitive Impairment and Mild Dementia due to Alzheimer Disease Jee-young Han; Lilah Besser; Chengjie Xiong; Walter Kukull, PhD, FAAN; John C. Morris, MD, FAAN Objective: Demonstrate the utility of cholinesterase inhibitor use in mild cognitive impairment. Background: Cholinesterase inhibitors (ChEIs) are approved for the symptomatic treatment of Alzheimer disease (AD) but their efficacy is uncertain in mild cognitive impairment (MCI) despite its frequent use. We investigated whether the use of ChEIs benefits cognitive outcomes in MCI compared with mild AD dementia (ADdem). Design/Methods: Data from 2,264 individuals clinically diagnosed with ADdem (Clinical Dementia Rating [CDR]=0.5 or 1) or MCI due to AD(MCI-AD) at Alzheimer's Disease Centers were available from the National Alzheimer's Coordinating Center's Uniform Data Set (UDS). Multivariable linear mixed models were run separately for MCI-AD and ADdem to examine the annual change in the CDR sum of boxes (CDR-SB). We compared slopes before and after ChEI initiation among ChEI users, and then compared change in scores during the entire UDS follow-up in ChEI users versus non-users. Results: 35% of 966 MCI-AD and 72% of 1,298 ADdem participants were ChEI users. In both groups, ChEI users had higher education, were less often African American/other race, and more often had at 1 APOE e4 allele (p<0.05). Comparing the slopes before and after ChEI initiation, the decline was significantly steeper at ChEI initiation in both groups (e.g., CDR-SB change in MCI-AD: 0.03 points/year before initiation, 0.85 points/ year after initiation). Comparing change in scores over the entire UDS follow-up, ChEI users in both the MCI-AD and ADdem groups had a significantly faster cognitive decline compared to the ChEI non-users (e.g., CDR-SB change in MCI-AD: 0.70 points/year among ChEI users, 0.21 points/year


P5.411

Poster Session V, 8:30 a.m.–7:00 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 Seizures are locked to long time-scale rhythms in epilepsy Maxime Baud, MD, PhD; Jonathan Kleen, MD, PhD; Emily Mirro; Jason Andrechak; David KingStephens, MD; Edward Chang; Vikram Rao, MD Objective: We investigated whether there are rhythms in seizure activity over multiple days, weeks or months (“multidien”) among patients with refractory epilepsy. Background: Epilepsy is defined by the seemingly random occurrence of seizures. However, recent quantitative analyses have described circadian and cluster organization, suggesting that seizures may be temporally regulated over long timescales. An extension of this concept is whether seizure timing is related to fluctuations in Interictal Epileptiform Activity (IEA), a marker of brain irritability. We quantified continuous IEA and seizure detection from 37 patients implanted intracranially for years with the Responsive NeuroStimulation system1 (ambulatory electrocorticography). Design/ Methods: We formatted IEA hourly counts into continuous time-series and applied wavelet decomposition to determine any component multidien rhythms. In a subset of 14 patients who had reliable seizure detection, we then estimated the phase timing of seizures in relation to peak periodicities of IEA using circular statistical analyses (mean resultant vector length, Omnibus test). Results: Beyond the expected circadian distribution of IEA (confirmed here), we also found robust superimposed multidien rhythms of IEA. Cycle durations differed between patients, and they were stable over time including some recorded up to 10 years. Both females and males demonstrated these multidien rhythms, and there

was no coherence with the lunar cycle. Seizures were phase-locked to the underlying multidien rhythms of IEA, occurring preferentially during the upslope of the period (p<0.05 for 13 out of 14 subjects). Conclusions: Using very long continuous electrocorticography recordings, we found that seizures and IEA are substantially influenced by underlying rhythms in long timescales (several days to weeks or more). These multidien rhythms suggest underlying therapeutic endocrine or metabolic targets that deserve further study. They also highlight opportunities to decrease refractory seizure burden through dynamic predictive therapeutic adjustments. Study Supported By: Supported by National Institutes of Health (NIH) grants R25NS070680-07 (JK) and R01-DC012379 (EC).

EMERGING SCIENCE



among non-users). Conclusions: Preliminary evidence from this study unexpectedly suggests that ChEI prescription and use in individuals with MCI-AD or ADdem may not improve the overall course. This faster decline seen in ChEI users after ChEI initiation may imply the expected decline that resulted in ChEI use.

P5.412

Poster Session V, 8:30 a.m.–7:00 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM FRIDAY, APRIL 21, 2017 The differential effects of eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids on seizure frequency in patients with drug-resistant epilepsy – A Randomized, double-blind, placebo-controlled trial Ahmed Daak, MD, PhD; Fatima Suliman, MD; Mustafa Elbashir, MD, PhD; Manar Elhasan, PhD; Manar Ahmed, MD, PhD; Kebreab Ghebremeskel, PhD Objective: To investigate the effect of DHA and EPA on seizure rate in patients with DRE. Background: About 30 percent of epileptic patients do not respond to treatment. Cell membrane lipids play a critical role in antiepileptic drugs’ transport and efficacy. Drug resistant cells have been shown to have altered lipid profiles. In addition, several animal models, as well as some clinical studies, support EPA and DHA as being involved in maintenance and modulation of neuronal functions as well as in the inhibition of neuronal excitability and seizure latency and frequency Design/Methods: A double-blind, randomized, placebo-controlled clinical trial included ninety nine (n=99) DRE

89


Emerging Science patients, aged 5 -16 (n=85) and 17- 45 (n=14). Patients were recruited from the Neurological Department, Khartoum Hospital, Sudan.After randomization, patients were given 2, 4 or 6 capsules of DHA (417.8 mg DHA and 50.8 mg EPA/capsule, n=33), EPA (385.6 mg EPA and 81.2 mg DHA/capsule, n=33) or placebo (high oleic acid sunflower seed oil, n=33) for one year. The primary outcome measure was the effect of treatment on seizure rate (ITT approach). Results: Fifty-nine patients (n=59) completed the study (59.6%). No treatment-emergent adverse event (TEAE) occurred during the study.The average number of seizures per year were EPA, 113.7±13.1, DHA, 145.5±16.1 and placebo, 182.8±16.1. Age and gender, seizure type adjusted seizure incidence rate ratios (IRRs) of the EPA and DHA groups compared with the placebo were 0.58 (CI= 0.42-0.90, p=0.009, 42% reduction) and 0.61 (CI = 0.39-0.87, p= 0.01, 39% reduction), respectively. There was no difference in IRR between the EPA and DHA groups (p=0.8). Conclusions: This study demonstrates that EPA and DHA are effective in reducing seizure frequency in DRE. Further larger multi-center studies are needed.

trial, adults with EM (n=955) were randomized 1:1:1 to subcutaneous monthly placebo or erenumab 70mg or 140mg for 24 weeks. The primary endpoint was change from baseline in mean monthly migraine days (MMDs) over weeks 13-24. Secondary endpoints were ≥50% reduction in MMDs; change in mean acute migraine-specific medication days; change in mean Physical Impairment (PI) and Impact on Everyday Activities (EA) scores (as measured by the Migraine Physical Function Impact Diary [MPFID]). P-values for pairwise comparisons of each erenumab dose with placebo are presented. Statistical significance was determined after adjustment for multiple comparisons. Results: Subjects reported 8.3 MMDs at baseline and experienced -3.2, -3.7, and -1.8-day reductions in the 70mg, 140mg, and placebo groups, respectively (p<0.001 for both). A ≥50% reduction in MMDs was achieved by 43%, 50%, and 27% in the 70mg, 140 mg, and placebo groups (p<0.001 for both), and monthly acute migraine-specific medication days were reduced by -1.1, -1.6, and -0.2 days (p<0.001 for both). Subjects had improved PI scores (-4.2, -4.8, -2.4 points in the 70mg, 140mg, and placebo groups; p<0.001) and EA scores (-5.5, -5.9, and -3.3 points; p<0.001). The safety/tolerability profile Clinical Trials Plenary Session of erenumab was similar to placebo; subjects 9:15 a.m.–11:30 am most frequently reported nasopharyngitis, upper respiratory tract infection, and sinusitis. EMBARGOED FOR RELEASE UNTIL 12:01 Conclusions: Erenumab 70mg and 140mg AM FRIDAY, APRIL 21, 2017 significantly reduced migraine frequency and Phase 3, Randomized, Double-Blind, Placebouse of migraine-specific medications, reducing Controlled Study to Evaluate the Efficacy and migraine’s impact on physical impairment and Safety of Erenumab (AMG 334) in Migraine everyday activities compared with placebo in Prevention: Primary Results of the STRIVE Trial this EM trial. Numerically greater efficacy was Peter Goadsby, MD, PhD; Uwe Reuter; Jo Bonner, observed for the 140mg dose consistently across all endpoints. MD; Gregor Broessner; Yngve Hallstrom; Feng Zhang; Sandhya Sapra; Hernan Picard; Daniel Study Supported By: Mikol; Robert Lenz Amgen Objective: To evaluate the efficacy and safety/ tolerability of erenumab (AMG 334) in a phase 3 trial of subjects with episodic migraine (EM) (NCT02456740). Background: Calcitonin gene-related peptide (CGRP) plays an important role in migraine pathophysiology. Erenumab is a fully human monoclonal antibody that inhibits the CGRP receptor. Design/Methods: In this multinational, double-blind, placebo-controlled

90

2017 AAN Annual Meeting On-site Guide


HARNESSING SCIENCE

to improve lives

At MT Pharma America, we understand that people with debilitating neurological diseases are determined to live life on their own terms. This is especially true for people living with amyotrophic lateral sclerosis, or ALS, our current focus. That is why we have paired a global expertise in research and development with veterans in the US life sciences industry. We are working together with advocacy organizations to expand disease education and elevate awareness that may lead to improvements in diagnosis, treatment, and discovery.

Discover our current efforts at Booth 721

and mt-pharma-america.com

Inspired by patients. Grounded in science.


1678

Today

Inspired by patients. Grounded in science.


Exhibitor List—by Topic* Alzheimer's/Other Dementias

Institute

1163 AFTD and FTD Disorders Registry 1220 Cleveland Clinic 1239 Huntsville Hospital Neurology Associates

1244 Lewy Body Dementia Association

Anxiety and Depression 239 240 685 858

Jali Medical Inc. Advanced Brain Monitoring Mayo Medical Laboratories Medscape Neurology

Autism 1059 Fulgent Genetics Biotechnology 112 Ultragenyx Pharmaceutical 235 EUROIMMUN 324 CorTech Labs 334 McKesson Specialty Health 335 Wilson Therapeutics 337 Aureus a Meijer Specialty Pharmacy 339 PRA Health Sciences 369 KRONUS, Inc. 801 Cytonkinetics, Inc. 906 Alexion Pharmaceuticals 955 Catalyst Pharmaceuticals 1060 Ripple 1064 Trialspark

EXHIBITORS BY TOPIC

177 MagQu 224 Icometrix 235 EUROIMMUN 240  Advanced Brain Monitoring 244 Biogen 260 AbbVie 272 Cerebral Assessment Systems, Inc. 283 Allergan, Inc. 324 CorTechs Lab 329 Avanir Pharmaceuticals Medical Affairs 445 Biogen- Medical 454 Allergan, Inc. 591 Lilly 685 Mayo Medical Laboratories 740 NEUROLOGY REVIEWS 793 King-Devick Technologies, Inc. 834 GE Healthcare 858 Medscape Neurology 875 DriveABLE 957 ProtoKinetics, Gait Analysis Walkways 961 PreventionGenetics  1010 Sensonics International 1053 Practical Neurology 1122 Spectrum Health Medical Group 1134 MNG Laboratories 1150 Neuronetrix 1053 Practical Neurolgy 1218 Mountain State Health Alliance 1225 Alliance for Patient Access 1159 Saint Luke's Marion Bloch Neuroscience

1260 Alzheimer's Association

Child Neurology 104

National Institute of Neurological Disorders & Stroke

112 Ultragenyx Pharmacuetical 128 BKIN Technologies Ltd. 201 Ipsen Biopharmaceuticals 274 GeneDx 311 NIHON KOHDEN AMERICA, INC. 324 CorTech Labs 336 Prevea Health 376 Invitae 377 Ambry Genetics

* Only exhibitors who submitted topic information are listed. Not inclusive. 

93


Exhibitor List—by Topic* 378 Mallinckrodt Pharmaceuticals 383 Sage Therapeutics 483 Upsher-Smith Laboratories, Inc.  493 AveXis, Inc. 535 Natus Neurology  734 Global Neuro-Diagnostics 735 Neurovirtual  793 King-Devick Technologies, Inc. 911 Ambu, Inc. 955 Catalyst Pharmaceuticals 961 PreventionGenetics 963 MediMax Tech, Inc. 1006 Greenwich Biosciences, Inc. 1012 Pfizer 201 Lifeline Biopharmaceuticals 1017 Providence Health & Services 1018 Ochsner Health System 1134 MNG Laboratories 1147 The Assistance Fund  1162 Safe Passage 1225 American Association of Neuromuscular and Electrodiagnostic Medicine

1228 Electrical Geodesics, Inc. (EGI) 1257 International Essential Tremor Foundation

Chronic Pain/Neuropathic Pain 135 MULTIGON INDUSTRIES,INC. 173 HeadAid 225 Corinthian Reference Lab 338 Validus Pharmaceuticals LLC 591 Lilly 685 Mayo Medical Laboratories 741 KabaFusion 907 Abbott/St. Jude Medical 911 Ambu, Inc. 963 MediMax Tech, Inc. 1063 Ipsum Diagnostics 1218 Mountain State Health Alliance 94

2017 AAN Annual Meeting On-site Guide

1221 PeaceHealth 1235 National Headache Foundation  1220 Cleveland Clinic 1236 Memorial Health System Dystonias 201 Ipsen Biopharmaceuticals 467 Medtronic  911 Ambu, Inc. 1241 The MSA Coalition & The MSA Shoe Charity

1261 National Spasmodic Torticollis Association

1263 Dystonia Medical Research Foundation Electronic Health Records 124

DynaMed Plus/EBSCO Health

Electronics 125 OtoSim, Inc. 1060 Ripple Epilepsy 112 Ultragenyx Pharmacuetica 148 Sentara Medical Group 237 Cascade Survey Research 274 GeneDx 301 Eisai Inc. 311 NIHON KOHDEN AMERICA, INC. 324 CorTechs Labs 338 Validus Pharmaceuticals LLC 373 NeuroPace, Inc 375 United Diagnostics 376 Invitae 377 Ambry Genetics 383 Sage Therapeutics 417 UCB Inc 426 Cadwell Industries, Inc.  467 Medtronic


EXHIBITORS BY TOPIC

483 Upsher-Smith Laboratories, Inc. Fibromyalgia 513 Sunovion Pharmaceuticals, Inc.  225 Corinthian Reference Lab 535 Natus Neurology 1063 Ipsum Diagnostics 734 Global Neuro-Diagnostics General Neurology 735 Neurovirtual 104 National Institute of Neurological 738 Blackrock NeuroMed, LLC Disorders & Stroke 740 NEUROLOGY REVIEWS 110 Impeto Medical  745 LivaNova 112 Ultragenyx Pharmacuetical 807 Mount Sinai Health System 125 OtoSim Inc.   875 Clinical Neurology News.Com 128 BKIN Technologies Ltd. 911 Ambu, Inc. 148 Sentara Medical Group 961 PreventionGenetics 234 AxelaCare 963 MediMax Tech, Inc.  235 EUROIMMUN   969 Sun Neurosciences 237 Cascade Survey Research   971 Duke Clinical Research Institute  239 Jali Medical Inc. 1006 Greenwich Biosciences 329 Avanir Pharmaceuticals Medical Affairs  1013 Carle Physician Group 336 Prevea Health 1016 Lifelines Neurodiagnostics 339 PRA Health Sciences 1018 Ochsner Health System 1019 The Ohio State University Department of 367 Alnylam Pharmaceuticals 373 NeuroPace, Inc   Neurology 377 Ambry Genetics 1021 Penn State Hershey Medical Center 378 Mallinckrodt Pharmaceuticals  1025 Carolinas HealthCare System 379 National ALS Registry 1053 Practical Neurology 409 Bayer HealthCare 1123 Lafayette General Health 426 Cadwell Industries, Inc. 1134 MNG Laboratories 467 Medtronic   1140 LifePoint Health 513, 715 Sunovion Pharmaceuticals, Inc.   1159 Saint Luke's Marion Bloch Neuroscience Institute 535 Natus Neurology 1162 SafePassage 735 Neurovirtual  1165 Epilepsy Foundation  736 EAN - European Academy of Neurology 1220 Cleveland Clinic 738 Blackrock NeuroMed, LLC 1225 Alliance for Patient Access 740 NEUROLOGY REVIEWS  1228 Electrical Geodesics, Inc. (EGI) 741 KabaFusion  1234 Managing Epilepsy Well Network 875 DriveABLE 1239 Huntsville Hospital Neurology 885 Clinical Neurology News.Com   Associates 906 Alexion Pharmaceuticals * Only exhibitors who submitted topic information are listed. Not inclusive. 

95


Exhibitor List—by Topic* 907 Abbott/St. Jude Medical 924 The JAMA Network 963 MediMax Tech, Inc. 974 SpecialtyCare 1008 Southcoast Health 1010 Sensonics International 1013 Carle Physician Group  1016 Lifelines Neurodiagnostics Systems, Inc. 1017 Providence Health & Services 1018 Ochsner Health System 1019 The Ohio State University Department of Neurology 

1020 Cone Health 1021 Penn State Hershey Medical Center 1022 Medical Associates Clinic  1023 Billings Clinic 1224 St. Peter's Hospital 1025 Carolinas HealthCare System 1035 Yuma Regional Medical Center 1059 Fulgent Genetics 1119 UnityPoint Clinic 1120 Baystate Health 1121 Via Christi Health 1122 Spectrum Health Medical Group   1123 Lafayette General Health 1128 SoutheastHEALTH 1140 LifePoint Health   1120 Bellin Health 1136 Duke Health 1156 Cambridge University Press 1160 Owensboro Health Regional Hospital 1161 International Parkinson and Movement Disorder Society (MDS)

1162 SafePassage 1218 Mountain States Health Alliance   1220 Cleveland Clinic  1221 PeaceHealth 1222 Archbold Medical Center  96

2017 AAN Annual Meeting On-site Guide

1228 Electrical Geodesics, Inc. (EGI) 1229 Baylor Scott & White Health, Neuroscience Institute

1236 Memorial Health System 1239 Huntsville Hospital Neurology Associates

1241 The MSA Coalition & The MSA Shoe Charity

1256 Cape Fear Valley Health System 1257 International Essential Tremor Foundation  

Headache/Migraine 127 Health Monitor Network 148 Sentara Medical Group 173 HeadAid 283, 454 Allergan, Inc. 329 Avanir Pharmaceuticals Medical Affairs 401 Acorda Therapeutics, Inc. 483 Upsher-Smith Laboratories, Inc.  559, 771 Teva CNS 591 Lilly 736 EAN - European Academy of Neurology 740 NEUROLOGY REVIEWS 751 Amgen 785 CEFALY Technology 807 Mount Sinai Health System 853 IMPAX Pharmaceuticals 875 DriveABLE 927 eNeura Inc. 1019 The Ohio State University Department of Neurology

1037 1122 1136 1223 1229

Alder BioPharmaceuticals Spectrum Health Medical Group Duke Health DENT Neurologic Institute Baylor Scott & White Health, Neuroscience Institute

1235 National Headache Foundation


1239 Huntsville Hospital Neurology Associates

1252 American Headache Society Health Information Management 177 MaqQu 1010 Sensonics International 1064 Trialspark 1152 Logistics Health Inc. 1235 National Headache Foundation 1245 American Heart Association

224 Icometrix 277 Bayer 324 CorTech Labs 373 NeuroPace, Inc 834 GE Healthcare 871 Shimadzu Scientific Instruments, Inc. 1153 Cohen Veterans Bioscience 1223 DENT Neurologic Institute Medical Equipment 110 125 171 175 272 311 374 375 535 738 907 927 957

Impeto Medical OtoSim Inc. The Electrode Store medi USA Cerebral Assessment Systems, Inc. NIHON KOHDEN AMERICA, INC Micromedical Technologies, Inc. United Diagnostics

Multiple Sclerosis 128 BKIN Technologies Ltd. 147 Saol Therapeutics 224 Icometrix  244 Biogen   260 AbbVie 324 CorTechs Labs   334 McKesson Specialty Health 337 Aureus a Meijer Specialty Pharmacy 378 Mallinckrodt Pharmaceuticals 401 Acorda Therapeutics, Inc. 409 Bayer HealthCare  445 Biogen- Medical 473 EMD Serono  501 Genentech, A Member of the Roche Group 

559, 771 Teva CNS 685 Mayo Medical Laboratories 741 KabaFusion  779 Celgene Corporation 793 King-Devick Technologies, Inc. 807 Mount Sinai Health System 957 ProtoKinetics, Gait Analysis Walkways 975 MedDay Pharmaceuticals  1017 Providence Health & Services 1018 Ochsner Health System  1019 The Ohio State University Department of Neurology

Natus Neurology Blackrock NeuroMed, LLC Abbott/St. Jude Medical eNeura Inc. ProtoKinetics, Gait Analysis Walkways

EXHIBITORS BY TOPIC

Imaging

1010 Sensonics International 1016 Lifelines Neurodiagnostic Systems, Inc. 1164 Rimed USA, Inc.

1021 1053 1122 1147

Penn State Hershey Medical Center Practical Neurology Spectrum Health Medical Group   The Assistance Fund

* Only exhibitors who submitted topic information are listed. Not inclusive. 

97


Exhibitor List—by Topic* 1225 Alliance for Patient Access 1159 Saint Luke's Marion Bloch Neuroscience Institute

1227 MotherToBaby Pregnancy Studies conducted by OTIS

1229 Baylor Scott & White Health, Neuroscience Institute

1238 Neuro-Immunology Laboratories - UBC 1247 ACTRIMS 1259 Multiple Sclerosis Foundation Muscular Dystrophy 201 Ipsen Biopharmaceuticals 274 GeneDx 685 Mayo Medical Laboratories  961 PreventionGenetics  1134 MNG Laboratories  1147 The Assistance Fund   1225 Alliance for Patient Access Neuromuscular 112 Ultragenyx Pharmacuetical 147 Saol Therapeutics 171 The Electrode Store   225 Corinthian Reference Lab  244 Biogen   274 GeneDx 336 Prevea Health  367 Alnylam Pharmaceuticals 369 KRONUS, Inc.  376 Invitae  426 Cadwell Industries, Inc.  445 Biogen- Medical  493 AveXis 535 Natus Neurology   737 KEGO Corporation 741 KabaFusion  801 Cytokinetics, Inc.  889 Strongbridge Biopharma  98

2017 AAN Annual Meeting On-site Guide

911 Ambu, Inc. 923 Synapse Biomedical Inc 955 Catalyst Pharmaceuticals 961 PreventionGenetics 963 MediMax Tech, Inc. 971 Duke Clinical Research Institute 984 Strongbridge Biopharma Medical Information

1012 Pfizer   1013 Carle Physician Group   1018 Ochsner Health System  1019 The Ohio State University Department of Neurology

1021 1134 1140 1220 1225

Penn State Hershey Medical Center MNG Laboratories   LifePoint Health  Cleveland Clinic American Association of Neuromuscular and Electrodiagnostic Medicine

1229 Baylor Scott & White Health, Neuroscience Institute

1236 Memorial Health System 1238 Neuro-Immunology Laboratories - UBC 1249 National Ataxia Foundation Non-Profit 241 379 736 791 895 921 924 1011 1020 1023 1119 1126

WellStar Health System National ALS Registry EAN - European Academy of Neurology Mayo Clinic Indiana University Kelly School of Business, Business of Medicine Physician MBA ProMedica Health System The JAMA Network Intermountain Healthcare Cone Health Billings Clinic UnityPoint Clinic Gundersen Health System


Neuroscience Institute  

1236 Memorial Health System 1238 Neuro-Immunology Laboratories - UBC 1239 Huntsville Hospital Neurology Associates 

1244 1245 1248 1249 1256 1257

Lewy Body Dementia Association American Heart Association Aurora Health Care   National Ataxia Foundation Cape Fear Valley Health System International Essential Tremor Foundation

1260 Alzheimer's Association Pain and Palliative Care 135 MULTIGON INDUSTRIES,INC.   225 Corinthian Reference Lab  1008 Southcoast Health 1063 Ipsum Diagnostics 1145 EndBrainCaner Initiative 1218 Mountain States Health Alliance 1221 PeaceHealth  1236 Memorial Health System

Parkinson's Disease 104

National Institute of Neurological Disorders & Stroke

110 Impeto Medical 169 ACADIA Pharmaceuticals Inc. 177 MagQu 260 AbbVie 401 Acorda Therapeutics, Inc. 417 UCB Inc   467 Medtronic 489 ACADIA Pharmaceuticals Inc.   559,771 Teva CNS 573 AbbVie Neuroscience   685 Mayo Medical Laboratories 793 King-Devick Technologies, Inc.    807 Mount Sinai Health System  834 GE Healthcare  853 IMPAX Pharmaceuticals 907 Abbott/St. Jude Medical 957 ProtoKinetics, Gait Analysis Walkways  969 Sun Neurosciences  1010 Sensonics International 1053 Practical Neurology 1119 UnityPoint Clinic 1129 Great Lakes Neurotechnologies   1136 Duke Health 1147 The Assistance Fund 1161 International Parkinson and Movement

EXHIBITORS BY TOPIC

1128 SoutheastHEALTH 1120 Baystate Health 1126 Gundersen Health System 1145 EndBrainCancer Initiative 1147 The Assistance Fund 1149 Bellin Health 1153 Cohen Veterans Bioscience 1156 Cambridge University Press 1157 Dysautonomia International 1160 Owensboro Health Regional Hospital 1163 AFTD and FTD Disorders Registry 1165 Epilepsy Foundation 1222 Archbold Medical Center 1229 Baylor Scott & White Health,

Disorder Society (MDS)

1220 Cleveland Clinic 1225 Alliance for Patient Access 1159 Saint Luke's Marion Bloch Neuroscience Institute

1172 SpeechVive 1241 The MSA Coalition & The MSA Shoe Charity

1244 Lewy Body Dementia Association

* Only exhibitors who submitted topic information are listed. Not inclusive. 

99


Exhibitor List—by Topic* Pharmaceutical 112 Ultragenyx Pharmacuetical 147 Saol Therapeutics  229 Lundbeck 234 AxelaCare 277 Bayer 283, 454 Allergan, Inc. 329 Avanir Pharmaceuticals Medical Affairs 335 Wilson Therapeutics  337 Aureus a Meijer Specialty Pharmacy 338 Validus Pharmaceuticals LLC 339 PRA Health Services 473 EMD Serono 493 AveXis  501 Genentech, A Member of the Roche Group  

585 715 779 801 889 906 965 984 1006 1010 1016 1039 1058 1059 1260

Neurocrine Biosciences, Inc.   Sunovion Pharmaceuticals, Inc. Celgene Corporation   Cytokinetics, Inc. Strongbridge Biopharma  Alexion Pharmaceuticals  Depomed, Inc. Strongbridge Biopharma Medical Information  Greenwich Biosciences, Inc. Sensonics International    Lifelines Neurodiagnostic Systems Inc CuraScript SD  US Bioservices Fulgent Genetics Alzheimer's Association 

Practice/Policy 334 McKesson Specialty Health 740 NEUROLOGY REVIEWS 918 Frontiers 1225 Alliance for Patient Access  100

2017 AAN Annual Meeting On-site Guide

1112 Neurology Career Center 1160 Owensboro Health Regional Hospital 1161 International Parkinson and Movement Disorder Societty (MDS)

1223 DENT Neurologic Institute   Publisher 124 DynaMed Plus/EBSCO Health 127 Health Monitor Network 439 Wolters Kluwer   795 Wiley  823 McGraw-Hill Education  825 MedLink Neurology   875 Clinical Neurology News.Com  816 DEMOS MEDICAL PUBLISHING 818 Frontiers 916 OXFORD UNIVERSITY PRESS  917 Springer Nature   922 NEJM Group  924 The JAMA Network 1028 PracticeLink   1156 Cambridge University Press 1245 American Heart Association Recruiter 144 145 238 241 270

Weatherby Healthcare HCA (Hospital Corporation of America) Hayes Locums   WellStar Health System Kaiser Permanente-Southern California Medical Group

322 Jackson & Coker   336 Prevea Health 818 Frontiers 836 Enterprise Medical Recruiting 892 LocumTenens.com 974 SpecialtyCare 994 Sanford Health


Neuroscience Institute  

1248 Aurora Health Care 1256 Cape Fear Valley Health System Restless Legs Syndrome 175 medi USA 417 UCB Inc 1063 Ipsum Diagnostics Sleep Disorders 171 175 240 311

The Electrode Store medi USA Advanced Brain Monitoring NIHON KOHDEN AMERICA, INC.

535 Natus Neurology   735 Neurovirtual   735 Neurovirtual 737 KEGO Corporation  963 MediMax Tech, Inc.   971 Duke Clinical Research Institute 1022 Medical Associates Clinic  1063 Ipsum Diagnostics 1241 The MSA Coalition & The MSA Shoe Charity

Sports and Concussion 135 MULTIGON INDUSTRIES, INC. 173 HeadAid 374 Micromedical Technologies, Inc.

EXHIBITORS BY TOPIC

1011 Intermountain Healthcare   1021 Penn State Hershey Medical Center  1023 Billings Clinic 1024 Mercy Clinic  1025 Carolinas HealthCare Systems 1026 Staff Care, Inc.   1027 Mercy Health  1028 PracticeLink   1051 CompHealth   1118 Rochester Regional Health   1121 Via Christi Health 1122 Spectrum Health Medical Group 1124 Community Health System 1125 Eastern Maine Health Systems (EMHS) 1126 Gundersen Health System  1128 SoutheastHEALTH   1138 Memorial Healthcare System    1149 Bellin Health 1152 Logistics Health Inc. 1160 Owensboro Health Regional Hospital 1222 Archbold Medical Center  1224 St. Peter's Hospital 1229 Baylor Scott & White Health,

Stroke 104

National Institute of Neurological Disorders & Stroke

128 BKIN Technologies Ltd. 135 MULTIGON INDUSTRIES,INC.   147 Saol Therapeutics  14 224 Icometrix 239 Jali Medical Inc. 336 Prevea Health   467 Medtronic  585 Neurocrine Biosciences, Inc. 735 Neurovirtual   807 Mount Sinai Health System 858 Medscape Neurology 921 ProMedica Health System   957 ProtoKinetics, Gait Analysis Walkways  971 Duke Clinical Research Institute  1008 Southcoast Health 1013 Carle Physician Group 1017 Providence Health & Services  1018 Ochsner Health System 

* Only exhibitors who submitted topic information are listed. Not inclusive. 

101


Exhibitor List—by Topic* 1019 The Ohio State University Department of Neurology

1053 1118 1121 1122 1123 1140 1159

Practical Neurology Rochester Regional Health Via Christi Health Spectrum Health Medical Group Lafayette General Health  LifePoint Health Saint Luke's Marion Bloch Neuroscience Institute  

1164 Rimed USA, Inc. 1172 SpeechVive   1218 Mountain States Health Alliance   1220 Cleveland Clinic  1236 Memorial Health System   1239 Huntsville Hospital Neurology Associates  

Traumatic Brain Injury 104

National Institute of Neurological Disorders & Stroke

128 BKIN Technologies Ltd.   135 MULTIGON INDUSTRIES, INC. 147 Saol Therapeutics  173 HeadAid   224 Icometrix  324 CorTechs Labs 374 Micromedical Technologies Inc. 426 Cadwell Industries, Inc. 793 King-Devick Technologies, Inc. 875 DriveABLE 921 ProMedica Health System   957 ProtoKinetics, Gait Analysis Walkways  971 Duke Clinical Research Institute 1118 Rochester Regional Health  1152 Logistics Health Inc. 1153 Cohen Veterans Biosciences 1164 Rimed USA, Inc. 1165 Epilepsy Foundation  102

2017 AAN Annual Meeting On-site Guide

1172 SpeechVive 1218 Mountain States Health Alliance Unlisted Area of Focus 124 DynaMed Plus/EBSCO Health 139 Quest Diagnostics   237 Cascade Survey Research  268 Pairnomix  277 Bayer 310 United Council for Neurologic Subspecialties

369 KRONUS, Inc.   379 National ALS Registry  383 Sage Therapeutics  493 AveXis   585 Neurocrine Biosciences, Inc.   741 KabaFusion   889 Strongbridge Biopharma 895 Indiana University Kelley School of Business, Business of Medicine Physican MBA

923 Synapse Biomedical Inc 927 eNeura Inc.   974 SpecialtyCare 981 Outcome Health 984 Strongbridge Biopharma Medical Information  

1013 Carle Physician Group   1022 Medical Associates Clinic   1041 RDL Reference Laboratory   1060 Ripple   1064 Trialspark 1112 Neurology Career Center 1145 EndBrainCancer Initiative  1163 AFTD and FTD Disorders Registry   1223 DENT Neurologic Institute  1241 The MSA Coalition & The MSA Shoe Charity 

1249 National Ataxia Foundation


Our mission is to develop therapies that restore function and improve the lives of people with neurological disorders. www.acorda.com

ACORDA THERAPEUTICS and the stylized logo are registered trademarks of Acorda Therapeutics, Inc. Š2017, Acorda Therapeutics, Inc. All rights reserved.

UB5504 3/17


Exhibitor Listâ&#x20AC;&#x201D;by Booth Number Exhibition Hall Booth Numbers 104

National Institute of Neurological Disorders & Stroke

110 Impeto Medical 112 Ultragenyx Pharmacuetical 116 Supernus Pharmaceuticals Inc. 124 DynaMed Plus/EBSCO Health 125 OtoSim Inc. 127 Health Monitor Network 128 BKIN Technologies Ltd. 135 MULTIGON INDUSTRIES,INC. 137 Jari Electrode Supply 139 Quest Diagnostics 144 Weatherby Healthcare 145 HCA (Hospital Corporation of America) 146 Monteris Medical 147 Saol Therapeutics 148 Sentara Medical Group 164 Supernus Pharmaceuticals Inc. 169 ACADIA Pharmaceuticals Inc. 171 The Electrode Store 173 HeadAid 175 medi USA 177 MagQu 201 Ipsen Biopharmaceuticals 223 RosmanSearch, Inc. 224 Icometrix 225 Corinthian Reference Lab 229 Lundbeck 234 AxelaCare 235 EUROIMMUN 237 Cascade Survey Research 238 Hayes Locums 239 Jali Medical Inc. 240 Advanced Brain Monitoring 241 WellStar Health System 244 Biogen 104

2017 AAN Annual Meeting On-site Guide

260 AbbVie 268 Pairnomix 270 Kaiser Permanente-Southern California Medical Group

272 Cerebral Assessment Systems, Inc. 274 GeneDx 275 WCN 2017 Kyoto 277 Bayer 279 Rhodes Pharmaceuticals 283 Allergan, Inc. 301 Eisai Inc. 308 American Board of Psychiatry & Neurology

310

United Council for Neurologic Subspecialties

311 NIHON KOHDEN AMERICA, INC. 322 Jackson & Coker 324 CorTechs Labs 329 Avanir Pharmaceuticals Medical Affairs 334 McKesson Specialty Health 335 Wilson Therapeutics 336 Prevea Health 337 Aureus a Meijer Specialty Pharmacy 338 Validus Pharmaceuticals LLC 339 PRA Health Sciences 367 Alnylam Pharmaceuticals 369 KRONUS, Inc. 373 NeuroPace, Inc 374 Micromedical Technologies, Inc. 375 United Diagnostics 376 Invitae 377 Ambry Genetics 378 Mallinckrodt Pharmaceuticals 379 National ALS Registry 383 Sage Therapeutics 401 Acorda Therapeutics, Inc. 409 Bayer HealthCare 417 UCB Inc 


426 Cadwell Industries, Inc. 439 Wolters Kluwer 445 Biogen- Medical 454 Allergan, Inc. 467 Medtronic 473 EMD Serono 483 Upsher-Smith Laboratories, Inc. 489 ACADIA Pharmaceuticals Inc. 493 AveXis 501 Genentech, A Member of the Roche Group

EXHIBITORS BY BOOTH

513 Sunovion Pharmaceuticals, Inc. 523 Sanofi Genzyme - MS 535 Natus Neurology 547 Novartis Pharmaceuticals 559 Teva CNS 573 AbbVie Neuroscience 585 Neurocrine Biosciences, Inc. 591 Lilly 685 Mayo Medical Laboratorie 715 Sunovion Pharmaceuticals, Inc. 721 MT Pharma America 729 Sanofi Genzyme - Genetics 734 Global Neuro-Diagnostics 735 Neurovirtual 736 EAN - European Academy of Neurology 737 KEGO Corporation 738 Blackrock NeuroMed, LLC 739 NOVA Surgical 740 NEUROLOGY REVIEWS 741 KabaFusion 745 LivaNova 751 Amgen 771 Teva CNS 779 Celgene Corporation 785 CEFALY Technology 791 Mayo Clinic

793 King-Devick Technologies, Inc. 795 Wiley 801 Cytokinetics, Inc. 807 Mount Sinai Health System 811 Arbor Pharmaceuticals, LLC 816 DEMOS MEDICAL PUBLISHING 818 Frontiers 823 McGraw-Hill Education 825 MedLink Neurology 834 GE Healthcare 836 Enterprise Medical Recruiting 838 Elsevier, Inc. 853 IMPAX Pharmaceuticals 858 Medscape Neurology 885 Clinical Neurology News.Com 889 Strongbridge Biopharma 892 LocumTenens.com 894 Novocure 895 Indiana University Kelley School of Business, Business of Medicine Physician MBA

906 Alexion Pharmaceuticals 907 Abbott/St. Jude Medical 916 OXFORD UNIVERSITY PRESS 917 Springer Nature 921 ProMedica Health System 922 NEJM Group 923 Synapse Biomedical Inc 924 The JAMA Network 925 Hartford HealthCare 927 eNeura Inc. 945 US WorldMeds 953 US WorldMeds 955 Catalyst Pharmaceuticals 957 ProtoKinetics, Gait Analysis Walkways 961 PreventionGenetics 871 Shimadzu Scientific Instruments, Inc. 105


Exhibitor Listâ&#x20AC;&#x201D;by Booth Number 873 Coram CVS Specialty Infusion Services 875 DriveABLE 911 Ambu, Inc. 963 MediMax Tech, Inc. 965 Depomed, Inc. 969 Sun Neurosciences 971 Duke Clinical Research Institute 974 SpecialtyCare 975 MedDay Pharmaceuticals 981 Outcome Health 984 Strongbridge Biopharma Medical Information

994 Sanford Health 1006 Greenwich Biosciences, Inc. 1008 Southcoast Health 1010 Sensonics International 1011 Intermountain Healthcare 1012 Pfizer 1013 Carle Physician Group 1016 Lifelines Neurodiagnostic Systems, Inc. 1017 Providence Health & Services 1018 Ochsner Health System 1019 The Ohio State University Department of Neurology

1020 Cone Health 1021 Penn State Hershey Medical Center 1022 Medical Associates Clinic 1023 Billings Clinic 1024 Mercy Clinic 1025 Carolinas HealthCare System 1026 Staff Care, Inc. 1027 Mercy Health 1028 PracticeLink 1029 Pikeville Medical Center, Inc. 1035 Yuma Regional Medical Center 1037 Alder BioPharmaceuticals 1039 CuraScript SD 106

2017 AAN Annual Meeting On-site Guide

1041 RDL Reference Laboratory 1051 CompHealth 1052 Diplomat 1053 Practical Neurology 1054 Neuro Central 1055 Signature Healthcare 1056 CentraCare Health 1057 OhioHealth 1058 US Bioservices 1059 Fulgent Genetics 1060 Ripple 1061 g.tec GUGER TECHNOLOGIES 1062 TS Medical 1063 Ipsum Diagnostics 1064 Trialspark 1065 Neurology Advisor 1069 Theranica Bio-Electronics Ltd. 1112 Neurology Career Center 1116 Norton Healthcare 1118 Rochester Regional Health 1119 UnityPoint Clinic 1120 Baystate Health 1121 Via Christi Health 1122 Spectrum Health Medical Group 1123 Lafayette General Health 1124 Community Health Systems 1125 Eastern Maine Health Systems (EMHS) 1126 Gundersen Health System 1128 SoutheastHEALTH 1129 Great Lakes Neurotechnologies 1134 MNG Laboratories 1136 Duke Health 1138 Memorial Healthcare System 1140 LifePoint Health 1145 EndBrainCancer Initiative 1147 The Assistance Fund 1149 Bellin Health 


1150 Neuronetrix 1152 Logistics Health Inc. 1153 Cohen Veterans Bioscience 1154 Tallahassee Memorial HealthCare 1156 Cambridge University Press 1157 Dysautonomia International 1159 Saint Luke's Marion Bloch Neuroscience Institute

1160 Owensboro Health Regional Hospital 1161 International Parkinson and Movement Disorder Society (MDS)

Center

1256 Cape Fear Valley Health System 1257 International Essential Tremor Foundation

1258 1259 1260 1261

Society for Neuroscience

EXHIBITORS BY BOOTH

1162 SafePassage 1163 AFTD and FTD Disorders Registry 1164 Rimed USA, Inc. 1165 Epilepsy Foundation 1168 Partners Multiple Sclerosis Center 1172 SpeechVive 1218 Mountain States Health Alliance 1220 Cleveland Clinic 1221 PeaceHealth 1222 Archbold Medical Center 1223 DENT Neurologic Institute 1224 St. Peter's Hospital 1225 Alliance for Patient Access 1227 MotherToBaby Pregnancy Studies

1244 Lewy Body Dementia Association 1245 American Heart Association 1246 Legacy Medical Group 1247 ACTRIMS 1248 Aurora Health Care 1249 National Ataxia Foundation 1252 American Headache Society 1253 Defense and Veterans Brain Injury

Multiple Sclerosis Foundation Alzheimer's Association National Spasmodic Torticollis Association

1263 Dystonia Medical Research Foundation 1264 MS Cure Fund 1265 Benign Essential Blepharospasm Research Foundation

1269 Cleveland Clinic Abu Dhabi 1271 Huntington's Disease Youth Organization 1275 DigiTrace EEG Services

conducted by OTIS

1228 Electrical Geodesics, Inc. (EGI) 1229 Baylor Scott & White Health, Neuroscience Institute

1234 1235 1236 1238 1239

Managing Epilepsy Well Network National Headache Foundation Memorial Health System Neuro-Immunology Laboratories - UBC Huntsville Hospital Neurology Associates

1240 University of Florida Health 1241 The MSA Coalition & The MSA Shoe Charity

107


New Exhibitor

Exhibit Hall Passport Destination

Abbott/St. Jude Medical Booth

907

6300 Bee Caves Rd. Blgd 2 Suite 100 Austin, TX 78746 United States sjm.com

At Abbott, we’re committed to helping you live your best possible life through the power of health. For more than 125 years, we’ve brought new products and technologies to the world—in nutrition, diagnostics, medical devices and branded generic pharmaceuticals—that create more possibilities for more people at all stages of life. Today, 94,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.

AbbVie Booth

260

1 North Waukegan Rd North Chicago, IL 60064 United States abbvie.com

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries.

expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.

ACADIA Pharmaceuticals Inc. Booth

169

3611 Valley Centre Drive Suite 300 San Diego, CA 92130 United States acadia-pharm.com

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders. Visit Booth No. 169 to learn more.

ACADIA Pharmaceuticals Inc. Booth

489

3611 Valley Centre Driv Suite 300 San Diego, CA 92130 United States acadia-pharm.com

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders. Visit Booth No. 489 to learn more.

Acorda Therapeutics, Inc. AbbVie Neuroscience Booth

573

1 N. Waukegan Road North Chicago, IL 60064 United States abbvie.com

AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the

108

2017 AAN Annual Meeting On-site Guide

Booth

401

420 Saw Mill River Road Ardsley, NY 10502 United States acorda.com

Acorda Therapeutics is a 22 year old biotechnology company based in Westchester County, New York. The Company's mission is to develop therapies that will restore function and improve the lives of people with neurological disorders. Acorda has


LET’S GET REAL

Visit booth 573 to learn more about

carbidopa/levodopa 4.63 mg/20 mg per mL

VISIT BOOTH

EXHIBITORS BY NAME

573

Check us out at DuopaPro.com

©2017 AbbVie Inc.

North Chicago, IL 60064

855-1905124

March 2017


Exhibitor Descriptions a pipeline of neurological therapies addressing a range of disorders, including Parkinson's disease, migraine and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg.

AFTD and FTD Disorders Registry Booth

1163

ACTRIMS Booth

1247

22 North Carroll St. Suite 300 Madison, WI 53703 United States actrims.org

The Americas Committee for Treatment & Research in Multiple Sclerosis (ACTRIMS®) provides leadership in the field of multiple sclerosis and other demyelinating diseases. ACTRIMS invites researchers, clinicians, residents, students, postdoctoral fellows and patient advocates for MS to attend ACTRIMS Forum 2018 on February 1-3, 2018 in San Diego, CA. Visit www.actrims.org/ forum2018 for additional information.

Advanced Brain Monitoring Booth

240

2237 Faraday Avenue Suite 100 Carlsbad, CA 92008 United States advancedbrainmonitoring.com

Advanced Brain Monitoring is a neuro-diagnostics device company specializing in the acquisition and analysis of awake and sleep EEG, and in the development of EEG-based biomarkers. Our products are used in clinical trials and in clinical practice to interpret brain function as it relates to early stage neuro-degeneration and chronic diseases. Our seven FDA-cleared systems have been used on over 1.5 mm patients worldwide, and earned the GHP 2016 Most Innovative Medical Device Company award.

Radnor Station Bldg 2 Suite 320 290 King of Prussia Road Radnor, PA 19087 United States theaftd.org

AFTD strives to improve the quality of life of people affected by FTD. We fund competitive grant programs including FTD Biomarkers and TreatFTD, and provide education and support to families living with FTD disorders. The FTD Disorders Registry was founded by AFTD and The Bluefield Project. The Registry is open to persons diagnosed with an FTD disorder, their caregivers, family members and friends in the US and Canada. Registry data will be used to support research studies and clinical trials.

Alder BioPharmaceuticals Booth

1037

11804 North Creek Parkway South Bothell, WA 98011 United States alderbio.com

Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies. Alder’s lead pivotal-stage product candidate, eptinezumab, is being evaluated for migraine prevention. Eptinezumab is a monoclonal antibody that inhibits calcitonin gene-related peptide (CGRP), a protein active in mediating the initiation of migraine. For more information, please visit http:// www.alderbio.com.

Alexion Pharmaceuticals Booth

906

100 College Street New Haven, CT 06510 United States alexion.com

Alexion is a global biopharmaceutical company focused on life-transforming therapies for patients with devastating, rare diseases. Alexion developed the first and only approved complement inhibitor for PNH & aHUS. The Company is strengthening and broadening its complement portfolio, including evaluating complement

110

2017 AAN Annual Meeting On-site Guide


New Exhibitor inhibition in additional ultra-rare disorders. Alexion's metabolic franchise includes two highly innovative enzyme replacement therapies for two ultra-rare, life-threatening disorders.

Exhibit Hall Passport Destination

seven working groups, two of which include the Physicians Neurological Disease Working Group and the National Physicians Biologics Working Group.

Alnylam Pharmaceuticals Booth

367 Allergan, Inc. Booth

454

2525 Dupont Drive Irvine, CA 92612 United States allergan.com

Alnylam is developing an entirely new class of medicines based on the breakthrough discovery in biology known as RNA interference, or RNAi. Alnylam believes that RNAi therapeutics is a promising approach to silence disease-causing genes, and represent an opportunity to transform the treatment of many diseases.

Alzheimer’s Association Booth

1260 Allergan, Inc. Booth

283

2525 Dupont Drive Irvine, CA 92612 United States allergan.com

Allergan plc (NYSE: AGN), is a bold, global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. For more information, visit Allergan's website at www.Allergan.com.

Alliance for Patient Access Booth

1225

1275 Pennsylvania Ave NW Suite 1100 Washington, DC 20004 United States allianceforpatientaccess.org

The Alliance for Patient Access is a national network of more than 800 physicians dedicated to ensuring patient access to approved therapies and appropriate clinical care. AfPA accomplishes this mission by recruiting, training and mobilizing policy-minded physicians to be effective advocates for patient access. AfPA convenes



EXHIBITORS BY NAME

Allergan plc (NYSE: AGN), is a bold, global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. For more information, visit Allergan's website at www.Allergan.com.

25 Recreation Park Drive Suite 200 Hingham, MA 02043 United States alnylam.com

225 North Michigan Avenue 17th Floor Chicago, IL 60601 United States alz.org

The Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research. The Association hosts the annual Alzheimer's Association International Conference® (AAIC®), bringing the world's leading dementia scientists together to share the latest research. Visit our booth to learn more about AAIC 2017, the International Research Grant Program®, the Association's membership society (ISTAART), TrialMatch®, and patient and caregiver resources.

Ambry Genetics Booth

377

15 Argonaut Aliso Viejo, CA 92656 United States ambrygen.com

Ambry is a genetics-based healthcare company that is dedicated to open scientific exchange so we can work together to understand all human disease faster and save millions of lives. For more information about Ambry Genetics, visit www. ambrygen.com.

111


New Exhibitor

Exhibit Hall Passport Destination

Ambu, Inc. Booth

911

6230 Old Dobbin Lane Suite 250 Columbia, MD 21045 United States ambu.com

Ambu manufactures and sells quality electrodes that optimize workflow, reduce costs and improve patient care. Our neurodiagnostic electrodes include disposable products to help meet your needs. Our Neuroline 100% disposable cups are made of a highly conductive Ag/AgCL, offering low impedance levels for clear and precise readings while reducing the growing risk of cross contamination. We also specialize in a full line of needles and electrodes for IOM, EMG, NCS, EP, Sleep and EEG studies.

American Board of Psychiatry & Neurology Booth

308

2150 E. Lake Cook Rd. Ste. 900 Buffalo Grove, IL 60089 United States abpn.com

The American Board of Psychiatry and Neurology serves the public interest and the professions of psychiatry and neurology by promoting excellence in practice through its certification and maintenance of certification processes. ABPN also oversees the certification process for physicians seeking certification in child and adolescent psychiatry.

American Headache Society Booth

1252

19 Mantua Rd Mt Royal, NJ 08061 United States americanheadachesociety.org

The American Headache SocietyÂŽ(AHS) is the professional organization for the study and management of headache and face pain. AHS activities include an annual scientific meeting, a comprehensive headache symposium, regional symposia for neurologists and family practice physicians, and publication of the journal Headache. AHS established the American Migraine Foundation to raise awareness about migraine and related disorders and raise funds to establish the American Registry for Migraine Research.

112

2017 AAN Annual Meeting On-site Guide

American Heart Association Booth

1245

7272 Greenville Ave Dallas, TX 75231 United States myamericanheart.org

Visit the AHA booth to receive information on AHA scientific conferences. AHA/ASA professional membership, scientific publications, AHA's Focus on Quality Program, patient education, Connected Heart Health and much more. Learn how you can join more than 30,000 professional members and receive more benefits than ever!

Amgen Booth

751

One Amgen Center Dr Thousand Oaks, CA 91320 United States amgen.com

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Arbor Pharmaceuticals, LLC Booth

811

6 Concourse Parkway Suite 1800 Atlanta, GA 30328 United States arborpharma.com

Arbor Pharmaceuticals, headquartered in Atlanta, Georgia, is a specialty pharmaceutical company currently focused on the cardiovascular, hospital, neuroscience and pediatric markets. The company has over 700 employees promoting its products to physicians, hospitals, and pharmacists. Arbor currently markets over twenty NDA or ANDA approved products with over 35 more in development. For more information, visit www. arborpharma.com or send email enquiries to info@arborpharma.com.


Exhibitor Descriptions Archbold Medical Center Booth

1222

PO Box 1018 Thomasville, GA 31799 United States archbold.org

A well-established hospital-employed neurology practice is seeking a BC/BE Outpatient Neurologist and a Neurohospitalist to practice in Thomasville, GA. Archbold Medical Center is a 540 bed regional healthcare system, which is consistently recognized as a Top Hospital in Georgia. Excellent recruitment package including guaranteed income, great benefits, relocation, sign-on bonus, robust CME allowance and loan repayment. Situated just 30 miles from Tallahassee, FL and 1 hour from the Gulf Coast.

Avanir Pharmaceuticals Medical Affairs Booth

329

30 Enterprise Ste 400 Aliso Viejo, CA 92656 United States www.avanirmedinfo.com

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders. Avanir Medical Information responds to unsolicited inquiries to help facilitate appropriate therapeutic utilization of Avanir medications. We strive to provide the highestquality service to healthcare practitioners.

Aureus a Meijer Specialty Pharmacy Booth

337

300 Merchant Lane Suite 305 Pittsburgh, PA 15205 United States aureushealthservices.com

Aureus is a national specialty pharmacy. Our mission is to deliver customized pharmacy and healthcare services that optimize outcomes for patients, physicians, payers and pharmaceutical manufacturers. Partnership with Aureus will provide you and your MS patients the highest level of customer care. Our experienced Clinical Care Teams understand the hurdles MS patients face, so you can be confident your patients are receiving the care they need. Visit booth #337 to learn more.

Aurora Health Care Booth

1248

3000 W Montana Street Milwaukee, WI 53215 United States aurora.org/doctor

Aurora Health Care is the largest Wisconsin-based health care system. Our integrated delivery model allows Aurora physicians and advanced practice professionals to support their patients, connect with colleagues and offer state-of-the-art, top tier quality care. For more information about our neurology opportunities, please call 800-307-7497 or visit our website at aurora.org/doctor.

114

2017 AAN Annual Meeting On-site Guide

AveXis Booth

493

2275 Half Day Rd Suite 200 Bannockburn, IL 60015 United States www.avexis.com

AveXis is a clinical-stage gene therapy company dedicated to developing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. We are relentlessly focused on bringing gene therapy out of the lab and into the clinical setting. For additional information, please visit www.avexis.com.

AxelaCare Booth

234

15529 College Blvd Lenexa, KS 66219 United States axelacare.com

AxelaCare, a BriovaRx Infusion Services company, is a home infusion care provider serving patients across the U.S. with a national network of pharmacies. We specialize in Immune globulin (IgG), Parenteral Nutrition (PN), Anti-infectives, Hydration, Biologics and other specialty infusions. Our comprehensive services include specially


New Exhibitor trained on-staff nurses and pharmacists, around-the-clock clinical support, reimbursement specialists and on-going patient education for safety and comfort.

Bayer

Booth

277

1 Bayer Drive Indianola, PA 15051 United States radiologysolutions.bayer.com

Bayer HealthCare Booth

409

100 Bayer Blvd. Whippany, NJ 07981 United States bayer.com

Bayer has been committed to supporting people with multiple sclerosis (MS) for more than 20 years. Since 1995, our robust patient support programs and services have made a difference in their lives. As we continue our collaboration with the MS community, we look forward to a future of innovation that builds on our shared history of progress. To learn more, please visit Booth #1415.

Baylor Scott & White Health, Neuroscience Institute Booth

1229

2401 S. 31st ST Temple, TX 76508 United States Jobs.BSWHealth.com

As the largest not-for-profit health care system in Texas and one of the largest in the United States, Baylor Scott & White Health was born from the 2013 combination of Baylor Health Care System and Scott & White Healthcare. Today, Baylor Scott & White includes 48 hospitals, more than



1,000 patient care sites, more than 5,500 active physicians, over 44,000 employees and the Scott & White Health Plan. Stop by and visit our booth to learn about our neurology job opportunities in Central Texas.

Baystate Health Booth

1120

280 Chestnut St. Springfield, MA 01199 United States choosebaystatehealth.org

Baystate Health, Massachusetts' 3rd-largest healthcare system, ranks consistently among the nation's top hospitals and healthcare organizations. As a not-for-profit, mission-driven, integrated health system, Baystate Health serves a population of more than 800,000 people in communities across western Massachusetts. Patient-centered care is at the core of Baystate Health's culture. We are committed to hiring clinicians who value a culture of compassion and appreciate diversity.

EXHIBITORS BY NAME

Bayer's Radiology Product Portfolio transforms insight into innovation with the goal of enabling improved patient care and productivity in CT, MRI, PET and interventional studies. Our evolving portfolio includes medical devices, contrast media, integrated dose-management software (radiation dose and contrast dose) and equipment service.

Exhibit Hall Passport Destination

Bellin Health Booth

1149

744 S Webster Ave Green Bay, WI 54301 United States bellin.org

Green Bay, WI is known for the Packers & offers an ideal setting for working, living & raising a family. It is also home to Bellin Health, a fast growing, innovative network of hospitals, physicians, & clinics throughout Northeastern WI & Upper MI. We are a 220 bed hospital recognized by Consumer Reports as the #1 hospital in the nation for patient safety. Our vision is that the people in our region will be the healthiest in the nation. Consider joining our Neuro Team & help us reach our vision!

Benign Essential Blepharospasm Research Foundation Booth

1265

P.O. Box 12468 Beaumont, TX 77726-2468 United States blepharospasm.org

115


New Exhibitor

Exhibit Hall Passport Destination

Billings Clinic Booth

1023

801 North 29th St Billings, MT 59101 United States billingsclinic.com

Seeking BE/BC Neurologists & Neurohospitalists to join our region's largest tertiary referral center and become part of a growing team of neurologists. Nationally recognized for clinical excellence and a proud member of the Mayo Clinic Care Network. Located in Montana and voted “America's Best Town” by Outside Magazine, Billings is a friendly college community, great place to raise a family near the majestic Rocky Mountains. 300 Days of Sunshine!

Biogen Booth

244

133 Boston Post Road Weston, MA 02493 United States biogen.com

Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS). Building on its heritage in biologics, Biogen also manufactures and commercializes high-quality biosimilars.

Biogen- Medical Booth

445

133 Boston Post Road Weston, MA 02493 United States biogen.com

Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the

116

2017 AAN Annual Meeting On-site Guide

first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (ALS). Building on its heritage in biologics, Biogen also manufactures and commercializes high-quality biosimilars.

BKIN Technologies Ltd. Booth

128

140 Railway St. Kingston, ON K7K 2L9 Canada bkintechnologies.com

KINARM Labs™ provide robust and objective measures of brain function and dysfunction by the precise measurement of human behavior with robotics. Created by neuroscientists, KINARM Labs allow clinician-scientists to detect and quantify the sensory, motor and cognitive impact of a diverse range neurological impairments caused by stroke, cardiac arrest, TIA, mTBI, concussion, MS or Parkinson's - all in a short < 1h assesment. KAINARM Labs is an essential tool in personilation of new CNS Therapies.

Blackrock NeuroMed, LLC Booth

738

630 Komas Drive Suite 200 Salt Lake City, UT 84108 United States blackrockneuromed.com

Blackrock NeuroMed Cervello product offers the most powerful EEG Neurodiagnostic systems in the market today. Cervello EEG systems are based on technology that has been used by the Neuroscience research community for many years and deals with much higher sampling rates (256 Hz to 30kHz) with up to 256 channels. Blackrock NeuroMed Cervello EEG systems has the complete product line from Routine EEG/Video systems 32, 64, 128, and 256 channel, Home EEG/ Video Ambulatory, to Full room LTM systems.

Cadwell Industries, Inc. Booth

426

909 N. Kellogg Street Kennewick, WA 99336 United States cadwell.com

At Cadwell, we help you help your patients. Our neurodiagnostic and neuromonitoring solutions are designed to deliver efficient workflow, quality data,


Exhibitor Descriptions reliable performance and easy reporting wherever and whenever you need it. Our brands include Arc EEG, LTM and ICU cEEG; Sierra® EMG and EP with integrated ultrasound; Cascade® IONM; Easy® PSG and CadLink™ data management. We combine customer input with our employees' expertise to provide innovative, industry-leading solutions.

Cambridge University Press Booth

1156

1 Liberty Plaza New York, NY 10006 United States cambridge.org/us/academic

Cambridge’s publishing in books and journals combines state-of-the-art content with the highest standards of scholarship, writing and production. Visit our stand to browse new titles, available at a 20% discount, and to pick up sample issues of our journals. Visit our website to see everything we do: www.cambridge.org/us/academic.

Cape Fear Valley Health System Booth

1256

101 Robeson Street Suite 303 Fayetteville, NC 28301 United States capefearvalley.com

Cape Fear Valley is a 916-bed, 8-hospital regional health system, the 8th largest in North Carolina, with more than 1 million inpatient and outpatients annually. A private not-for-profit organization with 7,000 employees and 850 physicians.

Carle Physician Group Booth

1013

611 West Park Street UrbanaIL 61801 United States carleconnect.com/Careers.aspx

Carle Physician Group, a 400+ physician multispecialty group, is part of a not-for-profit integrated network of healthcare services that includes Carle Foundation Hospital, a 393-bed Magnet® Level I Trauma Center with Level III perinatal services, and clinics located in 19 communities throughout Illinois. Carle has been named among the top 10 percent of hospitals in the nation, received a five-star rating for treatment of stroke and received the Stroke Care Excellence Award™ from Healthgrades.

118

2017 AAN Annual Meeting On-site Guide

Carolinas HealthCare System Booth

1025

4135 South Stream Blvd Suite 300 Charlotte, NC 28217 United States choosecarolinashealthcare.org

Carolinas HealthCare System, one of the nation's leading and most innovative healthcare organizations, provides a full spectrum of healthcare and wellness throughout the Carolinas. Our Neurosciences Institute® Neurology, leads in advanced neurological care with treatment, research, rehabilitation and specialty programs. We provide a level of expertise unmatched in the region. Our programs lead nationally in the development of quality improvement and clinical outcomes in the neurosciences.

Cascade Survey Research Booth

237

PO Box 122 Virginia City, NV 89440 United States cascade-research.com

Cascade Survey Research conducts fast and easy SurveyStation Touchscreen Computer based Market Research Intercept Surveys at Professional Meetings and Events. We collect the valid and accurate data required for the effective development of marketing, sales, and new product development strategies in dynamic markets.

Catalyst Pharmaceuticals Booth

955

355 Alhambra Circle Suite 1250 Coral Gable, FL 33134 United States catalystpharma.com/

Catalyst Pharmaceuticals, Inc., is dedicated to advancing therapies targeting rare neuromuscular and neurological diseases: Lambert - Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndromes (CMS), MuSK Myasthenia Gravis, Infantile Spasms. Catalyst is currently enrolling a confirmatory study for the treatment of patients diagnosed with LEMS with its lead program Amifampridine Phosphate. In addition Catalyst is enrolling a pediatric and adult study in CMS


New Exhibitor CEFALY Technology Booth

785

187 Danbury Road Wilton, CT 06897 United States cefaly.us

CEFALY Technology has developed the first and unique medical device for the prevention of migraine, the CefalyÂŽ which has been FDA approved in March 2014. The company's mission is to research and develop non-invasive and drug-free medical treatments for neurological diseases. Besides the CefalyÂŽ device for migraine prevention, the company is leading researches with medical devices for the treatment of coma, epilepsy and fibromyalgia.

Booth

779

86 Morris Avenue Summit, NJ 07901 United States celgene.com

Celgene Corporation (Nasdaq:CELG) is a global biopharmaceutical company that is helping healthcare providers turn incurable cancers into chronic, manageable diseases, as well as manage serious inflammatory conditions through innovative therapies. This dedication to medical progress goes hand-in-hand with our industryleading patient support and access programs. Together, these aspects form the core of our commitment to patients worldwide. For more information, visit www.celgene.com

CentraCare Health Booth

1056

1406 Sixth Avenue North St. Cloud, MN 56303 United States centracare.com

CentraCare Health is a physician-driven, multidisciplinary system with over 450 physicians on the medical staff of St. Cloud Hospital. The system seves moe than 700,000 people in a 12-county area and offers a variety of outreach services to more than 35 communities. CentraCare Health is a collaborative group of Central Minnesota healthcare professionals, working together to provide comprehensive, high-quality care, close to home. It apsires to be the leader in



Minnesota for quality, safety, service, and value. CentraCare Health has been voted Best Place to Work in Minnesota for by the Minneapolis/St. Paul Business Journal.

Cerebral Assessment Systems, Inc. Booth

272

2085 Brighton Henrietta Town Line Rd Rochester, NY 14623 United States cerebralsystem.com

Cognivue is the world's first FDA-approved, computerbased solution for physicians to routinely measure and monitor brain health and detect early signs of impairment. It is based on years of neurophysiology and psychophysical research focusing on early detection of LLCD and dementia. It immediately creates an easy-to-interpret, single-page report combining cognitive impairment assessment scores and graphs to aid interpretation and discussion between physician, patient, and family.

EXHIBITORS BY NAME

Celgene Corporation

Exhibit Hall Passport Destination

Cleveland Clinic Booth

1220

1950 Richmond Rd TR302 Lyndhurst, OH 44124 United States my.clevelandclinic.org/

The multidisciplinary Cleveland Clinic Neurological Institute, includes more than 300 medical, surgical and research specialists dedicated to the treatment of adult and pediatric patients with neurological and psychiatric disorders. The institute offers a disease-specific, patient focused approach to care. Our unique, fully integrated model strengthens our current standard of care, allows us to measure quality and outcomes on a continual basis, and enhances our ability to conduct research.

Cleveland Clinic Abu Dhabi Booth

1269

Dubai 00971 United Arab Emirates pinnaclemena.com

119


Exhibitor Descriptions Clinical Neurology News.Com Booth

885

7 Century Drive Suite 302 Parsippany, NJ 07054 United States clinicalneurologynews.com

ClinicalNeurologyNews.com is a trusted source

for independent news and views for neurologists since early 2005. The content has been crafted with your needs in mind--featuring the latest medical and subspecialty news, thought leader commentary, conference coverage, CME, practice management, and so much more. Twice a week, we email the NEXUS, an eNewsletter, with the latest neurology news and developments.

Cohen Veterans Bioscience Booth

1153

4 Spring Hill Road Annandale, NJ 08801 United States percolationcom.com/

Cohen Veterans Bioscience is the only 501(c)3 non-profit research organization with a singular focus on post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) research. We are dedicated to funding basic, translational, and clinical research with the goal of fast-tracking the development of diagnostic tests and personalized therapeutics for the millions of veterans and civilians who suffer the devastating effects of trauma on the brain.

CompHealth Booth

1051

7259 S. Bingham Junction Boulevard Midvale, UT 84047 United States comphealth.com

Founded in 1979, CompHealth is the largest locum tenens staffing agency in the United States. CompHealth also specializes in temporary and permanent allied healthcare staffing. CompHealth is part of the CHG Healthcare Services family of companies, which is recognized on FORTUNE magazineâ&#x20AC;&#x2122;s list of "100 Best Companies to Work For". www.comphealth.com

Cone Health Booth

1020

1200 N. Elm St. Greensboro, NC 27401 United States conehealth.com

Cone Health is recruiting Neuro-Hospitalists to join our inpatient, hospital-employed Neurology team in Greensboro, NC. Our Neuroscience program ranked in the top 10% in the U.S. in neurological outcomes in 2016 - http://www.conehealth.com/ services/neurosciences/. Our program includes a 14-bed neuro ICU, a 39-bed neuro med/surg unit, and a Joint Commission-certified Primary Stroke Center. Please send your CV to: Rebekah Driggers, MBA Director, Cone Health

rebekah.driggers@conehealth.com

Community Health Systems Booth

1124

4000 Meridian Blvd Franklin, TN 37067 United States chsmedcareers.com

Community Health Systems, Inc. is one of the nation's leading operators of general acute care hospitals. The organization's affiliates own, operate or lease approximately 150 + hospitals in 22 states with approximately 30,000 licensed beds. Affiliated hospitals are dedicated to providing quality healthcare for local residents and contribute to the economic development of their communities.

120

2017 AAN Annual Meeting On-site Guide

Coram CVS Specialty Infusion Services Booth

873

555 17th Street Suite 1500 Denver, CO 80202 United States coramhc.com

CVS Specialty and Coram provide compassionate, high-quality infusion care to patients where they live, work or travel. Local teams from more than 90 locations throughout the country offer the highest


New Exhibitor level of personalized care, education and support. With nearly 1,200 skilled clinicians and more than 30 years of experience, Coram CVS Specialty Infusion Services leads the industry with commitment from the heart. The company has achieved a 96 percent patient satisfaction rating for seven years.

Corinthian Reference Lab Booth

225

6201 Southwest Blvd Benbrook, TX 76132 United States corinthianreferencelab.com

CorTechs Labs Booth

324

4690 Executive Dr. Suite 250 San Diego, CA 92121 United States cortechslabs.com

CorTechs Labs develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making volumetric analysis of MRI images of the human brain a routine part of clinical practice. Our cutting-edge imaging analysis tools provide physicians a convenient way to quantify brain structures and compare results to age- and gendermatched norms, helping assess neurological issues, such as dementia, epilepsy, MS, and brain trauma.

CuraScript SD Booth

1039

255 Technology Park Lake Mary, FL 32746 United States curascriptsd.com

clinic administration to a wide range of medical providers, including physicians, infusion centers, acute care and treatment centers.

Cytokinetics, Inc. Booth

801

280 East Grand Avenue South San Francisco, CA 94080 United States cytokinetics.com

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology the company is developing small molecule drug candidates specifically engineered to increase muscle function and contractility.

EXHIBITORS BY NAME

CRL is a commercial diagnostic laboratory specializing in neurological disease detection. We specialize in epidermal nerve fiber density (ENFD) testing. ENFD testing offers patients objective evidence of a neuropathy which can hopefully lead to a more accurate diagnosis. Please contact Greg Davenport with questions or to receive additional information: 480-330-3684.

Exhibit Hall Passport Destination

Defense and Veterans Brain Injury Center Booth

1253

1335 East West Highway Silver Spring, MD 20910 United States dvbic.dcoe.mil

DEMOS MEDICAL PUBLISHING Booth

816

11 W 42ND Street New York, NY 07304 United States demosmedical.com

For more than 25 years, Demos Medical Publishing has served the information needs of medical professionals. We publish high-quality books and digital products for physicians and other healthcare providers, and have established an international reputation for excellence in our core areas of neurology, physical medicine and rehabilitation, pathology, and oncology.

With an expertise honed by more than a quarter of a century in the Specialty Distribution business, CuraScript SD supplies biologics, branded drugs, generics, vaccines, infused medications and ancillary supportive care products for office or



121


Exhibitor Descriptions DENT Neurologic Institute Booth

1223

3980 Sheridan Drive Suite B Amherst, NY 14223 United States dentinstitute.com

DENT Is the largest out-patient neurologic center in the United States. We are currently offering fellowship opportunities for 2017-18-19 in the fields of Neuroimaging (2), Headache (1), NeuroOncology (1), Neuro-Otology (1).

Depomed, Inc. Booth

965

7999 Gateway Blvd Suite 300 Newark, CA 94560 United States depomed.com

Depomed, Inc. is a leading specialty pharmaceutical company focused on developing and commercializing products for pain and neurology-related disorders. Founded in 1995, Depomed has built a strong market presence with a highly differentiated portfolio of six marketed products in the areas of mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain.

DigiTrace EEG Services Booth

1275 Diplomat Booth

1052

200 Corporate Place Suite 5B Peabody, MA 01960 United States

4100 S. Saginaw Street Flint, MI 48507 United States diplomat.is

DriveABLE Booth

875 122

10650 113 Street Edmonton, AB T5H 3H6 Canada driveable.com

2017 AAN Annual Meeting On-site Guide

Creating Safer Communities Through The Fusion Of Science And Technology. DriveABLE combines cuttingedge technology with proven research to deliver driver assessment tools for commercial fleets, governments, insurers, and the medical community. Established as a university spin-off, DriveABLE has been providing driver risk assessments for over 15 years. It is our goal to protect competent drivers, accurately identify cognitively unsafe drivers, and to help improve safety on our roads.

Duke Clinical Research Institute Booth

971

300 W Morgan St Suite 800 Durham, NC 27701 United States dcri.org

The Duke Clinical Research Institute (DCRI), part of the Duke University School of Medicine, is the largest academic research organization in the world. Its mission is to develop and share knowledge that improves the care of patients through innovative clinical research. From thought leadership to clinical practice, the DCRI conducts groundbreaking multinational clinical trials, manages major national patient registries, and performs landmark outcomes research.

Duke Health Booth

1136

4825 Creekstone Drive Suite 250 Durham, NC 27703 United States pdc.dukemedicine.org/careers

The Department of Neurology and Duke Health are currently expanding its faculty in the following three clinical arenas: Movement Disorders, Headache, and General Neurology (subspecialty focus accepted). Stop by our BOOTH #1136 to hear more about our available faculty opportunities! Or, apply directly online: http://pdc.dukemedicine.org/careers/neurologymovement-disorders http://pdc.dukemedicine. org/careers/headache-neurologist http://pdc. dukemedicine.org/careers/general-neurology


New Exhibitor DynaMed Plus/EBSCO Health Booth

124

10 Estes Street Ipswich, MA 01938 United States dynamed.com

DynaMed PlusÂŽ is the next-generation clinical information resource that optimizes speed to answer for the busy clinician. Evidence-based content is written by a world-class team of physicians who synthesize the evidence and provide objective analysis to help clinicians in their daily practice.

Dysautonomia International Booth

Dysautonomia International is a 501(c)(3) nonprofit that advocates on behalf of individuals with autonomic disorders through research, physician education, public awareness, and patient empowerment programs. Visit our booth for free patient education brochures.

Dystonia Medical Research Foundation Booth

1263

1 E. Wacker Drive Suite 1730 Chicago, IL 60601 United States dystonia-foundation.org

The mission of the Dystonia Medical Research Foundation (DMRF) is to advance research for more treatments and ultimately a cure, to promote awareness and education, and to support the needs and well being of affected individuals and families.

EAN - European Academy of Neurology Booth

736

European national neurological societies and > 800 individuals, represents > 21K neurologists. EAN has ongoing educational programmes, grants, teaching courses and online learning tools. Regional Teaching Courses are organised in Eastern Europe and SubSaharan Africa. A shared EAN/AAN membership agreement is active since January 1st, 2016 3rd EAN congress - Amsterdam, The Netherlands June 24-27, 2017.

Eastern Maine Health Systems (EMHS) Booth

1125

931 Union Street Bangor, ME 04401 United States careers.emhs.org/

Located in Bangor, Eastern Maine Medical Center serves communities throughout central, eastern, and northern Maine. EMMC is a comprehensive, 411-bed medical center. The medical center and its medical staff of more than 450 physicians provide specialty and intensive services to the northern two-thirds of the state. EMMC also provides outreach clinics to many local hospitals in the region, allowing easier access for patients and supporting the role of those hospitals in their communities.

Eisai Inc. Booth

301

EXHIBITORS BY NAME

1157

P.O. Box 596 East Moriches, NY 11940 United States dysautonomiainternational.org

Exhibit Hall Passport Destination

100 Tice Blvd Woodcliff Lake, NJ 07677 United States us.eisai.com/

As the U.S. pharmaceutical subsidiary of Tokyobased Eisai Co., Ltd., we are a fully integrated pharmaceutical business with discovery, clinical, and marketing capabilities. Our key areas of focus include oncology and neurology (dementia-related diseases and neurodegenerative diseases). To learn more about Eisai Inc., please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn.

Breitegasse 4-7 Vienna 1070 Austria ean.org

The EAN-European Academy of Neurology brings together European neurologists. The membership, 47



123


Exhibitor Descriptions

Electrical Geodesics, Inc. (EGI) Booth

1228

500 East 4th Avenue Eugene, OR 97401 United States egi.com

EGI offers neuromonitoring systems for clinical and research use. Dense array EEG systems feature 256 channels for the highest resolution brain monitoring and source estimation and the Geodesic Sensor Net for whole-head EEG capture. EGI offers products for LTM, ICU, and the complete neurology clinic including video EEG, ambulatory EEG, EMG/NCV, and EP. Come by our booth to see the new GeoSource 3 Research software and the new GTEN 100 Research system for neuromodulation.

Elsevier, Inc. Booth

838

245 Peachtree Center Avenue NE #1900, Marquis One Tower Atlanta, GA 30303 United States elsevier.com

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and make groundbreaking discoveries. Elsevier, part of RELX Group plc, provides web-based, digital solutionsâ&#x20AC;&#x201D;among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKeyâ&#x20AC;&#x201D;and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles.

EMD Serono Booth

473

One Technology Place Rockland, MA 02370 United States emdserono.com

EMD Serono is the North America biopharma business of Merck KGaA, Darmstadt, Germany - a leading science and technology company - focused exclusively on specialty care. For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. EMD Serono has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in oncology, immuno-oncology and immunology.

EndBrainCancer Initiative Booth

1145

14959 NE 95th Street Redmond, WA 98052 United States endbraincancer.org

The www.EndBrainCancer Initiative (formerly The Chris Elliott Fund) is a brain tumor patient advocacy 501(c)3 nonprofit social enterprise organization. Our goal is to extend lives, increase survivorship, and improve quality of life for patients nationally, quickly & personally connecting adult & pediatric patients, caregivers & families with our network of regional experts in Brain Tumor Treatment & Research across the US for the best & most advanced treatment options & clinical trials available

eNeura Inc. Booth

927

715 N. Pastoria Ave. Sunnyvale, CA 94085 United States eneura.com

eNeura Inc., a privately held medical technology company, is pioneering the use of portable, non-invasive Single-pulse Transcranial Magnetic Stimulation

124

2017 AAN Annual Meeting On-site Guide


New Exhibitor (sTMS) devices for treatment of migraine. Prescribed by physicians but designed for patient use, it is the first truly portable, convenient sTMS product that will allow migraine with aura patients to administer treatment as neededâ&#x20AC;&#x201D;at home, in the office or on the go.

Enterprise Medical Recruiting Booth

836

714 Spirit 40 Park Drive Suite 125 St. Louis, MO 63005 United States enterprisemed.com

Epilepsy Foundation Booth

1165

8301 Professional Place, East Suite 200 Landover, MD 20785 United States epilepsy.com

The Epilepsy Foundation is your unwavering ally on your journey with epilepsy and seizures. The Foundation is a community-based, family-led organization dedicated to improving the lives of all people impacted by seizures.

EUROIMMUN Booth

235

Seekamp 31 Luebeck 23560 Germany euroimmun.com

EUROIMMUN provides a comprehensive range of multiparametric tests for anti-neuronal autoantibodies, encompassing over 30 defined specificities. Autoantibody detection can establish a diagnosis of autoimmune encephalitis, paraneoplastic syndrome or neuromyelitis optica and clarify symptoms such as memory deficits, psychosis and seizures. EUROIMMUN also offers assays for neurodegeneration biomarkers, for example in Alzheimer's disease, and for pathogenspecific antibodies affecting the CNS.



Frontiers Booth

818

EPFL Innovation Park Building I Lausanne 1015 Switzerland frontiersin.org

Frontiers is a leading open-access academic publisher, with prestigious and well respected editorial boards. We provide rigorous peer review and fast publication. Our goal is to increase the visibility of research articles and their authors.

Fulgent Genetics Booth

1059

4978 Santa Anita Suite 205 Temple City, CA 91780 United States FulgentGenetics.com

EXHIBITORS BY NAME

Since 1990, Enterprise Medical Recruiting has been leading the national market in successful healthcare recruitment. Our clients consist of health systems, hospitals, medical groups, physician practices, academic institutions and community health organizations. We fulfill over 300 physician, advanced practice provider and healthcare leadership assignments annually. Please visit with us for your complimentary recruitment consultation.

Exhibit Hall Passport Destination

Developing flexible and affordable genetic testing that improves the everyday lives of those around us. Founded in 2011, Fulgent began with two simple ideas; flexibility and affordability. Today, we strive to create the most effective and wide ranging tests on the market. All of this is done in the pursuit of bettering the everyday lives of our customers. We shine brightest when meaningful relationships, passion, and purpose come together.

g.tec GUGER TECHNOLOGIES Booth

1061

Sierningstrasse 14 Schiedlberg 4521 Austria gtec.at

GE Healthcare Booth

834

100 Results Way Marlborough, MA 01752 United States gehealthcare.com

GE Healthcare provides transformational medical technologies & services to meet the demand for increased access, enhanced quality & more affordable healthcare around the world. GE works on things that matter - great people & technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring & diagnostics to drug discovery, biopharm

125


Exhibitor Descriptions manufacturing technologies & performance improvement, GE Healthcare helps medical professionals deliver great healthcare to patients.

GeneDx Booth

274

481 Edward H Ross Drive Elmwood Park, NJ 07407 United States GeneDx.com

GeneDx was founded in 2000 by two NIH scientists, and offers sequencing and deletion/duplication testing for inherited cardiac, mitochondrial, neurological, and inherited cancer disorders, plus other rare genetic disorders. Whole exome sequencing, microarray-based, targeted variant testing, and prenatal diagnostic services are also offered. More than 100 geneticists and genetic counselors are currently employed by GeneDx. Visit www.GeneDx.com for more information, or email

GeneDx@GeneDx.com

Genentech, A Member of the Roche Group Booth

501

1 DNA Way South San Francisco, CA 94080 United States gene.com

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years. At Genentech, we use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, we are among the world’s leading biotech companies, with multiple products on the market and a promising development pipeline.

Global Neuro-Diagnostics Booth

734

2670 Firewheel Drive Suite B Flower Mound, TX 75028 United States globalneuro.net

Global Neuro-Diagnostics (GND) is an IDTF that provides Long-Term Video Electroencephalogram

126

2017 AAN Annual Meeting On-site Guide

(VEEG) ambulatory diagnostic services. GND provides a proven patented solution that collects and synchronizes multi-camera video, audio, and EEG data enabling GND to provide a one-stop and cost-effective solution in the comfort of patient’s homes utilizing GND’s highly skilled Registered EEG Technologists.

Great Lakes Neurotechnologies Booth

1129

10055 Sweet Valley Drive Ste 1 Valley View, OH 44125-4245 United States GLNeuroTech.com

Great Lakes NeuroTech focuses on wearable sensors, mobile apps, and web applications to capture objective measures for clinical trials and patient care. Kinesia technology provides objective Parkinson's monitoring for clinical trials, patient care, and programming deep brain stimulation: http://glneurotech.com/kinesia/ . BioRadio technology provides wearable, wireless tech for capturing cardiorespiratory measures for clinical trials: https://glneurotech.com/bioradio/

Greenwich Biosciences, Inc. Booth

1006

5750 Fleet Street Suite 200 Carlsbad, CA 92008 United States greenwichbiosciences.com

Our strategy is to be the world leader in the field of cannabinoid science. We focus on the research, development and commercialization of cannabinoid molecules as novel pharmaceutical therapies. Our lead product candidate, Epidiolex (CBD), is currently in Phase 3 trials in Dravet Syndrome, Lennox Gastaut Syndrome, Infantile Spasms, and to treat the seizures associated with Tuberous Sclerosis Complex.

Gundersen Health System Booth

1126

1900 South Ave. La Crosse, WI 54601 United States gundersenhealth.org/ medcareers

Gundersen Health System, based in La Crosse, WI, invites you to join us in our mission to deliver excellence in patient care, education, and research, and to improve


New Exhibitor health in the communities we serve. We are a physicianled, teaching hospital, employing over 500 medical staff. Located along the upper Mississippi River, La Crosse and surrounding communities offer unparalleled natural beauty. Fine arts and performing arts, great restaurants, and good schools make this a great place to live!

Exhibit Hall Passport Destination

HCA (Hospital Corporation of America) Booth

145

Hartford HealthCare Booth

925

1290 Silas Deane Highway Wethersfield, CT 06109 United States joinhartfordhealthcare.com

Hayes Locums Booth

238

6700 North Andrews Avenue Suite 600 Fort Lauderdale, FL 33309 United States hayeslocums.com

Our mission is to provide dependable and trustworthy placement services on a temporary and permanent basis to both physicians and healthcare institutions nationwide. We have a network of physicians who are interested in short and long-term locum tenens assignments, as well as permanent placement. Getting you placed at the right assignment is just the beginning of our first-class service. Our goal is to focus on your needs, so you can take care of the needs of your patients.



HCA owns and operates over 160 hospitals across the Unites States, which makes us one of the nation's leading providers of healthcare services. We believe exceptional patient outcomes only come through a dedicated community of care, placing our physicians at the forefront.

HeadAid Booth

173

3441 West MacArthur Blvd Santa Ana, CA 92704 United States headaid.net

EXHIBITORS BY NAME

Hartford HealthCare is the largest integrated health system in CT with 5 hospitals including Hartford Hospital, an 867 bed tertiary academic center and the largest Stroke Center in New England. Physician-in-Chief Mark J. Alberts MD, leads the Neuroscience Institute, a growing, integrated multidisciplinary care system offering Vascular/Stroke, Headache, Neurohospitalist, Neuro Critical Care, Neurohospitalist Fellowship and more. Close to NYC and Boston, superb schools, stunning suburban and shoreline choices. Contact patti.lowicki@hhchealth.org

2 Maryland Farms Suite 210 Brentwood, TN 37027 United States practicewithus.com

HeadAid is dedicated to developing all-natural solutions to address the symptoms experienced by people who suffer from headaches, migraine, or post-concussion. The products come in abortive and preventative formulas free from side-effects, drug to drug interactions, and can be use by adolescents. They are easy-to-use, affordable, proven clinically effective, and taste great! Their delivery mechanism is in an effervescent stick pack that mix in water. NO PILLS or Capsules!

Health Monitor Network Booth

127

135 Chestnut Ridge Rd Health Monitor 2nd FL Montvale, NJ 07645 United States healthmonitornetwork.com

Health Monitor NetworkÂŽ is the nation's leading patient engagement company (40+ million patients and 360,000+ physicians). Our mission is to facilitate dialogue between patients and healthcare professionals through the quality, independence of our content, and the strength of 30+ exclusive strategic relationships with healthcare associations and advocacy organizations, including AAN, MSSA, AANP, AAPA and various state associations. Please see how we enhance the patient experience at Booth# 127.

127


Exhibitor Descriptions Huntington’s Disease Youth Organization Booth

1271

6372 La Costa Dr. #301 Boca Raton, FL 33433 United States hdyo.org

Huntsville Hospital Neurology Associates Booth

1239

101 Sivley Road Huntsville, AL 35801 United States hhsys.org

Established group with board certified physicians and nurse practitioners; shared call would be 1:6 days/weekends. This is a traditional Neurology opportunity with a mix of inpatient, outpatient and movement disorders. Excellent salary and benefits package including health, dental, disability and malpractice insurance, 401K, CME allowance and paid vacation. Teaching opportunities through UAB with med students, FP and IM residents. EMR, Open ICUs, Hospitalist service available for admissions.

Icometrix Booth

224

Kolonel Begaultlaan 1b 12 LeuvenBelgium 3012 Belgium icometrix.com

icometrix is the worldwide standard in MRI biomarkers in routine clinical practice. They developed icobrain, which detects FLAIR white matter hyperintenstities, calculates lesion volume and measures the whole brain and grey matter volume and changes. icometrix also acts as an image analysis expert in clinical trials and research studies, offering fast and high quality processing. icometrix is internationally active, with headquarters in Leuven, Belgium and an office in Boston, USA.

128

2017 AAN Annual Meeting On-site Guide

IMPAX Pharmaceuticals Booth

853

31047 Genstar Road Hayward, CA 94544 United States impaxlabs.com

Impax Specialty Pharma is a branded product division of Impax Laboratories™, Inc. Impax Specialty Pharma is focused on targeting significant unmet needs, with a primary focus on developing treatments for neurological disorders.

Impeto Medical Booth

110

8910 University Center Lane Suite 615 San Diego, CA 92122 United States sudoscan.com

Impeto Medical Inc. is a privately owned medical device company founded in 2005, with US operations based in San Diego, California. Impeto Medical manufactures and markets devices for non-invasive assessment of eccrine sweat gland activity through sudorimetry. SUDOSCAN and SUDOSCAN2 are FDA cleared for use within the US. Additional product lines, such as EZSCAN2 are approved for use in other regions outside of the United States.

Indiana University Kelley School of Business, Business of Medicine Physician MBA Booth

895

801 West Michigan Street BS 3024 Indianapolis, IN 46202 United States kelley.iupui.edu/programs/ physician-mba/

IU Kelley’s Physician MBA is designed for physician leaders and tailored to the physician learning style. Our one-of-a-kind curriculum, focused at the intersection of business and medicine, combines business and leadership fundamentals with specialized, strategic healthcare courses. Our 21-month MBA at our top ranked business school blends online on-demand and interactive learning with monthly weekend instruction in Indianapolis from research-active faculty--while earning CMEs quarterly.


New Exhibitor Intermountain Healthcare Booth

1011

36 South State St. 21st floor Salt Lake City, UT 84111 United States Physicianjobsintermountain.org

International Essential Tremor Foundation Booth

1257

11111 W. 95th St. Suite 260O Verland Park, KS 66214 United States essentialtremor.org

The mission of the International Essential Tremor Foundation (IETF) is to provide global educational information, services, and support to children and adults challenged by essential tremor (ET), to their families and health care providers, as well as to promote and fund ET research. Founded in 1988 as a 501(c)3 non-profit membership organization, the IETF consists of patients, physicians, educators, health care workers, parents, relatives, friends and volunteers.

International Parkinson and Movement Disorder Society (MDS) Booth

1161

555 East Wells Street Suite 1100 Milwaukee, WI 53202 United States www.movementdisorders.org

The International Parkinson and Movement Disorder Society (MDS) is a professional society bringing together over 6,000 clinicians, scientists, and other healthcare professionals who are interested in Parkinsonâ&#x20AC;&#x2122;s disease, related neurodegenerative and neurodevelopmental



disorders, hyperkinetic movement disorders, and abnormalities in muscle tone and motor control. MDS provides professionals with a variety of educational and networking opportunities across the globe, among many online resources.

Invitae Booth

376

1400 16th St San Francisco, CA 94103 United States www.invitae.com

Invitae's mission is to bring genetic information into mainstream medical practice to improve healthcare for everyone. We offer clinically validated, affordable genetic testing for neurology, pediatric, metabolic, cardiology, oncology and more.

EXHIBITORS BY NAME

Booth 1011: Visit Intermountain Healthcare to learn about exciting physician job opportunities (Forbes 2015-one of nationâ&#x20AC;&#x2122;s top 25 employers). Intermountain Healthcare, a Utah-based nonprofit system of 22 hospitals, 185 clinics, a Medical Group (1,000+ employed physicians), a health plans division (Select Health), and other health services, is recognized as a leader in clinical quality improvement and efficient healthcare delivery. www.intermountainhealthcare. org, PhysicianJobsIntermountain.org

Exhibit Hall Passport Destination

Ipsen Biopharmaceuticals Booth

201

106 Allen Road 3rd Floor Basking Ridge, NJ 07920 United States ipsenus.com

Ipsen Biopharmaceuticals, Inc. is the US affiliate of Ipsen, a global specialty-driven pharmaceutical group. At Ipsen Biopharmaceuticals, we focus our resources, investments, and energy on discovering, developing, and commercializing new therapeutic options for oncologic, neurologic, and endocrine diseases. For more information on Ipsen in North America, please visit www.ipsenus.com or www.ipsen.ca

Ipsum Diagnostics Booth

1063

1360 Center Drive Suite 210 Atlanta, GA 30338 United States ipsumdiagnostics.com

Ipsum Diagnostics is a pathology laboratory specializing in the diagnosis of small fiber neuropathy through epidermal nerve fiber density testing (ENFD). We provide clear and concise reports, fast turnaround time, attentive customer service and EMR integration. Every report is reviewed by a board certified dermatopathologist with over 30 years of experience. For more information, please go to www.ipsumdiagnostics.com.

129


Jackson & Coker Booth

322

3000 Old Alabama Road Suite 119-608 Alpharetta, GA 30022 United States jacksoncoker.com

Jackson & Coker is among the largest and most well-recognized physician staffing firms in the United States, bringing together permanent and temporary (locum tenens) physician placement under one entity. The firm is dedicated to uniting top physicians with the hospitals and medical facilities that need them, ensuring patients have access to life-saving healthcare in their own communities. For more information, visit JacksonCoker.com.

Jali Medical Inc. Booth

239

330 Bear Hill Rd. Suite 303 Waltham, MA 02451 United States jalimedical.com

US distributor for reputable neuromodulation devices that include magnetic and electrical nerve stimulation, TMS,tDCS, tACS, EEG, EMG and neuronavigation. We distribute for Magstim Company, Rogue Research, Rogue Resolutions, ANT Neuro, Mega Electronics, Delsys.

Jari Electrode Supply Booth

137

380 Tomkins Court Gilroy, CA 95023 United States

KabaFusion Booth

741

17777 Center Court Dr. N. Suite 550 Cerritos, CA 90703 United States kabafusion.com

KabaFusion is a pharmacist-owned, patient-focused team of professionals with extensive experience in home infusion and specialty infusion therapy. Services are provided from our seven specialty pharmacies located in CA, TX, NJ, MA, IL, FL and PA, serving over 30 states across the country. Our pharmacists, nurses, and reimbursement specialists work as a team to

130

2017 AAN Annual Meeting On-site Guide

provide your patient with compassionate, efficient, and reliable care.

Kaiser Permanente-Southern California Medical Group Booth

270

393 E. Walnut St. Pasadena, CA 91188 United States physiciancareers.kp.org/scal

Within the Permanente Medical Groups, physicians find recognition, stability, opportunity, and independence. Driven by the needs of our members and built on a platform in which medical decisions are made by physicians, each of our locations is able to self-manage the resources necessary for the delivery of excellent patient care. Beyond the practice of medicine, our physicians are provided with many personal and professional opportunities.

KEGO Corporation Booth

737

1191 Brock McVey Drive Lexington, KY 40509 United States kegodiagnostics.com

KEGO is an international distributor of sleep and neurodiagnostic supplies. With locations in the USA and Canada, KEGO is your national â&#x20AC;&#x153;One Stop Shop", representing major manufacturers of sleep and neurodiagnostic products. Check out the full line of KEGO products at www.kegodiagnostics.com. What can KEGO do for you today?

King-Devick Technologies, Inc. Booth

793

2 mid america Plaza Suite #110 Oakbrook Terrace, IL 60181 United States kingdevicktest.com

King-Devick Technologies, Inc. offers a broad set of evidence-based solutions utilizing integrated technology for concussion management and indicators of neurological function. King-Devick products have been scientifically validated in more than 80 recent peer reviewed articles published in elite medical journals related to concussion management, reading solutions, Alzheimer's disease, hypoxia, multiple sclerosis, Parkinson's disease, extreme sleep deprivation and ALS.


New Exhibitor KRONUS, Inc. Booth

369

170 S. Seneca Springs Way Suite 105 Star, ID 83669 United States kronus.com

For more than 30 years, KRONUS has served as a leading provider of specialized immunoassay test kits to medical professionals at the world's most respected research and clinical laboratory facilities. The Company will be presenting information on its neuroimmunologyrelated test kits. Please take a few moments to visit our informative exhibit at booth number 369 and learn more about our unique and innovative product line.

Booth

1123

1214 Coolidge Street Lafayette, LA 70520 United States lafayettegeneral.com

Lafayette General Health (LGH) is Acadiana's largest non-profit, community-owned regional health system. The system serves the south-central region of Louisiana by aligning with facilities across Acadiana. With Lafayette General Medical Center (LGMC) as the flagship hospital, LGH also owns and operates six other hospitals,two of which are teaching hospitals providing graduate medical education across many disciplines. LGMD Physician Group employs over 60 physicians across many specialties.

Legacy Medical Group Booth

1246

1120 NW 2oth Ave Ste Suite 111 Portland, OR 97209 United States legacyhealth.org

raising awareness of the Lewy body dementias (LBD), supporting people with LBD, their families and caregivers and promoting scientific advances. The Association’s purposes are charitable, educational, and scientific.

Lifelines Neurodiagnostic Systems, Inc. Booth

1016

Troy, IL 62294 United States lifelinesneuro.com

Lifelines Neurodiagnostic Systems is celebrating 15 years as a pioneer in EEG. We implement our mission, Changing Lives Through Neurodiagnostic Innovation, by monitoring EEG in difficult places. Our Cloud-based platform is of the highest levels of security, AES 256-bit encryption and HIPAA compliance optimized. Our EEG platform allows real-time monitoring anywhere, anytime; in the patients’ home, clinical studies across the world, and clinical environments in the ED and NICU.

EXHIBITORS BY NAME

Lafayette General Health

Exhibit Hall Passport Destination

LifePoint Health Booth

1140

330 Seven Springs Way Brentwood, TN 37027 United States LifePointGoodLife.com

LifePoint Health is a leading healthcare provider in 72 communities and 22 states; offering comprehensive inpatient, outpatient and post-acute services. In collaboration with Duke University, we created the LifePoint National Quality Program to ensure consistent, high standards of quality and patient safety. We are eager to discuss our rewarding opportunities for both general and fellowship trained Neurologists. Visit us in Booth 1140 for more info on our global Neurology initiatives.

Lewy Body Dementia Association Booth

1244

912 Killian Hill Rd SW 2nd Floor Suite Lilburn, GA 30047 United States lbda.org

The Lewy Body Dementia Association (LBDA) is a 501(c)(3) nonprofit organization dedicated to



131


Exhibitor Descriptions facilities and agencies nationwide.

Logistics Health Inc. Booth

1152 Lilly

Booth

591

Lilly Corporate Center Indianapolis, IN 46285 United States lilly.com

Lilly for Better HealthÂŽ is a multi-channel effort that goes beyond medicine to support an individual's personal health care journey. We create and support various resources that demonstrate the importance of everyday health and wellness to manage conditions and help make life better overall.

LivaNova Booth

745

100 Cyberonics Blvd Houston, TX 77058 United States vnstherapy.com

IT'S NOT JUST AN APPOINTMENT. IT'S AN HONOR. At our core is an unwavering dedication to serving the health care needs of the brave men and women who keep America safe and running. Supported by a nationwide provider network, we provide customized health care solutions to government and commercial clients. LHI has a variety of opportunities for you to become involved by providing care for this deserving population, including general medicine and most specialties.

Lundbeck Booth

229

Six Parkway North Deerfield, IL 60015 United States lundbeckus.com

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a commitment to improve the lives of patients worldwide. LivaNova's advanced technologies and breakthrough treatments provide meaningful solutions for patients, healthcare professionals and healthcare systems across three business franchises: Cardiac Surgery, Neuromodulation and Cardiac Rhythm Management. LivaNova PLC is proud to sponsor AAN and advance the wellbeing of those living with epilepsy.

Lundbeck, a global pharmaceutical company based in Denmark and founded in 1915, strives for global leadership in psychiatry and neurology by improving the lives of patients. One of the world's leading companies specializing in brain disorders, Lundbeck is focused on innovating treatments for depression, schizophrenia, Parkinson's disease and Alzheimer's disease.

LocumTenens.com

MagQu

Booth

892

2655 Northwinds Parkway Alpharetta, GA 30009 United States locumtenens.com

Founded in 1995, LocumTenens.com is a full-service staffing firm serving physicians, advanced practice professionals and healthcare facilities looking to solve employment shortages. Operator of the largest online job board for the locums industry, LocumTenens. com provides job-seeking providers direct access to thousands of jobs, in all specialties, posted directly by

132

328 Front St South La Crosse, WI 54601 United States logisticshealth.com

2017 AAN Annual Meeting On-site Guide

Booth

177

3F., No. 12, Ln. 538 Zhongzheng Rd., Xindian Dist. New Taipei City 23141 Taiwan magqu.com

MagQu is an in vitro diagnostic (IVD) company providing ultra-sensitive and blood assaying kits for specific biomarkers of various dementias, including beta-amyloid 1-40, beta-amyloid 1-42, total tau, phosphorylated tau, alpha-syncluclein and phosphorylated alpha-syncluclein. MagQu's


New Exhibitor products are designed and perfect for both academic and clinical application. MagQu focuses on early diagnosis and dementias monitoring by MagQu's ImmunoMagetic Reduction(IMR) test.

Exhibit Hall Passport Destination

Mayo Medical Laboratories Booth

685

Mallinckrodt Pharmaceuticals Booth

378

NJ United States mallinckrodt.com

Managing Epilepsy Well Network Booth

1234

One Medical Center Drive Lebanon, NH 03766 United States ManagingEpilepsyWell.org

The Managing Epilepsy Well (MEW) Network is a team of people who care about the health of people with epilepsy. MEW Network members come from U.S. universities, community-based organizations and the Centers for Disease Control and Prevention (CDC). As a non-profit entity, we work together to promote epilepsy self-management research and improve the quality of life for people with epilepsy.

Mayo Clinic Booth

791

200 First Street SW BioBusiness 8 Rochester, MN 55905 United States mayoclinic.org

Mayo Medical Laboratories is a global reference laboratory operating within Mayo Clinic's Department of Laboratory Medicine and Pathology. Our comprehensive neurology testing menu, as well as the expertise of Mayo Clinic neurologists, lab directors and genetic counselors, provides the detailed clinical information to diagnose and treat hundreds of neurological conditions.

McGraw-Hill Education Booth

823

2 Penn Plaza 9th Floor New York, NY 10121 United States mcgrawhillmedical.com

EXHIBITORS BY NAME

Mallinckrodt Pharmaceuticals is a global specialty biopharmaceutical and medical imaging company. The company's Autoimmune and Rare Diseases business includes H.P. ActharÂŽ Gel (repository corticotropin injection), indicated for use in multiple specialties including neurology, rheumatology, nephrology and pulmonology. Mallinckrodt's other areas of focus include analgesics and central nervous system drugs for prescribing by office- and hospital based physicians.

3050 Superior Drive NW Rochester, MN 55905 United States MayoMedicalLaboratories.com

McGraw-Hill Education is a premier publisher of medical print and electronic media including Adams & Victor's Principles of Neurology and the Neurology Collection on AccessMedicineÂŽ.

McKesson Specialty Health Booth

334

123 Mission Street San Francisco, CA 94105 United States mckessonspecialtyhealth.com

McKesson Specialty Health is the leading provider of specialty pharmaceutical distribution services and practice management solutions to neurology offices. We deliver innovative drug therapies and offer support services that help practices grow revenue and profitability, control drug costs and capture operational efficiencies. Our neurology specialist team will work directly with you to ensure your practice's success.

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. The Referring Provider Office is a resource for all providers outside of Mayo Clinic, whether you are getting in touch with Mayo for the first time or have an ongoing relationship with us and our providers. We want to collaborate with you!



133


Exhibitor Descriptions MediMax Tech, Inc. Booth

963 MedDay Pharmaceuticals Booth

975

96 Boulevard Haussman PARIS 75008 France medday-pharma.com

MedDay addresses areas of unmet need in neurological and psychiatric diseases through the brain metabolism. This approach relies on unique clinical and pharmaceutical development expertise in the field of rare inborn errors of metabolism.

medi USA Booth

175

6481 Franz Warner Parkway Whitsett, NC 27377 United States restiffic.com

restiffic is the newest addition to the medi portfolio of products. medi is a global leader in the medical compression, orthopedic, prosthetic, foot orthotic, and retail compression markets, and is committed to helping people all around the world live more independent, productive, and satisfying lives.

Medical Associates Clinic Booth

1022

1500 Associates Dr, Dubuque,IA 52002 United States mahealthcare.com

Medical Associates Clinic, with over 170 providers, is the area's largest leading healthcare provider and multispecialty group practice. It has received multiple recognitions including MGMA's “Better Performing Groups”and U.S. News and Word Report's “America's Best Health Plans”and continually provides its physician owner's annual incomes above national averages. Medical Associates is an AGMA “Best Practice”for physician satisfaction and ranks in the top 5 percentile for employee engagement.

134

2017 AAN Annual Meeting On-site Guide

2805 E Ana St East Rancho Dominguez, CA 90221 United States mmtneuro.com

Our company manufactures Neurological, Surgical and Electrotherapy/Chiropractic supplies and products. Since 2004, MMT has made it our mission to provide customers with highest quality medical products, cost effective savings and great customer service. Come stop by at booth #963 and meet with the MediMax Tech Team.

MedLink Neurology Booth

825

10393 San Diego Mission Rd Suite 120 San Diego, CA 92108 United States medlink.com

Thousands of neurologists worldwide rely on MedLink® Neurology to quickly find authoritative, current answers to their clinical questions, as well as to earn free CME credits with routine use. Whether clinician, scientist, or member of industry, ask us how you can benefit by connecting with this select community. Visit us in Publisher’s Row and sign up for 30 days of free access to MedLink Neurology -- available only at the AAN meetings.

Medscape Neurology Booth

858

395 Hudson St 3rd Floor New York, NY 10014 United States medscape.com/neurology

Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME.


New Exhibitor Medtronic Booth

467

710 Medtronic Pkwy Minneapolis, MN 55432-5603 United States medtronic.com

Through innovation and collaboration, Medtronic improves the lives and health of millions of people each year. Visit our booth #467 for information on our treatments for Parkinson's disease, essential tremor, normal pressure hydrocephalus and large vessel occlusion ischemic stroke. In addition, see how medical technology can help you manage patients with cryptogenic stroke.

Memorial Health System

1236

401 Matthew Street Marietta, OH 45750 United States mhsystem.org

The Memorial Health System is a not-for-profit health system located in Marietta, Ohio. The system is governed by a volunteer board of community members that are committed to providing comprehensive services that meet the needs of our region. We are comprised of a network of two hospitals and outpatient service sites. We work in innovative ways to meet the healthcare challenges of today, while preparing for the health needs of our communities in the future.

Memorial Healthcare System Booth

1138

3501 Johnson Street Hollywood, FL 33021 United States memorialphysician.com

Memorial Neuroscience Institute uses advanced technology and innovative procedures to treat patients with neurooncological, neurovascular, neuromuscular and neuroinflammatory problems. The institute offers a range of surgical services, including radiosurgery, pituitary surgery, cerebrovascular neurosurgery and spine surgery. Memorial Neuroscience Institute offers minimally invasive procedures such as image-guided brain surgery, minimally invasive spine surgery and neurovascular interventions.



Mercy Clinic Booth

1024

1965 S. Fremont Suite 200 Springfield, MO 65804 United States mercy.net

Mercy, named one of the top five large U.S. health systems in 2016 by Truven, an IBM company, serves millions annually. Mercy includes 45 acute care and specialty (heart, children's, orthopedic and rehab) hospitals, more than 700 physician practices and outpatient facilities, 40,000 co-workers and more than 2,000 Mercy Clinic physicians in Arkansas, Kansas, Missouri and Oklahoma. Mercy also has outreach ministries in Louisiana, Mississippi and Texas.

EXHIBITORS BY NAME

Booth

Exhibit Hall Passport Destination

Mercy Health Booth

1027

2200 Jefferson Ave. Toledo, OH 43604 United States mercy.com

Mercy is a recognized leader in providing quality, cost-effective healthcare and is a regional leader in collaboration with other community organizations to meet community needs. Mercy is a preferred provider in the majority of health insurance plans, we actively work to control healthcare costs through managed care contracts and insurance initiatives. Mercy encompasses seven hospitals and offers a medical staff of over 1,500 members to support the comprehensive range of services.

Micromedical Technologies, Inc. Booth

374

10 Kemp Drive Chatham, IL 62629 United States micromedical.com

Micromedical by Interacoustics leads the industry by providing state of the art turnkey Balance Centers to clinicians whose patient populations include those with vestibular or neurological disorders, traumatic brain injury or individuals who are pursuing balance enhancement.

135


Exhibitor Descriptions MNG Laboratories Booth

1134

5424 Glenridge Dr. Atlanta, GA 30342 United States mnglabs.com

MNG Laboratories is the leading provider of neurogenetic testing specializing in cellular energetics defects, muscular dystrophies, epilepsy, intellectual disabilities and cardiomyopathy. Our extensive offering of NGS panels, proprietary MNG Genome MaNaGer™ database and our Neurogenetic Answers™ reporting platform is recognized by genetic experts around the world. We are proud to offer first-in-class reporting and fast turnaround times at affordable prices.

Monteris Medical Booth

146

14755 27th Ave N Suite C Plymouth, MN 55447 United States monteris.com

Monteris Medical is a privately held company developing devices for minimally-invasive, MR-guided, robotically controlled neurosurgery. Monteris markets the NeuroBlate® system for controlled, volumetric ablation of brain lesions. Monteris also offers the various Stereotactic anchoring devices for image-guided trajectory alignment, and the AtamA™ Stabilization System for MR based procedures requiring versatile head fixation. For more information on Monteris Medical please visit www.monteris.com.

MotherToBaby Pregnancy Studies conducted by OTIS Booth

1227

9500 Gilman Drive Mail Code 0828 La Jolla, CA 92093 United States mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists (OTIS), provides evidence-based information about medications and other exposures during pregnancy and lactation. MotherToBaby Pregnancy Studies

136

2017 AAN Annual Meeting On-site Guide

conducted by OTIS is evaluating effects to the fetus from Multiple Sclerosis and the safety of medications used to treat MS during pregnancy.

Mount Sinai Health System Booth

807

One Gustave L. Levy Place New York, NY 10029 United States mountsinaihealth.org/patientcare/neurology

Icahn School of Medicine at Mount Sinai Department of Neurology The Estelle and Daniel Maggin Department of Neurology at the Icahn School of Medicine at Mount Sinai in New York City has over a 100-year history, with an international reputation for excellence across inpatient and outpatient neurological subspecialties. Directed by Barbara G. Vickrey, MD, MPH, the department continues to advance clinical care, academic training, and elucidate the underlying mechanisms of neurological disease.

Mountain States Health Alliance Booth

1218

16000 Johnston Memorial Drive Abingdon, VA 24211 United States mountainstateshealth.com/

Mountain States Health Alliance, located in NE Tennessee & SW Virginia are currently seeking Employed, Neuro-Hospitalists in Kingsport & Johnson City, TN. Employed, Out-Patient Clinic, Adult Neurologists are needed in Abingdon, VA. Mountain States Health Alliance is a dynamic 13-hospital regional health system in one of the most beautiful areas of the southeastern part of the U.S. (NE Tennessee & SW Virginia). We also have excellent public schools & a multitude of outdoor recreation options.

MS Cure Fund Booth

1264

20 Park Plaza Suite 400 Boston, MA 02116 United States mscurefund.org


New Exhibitor

Exhibit Hall Passport Destination

National ALS Registry Booth

379 MT Pharma America Booth

721

525 Washington Blvd Suite 400 Jersey City, NJ 07310 United States mt-pharma.co.jp/e/index.php

Mitsubishi Tanabe Pharma

MULTIGON INDUSTRIES,INC. Booth

Multigon Industries is exhibiting its NEXGEN Digital Transcranial Doppler (TCD) Ultrasound with Robotic Headband for Long-term monitoring. The ROBOTOC2MD locks on to the signal and maintains it despite patient or headband movement. Other functions include emboli montitoring , PFO’s,Vasomotor reactivity, integrated capnostat, management of vasospasm. 6 CPT codes can be utilized. PAINSHIELD is wearable ultrasound for treatment of Trigeminal Neuralgia,tendon, ankle, knee,joint and pelvic pain

Multiple Sclerosis Foundation Booth

1259

6520 North Andrews Ave Fort Lauderdale, FL 33309 United States msfocus.org

The Multiple Sclerosis Foundation, known in the MS community as MS Focus, is a nonprofit organization focused on providing free services that address the critical needs of people with MS and their families, helping them maintain the best quality of life. The symptoms of MS may increase in severity over time. This presents many challenges families must face. MS Focus is here to provide the support, education, and assistance needed to adapt to these challenging circumstances.



The main goals of the congressionally mandated National ALS Registry are to better describe the incidence and prevalence of ALS, examine risk factors such as environmental and occupational factors, and characterize the demographics of persons living with ALS. The National ALS Registry recently launched the National ALS Biorepository to further expand ALS research into areas such as genetics, biomarkers, and environmental toxicants.

National Ataxia Foundation Booth

1249

EXHIBITORS BY NAME

135

525 Executive Boulevard Elmsford, NY 10523 United States multigon.com

4770 Buford Hwy Atlanta, GA 30341 United States cdc.gov/als

2600 Fernbrook Lane N Suite 119 Minneapolis, MN 55447 United States ataxia.org

The National Ataxia Foundation, founded in 1957 as a nonprofit organization, has a mission to find the cause and cure for ataxia. The Foundation supports promising research and provides programs and services to those affected by ataxia. Empowering persons at risk to receive an accurate diagnosis and treatment. Increasing awareness about ataxia. Funding world-wide ataxia research designed to better understand ataxia, gene discovery and translate this information into treatment methods.

National Headache Foundation Booth

1235

820 N. Orleans St. Suite 201 Chicago, IL 60610 United States headaches.org

The National Headache Foundation's mission is “To cure headache, and end its pain and suffering.”Its vision is “A World Without Headache.”It is the premier educational and informational resource for those with headache, health care providers, and the public. It publishes the quarterly magazine, HeadWise® and the monthly e-newsletter, NHF News to Know. For information or a list of physicians in a geographical area who treat headache, visit www.headaches. org, or call 1-888-NHF-5552.

137


Exhibitor Descriptions National Institute of Neurological Disorders & Stroke Booth

104

Building 31, Room 8A07 31 Center Dr., MSC 2540 Bethesda, MD 20892-2540 United States ninds.nih.gov

The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, provides members of the American Academy of Neurology with information on available research support and offers free publications for patients and their families on a wide variety of neurological disorders. Members of the NINDS staff will be available at the exhibit booth to assist you. Printed material is available.

National Spasmodic Torticollis Association Booth

1261

9920 Talbert Ave. Fountain Valley, CA 92708 United States torticollis.org

NEJM Group Booth

922

860 Winter Street Waltham, MA 02451 United States nejmgroup.org

NEJM Group creates high-quality medical resources for research, learning, practice while meeting the demand for medical knowledge among academic researchers and teachers, physicians, clinicians, executives and others in health care. NEJM Group products include the New England Journal of Medicine, NEJM Journal Watch, NEJM Knowledge+, NEJM Catalyst and NEJM Resident 360. NEJM Group is a division of the Massachusetts Medical Society. For more information visit www.nejmgroup.org.

Neuro Central Booth

1054

Future Medicine, Unitec House London N3 1QB United Kingdom neurology-central.com

Spasmodic Torticollis, also known as “Cervical Dystonia”is a painful and debilitating neurological movement disorder. Approximately 3 in every 10,000 people are known to suffer from ST. Many of those people have not been diagnosed or have been misdiagnosed. The mission of the NSTA is to support the needs and well-being of affected individuals and families; to promote awareness and education; to advance research for more treatments and ultimately a cure.

Neuro Central is a free online hub that bridges the gap between neuroscience and neurology, supporting synergistic progression through collaboration and learning. Designed for researchers and clinicians, and endorsed by an expanding board of Expert Panel members from across the globe, we keep you up to date with the latest news, interviews, opinions, podcasts and more, plus peer-reviewed articles from our partnered journals.

Natus Neurology

Neurocrine Biosciences, Inc.

Booth

535

3150 Pleasant View Road Middleton, WI 53562 United States natus.com

Natus is a leading provider of healthcare products used for the diagnosis and monitoring of neurological disorders, such as epilepsy, sleep disorders, stroke, neuropathies, neuromuscular diseases, myopathies and neurosurgical procedures. Product offerings include computerized neurodiagnostic systems for neurology, polysomnography, software systems and

138

a complete range of supplies and accessories for managing and tracking disorders from hospitals to private practice.

2017 AAN Annual Meeting On-site Guide

Booth

585

12780 El Camino Real San Diego, CA 92130 United States neurocrine.com

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals utilizing our novel R&D platform. Neurocrine’s efforts are focused on conditions with high unmet medical needs, specifically in neurological and endocrine based diseases and disorders.


New Exhibitor Neuro-Immunology Laboratories - UBC Booth

1238

2211 Wesbrook Mall S-157, UBC Hospital Vancouver, BC V6T 2B5 Canada neuroimmunology.med.ubc.ca

practice. NEUROLOGY REVIEWS covers major medical conferences and monitors the peer review literature to report the latest research findings.

Neuronetrix Booth

1150

1044 E Chestnut St Louisville, KY 40204 United States neuronetrix.com

Neuronetrix is transforming the diagnosis of patients with cognitive disorders by providing accurate and meaningful diagnostic information to health care professionals early in the disease process. This information is critical to clinicians who wish to provide optimal care for their patients and to scientists who are searching for ways to treat these devastating disorders.

Neurology Advisor

NeuroPace, Inc

1065

New York, NY 10001 United States neurologyadvisor.com

Neurology Career Center Booth

1112

201 Chicago Ave Minneapolis, MN 55415 United States AAN.com/careers

The AAN’s Neurology Career Center is the world’s largest neurology-specific career resource. Search over 500 open neurology positions nationwide. Create a Job Alert to receive notication when new positions of interest are posted. Download articles on career topics. AAN Junior members can access the Salary Calculator tool. A variety of advertising options exist for employers including online, print and e-mail options.

NEUROLOGY REVIEWS Booth

740

7 Century Drive Suite 302 Parsippany, NJ 07054 United States neurologyreviews.com

NEUROLOGY REVIEWS is a clinical news publication with articles and timely department features that keep neurologists, primary care physicians, and other healthcare professionals informed of the latest news affecting their

Booth

373

EXHIBITORS BY NAME

The Neuro-Immunology Laboratory, a non-profit facility, is a division of UBC Diagnostic Services Laboratory and is part of the Division of Neurology (Department of Medicine), at the University of British Columbia (UBC). Founded in 1984 we specialize in neuroimmunology and neurogenetics. We perform diagnostic testing covered by Medical Services Plan of BC and are accredited by the Diagnostic Accreditation Program (DAP) of British Columbia.

Booth



Exhibit Hall Passport Destination

455 N. Bernardo Avenue Mountain View, CA 94043 United States neuropace.com

NeuroPace manufactures devices for the treatment of neurological disorders with responsive stimulation. The RNS® System is an award-winning technology recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS® System is the world's first and only medical device that can monitor and respond to brain activity, and is designed to prevent seizures at their source. The RNS® System has been implanted in over 1,000 patients to date.

Neurovirtual Booth

735

2315 NW 107th Ave Suite 27 Doral, FL 33172 United States neurovirtual.com

At Neurovirtual, we specialize in the development, manufacturing, and marketing of premium-quality diagnostic devices used in the fields of Neurology and Sleep Medicine. Our mission is to provide the latest technology at a fair price. Our corporate culture promotes quality, innovation, and a peoplefirst approach to every facet of the ownership experience, with round-the-clock access to live help and software solutions that evolve with you.

139


Exhibitor Descriptions NIHON KOHDEN AMERICA, INC. Booth

311

15353 Barranca Parkway Irvine, CA 92618 United States us.nihonkohden.com

Nihon Kohden is the leading manufacturer, developer and supplier of instrumentation and services for Epilepsy Monitoring, Electroencephalography, Ambulatory and OCST Recording, Polysomnography, Electromyography, Evoked Potentials, Intra-operative and cEEG ICU monitoring. Nihon Kohden's products offer the flexibility and expandability needed to meet the changing demands of today's neurodiagnostic field.

Norton Healthcare Booth

1116

4801 Olympia Park Plaza, Suite 3000 Louisville, KY 40241 United States nortonhealthcare.com/pages/ nni.aspx

Norton Neurology Services, a part of Norton Neuroscience Institute in Louisville, Kentucky, is recruiting for multiple neurologists and neurology subspecialists to join the team of 19 neurologists and nine advanced practice providers. The practice offers multispecialty neurology and support services for patients and their families/ caregivers. The group has a referral base of over 850 providers. To meet with our physician contact Amanda Bailey at 502-439-5144 or Amanda.

bailey@nortonhealthcare.org

NOVA Surgical Booth

739

41050 Grenata Preserve Place Leesburg, VA 20175 United States novasurgical.net

Nova Surgical is a medical instrument company specializing in the design and manufacture of diagnostic products. Quality perfect, affordable and practical equipments.

140

2017 AAN Annual Meeting On-site Guide

Novartis Pharmaceuticals Booth

547

One Health Plaza East Hanover, NJ 07936-1016 United States

Novocure Booth

894

195 Commerce Way Portsmouth, NH 03801 United States novocure.com

Novocure is a Jersey Isle oncology company pioneering a novel therapy for solid tumors called TTFields. Novocure's US operations are based in Portsmouth, NH and New York, NY. Additionally, the company has offices in Germany, Switzerland, and Japan and a research center in Haifa, Israel. For additional information about the company, please visit www.novocure.com or follow us at

www.twitter.com/novocure.

Ochsner Health System Booth

1018

1514 Jefferson Hwy New Orleans, LA 70121 United States ochsner.org

Ochsner Neuroscience Institute earns national and regional recognition as a leader in providing quality neuroscience services. Our multidisciplinary team offers the latest diagnostic and therapeutic options and is actively recruiting BC/BE Neurologists to join its group of 32 neurologists. We are a Top 25 Neuroscience Center in the latest US News & World Report rankings. Ochsner Health System is Louisiana's largest non-profit, academic, healthcare system, employing more than 1,000 physicians.


New Exhibitor OhioHealth Booth

1057

180 E. Broad St. Columbus, OH 43215 United States ohiohealth.com

OtoSim Inc. Booth

125

OtoSim Inc. c/o The Hospital for Sick Children 555 University Ave, Room 8436TorontoON M5G 1X8 Canada otosim.com

OtoSim Inc. developed OphthoSim to bridge the distance between traditional learning and clinical experience. Through the use of a tracked scope, neurology teaching faculty can see exactly where within the simulated fundus the student is viewing. Dozens of examples of neuropathies, degenerative diseases and papilledema can be reviewed, discussed and verified. Visit us at www.otosim.com or email us at sales@otosim.com or call 647.792.7735.

Outcome Health Booth

981

330 N Wabash Ave STE 2500 Chicago, IL 60611 United States contextmediahealth.com

digital waiting room screen, patient mobile, digital wallboard, exam room tablet and infusion room tablet, help physicians and patients work together to achieve better outcomes.

Owensboro Health Regional Hospital Booth

1160

PO Box 20007 Owensboro, KY 42304 United States owensborohealth.org

Owensboro Health is a community-focused, nonprofit health care system in KY that provides medical advancements and compassionate care to help improve the community. Owensboro Health Regional Hospital is a top-ranked hospital located 120 miles north of Nashville, TN and 100 miles southwest of Louisville, KY. We are looking for Neurologist to join our team of 175 healthcare providers who use the latest technologies, innovations and protocols to serve our 17 county area.

EXHIBITORS BY NAME

OhioHealth is home to one of the nation's largest comprehensive neuroscience programs. Our recently completed $321 million OhioHealth Neuroscience Center features an unmatched, complete range of neuroscience care such as inpatient and outpatient treatment, neurodiagnostics, interventional procedures, research clinical trials, surgery and education. The nine-story tower includes 224 private rooms and 409,000 square feet dedicated to our brain and spine patients. Riverside Methodist is also certified by The Joint Commission as a Comprehensive Stroke Center, and was ranked a 2016-2017 “Best Hospital”for neurology and neurosurgery by U.S. News & World Report. Learn more at OhioHealth.com/Neuroscience.

Exhibit Hall Passport Destination

OXFORD UNIVERSITY PRESS Booth

916

198 Madison Avenue New York, NC 10016 United States global.oup.com

Oxford University Press is proud to publish some of the world’s premier books, journals, and online resources in Neurology. Visit our booth for discounts on new and classic titles and free journal samples. www.oup.com/us

Pairnomix Booth

268

6701 Evenstad Dr. Maple Grove, MN 55369 United States pairnomix.com

Pairnomix is a genetic evaluations company, formed to empower physicians and patients who want to know more about rare genetic mutations and potential new uses for drugs that could be prescribed today.

Outcome Health develops innovative technologies that provide actionable intelligence on conditions, treatments and lifestyle choices during key moments in care. Our platforms, which include the



141


Exhibitor Descriptions Partners Multiple Sclerosis Center Booth

1168

60 Fenwood Road Suite 1B Boston, MA 02115 United States partnersmscenter.org

PeaceHealth Booth

1221

1115 SE 164th Ave. Vancouver, WA 98683 United States peacehealth.org

PeaceHealth is a nonprofit Catholic health system serving communities in Washington, Oregon & Alaska. PeaceHealth has approximately 16,000 caregivers, a medical group with more than 800 physicians/ providers & 10 medical centers serving urban & rural communities. In 1890, the Sisters of St. Joseph of Peace founded what has become PeaceHealth. PeaceHealth continues the Sister’s legacy by serving it’s communities with a spirit of collaboration and stewardship. This is The Spirit of PeaceHealth!

Penn State Hershey Medical Center Booth

1021

90 Hope Drive, Suite 1103 MC A595 Hershey, PA 17033 United States hmc.pennstatehealth.org

Penn State Health Milton S. Hershey Medical Center, Penn State College of Medicine and Penn State Hershey Children’s Hospital are committed to enhancing the quality of life through improved health, the professional preparation of those who will serve the health needs of others, and the discovery of knowledge that will benefit all. We are a 551-bed Level I regional trauma center academic medical center. Visit us at www.hmc.pennstatehealth.org and see why so many people call Hershey, PA home!

Pfizer

Booth

1012 142

10017 United States pfizer.com

At Pfizer, one of the world’s premier innovative biopharmaceutical companies, we apply science 2017 AAN Annual Meeting On-site Guide

and our global resources to bring therapies to people that extend and significantly improve their lives. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

Pikeville Medical Center, Inc. Booth

1029

911 Bypass Road Pikeville, KY 41501 United States pikevillehospital.org

In its 92nd year, Pikeville Medical Center is a 300-bed facility and offers more than 400 services, including every major specialty and most subspecialties. The nation's only repeat winner of National Hospital of the Year, PMC is dedicated to providing quality regional health care in a Christian environment.

PRA Health Sciences Booth

339

995 Research Park Blvd Suite 200 Charlottesville, VA 22911 United States prahs.com

PRA is one of the world’s leading global contract research organizations, providing outsourced clinical development services to biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes 70+ offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East, and approximately 13,000 employees worldwide. PRA has participated in 285+ neuroscience and pain clinical projects globally in every phase, virtually every indication. Visit http://prahs.com/ therapeutic-expertise/neurology-psychiatry/ for more information.

Practical Neurology Booth

1053

1008 Upper Gulph Road Suite 200 Wayne, PA 19087 United States practicalneurology.com

READERS TURN TO PRACTICAL NEUROLOGY® BECAUSE THEY TRUST ITS STRAIGHT FORWARD CLINICAL & PRACTICE MANAGEMENT ADVICE. PRESSED FOR TIME AND FACED WITH MULTIPLE INFORMATION SOURCES, READERS FAVOR PRACTICAL NEUROLOGY® MAGAZINE’S UNIQUE EDITORIAL STYLE THAT CUTS TO THE HEART OF


New Exhibitor THE ISSUES WITH AUTHORITATIVE CONTENT AND SUMMARY POINTS. PUBLISHED 9X’s A YEAR PRACTICAL NEUROLOGY® IS DELIVERED TO OVER 18,000 NEUROLOGY PROFESSIONALS INCLUDING THE FULL UNIVERSE OF PRACTICING U.S. NEUROLOGISTS.

PracticeLink Booth

1028

415 2 Avenue Hinton, WV 25951 United States practicelink.com nd

Prevea Health Booth

336

2710 Executive Drive Green Bay, WI 54307 United States prevea.com

Visit us at Booth #336 - PREVEA HEALTH is seeking Neurologists (General, Interventional and Pediatric) to join our physician owned and led multi-specialty group. Prevea offers physicians a voice in their practice, something that is difficult to find in most practice settings today. Prevea has a unique partnership with (6) Hospital Sisters Health System Wisconsin based hospitals located in NE and Western Wisconsin. While at the AAN conference contact Becky @ 608-290-2362

PreventionGenetics Booth

961

3800 South Business Park Ave Marshfield, WI 54449 United States preventiongenetics.com

Founded in 2004 and located in Marshfield, Wisconsin, PreventionGenetics is a CLIA and ISO 15189:2012 accredited clinical DNA testing laboratory. PreventionGenetics provides patients with sequencing and deletion/duplication tests for nearly all clinically relevant genes. These tests include our powerful and comprehensive whole exome sequencing test, PGxome™.



ProMedica Health System Booth

921

5855 Monroe Street Sylvania, OH 43560 United States promedica.org

ProMedica is a large not-for-profit, integrated health-care system. ProMedica Physicians is a multi-specialty network of more than 900 physicians and midlevel providers throughout northwest Ohio and southeast Michigan. The ProMedica Physicians professional team handles every aspect of practice management including billing, coding, compliance, human resources, legal issues and marketing to name a few.

ProtoKinetics, Gait Analysis Walkways Booth

957

EXHIBITORS BY NAME

Physicians searching for their first or next practice rely on PracticeLink® The Career Advancement Resource for Physicians. PracticeLink helps physicians find the practice opportunities that best suit their personal and professional needs, and provides helpful career development and job-search information. Find your next practice on PracticeLink.com

Exhibit Hall Passport Destination

60 Garlor Drive Havertown, PA 19083 United States protokinetics.com

Postural control, dynamic balance, and transitional gait performance [starting, turning, braking] are critical components to quantify in clinical practice; the PKMAS Primary Gait Screen (PGS) is a unique protocol that addresses these transitional movements in a single test (typically performed in less than one minute) that requires no editing and is easy to administer. Data are available immediately. Key gait metrics include efficiency, symmetry, and speed. Over 29 clinical sites and counting...

Providence Health & Services Booth

1017

1201 NE Lloyd Blvd Suite 510 Portland, OR 97232 United States providence.org/providerjobs

Providence Health & Services, rated among the most integrated health systems in the nation, recruits over 1,000 physicians and advanced practice providers each year into its network of hospitals, medical groups and private practice partners in Alaska, California, Montana, Oregon and Washington. Providence is affiliated with Swedish Health Services, Pacific Medical Centers, Kadlec and other like-minded not-for-profit groups, expanding our reach even further.

143


Exhibitor Descriptions Quest Diagnostics Booth

139

3 Giralda Farms Madison, NJ 07940 United States athenadiagnostics.com

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world’s largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. We serve half of the physicians and hospitals in the United States. QuestDiagnostics.com.

RDL Reference Laboratory Booth

1041

10755 Venice Blvd Los Angeles, CA 90034 United States rdlinc.com

RDL Reference Laboratory provides innovative, cost-effective laboratory testing to rheumatologists, hospitals, laboratories and physicians. Testing includes ANA profiles, MyoMarker™ panels, AntiHMGCR, FARR by RIA and Vasculitis panels.

Rhodes Pharmaceuticals Booth

279

One Dock Street Stamford, CT 06902 United States guidemarkhealth.com

Rimed USA, Inc. Booth

1164

11-11 44th Dr Suite G Long Island City, NY 11101 United States rimed.com

Rimed has been leading the Transcranial Doppler (TCD) system market for over 30 years. TCD is an invaluable examination, allows real-time monitoring of cerebral blood flow velocities. Our products help clinicians improve patient care in over 100 countries, with over 5,000 installations in Stroke, Neurocritical Care, Neurology, Neurosurgery departments.

144

2017 AAN Annual Meeting On-site Guide

Ripple Booth

1060

2056 South 1100 East Salt Lake City, UT 84106 United States rippleneuro.com

Ripple provides high performance electrophysiology data acquisition systems for in vivo neuromuscular recording and stimulation. Our systems are compact, portable, and heavily optimized for real-time, closed-loop control applications with up to 512 channels of EMG, EEG, and microelectrode data. Our software is cross platform, and can be run on Windows, Mac OS X, and Linux.

Rochester Regional Health Booth

1118

100 Kings Highway South Rochester, NY 14617 United States rochesterregional.org

Rochester Regional Health is an integrated health services organization serving the people of Western New York, the Finger Lakes and beyond. The system provides care from 150 locations, including five hospitals; 100 primary and specialty practices, rehabilitation centers and ambulatory campuses; senior services, facilities and independent housing; behavioral health services; and ACM Medical Laboratory, a global leader in patient and clinical trials.

RosmanSearch, Inc. Booth

223

30799 Pinetree Rd Suite 250 Pepper Pike, OH 44122 United States rosmansearch.com

RosmanSearch is a Neurosurgery, Neurology and APP recruitment firm. We place quality providers with quality practices nationwide. We are the only search firm with dedicated teams specializing in neuroscience. Our mission is to be the best, the most expert, and the one that is known for quality—every time!


New Exhibitor SafePassage Booth

1162

915 Broadway Suite 1200 New York, NY 10010 United States safepassagehealth.com

Sage Therapeutics Booth

383

treat the full range of neurological conditions, subspecialty-trained neurosurgeons, pioneers in cochlear implants, and a clinical team that participates in clinical research trails.

Sanford Health Booth

994

1305 W. 18th Street Sioux Falls, SD 57105 United States sanfordhealth.org

Sanford Health is the largest rural not-for-profit health care system in the nation and is dedicated to excellence in patient care and pioneering integrated care. Our reputation of excellence is founded on our talented team of more than 28,000 employees and over 1,400 primary and specialty care physicians located in 140 locations throughout Iowa, Minnesota, Montana, Nebraska, North Dakota, and South Dakota.

EXHIBITORS BY NAME

SafePassage's EEG team partners with hospitals and neurology practices to provide high quality video EEG in the comfort of a patients' home. SafePassage is dedicated to providing the highest accuracy in EEG interpretation. Our scanning technologists review EEG data with oversight from our full-time Medical Director and Board-Certified Epileptologist, Dr. Alan Ettinger. The use of our in-home video EEG can significantly reduce patient backlog without capital expense or increased overhead.

Exhibit Hall Passport Destination

215 First Street Suite 220 Cambridge, MA 02146 United States sagerx.com

Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. Sage’s lead program, SAGE-547, is in Phase 3 clinical development for super-refractory status epilepticus. Sage is developing its next generation modulators, including SAGE-217, SAGE-689 and SAGE-718, with a focus on acute and chronic CNS disorders. For more information, please visit www.sagerx.com.

Sanofi Genzyme - Genetics Booth

729

500 Kendall Street Cambridge, MA 02142 United States sanofigenzyme.com

Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.

Saint Luke’s Marion Bloch Neuroscience Institute Booth

1159

901 East 104th Street Kansas City, MO 64063 United States saintlukeshealthsystem.org

Saint Luke’s Marion Bloch Neuroscience Institute has neuroscience experts who help patients with the most complex brain and spine disorders in the Greater Kansas City area. Our specialists include, a nationally recognized stroke team, a Level 4 Comprehensive Epilepsy Center, neurologists who



Sanofi Genzyme - MS Booth

523

500 Kendall Street Cambridge, MA 02142 United States sanofigenzyme.com

Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help

145


New Exhibitor

Exhibit Hall Passport Destination

people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Learn more at www.sanofigenzyme.com.

Saol Therapeutics Booth

147

1000 Holcomb Woods Parkway Suite 270 Roswell, GA 30076 United States saolrx.com

Saol Therapeutics (pronounced “Sail“) is a privately held specialty pharmaceutical company focused on providing therapies to patients with rare diseases. The company currently markets a therapy for the treatment of severe spasticity and has a strategic growth emphasis on the neurologic therapeutic area. For more information, visit www.saolrx.com.

Sensonics International Booth

1010

125 White Horse Pike Haddon Heights, NJ 08035-1909 United States smelltest.com

Sensonics, Inc. provides the medical, scientific and industrial communities with the best smell and taste tests for assessing chemosensory function. The Smell Identification Test™ is the most widely used quantitative olfactory test in the world.

Healthcare, comprised of 13 hospitals across Virginia and Northeast North Carolina, is one of most integrated and progressive not-for-profit healthcare organizations in the nation.

Shimadzu Scientific Instruments, Inc. Booth

871

7102 Riverwood Drive Columbia, MD 21046 United States shimadzu.com

The LIGHTNIRS functional near-infrared spectroscopy (fNIRS) system expands opportunities for brain imaging research by providing high-quality Blood Oxygen Level Dependent (BOLD) signals of the cerebral cortex in a compact, wearable design. Its portability provides researchers enhanced flexibility, allowing them to bring the instrument to various locations for measurements or to have subjects wear it during activities requiring more mobility.

Signature Healthcare Booth

1055

680 Centre St. Brockton, MA 02302 United States mysignaturecare.org/Main/ Home.aspx

Society for Neuroscience Booth

1258

1121 14th Street NW Suite 1010 Washington, DC 20005 United States

Sentara Medical Group Booth

148

835 Glenrock Road Suite 100 Norfolk, VA 23502 United States sentara.com

Sentara Medical Group, a division of Sentara Healthcare, is an award-winning, clinically integrated multi-specialty group known for its technical innovation and quality. Located in coastal Virginia, we bring together more than 850 providers to provide quality care to our communities. Sentara

146

2017 AAN Annual Meeting On-site Guide

Southcoast Health Booth

1008

200 Mill Road Suite 180 Fairhaven, MA 02719 United States southcoast.org/

Southcoast Health is one of the largest and fastest growing health systems in New England. We are exceptionally located on the southeastern coastline of Massachusetts. As a thriving


AT THE AAN ANNUAL MEETING

DISCOVER ADVANCED NEUROMUSCULAR TESTING Muscle biopsy Acid a-glucosidase Various blood tests Electrocardiograms Nerve conduction tests Pulmonary function tests Reflex testing X-rays Magnetic resonance imaging Sleep studies Targeted DNA analysis1 Learn more about panel testing for neuromuscular disorders—including Pompe disease. A complimentary program is available for targeted DNA analysis of up to 31 separate conditions.1

Testing early can help impact a 13-year diagnostic delay for Pompe disease.* 2-4 Visit Sanofi Genzyme at Booth #729 to learn more. * Based on the median diagnostic gap. References: 1. Limb Girdle Muscular Dystrophy Consortium. http://www.lgmd-diagnosis.org/physician-portal. Accessed March 30, 2015. 2. Toscano A, Montagnese F, Musumeci O. Early is better? A new algorithm for early diagnosis in late-onset Pompe disease (LOPD). Acta Myol. 2013;32(2):7881. 3. Kishnani PS, Amartino HM, Lindberg C, Miller TM, Wilson A, Keutzer J; Pompe Registry Boards of Advisors. Timing of diagnosis of patients with Pompe disease: data from the Pompe Registry. Am J Med Genet A. 2013;161A(10):24312443. 4. Winkel LP, Hagemans ML, van Doorn PA, et al. The natural course of non-classic Pompe’s disease; a review of 225 published cases. J Neurol. 2005;252(8):875-884.

www.pompe.com ©2017 Genzyme Corporation. All rights reserved. GZUS.PD.15.07.1915(1)


Exhibitor Descriptions part of the New England medical community, Southcoast Health offers practice excellence in an environment you want to call home.

SoutheastHEALTH Booth

1128

1701 Lacey Street Cape Girardeau, MO 63701 United States sehealth.org

At SoutheastHEALTH, the region's premier healthcare system in Southeast Missouri, our patients receive excellent care of the highest quality, close to home. Within our network are more than 50 care locations in 14 communities, including hospitals, primary and specialty care clinics representing over 30 clinical specialties and extending care for patients in a fourstate area. Southeast Hospital in Cape Girardeau has been a trusted health care resource in the community for nearly 100 years.

SpecialtyCare Booth

974

214 Centerview Drive Suite 100 Brentwood, TN 37027 United States specialtycare.net

About SpecialtyCare More than 13,500 physicians at 1,300 hospitals trust SpecialtyCare to provide perfusion, intraoperative neuromonitoring, autotransfusion, sterile processing, surgical assist, and minimally invasive surgical support for over 380,000 procedures annually. Our commitment to improving patient outcomes and financial results and ensuring compliance enables our customers to be certain they have the best partner for clinical excellence.

Spectrum Health Medical Group Booth

1122

333 Bridge Street NW 4th Floor| Suite 410 Grand Rapids, MI 49504 United States spectrumhealth.org

Spectrum Health is a not-for-profit health system, based in West Michigan, offering a full continuum of care needs. Spectrum Health is comprised of 12 hospitals;180 ambulatory and service sites;

148

2017 AAN Annual Meeting On-site Guide

1,600 employed physicians and advanced practice providers including members of the Spectrum Health Medical Group; and Priority Health, a 725,000-member health plan. Spectrum Health is West Michigan's largest employer with 25,500 employees.

SpeechVive Booth

1172

603 Wexford Drive Lafayette, IN 47905 United States speechvive.com

SpeechVive, giving people with Parkinson's a voice! SpeechVive is a behind the ear smart device which helps people with Parkinson's disease speak more loudly and communicate more effectively. The SpeechVive device is supported by over 5 years of clinical data which demonstrated SpeechVive to be effective in improving volume, articulation, and speech rate in 90% of the people participating in two multi-site clinical trials.

Springer Nature Booth

917

233 Spring Street New York, NY 10013 United States springernature.com

Springer Nature is one of the world's leading global research, educational and professional publishers, home to an array of respected and trusted brands providing quality content through a range of innovative products and services. Springer Nature is the world's largest academic book publisher and numbers almost 13,000 staff in over 50 countries. www.springernature.com

St. Peterâ&#x20AC;&#x2122;s Hospital Booth

1224

2475 Broadway Helena, MT 59601 United States stpetes.org

Nestled at the base of the Rocky Mountain Front, St. Peter's Hospital is a progressive, state-of-theart 123-bed independent community hospital in Montana's capital city. Experienced Neurologists as well as Residents are encouraged to apply. Our medical group combines the best of both office and hospital based practices and is looking to add an


New Exhibitor additional Neurologist to an already amazing practice that includes a fellowship trained Neuromuscular Neurologist and Neurology Nurse Practitioner.

Staff Care, Inc. Booth

1026

8840 Cypress Waters Blvd Suite 300 Dallas, TX 75019 United States staffcare.com

Sun Neurosciences Booth

969

600 College Road East Suite 2100 Princeton, NJ 08540 United States sunpharma.com

Sun Pharma Neurology is dedicated to research and development utilizing cutting-edge technologies to find optimal treatment solutions for our patients afflicted with neurological diseases. Sun Pharma continues to develop high-quality, branded therapeutics as we always strive to create a better quality of life for all those affected.

EXHIBITORS BY NAME

Staff Care is an AMN Healthcare company that provides locum tenens recruitment and staffing services. We match physicians, as well as other healthcare professionals, including dentists, CRNAs, nurse practitioners and physician assistants, with all types of medical facilities and healthcare organizations.

Exhibit Hall Passport Destination

Strongbridge Biopharma Booth

889

900 Northbrook Blvd Suite 200 Trevose, PA 19053 United States strongbridgebio.com/

Strongbridge Biopharma is a global commercialstage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. Strongbridge is building a portfolio of therapeuticallyaligned rare disease franchises. The focus of the neuromuscular franchise is primary periodic paralysis. Primary periodic paralysis is a group of rare hereditary disorders that causes potentially severe episodes of muscle weakness and/or paralysis.

Strongbridge Biopharma Medical Information Booth

984

900 Northbrook Blvd Suite 200 Trevose, PA 19053 United States strongbridgebio.com

Sunovion Pharmaceuticals, Inc. Booth

513

84 Waterford Dr Marlborough, MA 01752-7010 United States sunovion.com

Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological, and respiratory conditions. Additional information can be found on the Company's website: www.sunovion.com. Connect with us @Sunovion.

Visit the Strongbridge BioPharma Medical Information booth for information on primary periodic paralysis. Primary periodic paralysis in a group of rare hereditary disorders that causes potentially severe episodes of muscle weakness and/or paralysis.



149


New Exhibitor

Exhibit Hall Passport Destination

Sunovion Pharmaceuticals, Inc. Booth

715

84 Waterford Dr Marlborough, MA 01752-7010 United States sunovion.com

Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological, and respiratory conditions. Additional information can be found on the Company's website: www.sunovion.com. Connect with us @Sunovion.

Supernus Pharmaceuticals Inc. Booth

164

With more than 20 years of experience, Supernus is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) disorders. We are developing differentiated products by leveraging our proprietary and inlicensed technologies. We use such technologies to discover and develop novel uses for known drug compounds and to enhance their therapeutic benefits.

Synapse Biomedical Inc Booth

923 Supernus Pharmaceuticals Inc. Booth

116

Rockville, MD 20850 United States supernus.com

With more than 20 years of experience, Supernus is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) disorders. We are developing differentiated products by leveraging our proprietary and inlicensed technologies. We use such technologies to discover and develop novel uses for known drug compounds and to enhance their therapeutic benefits.

150

2017 AAN Annual Meeting On-site Guide

Rockville, MD 20850 United States supernus.com

300 Artino Street Oberlin, OH 44074 United States synapsebiomedical.com

Synapse Biomedical, Inc., established in 2002 and based in Oberlin, OH, is the manufacturer of the FDA approved, under an HDE, NeuRx Diaphragm Pacing System (DPS)- advanced pacing technology for use in patients with spinal cord injury (SCI) and ALS/ MND. Our research and development includes the areas of acute care and network neural prosthesis. technology.

Tallahassee Memorial HealthCare Booth

1154

1300 Miccosukee Road Tallahassee, FL 32308 United States tmh.org


Exhibitor Descriptions

Teva CNS Booth

559

deductibles and other health-related expenses. TAF currently covers more than 30-funds - each of which covers the FDA-approved medications that treat a specific disease. Since its founding TAF has helped more than 50,000 individuals access the medications they need.

11100 Nall Avenue Overland Park, MO 66211 United States tevausa.com/CNS.aspx

Teva CNS provides a total approach to disease management, offering sustainable, indispensable medicines and patient support services that improve outcomes in conditions affecting the central nervous system. Our mission is one of leadership in neuroscience, pain management, and neuropsychiatry, through the quality of our products and people, and our focus on patients.

The Electrode Store Booth

171

PO Box 188 Enumclaw, WA 98022 United States electrodestore.com

The Electrode Store is an ISO13485-certified manufacturer and distributor of EMG and EEG needle electrodes, surface electrodes, gels and accessories. We offer high quality products with quick shipping, knowledgeable customer service, and low prices. We offer monopolar and concentric needle electrodes, hypodermic needles for EMG-guided botulinum toxin injections, disposable and reusable surface electrodes, gels, pastes, accessories and more.

The JAMA Network Teva CNS Booth

771

Booth

11100 Nall Avenue Overland Park, MO 66211 United States tevausa.com/CNS.aspx

Teva CNS provides a total approach to disease management, offering sustainable, indispensable medicines and patient support services that improve outcomes in conditions affecting the central nervous system. Our mission is one of leadership in neuroscience, pain management, and neuropsychiatry, through the quality of our products and people, and our focus on patients.

The Assistance Fund Booth

1147

4700 Millenia Blvd Suite 410 Orlando, FL 32839 United States TAFcares.org

The Assistance Fund (TAF) is an independent charitable assistance foundation that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance,

152

2017 AAN Annual Meeting On-site Guide

924

330 N. Wabash Avenue Suite 39300 Chicago, IL 60611 United States jamanetwork.com

Building on a tradition of editorial excellence, The JAMA Network brings JAMA together with 11 specialty journals to offer enhanced access to the research, viewpoints, and medical news shaping medicine today and into the future. JAMA Cardiology, a new peer-reviewed journal, launched in 2016.

The MSA Coalition & The MSA Shoe Charity Booth

1241

9935-D Rea Road Charlotte, NC 28277 United States multiplesystematrophy.org

The Multiple System Atrophy Coalition® is a positive beacon of hope standing up to a little known, rare, insidious disorder. It’s primary purpose is to find a cure for this terrible disease. The MSA Shoe is a tool for spreading awareness, increasing support for patients and fighting MSA. The Shoe’s journey is undertaken in memory of all those that


New Exhibitor have died due to MSA and in support of all those presently fighting Multiple System Atrophy!

The Ohio State University Department of Neurology Booth

1019

45 Ha-Melakha st.Netanya 42507 Israeltheranica.com

Trialspark

131 West 11th St, #1 New York, NY 10011 United States trialspark.com

Trialspark is a digital health company that makes it easy for any doctor to get involved in clinical trials. Doctors can earn additional revenue and give their patients access to the newest treatments from Pharma companies like GSK, Merck, and Pfizer. Trialspark partners with doctors to create a trial site in his/her practice. We purchase equipment, hire and pay the research staff, and manage study operations, enabling physicians to focus on seeing patients as the Principal Investigator.



1062

UCB Inc

417

8255 Las Vegas Blvd. Las Vegas, NV 89123 United States tsmedgroup.com

1950 Lake Park Dr. Smyrna, GA 30305 United States ucb-usa.com

EXHIBITORS BY NAME

Theranica Bio-Electronics Ltd.

1064

TS Medical

395 W. 12th Ave. 7th Floor Columbus, OH 43210 United States medicalcenter.osu.edu

The Ohio State University Neurological Institute brings together 200 researchers and clinicians collaborating together in neurology, neurosurgery, physical medicine and rehabilitation, psychiatry, psychology, anesthesia and neuroscience research to create better methods of prevention, detection and treatment for patients with brain and spine conditions. Through this unique model, Ohio State Medical Center is poised to be at the forefront of neurological patient care and neuroscience research.

1069

Exhibit Hall Passport Destination

At UCB, we have a passionate, long-term commitment to discovering and developing innovative medicines that transform the lives of people living with severe immunological diseases and central nervous system disorders. With 8,500 employees in 40 countries, we invest approximately 28% of revenue in cutting-edge scientific research to meet unmet patient needs. For more information, visit www.ucb-usa.com.

Ultragenyx Pharmacuetical

112

60 Leveroni Court Novato, CA 94949 United States ultragenyx.com

Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies.

153


Exhibitor Descriptions United Council for Neurologic Subspecialties

Upsher-Smith Laboratories, Inc.

UCNS is a nonprofit organization founded in 2003 by the AAN, AUPN, ANA, CNS, and PCN to accredit fellowship training programs and certify physicians in emerging neurologic subspecialties. UCNS has accredited over 175 fellowship programs and certified over 2,650 physicians. Visit the booth to learn more about UCNS and neurologic subspecialty accreditation and certification.

Upsher-Smith Laboratories, Inc. is a family-owned, privately-held pharmaceutical company. We strive to be a trused source for quality, affordable generic and branded medications that measurably improve lives. Known for our industry relationships and consistent supply, we aspire to deliver value for our customers and the healthcare system at large. For more information, visit www.upsher-smith.com.

United Diagnostics

US Bioservices

Ambulatory Video EEG Booth 375 United is the North East's leading provider of Video EEG services, specializing in ambulatory in-home studies. • Remote access reading capability • Bluetooth enabled • Synchronized EEG and video • No patient access to batteries, (72 hours) • Technologist monitored patients in real time • R. EEG T. reviewed, annotated commentary on every study • Persyst software • Custom Report Templates • In Home Set Ups and Disconnects • Schedule 7 days a week for patients convenience

Providing trusted support for over 20 years, US Bioservices is AmerisourceBergen's specialty pharmacy offering nationwide dispensing and home infusion nursing services. Our comprehensive approach improves the patient experience while increasing transparency and collaboration with the practice. Focused on clinical integration, we partner with physicians to help patients realize the best outcomes.

310

375

201 Chicago Ave Minneapolis, MN 55415 United States ucns.org

50 Rose Place Garden City Park, NY 11040 United States unitedsleepd.com

UnityPoint Clinic

1119

8101 Birchwood Court Suite N Johnston, IA 50131 United States unitypoint.org

UnityPoint Health is comprised of more than 1,200 physicians, advanced practice providers at over 280 clinics in communities throughout Iowa, Illinois, and Wisconsin. UnityPoint Health has hospital medicine and specialty programs in all nine markets.

University of Florida Health

1240

154

FL United States ufhealth.org

2017 AAN Annual Meeting On-site Guide

483

1058

6701 Evenstad Dr. Maple Grove, MN 55369 United States upsher-smith.com

3101 Gaylord Parkway Frisco, TX 75034 United States usbioservices.com

US WorldMeds

945

4441 Springdale Rd Louisville, KY 40241 United States

US WorldMeds

953

4441 Springdale Rd Louisville, KY 40241 United States

Validus Pharmaceuticals LLC

338

119 Cherry Hill Road Suite 119 Parsippany, NJ 07054 United States validuspharma.com


New Exhibitor Validus Pharmaceuticals LLC presently promotes an extended release carbamazepine product that treats seizures, pain associated with trigeminal neuralgia, and acute manic and mixed episodes associated with Bipolar 1 Disorder, as well as a branded monoamine oxidase inhibitor indicated for depression.

itself as an expert in locum tenens staffing for physicians, physician assistants, and nurse practitioners. The company employs nearly 600 employees committed to filling locum tenens assignments in large-scale healthcare networks, hospitals, and clinics nationwide. Learn more at weatherbyhealthcare.com.

Via Christi Health

WellStar Health System

Via Christi Health’s rich history of serving the people of Kansas and the surrounding region dates back more than 100 years to the healing ministries of our founding congregations. Today, Via Christi Health is the largest provider of health care services in Kansas. Employing over 200 Physicians across 40 specialties, there is a vast opportunity to build your practice within Via Christi Health and the communities we serve. Ask us about our broadscope neurology opportunities in Wichita, KS!

WellStar, the largest health system in Georgia, is known for its innovative care models. As a non-profit, WellStar continues to reinvest in the health of the communities it serves. WellStar consists of 240 medical office locations, outpatient centers, health parks, pediatric center, nursing centers, hospice/homecare and 11 inpatient hospitals. With over 20,000 team members, WellStar remains committed to its Employer of Choice strategy that has led to numerous accolades for work-life balance.

WCN 2017 Kyoto

Wiley

1121

1100 N St. Francis Wichita, KS 67214 United States viachristi.org

Chester House, Fulham Green81-83 Fulham High Street London SW6 3JA United Kingdom wfneurology.org

The XXIII World Congress of Neurology will take place in Kyoto, Japan on September 16-21 2017. Cohosted by the Japanese Society of Neurology and Asian and Oceanian Association of Neurology, this year’s theme will be Defining the Future of Neurology. Hear all the advances in scientific and clinical neurology and participate in active discussions and cutting-edge lectures by the world's top scientists and neurologists including three Nobel laureates. Save on registration fees before 15 June 2017.

Weatherby Healthcare

144

6451 North Federal Highway Suite 800 Ft. Lauderdale, FL 33308 United States weatherbyhealthcare.com

Since 1995, Weatherby Healthcare has established

241

795

793 Sawyer Road Marietta, GA 30062 United States wellstar.org

EXHIBITORS BY NAME

275



Exhibit Hall Passport Destination

350 Main St Malden, MA 02148 United States wiley.com

Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments, and individuals increase the academic and professional impact of their work.

Wilson Therapeutics

335

Vä stra träd gardsgatan 15Stockholm SE-11153 Sweden wilsontherapeutics.com

Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for patients with rare diseases. Wilson Therapeutics’ lead product, WTX101, is initially being developed as a novel treatment for Wilson Disease and has been

155


Exhibitor Descriptions evaluated in a Phase 2 clinical study. Wilson Therapeutics is listed in the Mid Cap segment on Nasdaq Stockholm with the stock ticker WTX.

Wolters Kluwer

439

Two Commerce Sq2001 Market StreetPhiladelphiaPA 19103 United States lww.com

Wolters Kluwer Health is a global provider of information, business intelligence and point-ofcare solutions for the healthcare industry . Brands include Lippincott Williams & Wilkins, a leading international publisher of medical books, electronic media and journals and the official publisher of American Academy of Neurology. We proudly offer specialized publications and software for physicians, nurses, students and clinicians. Please visit booth #439 to browse our comprehensive product line.

Yuma Regional Medical Center

1035

2400 S. Avenue AYumaAZ 85364United States yumaregional.org

Take ADVANTAGE of this Rewarding opportunity to establish and build an extremely successful outpatient Neurology practice in a growing community of 200k plus residents. Yuma Regional Medical Center (YRMC), a 406 bed top-in-technology facility, is the only acute care hospital of its size within a 170 mile radius and provides almost all modalities of care. Yuma, Arizona sits on the edge of the Colorado River and is known as being the sunniest place in the world!

156

2017 AAN Annual Meeting On-site Guide


AWARDS

2017 Award Recipients

The research we celebrate, with the recipients below, has generated paradigmchanging discoveries in epilepsy, fundamental insights in multiple sclerosis, and

pioneering breakthroughs in pain, to name a few of the transformative advances

conceived by these luminaries. We honor those researchers and pay tribute to all those who play a role in the search for cures for brain disease, from mentors to colleagues to those just starting out on their journey.

Alliance Awards: Founders Award

Sponsored by the American Academy of Neurology and endowed by the former American Academy of Neurology Alliance Recipient:  Emer McGrath, MB, BCh Boston, MA

 hank You Statement: I would like to acknowledge the strong T support of my mentor, Dr. Sudha Seshadri, and the generous contribution of the participants in the Framingham Heart Study.

Why the Recipient Was Chosen: Dr. McGrath was selected as this year’s Founders Award recipient for her important work investigating the link between vascular disease, hypertension, and dementia. Though this link has been appreciated for some time, pathological details and mechanisms of disease remain unclear. Furthermore, methodologies of prior studies have limitations and conflicting findings. In this report, Dr. McGrath and her colleagues measured mid- and late-life blood pressures and the trajectory of blood pressure from mid- to late-life in a community-based cohort of allcause dementia and Alzheimer’s disease patients. They found an association between both elevated mid-life blood pressure as well as a step-wise increase in risk with higher trajectories. This study provides interesting data for larger clinical trials and proposes an important modifiable risk factor for the development of age-related cognitive decline.

Alliance Awards: S. Weir Mitchell Award

Sponsored by the American Academy of Neurology and endowed by the former American Academy of Neurology Alliance Recipient: Richard Ryan Darby, MD Boston, MA  hank You Statement: I would like to thank Michael Fox T for his mentorship and guidance on this project, teaching me 

159


2017 Award Recipients the technique needed to investigate these complex and rare delusions. I would also like to thank co-authors Simon Laganiere, Alvaro Pascual-Leone, and Sashank Prasad. Why the Recipient Was Chosen: Dr. Ryan Darby is this year’s S. Weir Mitchell Award recipient in recognition of his work on delusional misidentifications. This fascinating phenomenon has long depended on studying patients with focal lesions to determine brain-behavior relationships. However, Dr. Darby and his colleagues instead focused on how lesions may disrupt functionally connected regions of the brain. This novel approach led to the hypothesis that some delusions may arise in part by disruptions between brain regions involved in familiarity perception and belief evaluation. Importantly, their work establishes a framework in behavioral neurology whereby neural correlates for delusion formation may be approached with testable hypotheses.

American Brain Foundation Board Chair’s Award Sponsored by the American Brain Foundation Recipient: Francis I. Kittredge Jr., MD, FAAN Bangor, ME  hank You Statement: Thank you, Mr. Kevin Goodno, chair, T and the Board for this singular recognition. I look forward to the implementation of your new strategic plan for the American Brain Foundation. Including the public, our patients, their families, and their friends will afford the Foundation the opportunity to represent for neurological diseases nationally what the American Cancer Society has done for oncology. Why the Recipient Was Chosen: Francis I. Kittredge Jr., MD, FAAN, is a pioneer in neurology. Tucked into Dr. Kittredge’s long list of achievements is one which we at the American Brain Foundation would like to highlight. Dr. Kittredge was the founding president of the AAN Education and Research Foundation (1992-1996), which later became the AAN Foundation, and eventually emerged as today’s American Brain Foundation. Understanding the need to leverage philanthropy to fund brain disease research, Dr. Kittredge not only led the Foundation through its early days, he was a financially generous donor who created an endowment funding clinical research training scholarships in multiple sclerosis in perpetuity. As we celebrate the 25th anniversary of the American Brain Foundation—the philanthropic partner of the American Academy of Neurology—there is no more deserving person to receive our 2017 Board Chair’s Award.

160

2017 AAN Annual Meeting On-site Guide


AWARDS

Association of Indian Neurologists in America (AINA) Lifetime Achievement Award

Sponsored by the American Brain Foundation and endowed by the Association of Indian Neurologists in America (AINA) Recipient: Kapil D. Sethi, MD, FRCP, FAAN Augusta, GA

 hank You Statement: I am deeply honored and grateful to T receive this honor from an organization that I admire.

Why the Recipient Was Chosen: Dr. Sethi is Director of the Movement Disorders Program and Professor of Neurology at Georgia Regents University where he has worked since 1985. He is recognized in the US, India, and internationally as a leader in the field of movement disorders. He has been a great supporter of Indian neurologists, both in India and in the United States, making CME presentations throughout India, and training residents and fellows in the US. Dr. Sethi has published 160 original papers and close to 30 book chapters; participated in numerous clinical trials in Parkinson’s; and served as Associate Editor of the journal Movement Disorders. He has served on the board of directors of the AAN, president of the AINA from 1999-2001, and is well known to all members of the AAN because of his role in development and then leadership in NeuroBowl® as “judge.”

Award for Creative Expression of Human Values in Neurology

Sponsored by the Ethics, Law, and Humanities Committee, a joint committee of the American Academy of Neurology, the American Neurological Association, and the Child Neurology Society Recipient:  Kathryn Rae Wagner, MD, PhD Baltimore, MD

 hank You Statement: I would like to thank Lud Gutmann T for providing such beautiful examples of humanities writing in neurology, and Mary Gutmann who provided encouragement and constructive criticism of my work. I have been fortunate to have been mentored by several giants in neurology: Guy McKhann, Dan Drachman, John Griffin, and Justin McArthur who all made me a better observer of humankind.



161


2017 Award Recipients Why the Recipient Was Chosen: The creative expression award recognizes an outstanding poem, short story, or work of creative nonfiction that artistically expresses human values in the practice of neurology, including compassion for persons with neurological disorders and reflection by physicians involved in their care. Among this year’s submissions, Taking Emmanuel Home stood out for the exceptional degree of human compassion exhibited by the (pseudonymous) author, as well as for the quality of the prose. It’s truly a wonderful piece and most deserving of this year’s award.

Dreifuss-Penry Epilepsy Award Sponsored by the AAN and endowed by members of the AAN Epilepsy Section; Abbott Laboratories, Inc.; Cephalon, Inc.; Cyberonics, Inc.; Elan Pharmaceuticals, Inc.; GlaxoSmithKline; Novartis Neuroscience; Ortho-McNeil Neurologics; Pfizer Inc; Shire US, Inc; and UCB Pharma Recipient:  William Stacey, MD, PhD Ann Arbor, MI  hank You Statement: I am very grateful for persistent T mentoring by Brian Litt and Jack Parent, for innovative ideas and analysis from Stephen Gliske, and for years of collaboration from Christophe Bernard and Viktor Jirsa. Why the Recipient Was Chosen: Dr. William Stacey’s research makes use of the rich disciplines of computational science, engineering, electrophysiology and clinical epilepsy. He has made substantial inroads into identifying novel electrophysiological biomarkers for ictogenic cortex, seizure generation, and seizure dynamics. In addition to gaining new insights, he endeavors to make new techniques applicable in clinical practice and at the point of clinical decision making.

Sheila Essey Award: An Award for ALS Research Presented by the AAN and the ALS Association and supported through the philanthropy of the Essey family and the ALS Association Recipient: John M. Ravits, MD, FAAN La Jolla, CA  hank You Statement: I give special thanks to mentors Bob T Miller, Bud Rowland, Al La Spada, and Don Cleveland. I give thanks to supporters including the Wyckoff family, Lois Caprile, Pam Golden, Jerry Nepom at BRI, David Heckerman and Eric Horvitz at Microsoft Research, Bill Mobley at UCSD, ALSA, and NINDS.

162

2017 AAN Annual Meeting On-site Guide


AWARDS

Why the Recipient Was Chosen: Dr. Ravits is an outstanding ALS clinician who has performed ground-breaking work both in clinical and neuropathology research in ALS. For his work in promoting the hypothesis of ALS pathogenesis through neuroanatomic propagation and his work demonstrating antisense knock-down of C9orf72 RNA, he has received the 2017 Sheila Essey Award for ALS Research.

Norman Geschwind Prize in Behavioral Neurology Sponsored by the American Academy of Neurology and endowed through Dr. Geschwind’s family, friends, and colleagues; Pfizer Inc; and the Society for Behavioral and Cognitive Neurology Recipient: Peter Turkeltaub, MD, PhD Washington, DC

 hank You Statement: I would like to thank my former and T current mentors: Drs. Guinevere Eden, H. Branch Coslett, Roy Hamilton, Rhonda Friedman, Elissa Newport, and Alexander Dromerick. I would also like to thank all of my students and fellows for their hard work, and our research participants for their dedication.

Wayne A. Hening Sleep Medicine Investigator Award Sponsored by the AAN and endowed by UCB Inc. Lilly USA, Elite Home Medical & Respiratory, Inc., Raleigh Neurology Associates, and friends of Dr. Wayne A. Hening Recipient:  Tiffany Braley, MD, MS Ann Arbor, MI

 hank You Statement: I would like to express my heartfelt T appreciation to Dr. Ron Chervin, an exceptional mentor and colleague who has been an unwavering source of support and inspiration throughout my sleep research career. I would also like to thank Dr. Benjamin Segal for his mentoring in multiple sclerosis research. Why the Recipient Was Chosen: Dr. Tiffany Braley works at the interface between multiple sclerosis and sleep disorders, studying the relationship between fatigue and obstructive sleep apnea. She is receiving this award for her demonstration of the potential of applying solutions from sleep medicine to the disabling tiredness of patients with multiple sclerosis.



163


2017 Award Recipients Mitchell B. Max Award for Neuropathic Pain Sponsored by the AAN and endowed by the United States Cancer Pain Relief Committee, the Mayday Fund, and friends of Dr. Mitchell Max Recipient: C. Peter N. Watson, MD Toronto, Ontario  hank You Statement: I am most honored and very pleased to T be receiving this award, as Dr. Mitchell Max was a good friend, a brilliant and generous colleague, and a long-time mentor, as were Harold Merskey, Ramon (Ray) Evans, JC Richardson (Rick), Jack Silversides (Silver), John Deck, and many others. Why the Recipient Was Chosen: Dr. Watson’s landmark studies laid the foundation for the contemporary treatment of neuropathic pain. His pioneering analgesic trials of patients with post herpetic neuralgia deepened our understanding of the pathophysiological and psychological aspects of chronic pain. The evidence for the use of therapies such as amitriptyline, nortriptyline, oxycodone, capsaicin, and lidocaine derives from studies he designed and conducted over the course of more than four decades. In addition to his research contributions, Dr. Watson is recognized as a gifted clinician and renowned educator in Canada and throughout the world. The opportunity to have Dr. Watson participate in the Academy’s 69th Annual Meeting in Boston will be an inspiration to neurologists focused on pain research. Recognizing his accomplishments highlights the importance of neurologists’ pioneering role in clinical pain research.

Lawrence C. McHenry Award: An Award for the History of Neurology Sponsored by the American Academy of Neurology Recipient:  Christopher J. Boes, MD, FAAN Rochester, MN  hank You Statement: I need to thank John Noseworthy, Bruce T Fye, Renee Ziemer, Bob Brown, Al Aksamit, and Neeraj Kumar. I also thank Douglas Lanska, Peter Koehler, Stephen Reich, Peter Goadsby, Ann Scott, and Rebecca Gowers. My wife Carrie and three kids have lovingly accepted my history of neurology obsession. Why the Recipient Was Chosen: Dr. Boes' outstanding historical scholarship details the friendship between two giants of 19th century medicine: William

164

2017 AAN Annual Meeting On-site Guide


AWARDS

Gowers and William Osler. Through his work, Dr. Boes chronicled the interactions, friendship, and professional work of the Drs. Osler and Gowers. This paper details through first-hand accounts, letters, and early manuscripts, the subtle influence these two men had on one another's lives. His work showcases, through the eyes of Dr. Osler, the interpretation of Dr. Gowers' progressive neurologic illness according to internal medicine of the time. Dr. Boes’ work is a concise, elegantly written history of Drs. Osler and Gower which sheds light on a mutually beneficial friendship that likely influenced the fields of medicine and neurology in the dawn of the 20th century.

Medical Student Essay Awards: Extended Neuroscience Award Sponsored by the American Academy of Neurology Recipient:  Aaron Bowen Denver, CO

 hank You Statement: I would like to thank my advisor, Dr. T Matthew Kennedy, not only for his intellectual input and financial support of this work, but also for his mentorship and guidance as I have developed my scientific career.

Why the Recipient Was Chosen: The committee awarded Aaron Bowen the Extended Neuroscience award for his essay investigating cellular trafficking pathways within neuronal dendrites and synapses. The detailed essay provided evidence for a Golgi-independent mode of local cellular trafficking and findings that neuronal firing may regulate the trafficking pathway.

Medical Student Essay Awards: G. Milton Shy Award in Clinical Neurology Sponsored by the American Academy of Neurology Recipient:  Moon Jeong Lee Baltimore, MD

 hank You Statement: I would like to thank Dr. Rachel Salas T and Dr. Charlene Gamaldo at Johns Hopkins for their incredible mentorship and support, Dr. Matthew Peters and Dr. Roy Durga for welcoming me to their clinic, Dr. Alyssa Gamaldo for her guidance with the data, and the AAN for their research support.



165


2017 Award Recipients Why the Recipient Was Chosen: Moon Jeong Lee is receiving this award for her study exploring the use of a sleep application in patients with brain injury. The essay was well written and may provide a novel method for evaluating sleep disruption in patients with history of acute brain injury.

Medical Student Essay Awards: Roland P. Mackay Award in Historical Aspects Sponsored by the American Academy of Neurology Recipient: Bob Sun Cleveland, OH  hank You Statement: I would like to thank Paul Ford, PhD, T Director of the NeuroEthics program at the Cleveland Clinic, who guided me through the independent study that resulted in this paper. Why the Recipient Was Chosen: The committee awarded Bob Sun the Roland P. McKay Award for the outstanding essay on the role of neuromodulation as a modern iteration of psychosurgery, the historical intervention for psychiatric disorders. The essay focuses on important historical events and places them into a modern context.

Medical Student Essay Awards: Saul R. Korey Award in Experimental Neurology Sponsored by the American Academy of Neurology Recipient:  Chelsea Zhang Dallas, TX  hank You Statement: I am deeply grateful for my colleagues T Jennifer Fehmel, Melanie Truong, the KD team, and my mentors Dr. Bert Vargas, Dr. Lauren Phillips, and Dr. Mark Alberts for all their guidance and encouragement. Why the Recipient Was Chosen: Chelsea Zhang’s excellent essay compares two objective balance measures that help screen for concussion. The essay demonstrated a high level of agreement between the K-D Balance and Sway Balance mobile device applications suggesting that either would function well as a sideline concussion measurement tool.

166

2017 AAN Annual Meeting On-site Guide


AWARDS

Movement Disorders Research Award

Sponsored by the AAN, the Parkinson’s Disease Foundation, and the AAN Movement Disorders Section and endowed by the Parkinson’s Disease Foundation Recipient:  Andrew Singleton, PhD Bethesda, MD

 hank You Statement: Thank you to my first teacher, Dr. Chris T Morris, and my mentor, Dr. John Hardy. Their style and approach continues to influence my work and career.

Why the Recipient Was Chosen: Dr. Singleton has made important landmark contributions to the field of PD genetics, which has revolutionized many aspects of PD research. He discovered that gene mutation of alpha-synuclein is a cause of Parkinson’s disease, which firmly established the importance of alphasynuclein in PD pathogenesis in a broarder context. He first reported G2019S mutation in Parkinson’s disease, which is one of the most common genetic causes of PD and important clues to the pathogenesis and therapeutic approaches in PD. He also collaborates extensively including leading an international genetics consortium using novel methods to investigate small effects of common genes in PD. His contributions extend to genetic causes of other movement disorders such as dystonia, and ataxia, as well as other neurological disorders such as ALS and frontotemporal dementia.

Neuro-oncology Investigator Award

Sponsored by the American Academy of Neurology and supported by friends of Dr. Jerome Posner Recipient:  Michelle Monje, MD, PhD Stanford, CA

 hank You Statement: I would like to thank Paul Fisher, Tracy T Batchelor, and Patrick Wen for demonstrating the excellence in clinical care and leadership I strive to emulate; Theo Palmer, Philip Beachy, and Ben Barres for ongoing scientific mentorship; and excellent trainees who contributed to this work, especially Humsa Venkatesh and Tessa Johung.

Why the Recipient Was Chosen: Michelle Monje is the recipient of the Neurooncology Investigator Award. Dr. Monje is an assistant professor in the University Tenure Line at Stanford University Department of Neurology. She trained in neurology at the Partners Program in Boston, in Neuro-oncology at Stanford, and is UCNS certified in Neuro-oncology. She is an active investigator with the Pediatric Brain Tumor Consortium (PBTC) and Chair of the PBTC Brainstem Glioma Working 

167


2017 Award Recipients Group. She received multiple awards including the Peter A. Steck Memorial Sward from the Pediatric Brain Tumor Foundation, and the “A” Award from Alex’s Lemonade Stand Foundation. Her laboratory work has been funded by the NIH and DoD among other sources, and is dedicated to the interface of developmental neurobiology and Neuro-Oncology such as the micro-environmental influences on gliomagenesis and treatment consequences. She also directs clinical trials for pediatric brain stem glioma.

Neuro-oncology Scientific Award Sponsored by the American Academy of Neurology and supported by friends of Dr. WK Alfred Yung Recipient: Mario Suva, MD, PhD Boston, MA  hank You Statement: This is a team work that would not have T been possible without a strong collaboration with Aviv Regev and Itay Tirosh at the Broad Institute. I am also extremely grateful to David Louis and Brad Bernstein at MGH for their mentorship and support throughout my career. Why the Recipient Was Chosen: Dr. Mario L. Suvà is the recipient of the Neurooncology Scientific Award. Dr. Suvà trained in Switzerland where he also received his PhD for work in the biology of cancer stem cells in gliomas and sarcomas. He is now an Assistant Professor of Pathology at Harvard Medical School where he also serves as a faculty member for the Biological and Biomedical Sciences Program and for the Harvard Stem Cell Institute. Additionally, he is a member of the Neuro-oncology Program at the Harvard Cancer Center, and of the Epigenomics, Cancer, and Cell Circuits Programs at the Broad Institute. He has received multiple awards including the "Weil Award" for best work in experimental neuropathology by the American Association of Neuropathologists and the Adult Basic Research Award from the Society for Neuro-oncology. His research is focused on the molecular biology of gliomas, particularly stem cells and cell lineages, and epigenetic influences at the single-cell level. He has made key contributions to the field.

168

2017 AAN Annual Meeting On-site Guide


AWARDS

Neuroendocrine Research Award

Sponsored by the American Academy of Neurology and supported by friends of Dr. Andrew Herzog Recipient: Gustavo Román, MD, DrHC Houston, TX

 hank You Statement: My gratitude to Erasmus University T Generation-R Mother-Child Cohort and to Drs. Albert Hofman, Henning Tiemeier, Akhgar Ghassabian, Jacoba BongersSchokking, Vincent Jaddoe, Yolanda de Rijke, Frank Verhulst, and Pere Berbel, Alicante, Spain. Research support by Nancy Lurie Marks Family Foundation, Wellesley, Massachusetts; and Jack S. Blanton endowment, Houston, Texas.

Why the Recipient Was Chosen: Dr. Gustavo Román has focused his research in the field of neuroendocrinology, specifically on the effects of thyroid function and autism. Through neuropathological animal studies and a large-scale population based epidemiological study, he has demonstrated that impaired thyroid function during pregnancy may be associated with increased risk of autism in progeny. These findings are novel and open a possible pathway for prevention of autism. His work highlights the importance of neuroendocrine pathways and their potential effects on neurological diseases such as autism.

Neuroscience Research Prize

Sponsored by the American Academy of Neurology and the Child Neurology Society Recipient: Pravin Ravishanker Sunnyvale, CA

 hank You Statement: I acknowledge all who have supported T me on my journey of constant experiential learning. I thank experts who have helped me comprehend complex topics in statistics, signal processing, graph theory, genomics, and neuroimaging used in this four-year progressive computational neuroscience research. Recipient:  Tejas Athni Macon, GA

 hank You Statement: My mentors were Dr. Nirmal Joshee, T Dr. Prahlad Parajuli, and Mr. Brajesh Vaidya, all of whom have provided me with invaluable guidance. I’d also like to thank Mrs. Susan Hanberry at Stratford Academy for sparking my interest in the biological sciences and supporting me throughoutthe process. 

169


2017 Award Recipients Recipient: Gokul Kannan Highland, MD  hank You Statement: My mentors, Dr. Sapna Kudchadkar T and Dr. Siva Pramodh Kambhampati, have been invaluable in my research experience. Dr. Kudchadkar has mentored me throughout the process and showed me the ropes of the field. Dr. Kambhampati worked one-on-one with me so that I understood every bit of the research. Why the Recipients Were Chosen: Our committee had a spirited discussion after detailed reading and analysis of our submissions. This year's Neuroscience Research Prize winners have produced outstanding scientific work, especially for their age. These young students demonstrated amazing intellectual curiosity and depth of knowledge. We are fortunate to have them share their research with us and hopeful that this will mark the beginning of a long and decorated career in the neurosciences.

Child Neurology Neuroscience Research Prize Sponsored by the American Academy of Neurology and the Child Neurology Society Recipient:  Lauren Singer Scarsdale, NY  hank You Statement: I would like to acknowledge Dr. Joseph T Buxbuam, Dr. Alex Kolevzon, Dr. Paige Siper, and Dr. Hala Harony-Nicolas. I also want to thank all the teachers in the science research program at Scarsdale High School. Why the Recipient Was Chosen: Our committee had a spirited discussion after detailed reading and analysis of our submissions. This year’s Neuroscience Research Prize nominees have produced outstanding scientific work, especially for their age. These young students demonstrated amazing intellectual curiosity and depth of knowledge. We are fortunate to have them share their research with us and hopeful that this will mark the beginning of a long and decorated career in the neurosciences.

170

2017 AAN Annual Meeting On-site Guide


AWARDS

Michael S. Pessin Stroke Leadership Prize

Sponsored by the AAN and endowed by Dr. Pessin’s family, friends, and colleagues. Recipient: James F. Burke, MD, MS Ann Arbor, MI

 hank You Statement: I am deeply indebted to a long list of T collaborators who have elevated the quality of my research. Most notably, Lesli Skolarus has sharpened my research questions and focus. My mentors Lewis Morgenstern and Rod Hayward have taught me how to think and act as a researcher.

Why the Recipient Was Chosen: In just a few short years since joining the faculty at the University of Michigan, James Burke, MD, MS, has emerged as a national leader in stroke health services research. He has made significant contributions on a broad range of topics that are likely to shape stroke care over the coming years, including regional variation in acute stroke treatment, inefficiencies in neuroimaging, cost of care, quality measures for stroke, and the burden on care providers. His voice will be essential to future national discussions on these topics.

Potamkin Prize for Research in Pick’s, Alzheimer’s, and Related Diseases

Sponsored by the AAN and the American Brain Foundation and funded through the philanthropy of the Potamkin family Recipient:  Claudia Kawas, MD Irvine, CA

 hank You Statement: I thank Robert Katzman, Robert Terry, T Leon Thal, and Peter Davies, all previous Potamkin Awardees, who lit my fire for aging research 35 years ago at AECOM, Maria Corrada for 25 years of incredible collaboration and friendship, and all my wonderful colleagues at UC Irvine. Recipient: Kristine Yaffe, MD San Francisco, CA

 hank You Statement: I cannot express enough appreciation T for my wise and generous mentors whose guidance has been essential in the success of my research. In addition, many of the most exciting aspects of my multi-disciplinary work result from collaborations with incredible colleagues, and without them, this research would not be possible.



171


2017 Award Recipients Why the Recipients Were Chosen: The Potamkin recipients have been on the forefront of studying Alzheimer’s disease and brain aging in population samples that have uniquely informed our understanding of how Alzheimer’s disease may develop. Dr. Kristine Yaffee has been involved in many large epidemiological cohort studies that have examined how factors such as general medical health, falls, insomnia, head injury and depression are associated with cognitive dysfunction late in life. Dr. Kawas, through her leadership of the 90+ study, has illuminated the clinical, neural, and pathological features of dementia and cognitive decline in the oldest old and thereby broadened our understanding of Alzheimer’s disease.

Safety and Quality Award Sponsored by the American Academy of Neurology Recipient: David Do, MD Philadelphia, PA  hank You Statement: Innovation can be at odds with what is T practical and efficient. Thank you to those who invested in me and my work, including the Department of Neurology, the Center for Health Care Innovation, and the Healthcare Leadership in Quality track at the Hospital of the University of Pennsylvania. Why the Recipient Was Chosen: David Do, MD, is being recognized for his work on automated solutions to improve nutrition in the critically ill. An automated system leveraged electronic data to assess nutritional needs, prompting providers to improve feed, and thereby reducing underfeeding and subsequent muscle breakdown, infections, and mortality. Recipient:  Preston Douglas, MD Maywood, IL  hank You Statement: Thank you for recognizing the work of T the interdisciplinary Loyola Neurology Care Team in their efforts to improve physician communication at the end-of-life, particularly in the setting of brain death. We will strive to carry on the AAN's mission to support and promote the highest quality patientcentered neurologic care. Why the Recipient Was Chosen: Preston Douglas, MD, is acceptingon behalf of a Loyal University treatment team using simulation-based training to improve brain death determination and communication to family members. The team taught incoming residents how to diagnose brain death and communicate effectively with family members in an empathetic and professional manner.

172

2017 AAN Annual Meeting On-site Guide


AWARDS

Recipient:  Raghav Govindarajan, MD Columbia, MO

 hank You Statement: I thank the AAN for recognizing our T patient safety project. The project highlights the importance of developing effective multidisciplinary team-based care. It is also important for neurologists to be actively involved in teaching/ mentoring all members of the health care team.

Why the Recipient Was Chosen: Raghav Govindarajan, MD, FISQua, FACSc, FCPP, is being recognized for his work teaching other health care providers to identify myasthenia gravis exacerbation through telephone and telemedicine encounters. This work further developed a multidisciplinary team approach to intervene rapidly using non-traditional patient encounters during a time of patient crisis. Recipient: James E. Siegler III, MD Philadelphia, PA

 hank You Statement: On behalf of the SPARCS collaborators T at the University of Pennsylvania, we are honored to receive the 2017 AAN Quality and Safety Award. It is our pleasure to share our work with you.

Why the Recipient Was Chosen: James Siegler, MD, is receiving this award for his work using Scheduled Provider Alert-Response Communication System (SPARCS) to improve nurse and resident communication, improving quality of life among treatment team members.

Irwin Schatz Award for Autonomic Disorders

Sponsored by the American Academy of Neurology and endowed by Lundbeck, Inc. Recipient: Phillip A. Low, MD, FAAN Rochester, MN

 hank You Statement: I have great respect for Irv Schatz and T what he stood for, especially ethics in medicine; and hence am very grateful for the recognition. My growth and development benefited greatly from my mentors, Jim McLeod and Paul Korner, for my early development in Sydney, Australia. Peter Dyck and Jack Whisnant provided the resources for setting up an Autonomic Laboratory and research at Mayo Clinic, and my peers and trainees provided stimulation. Why the Recipient Was Chosen: Dr. Low’s career accomplishments are well known to everyone in the field of medicine and of neurology in particular. Over the past 40 years, his leadership in both basic and clinical research has changed 

173


2017 Award Recipients our ability to care for patients with peripheral nerve and autonomic disorders. His world-renowned fame as innovative, brilliant researcher and clinician made him a frequently invited speaker to prestigious institutions and meetings all over the world. Indeed his achievements span the whole spectrum from basic research to clinical research, from teaching to excellence in clinical practice. His unparalleled energy, enthusiasm and generosity have allowed him to be the mentor to more than 30 trainees, all of whom continued into successful careers thanks to his professional and personal support. His unselfish efforts were recognized by his becoming the first to be awarded the Clinical Research Committee Mentorship Award from the Mayo Foundation in 2001.

Bruce S. Schoenberg International Award in Neuroepidemiology Sponsored by the American Academy of Neurology and endowed by GlaxoSmithKline, Inc. Recipient:â&#x20AC;&#x201A; Yogeshwar V. Kalkonde, MD, Gadchiroli Maharashtra, India  hank You Statement: I would like to thank our director, Dr. T Abhay Bang, for his guidance and Mr. Mahesh Deshmukh, Sindhu Nila, Mr. Dudhbale, Mr. Sahare, Mr. Bodhankar, Dr. Pitch Mandava, and Dr. Nikkil Sudharsanan for their technical support. Special thanks to the people of rural Gadchiroli for their cooperation. Why the Recipient Was Chosen: This is a well-conducted study of stroke in rural India. Population-based studies of neurological disorders in rural resource limited countries are rare, and this makes these data of even greater value.

Sleep Science Award Sponsored by the American Academy of Neurology and the Sleep Section and endowed by Cephalon, Inc. Recipient:â&#x20AC;&#x201A; Carlos H. Schenck, MD Minneapolis, MN  hank You Statement: John Eccles, Nobel Laureate in T Neurophysiology, was an Emeritus Professor at the State University of New York at Buffalo, and his lecture during my first year physiology class in 1973 focused solely on how the brain is very active during sleep. That left a lasting impression on me.

174

2017 AAN Annual Meeting On-site Guide


AWARDS

Recipient: Mark W. Mahowald, MD Minneapolis, MN

 hank You Statement: I have had the great fortune to have had T many mentors and colleagues. Dr. Milton Ettinger provided an excellent supportive milieu. Dr. Schenck has been an invaluable friend and colleague. Close collaboration with numerous basic science researchers provided encouragement and inspiration.

Why the Recipients Were Chosen: Drs. Schenck and Mahowald were colleagues together at the University of Minnesota for over 30 years. They published 87 papers together, nearly all of them on aspects of sleep disorders. The body of work they are most well-known for is that on parasomnias, conditions in which patients move about or undertake various activities while asleep.These range from sleep walking, sleep terrors, and enuresis in young people to dissociated states, including eating and violence during sleep in adults, to movement disorders such as restless legs and periodic limb movements associated with sleep. However, their most celebrated discovery came in 1986 when they described REM sleep behavior disorder. Although this was initially described as an idiopathic disorder, they noticed that by 1996 nearly 40 percent of their original cohort of REM sleep behavior disorder patients had developed Parkinson’s disease. They were the first to point out this association, and eventually after 25 years, more than 90 percent of the original cohort had developed a synucleinopathy: Parkinson’s disease, Lewy body dementia, or Multiple Systems Atrophy. This work and their initial observations have stood the test of time and been replicated by sleep and movement disorders specialists in various locations around the world. Their work provides insight not only into this sleep disorder, but into how synucleinopathies move through the brain over decades.

H. Richard Tyler Award

Sponsored by the American Academy of Neurology and the AAN History Section Recipient:  Douglas Lanska, MD, FAAN Tomah, WI

 hank You Statement: I am honored to receive the 2017 H. T Richard Tyler Award from the American Academy of Neurology. This is an amazing opportunity to access materials in one of the best medical library collections of neurology and neuroscience in the world. This collection is a testament to the foresight and leadership of the AAN, and especially the late Richard Tyler, MD Professor of Neurology emeritus at Harvard Medical School.



175


2017 Award Recipients Why the Recipient Was Chosen: Douglas Lanska, MD, was chosen because of his interesting proposal to study visual representations of the anatomy of the nervous system, particularly from the 16th-19th centuries. This award will allow Dr. Lanska to review the extensive holdings of anatomical treatises and atlases at the H. Richard Tyler Collection in the Bernard Becker Library.

Harold Wolff-John Graham Award: An Award for Headache/Facial Pain Research Sponsored by the American Academy of Neurology and endowed by Endo Pharmaceuticals. Recipient:â&#x20AC;&#x201A; Simple Futarmal Kothari Aarhus, Denmark  hank You Statement: I am extremely grateful to my mentor, T Professor Peter Svensson, for his outstanding source of inspiration with his vast knowledge and experience, great commitment, and extraordinary supervision; and to Associate Professor Lene Baad-Hansen for her friendly advice and endless support. Finally, I would like to thank my family, friends, and colleagues. Why the Recipient Was Chosen: Dr. Simple Futarmal Kothari is a fellow in headache medicine at the Institute of Odontology and Oral Health at Aarhus University in Denmark. She has published several studies that have made strides in better understanding of temporal mandibular pain by systematically evaluating a number of facets of the condition, including pain mechanisms, pathophysiology, functioning of analgesic systems, genotyping, imaging, and psychosocial features. She is on a path to make significant contributions to the field of facial pain. Her research shows that pathophysiologic mechanisms underlying pain in chronic trigeminomandibular joint pain patients involve central nociceptive pathways but not impaired endogenous pain inhibition. In addition, she found that conditioned pain modulation may be employed as a diagnostic tool to predict patients at risk of developing chronic pain.

176

2017 AAN Annual Meeting On-site Guide


AWARDS

Neurology® Resident & Fellow Section Writing Award

Recipients:  Elan L. Guterman, MD Neurology Resident, PGY-4 University of California, San Francisco

Recipient: Brian Yurgionas, MD, MS General Neurology and Neuromuscular Medicine Kaiser Permanente San Francisco

Recipient: Alexandra B. Nelson, MD, PhD Richard and Shirley Cahill Endowed Chair in Parkinson' Disease Research UC San Francisco Department of Neurology/ Weill Institute for Neurosciences UC San Francisco Kavli Institute for Fundamental Neuroscience  hank You Statement: Our case report explores the clinical manifestations T of episodic ataxia type 2, the underlying genetics, and diagnostic delays among patients with comorbid functional disorders. We are incredibly grateful for our patient and thankful to the Editors of Neurology’s Resident and Fellow section for recognizing our work with this exciting award.

Why the Recipients Were Chosen: The award winning ‘Pearls & Oy-sters’ paper by Elan L. Guterman, MD, Brian Yurgionas, MD, MS, and Alexandra B. Nelson, MD, PhD, is the report of a case of episodic ataxia type 2 with a pathogenic variant in the CACNA1A gene. The authors highlight the variability of the clinical presentation and describe the most effective currently known treatments. This case represents an example of current utilization of genetic testing in neurology clinical practice and emphasizes the importance of a precise diagnosis for optimal management.



177


2017 Award Recipients Jon Stolk Award in Movement Disorders for Young Investigators Sponsored by the AAN and endowed by Kyowa Pharmaceutical, Inc., Lineberry Research, Quintiles, Dr. Dennis Gillings, and VelaPharma Recipient:  Marios Politis, MD, MSC, DIC, PhD, FEAN London, United Kingdom  hank You Statement: My NIG Team at King's and Profs. T Lindvall, Kapur, Bjorklund, Richardson, and Shaw for the opportunity and guidance. Why the Recipient Was Chosen: We are thrilled to name Dr. Marios Politis as the recipient of this award which recognizes his outstanding work in the field of molecular imaging of neurodegenerative disease, particularly his studies on Parkinson’s and Huntington diseases. A tremendously productive investigator, Dr. Politis has published MRI and PET studies exploring many aspects of the etiology and responses to therapy in movement disorders, and, in particular, has played an important role in advancing understanding of disordered serotonergic neurotransmission in Parkinson’s.

Clinical Research Training Fellowships Cosponsored by the American Academy of Neurology and the American Brain Foundation Why the Recipient Was Chosen: “To demonstrate the AAN Board of Directors’ dedication to promoting neurology and neuroscience research and training, the AAN has launched an ambitious new program —the AAN Research Program. The Research Program Workgroup and other participating reviewers were honored to have had the opportunity to select the first recipients of two new awards— the Career Development Award and Neurology Research Training Scholarship, in addition to fifteen other existing awards in the Research Program portfolio. The recipients were selected based on the quality and originality of their proposed research, their ability and promise as a clinician-scientist, and the quality and nature of their training environment. On behalf of the reviewers and recipients, thank you to the existing and current partners who make many of these funding opportunities possible.” —Aleksandar Videnovic, MD, MSc, FAAN

178

2017 AAN Annual Meeting On-site Guide


Funded by the American Academy of Neurology

AWARDS

Career Development Award

Recipient:  Lidia Moura, MD, MPH Massachusetts General Hospital/Harvard Medical School

 hank You Statement: I’d like to thank my patients for T highlighting the gaps in our knowledge, my husband for showing unconditional love and understanding; my mentors for supporting my goals, the donors and sponsors of the AAN for allowing me to continue this journey, and God for providing me with health and inspirations.

Neurology Research Training Scholarship Funded by the American Academy of Neurology Recipient:  Hsiao-Tuan Chao, MD, PhD Baylor College of Medicine

 hank You Statement: I am immensely grateful for the support, T friendship, inspiration and guidance of my mentors Hugo J. Bellen, Huda Y. Zoghbi, Christian Rosenmund, John Swann, and Gary D. Clark. I will carry on their commitment and passion for biomedical research and mentoring the next generation of scientists and physician-scientists.

Clinical Research Training Fellowship in ALS Research Funded by the ALS Association

Recipient: Nicholas Olney, MD University of California, San Francisco

 hank You Statement: My prior mentors Dr. Howard Rosen, T Dr. Bruce Miller, Dr. Robert Levenson, and Dr. Catherine LomenHoerth have been dramatically influential to my career. My father, Dr. Richard Olney, who passed away from ALS, continues to inspire me and my research.



179


2017 Award Recipients Clinical Research Training Fellowship in Epilepsy Funded by Lundbeck Recipient: Adam Numis, MD, UCSF Epilepsy Center

Clinical Research Training Fellowship in Muscular Dystrophy Cosponsored by the American Academy of Neurology, the American Brain Foundation, and the Muscular Dystrophy Association Recipient: Johanna Hamel, MD University of Rochester, Department of Neurology  hank You Statement: First and foremost, I would like to T sincerely thank my mentor, Dr. Charles Thornton. I would also like to thank Drs. Griggs and Holloway for their support, along with neuromuscular specialists, pathologists, and patients with neuromuscular diseases who have inspired me along the way.

Clinical Research Training Fellowship in Parkinson’s Disease Funded by the American Academy of Neurology, the American Brain Foundation, and AbbVie Recipient:  Baijayanta Maiti, MD, PhD Washington University in St. Louis  hank You Statement: I am deeply indebted to Dr. Kevin M. T Flanigan (my PhD thesis advisor) and Dr. Joel S. Perlmutter (my mentor) for their insightful suggestions, inspiration, and guidance over the years.

180

2017 AAN Annual Meeting On-site Guide


Funded by Lundbeck Recipient:  Laurie Robak, MD, PhD Baylor College of Medicine

AWARDS

Clinical Research Training Fellowship in Parkinson’s Disease

 hank You Statement: I would like to thank Dr. Joshua T Shulman, my primary mentor, who has been an outstanding scientific mentor and given me valuable career advice. Drs. Joseph Jankovic and Huda Zoghbi, my co-mentors, have also provided excellent scientific and career advice.

Clinical Research Training Fellowship in Parkinson’s Disease

Cosponsored by the American Academy of Neurology, the American Brain Foundation, and the Parkinson’s Foundation Recipient: Michelle Fullard, MD University of Pennsylvania

 hank You Statement: I would like to thank my primary mentor, T Alice Chen-Plotkin, who helped me develop this project. I would also like to thank my mentorship team and our multiple partners and collaborators who span many different fields and who make an interdisciplinary project like this possible.

Clinical Research Training Fellowship in Tourette Syndrome

Cosponsored by the American Academy of Neurology, the American Brain Foundation, and the Tourette Association of America Recipient:  Flint Martin Espil, PhD Stanford University

 hank You Statement: I would like to acknowledge the T contributions from my graduate mentor, Dr. Douglas Woods; colleagues Drs. Ricketts, Capriotti, Conelea, Walther, and Snorrasson; and collaborators Drs. Carrion, Reiss, and Garner. Their support in my ability to pursue a career as a clinical scientist has been invaluable. 

181


2017 Award Recipients Recipient: Joseph F. McGuire, Ph.D University of California Los Angeles  hank You Statement: I am appreciative for the unwavering T support of my UCLA mentors, Drs. Susan Bookheimer, James McCracken, and John Piacentini. Moreover, I remain grateful for the continued support of all my past mentors who have influenced my decision to pursue Tourette syndrome research, Drs. Tanya Murphy, Lawrence Scahill, and Eric Storch.

Clinical Research Training Scholarship (formerly fellowship) Funded by the American Academy of Neurology Recipient:  Melissa M. Cortez, DO University of Utah  hank You Statement: I am very grateful to the AAN and ABF T for their commitment to supporting young clinician investigators like myself. I have been a member of the organization since I was a pre-medical student considering neurology, and have learned so much from attending the conference proceedings over the year. I am very proud to be the recipient of such a prestigious award. Recipient: Afsaneh Shirani, MD Washington University School of Medicine  hank You Statement: I am deeply grateful to my mentors T at Washington University, Drs. Anne Cross and Sheng-Kwei (“Victor”) Song. This scholarship would not have been possible without their support, and guidance. I also feel very fortunate to have worked with great mentors throughout my research career. I would particularly like to thank Drs. Olaf Stuve, Helen Tremlett, Emmanuelle Waubant, and Darin Okuda. Recipient:  Isaac Marin-Valencia, MD The Rockefeller University  hank You Statement: I would like to thank my current T mentors, Drs. Joseph Gleeson and Barry Coller at The Rockefeller University, for their unconditional support on this project, my former mentors at UT Southwestern, and mostly my wife, my parents, and my brother who have stood with me along the way.

182

2017 AAN Annual Meeting On-site Guide


AWARDS

Clinician Scientist Development Three-Year Award in ALS Funded by the ALS Association

Recipient:  Sabrina Paganoni, MD, PhD Harvard Medical School, Massachusetts General Hospital

 hank You Statement: I would like to thank my mentors, Dr. T Merit Cudkowicz and Dr. Michael Schwarzschild, the NEALS Consortium, and the ALS Association. I am fortunate to work with such a phenomenal community of clinician scientists dedicated to finding a cure for ALS.

Practice Research Training Scholarship (formerly Fellowship) Funded by the American Academy of Neurology Recipient:  Christopher Tarolli, MD University of Rochester

 hank You Statement: I am extremely grateful to my mentor, T Ray Dorsey, for his commitment to my education and his support. I’d also like to thank Robert Holloway and Benzi Kluger, leaders in neuropalliative care, for inspiring me to become involved in the field and for their assistance in conceptualizing this project.



183


2017 Award Recipients Susan S. Spencer Clinical Research Training Fellowship Cosponsored by the American Academy of Neurology, the American Brain Foundation, the American Epilepsy Society, and the Epilepsy Foundation Recipient: Alice D. Lam, MD, PhD Massachusetts General Hospital, Harvard Medical School  hank You Statement: Thanks very much to my research and T clinical mentors, Syd Cash and Andy Cole, and to my department chair, Merit Cudkowicz, at the Massachusetts General Hospital. Many thanks also to my PhD mentor, Ed Stuenkel, at the University of Michigan.

Research Training Fellowship in Ataxia Cosponsored by the American Academy of Neurology, the American Brain Foundation, and the National Ataxia Foundation Recipient:  Jill Sergesketter Butler, PhD University of Alabama at Birmingham  hank You Statement: I would like to thank my mentor and T colleague Marek Napierala, PhD, for his guidance and support while beginning my research career in the ataxia field. I am also grateful for the support and collaboration of David Lynch, MD, PhD, and his laboratory at the Children’s Hospital of Philadelphia.

Robert Katzman Clinical Research Training Fellowship in Alzheimer’s Research Cosponsored by the American Academy of Neurology, the American Brain Foundation, and the Alzheimer’s Association Recipient:  Joel Salinas, MD, MBA, MSc Massachusetts General Hospital, Harvard Medical School  hank You Statement: I am deeply grateful to the unrelenting T support of Drs. Caplan, Cudkowicz, Rosand, Schwamm, and Seshadri. I am also thankful to the researchers of the Framingham

184

2017 AAN Annual Meeting On-site Guide


AWARDS

Study and am most grateful to the Framingham Study participants who have committed so much of their time and effort to further medical research.

Clinician-Scientist Development Award in Multiple Sclerosis

Cosponsored by the American Academy of Neurology, the American Brain Foundation, and the National Multiple Sclerosis Society Recipient:  Ryan Schubert, MD San Francisco, CA

 hank You Statement: I have been advised and influenced by T many wonderful scientists, including my father Mark Schubert; Jamie Lee at the Mayo Clinic; Larry Steinman, Jeff Dunn, and Bob Axtell at Stanford; Steve Finkel and Bob Baker at USC; and now Steve Hauser, Michael Wilson, Jeff Gelfand, and Joe DeRisi at UCSF.

Lawrence M. Brass, MD, Stroke Research Award

Cosponsored by the American Academy of Neurology, the American Brain Foundation, and the American Heart Association/American Stroke Association Recipient:  Laura Graham, MPH Birmingham, AL

 hank You Statement: My primary mentors for this project are T Drs. Emily Levitan and Joshua Richman, both from the University of Alabama at Birmingham. I am also extremely grateful for the career guidance of Drs. Mary Hawn of Stanford University and Sara Knight of the University of Alabama at Birmingham.

American Academy of Neurology President’s Award Recipient:  Anthony G. Alessi, MD, FAAN Norwich, CT

 hank You Statement: I am honored to be the recipient of T the 2017 AAN President’s Award. I have been a member of the Academy for the past 34 years and am most proud of the AAN’s recent efforts to advocate for its members and make their lives and professional careers more fulfilling while encouraging young neurologists to reach their highest goals. 

185


2017 Award Recipients Why the Recipient Was Chosen: “It is my honor to name Anthony G. Alessi, MD, MMM, FAAN, the recipient of the 2017 President’s Award. He has been an AAN member since 1983, contributing in many critical areas. He has promoted our understanding of the challenges of private neurological practice. He has been a leader in advocacy for neurologists and our patients. Dr. Alessi served as chair of the AAN’s political action committee BrainPAC and received the Academy’s 2014 Kenneth M. Viste, Jr., MD, Patient Advocate of the Year Award for his persistent work advocating on behalf of people with neurologic disease, particularly the impoverished citizens of Haiti. He has had a long interest in sports neurology and has served in a number of capacities in various sports advocating for the safety of our athletes. Most recently, Dr. Alessi has been a tireless leader in developing neurologic care in underserved countries. His work in Haiti before, during, and after the tragic earthquake in 2010 has been exemplary and made a critical difference in the neurologic health of the Haitians. All of these roles have been accomplished with great enthusiasm and always putting the profession and patients at the forefront. For all his unselfish work to better our profession and the lives of the patients he serves, Dr. Anthony Alessi is a most deserving awardee.” —AAN President Terrence L. Cascino, MD, FAAN

A.B. Baker Award for Lifetime Achievement in Neurologic Education Funded by an endowment created by matching funds from the A.B. Baker Family Trust and Novartis Pharmaceuticals Recipient: Harold P. Adams, Jr., MD, FAAN Iowa City, IA  hank You Statement: I am truly honored to be the recipient T of this year’s A.B. Baker Award. I thank the American Academy of Neurology for this recognition. I also thank the Baker family for their support of this award. It is gratifying to be recognized for doing something that one enjoys doing. While I do not want to underestimate the importance of patient care or research, I believe teaching medical students and residents remains the highest priority of academic neurology. This award and other initiatives demonstrate our Academy’s commitment to the education of future physicians.

186

2017 AAN Annual Meeting On-site Guide


AWARDS

John Dystel Prize for Multiple Sclerosis Research

Sponsored by the AAN and National Multiple Sclerosis Society and made possible through a special contribution from the John Dystel Multiple Sclerosis Research Fund at the National Multiple Sclerosis Society. Recipient:â&#x20AC;&#x201A; Alan J. Thompson, MD, FRCP, FAAN London, United Kingdom

 hank You Statement: I am absolutely delighted to be receiving T this award. When I consider all those who are making such an amazing contribution to our understanding and treatment of multiple sclerosis, it is very humbling to be acknowledged in this way. I was fortunate in my career to have two extraordinary mentors, first in Dublin and then in Queen Squareâ&#x20AC;&#x201D;Professors Michael Hutchinson and Ian McDonald, who shared a passion for MS and a generosity of spirit. But there are many other colleagues, students, and friends who have advised, encouraged, and supported me over the years, including Olga Ciccarelli, David Miller, Xavier Montalban, Frederik Barkhof, Jenny Freeman, and Tim Coetzee. Very many thanks.

Why the Recipient Was Chosen: The 2017 Dystel Prize is awarded to Professor Alan Thompson in recognition of his unique and prolific contributions represented in over 500 publications that have profoundly influenced the understanding and awareness of progressive multiple sclerosis (MS). These contributions include landmark imaging studies, clinical studies of therapies and rehabilitation, and development of patient-reported outcome measures. As a key leader of the Progressive MS Alliance, he has been tireless in his efforts to energize coordinated international collaboration to find answers for progressive MS.

International Scholarship Award Sponsored by the American Academy of Neurology Recipients: Dr. Cyrus Escabillas Manila, Philippines

 hank You Statement: The success of this study would not T have been possible without my family, friends, and colleagues. To my mentor and co-author, Dr. Jose Navarro, for your unwavering support and for inspiring me to come up with this study. Thank



187


2017 Award Recipients you for bringing out my potentials beyond my capabilities. To the consultants of Jose R. Reyes Memorial Medical Center, Department of Neurology, for the motivation and compassion in helping me learn and practice neurology, thank you. And lastly, to my family, who has believed in me since day one, this award I share with you. Dr. Fabio Porto Sao Paulo, Brazil  hank You Statement: I would like to thank my wife Gislaine for T her unconditional support and the neurology department of the University of São Paulo for the opportunity to do this research. Dr. Alagoma Iyagba Port Harcourt, Nigeria  hank You Statement: With profound gratitude, I write to T appreciate my delight to the AAN on being selected for one of the International Scholarship Awards. Thank you very much for this career advancing opportunity. I would be communicating with respect to the travel arrangements for my attending. God bless you all and have a nice day. Dr. Miguel Wilken Buenos Aires, Argentina  hank You Statement: I want to thank the AAN for recognizing T me for this award. A lot of people contributed to this work. I want to acknowledge especially Dr. Lucas Alessandro and Dr. Mauricio Farez, who co-authored this work with me, and were also past recipients of this award. I want to thank also my mentors in the Raúl Carrea Institute for Neurological Research (FLENI), especially Dr. Martín Nogués, Dr. Alberto Rivero, Dr. Angel Cammarota, and Dr. Marcelo Merello. Dr. Julia Pakpoor Oxford, United Kingdom  hank You Statement: For being the most wonderful mentors, T I am immensely grateful to Prof. Gavin Giovannoni, Dr. Klaus Schmierer, and Prof. Michael Goldacre. I am grateful to Dr. Shivan Sivakumar for his bottomless encouragement. Finally, thank you to all co-authors, the University of Oxford, and to the AAN for giving me this opportunity!

188

2017 AAN Annual Meeting On-site Guide


AWARDS

Dr. Imen Kacem La Manouba, Tunis, Tunisia

 hank You Statement: I am thankful to the American Academy T of Neurology and very honored to receive this award. This scientific distinction is for me an opportunity to pay tribute to my first mentors in neurology, Prof. Riadh Gouider & Prof. Amina Gargouri. Their courage and dedication shaped my career. Prof. Gouider, I am proud to say that I am your pupil and mentee! Thank you for your continuous support, help, loyalty, and willingness. You have always demonstrated dynamism and I always admired your decisiveness. You have built a strong neurological community starting from a small team and this is quite impressive and highly commendable! Without you, we would not be! Lastly, I am also grateful for life lessons. For the team of the department of neurology of Razi Hospital, Tunisia: You are for me a second family, my spiritual family. My commitment is to preserve this flame of success alive for the Tunisian neurology. Dr. Lin Tan Qingdao Shandong, China

 hank You Statement: I sincerely appreciate all my coworkers, T especially my tutor. My tutor helps me form more concise ideas and to make myself the focal point of my study. Besides, special thanks to AAN for providing me the chance to attend the Annual Meeting. Finally, many thanks for the mice in my study. Dr. Roosevelt Francois Mirebalais, Haiti

 hank You Statement: I would like to thank the AAN for this T scholarship and for assisting me in planning my experience and Dr. Aaron Berkowitz for his help and mentorship. Dr. Janet Ebid Cairo, Egypt

 hank You Statement: I want to say thank you to Prof. T Tamer Emara, who helped me a lot to receive the International Scholarship Award.



189


2017 Award Recipients Dr. JieQiong Li Qingdao Shandong, China  hank You Statement: I want to thank my tutor Lan Tan and JinT Tai Yu for their generous cultivation. I also want to thank QingDao University and Qingdao Municipal Hospital. At last, I want to thank my family that gives me a lot of support. Dr. Kiran Patil Puducherry, India  hank You Statement: Thanks a ton to Mr. and Mrs. Vasant Hari T Patil, Dr. Sunil Narayan, Dr. Ramesh Babu, and JIPMER, India.

Dr. Seid Gugssa Addis Ababa, Ethiopia  hank You Statement: This is a new year surprise gift for me! T Thank you for breaking the good news to me!

Dr. Makoto Hara Tokyo, Japan  hank You Statement: It's great honor for me to be selected as T a recipient of the International Scholarship Award.

Dr. Fei Han Beijing, China  hank You Statement: It is a great honor for me to receive this T scholarship from AAN. I cherish this opportunity very much. This work is part of the population-based Shunyi study in rural China, set up by Pro. Yi-Cheng Zhu. The Shunyi study was designed to investigate the risk factors of cardiovascular diseases and age-related diseases, comprising nearly 2,000 participants and with brain MRI exams. Many clinicians and participants have contributed to this work. I would like to highly acknowledge my mentor and supervisor in PUMCH, Pro. Yi-Cheng Zhu and Pro.

190

2017 AAN Annual Meeting On-site Guide


AWARDS

Li-Ying Cui, who gave me great support and encouragement during my career all the time. Their style and approach contributes to influence my work and they are both good examples for me to follow. Dr. FeiFei Zhai Beijing, China

 hank You Statement: Iâ&#x20AC;&#x2122;d like to thank the AAN and I am T incredibly honored to win the International Scholarship Award. I would like to acknowledge my supervisor, Professor Yi-Cheng Zhu, and all members in our research group. They give me much help not only in my research work but also in my life. I also thank all medical workers and all participants in our cohort study.

Why the Recipients Were Chosen:The International Subcommittee is responsible for evaluating the applicants for the International Scholarship Award. The objective of the award is to provide eligible international candidates the opportunity to attend and participate in the Annual Meeting by providing up to $2,500 in reimbursement toward expenses. The awards are given to citizens of a nation outside the US and Canada who are 36 years of age or younger (unless a reasonable case can be made for why someone older should still be considered). Fifteen total awards are distributed, five are given based on the quality of abstract submitted and, new this year, ten awards are given based on quality of abstract as well as other criteria such as personal need and country of origin, with emphasis given to applicants from developing countries. This year we received 50 eligible applicants from around the world. The International Subcommittee evaluates all the International Scholarship applicants and makes a recommendation to the Member Engagement Committee (the MEC).

Kenneth M. Viste Jr., MD, Patient Advocate of the Year Award

Sponsored by the American Academy of Neurology and endowed by gifts from Dr. Visteâ&#x20AC;&#x2122;s colleagues, friends, and patients Recipient: E  laine C. Jones, MD, FAAN Bristol, RI

 hank You Statement: I am grateful to the AAN for providing T me the training and opportunities to get involved in advocacy. This is some of the most rewarding work that I do and now it is more important than ever that we are out there fighting for our patients



191


2017 Award Recipients and our profession. I have learned that one person can make a difference, but with more people involved the results can be even bigger. I encourage everyone to get involved wherever and however they can. Why the Recipient Was Chosen: Dr. Jones has demonstrated a sustained dedication and commitment to neurology advocacy for over a decade. A graduate of the first Palatucci Advocacy Leadership Forum class in 2003, she has selflessly taken time away from her solo practice to serve the neurology community by holding multiple leadership positions with the AAN, participating annually in Neurology on the Hill, and as leader and driving force of the Rhode Island Neurological Society.

Sidney Carter Award in Child Neurology J. Helen Cross, PhD UCL-Institute of Child Health, London, United Kingdom Title: Improving Outcomes in Childhood Epilepsy

H. Houston Merritt Lecture Nancy J. Newman, MD, FAAN Emory University School of Medicine, Atlanta, GA Title: Ophthalmoscopy in the 21st Century

Presidential Lecture Terrence L. Cascino, MD, FAAN Mayo Clinic, Rochester, MN Title: Burnout, Wellness and the Future of Our Profession

192

2017 AAN Annual Meeting On-site Guide


Ronald C. Petersen, PhD, MD, FAAN Mayo Clinic, Rochester, MN

AWARDS

Robert Wartenberg Lecture

Title: How Early Can We Diagnose Alzheimer’s Disease?

Medical Student Diversity Scholarships

The AAN is grateful to the following 2017 Medical Student Diversity Annual Meeting Scholarship supporters (as of January 9, 2017): The Allergan Foundation, Supernus Pharmaceuticals, Inc. Recipient:  Kamila Bond, Rochester, MN

 hank You Statement: Thank you so much for the opportunity T to travel to Boston and learn more about neurology as a Medical Student Diversity Program scholar! I am extremely grateful for the generosity and support of the AAN in making this valuable learning experience possible! Recipient: Jabari Bailey Washington, DC

 hank You Statement: I would like to thank the American T Academy of Neurology, The Allergan Foundation, and Supernus Pharmaceuticals, Inc. for your commitment to diversity. I am grateful for being selected as a recipient of the 2017 Medical Student Diversity Scholarship, which will aid me in identifying an outstanding mentor and developing my career as a future neurologist. Recipient: Reid Woods Washington, DC

 hank You Statement: Thank you for providing me with this T wonderful opportunity to learn more about the fascinating field of neurology. I am excited to learn new information, gain new mentors, and meet other colleagues interested in the same field.



193


2017 Award Recipients Recipient: Justin Williams Rochester, NY  hank You Statement: It is with a tremendous appreciation T for the opportunity I have been afforded by being awarded the Medical Student Diversity Scholarship that I thank you. It is an investment in my future, and I promise to pay it forward to my future patients and anyone else I encounter in my career as an academic neurologist. Recipient: Camilo Bermudez Noguera Nashville, TN  hank You Statement: I would like to thank everyone involved T with the AAN and the Medical Student Diversity Scholarship. Their support has greatly enriched my experience in the Annual Meeting and motivated me to pursue a career that bridges neurology and research. Recipient: Samantha Roman Halethorpe, MD  hank You Statement: Thank you for the opportunity to attend T the 2017 AAN Annual Meeting. This is the first time I will be attending a national meeting/research conference, and am excited by the learning and networking opportunities that will be available! Recipient: Mikalei Gordon Silver Spring, MD  hank You Statement: I would like to sincerely thank the AAN T for the contribution to my education and development in the field of neurology through the Medical Student Diversity Scholarship. I am both humbled and inspired to have been selected as a recipient of this award. I will make full use of the opportunities, resources, and mentorship provided to me and continue to strive toward a career in neurology. In the same spirit in which this award is given, I will be sure to reach back and foster high school and undergraduate students’ interest in the brain sciences within my community.

194

2017 AAN Annual Meeting On-site Guide


AWARDS

Recipient: Victor Ekuta San Diego, CA

 hank You Statement: I am writing to express my sincere T gratitude to you and the committee for selecting me as a Medical Student Diversity Scholarship Recipient. As an aspiring neurologist, I know I will greatly benefit from the lectures, mentorship, and networking opportunities. Thank you for supporting my personal and professional development. Recipient: Gabriel Reynaldo Arismendi North Bergen, NJ

 hank You Statement: The American Academy of Neurology T has a mission to improve care for patients suffering from neurological conditions. Offering scholarships such as the Medical Student Diversity Scholarship facilitates more aspiring neurologists to learn from today's top leaders in our field. Thank you for being a part of my career development. Recipient: Merrick Tan Arlington, VA

 hank You Statement: It is a blessing to receive such an T amazing scholarship from the AAN. Not only will I be given the means to make a trip to the annual meeting possible, but the guidance and mentorship, social events, and workshops set in place really makes this award so special. Thank you!

Why the Recipients Were Chosen: This year’s award recipients are outstanding medical students who share a common interest in advancing their knowledge and understanding of clinical neurology and neuroscience. The program offers them a unique opportunity to obtain mentorship, to attend the educational and scientific sessions, and to network at the 2017 Annual Meeting with the goal of inspiring them to continue their pursuit of a career in the neurosciences.

Program Director Recognition Award Recipient: Vicki Shanker, MD New York, NY

 hank You Statement: I am grateful to the selection committee T for honoring me with this award. I feel fortunate to have such a rewarding and important job. I am privileged to work in a supportive environment at Mount Sinai working with a GME and faculty dedicated to developing outstanding neurologists. 

195


2017 Award Recipients Recipient: Perry K. Richardson, MD Washington, DC  hank You Statement: I am truly honored to be nominated T for this important award. I thank the many residents and fellows I have been privileged to mentor, as well as my chair, Henry Kaminski, MD. I am especially grateful to our residency coordinator, Ms. Crystal Woods, who catalyzed my worthiness.

Program Coordinator Recognition Award Recipient: Terri Feist, BBA, CTAGME Cincinnati, OH  hank You Statement: I am extremely honored and grateful to T receive the 2017 Program Coordinator Recognition Award! I would like to thank the American Academy of Neurology for recognizing the role of the residency program coordinator as an integral part of residency training and graduate medical education by providing this award. Recipient: Jennifer C. Rew, M. Ed Richmond, VA  hank You Statement: I am extremely honored to receive this T award. I would like to thank my wonderful program directors at VCU for their amazing support, as well as our residents, fellows, and GME office. I would also like to thank my family for always encouraging me to strive for excellence.

Clerkship Coordinator Recognition Award Recipient: Penny McQueen Columbia, MO  hank You Statement: I am very appreciative to Drs. T Govindarajan, Sahota, and French for their support in creating such a wonderful learning environment for our medical students and empowering me to do my job well. I am also thankful to my family for their love, support and patience.

196

2017 AAN Annual Meeting On-site Guide


Recipient: Raghav Govindarajan, MD Columbia, MO

AWARDS

Clerkship Director Teaching Award

 hank You Statement: I thank my chairman Dr. Pradeep Sahota T for his guidance and mentorship; my coordinator Penny McQueen for her support and friendship; and most importantly, my students at the University of Missouri who inspire me daily to go above and beyond in both teaching and patient care.

Education Research Grant Recipient: Christina Ulane, MD, PhD New York, NY

 hank You Statement: Many colleagues inspired me to pursue T this project and grant, and I am thankful for their support and interest. I am grateful for the support of my chairman Dr. Richard Mayeux who places a priority on resident education, and to Dr. Blair Ford for cultivating the art of combining excellence in patient care with resident education. Recipient: Amy A. Pruitt, MD Philadelphia, PA

 hank You Statement: Dr. Laura Stein will be directing this T project with me. We both would like to thank the person for whom our new educational clinic will be named, Dr. Arthur Asbury. Dr. Asbury has been an extraordinary quadruple neurologic role model in research, clinical medicine, teaching, and administration. We hope to inspire others to follow his example! Recipient: Atul Kalunaria, MD Philadelphia, PA

 hank You Statement: This grant would not have been possible T without the immense help and guidance of my senior colleagues and mentor. A big thanks to Dr. Jensen, Dr. Pruitt, and Dr. Levine for their unconditional support and for their positive influence on my career. I look forward to working on this opportunity and I am sure that with the support of my colleagues it will be a success.



197


2017 Award Recipients Medical Education Research Training Fellowship Recipient:â&#x20AC;&#x201A;Gina L. Hadley, MD Oxford, UK  hank You Statement: Professor Gabriele De Luca has always T been incredibly supportive of my endeavors in medical education. I aspire to his amazing ability to captivate and educate students. Dr Veronica Santini at Stanford is now my enthusiastic co-supervisor. In addition, Professor Alastair Buchan at Oxford has been a longstanding and invaluable mentor.

Frank A. Rubino Award for Excellence in Clinical Neurology Teaching Funded by Mayo Clinic Frank A. Rubino, MD, Development Fund Recipient:â&#x20AC;&#x201A;Amy A. Pruitt, MD Philadelphia, PA  hank You Statement: I am grateful to the colleagues who T nominated me, to the sponsors of this award and to the American Academy of Neurology. Most of all, I thank the students who make teaching the art and science of clinical neurology one of the greatest rewards of our profession. Why the Recipient Was Chosen: Dr. Amy Pruitt embodies the spirit of the Frank A. Rubino Award. For over four decades, medical students, residents, practicing health care providers, and patients have benefited from her exceptional teaching skills, clinical acumen, and patient care at the institutional and national levels. She is the consummate clinician educator.

198

2017 AAN Annual Meeting On-site Guide


Annual Meeting Registrants



Oded Abramsky, MD, PhD Fatima Abrantes-Pais, MD Tapan Abrol, MD Nicole Absar, MD Martina Absinta, MD, PhD Amal Abu Libdeh, MBBS Bilal Abuasal, PhD Baha Abu-Esheh, MD Yousef Abu-Esheh Ahmad Abulaban, MD Mohammed Abunaib, MD Rana Abusoufeh, MD Diler Acar, MD Agustin Acebes Fuertes, MD Elsie Achieng, MD Anat Achiron, MD, PhD Adele Ackell, MD Michael Ackerl, MD Daniel Ackerman, MD Glen Ackerman, MD, FAAN Robert Ackerman, MD, FAAN Timothy Ackerman PharmD Albis Acosta, MD Juan Acosta, MD Lealani Acosta, MD Gyula Acsadi, MD, PhD Patrick Acuna, MD John Adair, MD Thomas Adam, MD Robert Adam Richard Adamczak Ivan Adamec, MD Bozena Adamkiewicz, PhD Harold Adams, MD David Adams, MD Brian Adams, PhD Amelia Adcock, MD Philip Adelman, MD Babatunde Ademiluyi, MD Jeremy Ader Ishan Adhikari, MD

Malik Adil, MBBS Charles Adler, MD, PhD, FAAN Dusit Adstamongkonkul, MD Livia Afonso, MD Tan Afsar Jagadish Agadi, MD Amy Agan Sonika Agarwal, MD Rajul Agarwal, MD Vikash Agarwal, MD Pinky Agarwal, MD, FAAN Shashank Agarwal, MD, MBBS Raja Agarwal, MD, MBBS Sachin Agarwal, MD, MPH Mukul Agarwal Agnieszka Agas Shruthi Agashe Rajiv Aggarwal, MD Mark Agius, MD Eliz Agopian, MD Federica Agosta, MD, PhD Shubhi Agrawal, MD Doris Aguilar Luis aguilar Florencia Aguirre, MD Claudio Aguirre, MD Geoffrey Aguirre, MD, PhD Andrea Aguirre, PhD Latanya Agurs, MD Antwan Ahad, MD Sahar Ahadi, MD Rina Aharoni, PhD Judith Aharon-Peretz, MD Antonia Ahern, MD Aditi Ahlawat, MD Sharat Ahluwalia, MD Brij Ahluwalia-Singh, MD, FAAN Ayesha Ahmad, MD Omar Ahmad, MD

REGISTRANTS

Raffaella (Pizzolato) Umeton, MD Gregory Aaen, MD Jan Aasly, MD, PhD Ghada Abbas, MD Syed Abbas, MD Puya Abbassi Sabra Abbott, MD, PhD Hesham Abboud, MD, PhD Abdalla Abdalla, MBBS Hasan Abdallah, MD Maria Abdel Masih, MD Safa Abdelhakim, MD Hoda Abdel-Hamid, MD Ahmed Abdelkader, MD, PhD Mourad Abdelmessih, MD Hosam Abdelmonem, MBBS Hosam Abdelmonem, PhD Hisham Abdelmotilib, MD Elie Abdelnour, MD Mahmoud AbdelRazek, MD Hossam AbdelSalam, MD Myriam Abdennadher, MD Christopher Abdo, DO Hamed Abdou, MD Ahmad Abdrabboh PharmD Anas Abdul Majeed, MD Mamdouh Abdulrazzak, MD Laleh Abedin Ignacio Abello, MD Nicholas Abend, MD Iryna Aberkorn, MD David Abernethy MB ChB, FRACP Renee Abiad Victor Abler, DO Yousry Aboelnaga, PhD Nada Abou Fayssal, MD Nuhad Abou Zeid, MD Fadi Abou-Mrad, MD, PhD, FAAN Anitha Abraham, MD Nitya Abraham Gary Abrams, MD

201


Annual Meeting Registrants BK Ahmad, MD Tazeen Ahmad, MD Faisal Ahmed, MD Iftekhar Ahmed, MD Samar Ahmed, MD Shaza Ahmed, MD Arshad Ahmed, MD, BS Sheikh Ahmed, MD, MRCP Mohamed Ahmed, PhD Byung Chan Ahn, MD Phillip Ahn, MD Brian Ahuja, MD Ndubuisi Ahuruonye Josef Aich Tazin Aijaz PharmD Laura Airas, MD, PhD Maria Ait Tihyaty, PhD John Aita, MD Venkatesh Aiyagari Norman Ajiboye Senda Ajroud-Driss, MD Bela Ajtai Mehmet Akalin, PhD Isaac Akers Naveed Akhtar, MD Sarah Akins Allen J. Aksamit, Jr., MD, FAAN Orhan Aktas, MD Ziad Al Abbasi, MD Fatema Al Amrani, MD Sarwer Al Bajalan, DO Ali Al Balushi, MD Nawaf Al hashemi, MBBS Fawaz Al Hussain, MD Zuhair Al Kawi, MD, FAAN Ammar Al Kawi, MD, FAAN Ali Al Khathaami, MD Abdulkarim Al Mutairi, MBBS, MD Amer adam Al Najjar Carpentier, MD Moteeb Al Otaibi, MD Youssef Al Said, MBBS

202

Abdulmuttaleb Al Sheikhly, MD Ziad Al Soufi Al Sukkary, MD Shorog Al Thubait, MD Fatmah Al Zahmi, MD Mohamed Al Zawahmah, MD, MBBS Karla Alaka Naila Alakbarova, MD Tariq Alam, MD Fidaul Alam, MD Gustavo Alameda, MD Yassar Alamri, MBBS Ali Basher Alanazi, MD Abdulmajeed Alanazi Adnan Al-Araji Thomas Alarcon, MD Tomas Alarcon-Aviles, MD Joseph Alario Abdulla Alawadhi, MD Mariam Al-Awadi, MD Sadaga Alawi, MD Osamah Albaker, MD Saleh Alballa, MD Gustavo Albanese, MD Carlo Albani, MD Afnan AlBassami, MBBS Christian Albert Mark Alberts, MD Ayman Alboudi, MD Karen Albright DO, MPH Salwa Albusaysi Roy Alcalay, MD Abdul Rahman Alchaki, MD Mark Alden Jillian Alderson, MD Hisham Aldhukair Lauren Aldridge PA Mohamed Aleem, MD Marco Alegria Loyola, MD Ramon Alemany, MD Jean Alencar, MD Jessica Alencar, MD

2017 AAN Annual Meeting On-site Guide

Bader Alenzi, MD Lucas Alessandro, MD Catherine Alessi, MD Anthony Alessi Helena Alessi David Alexander, MD Michael Alexander, MD, FAAN Nektaria Alexandri, MD Taysa Alexandrino Gonsalve, PhD Evgenia Alexandrova, MD Maria Alexianu, MD, PhD Zoi Alexopoulou, MD, PhD Nouf Al-Faidi, MD Fnu Alfandy Christopher Alfieri Isabel Alfradique-Dunham, MD Hussein Algahtani, MD, FRACP Musleh Algarni, MBBS Fouad Al-Ghamdi, MD Khulud Alhadi, MD Reem Alhammad, MD Talal Al-Harbi, MD Jasem Al-Hashel, MD Mohammad Alhatou, MD Kefah Al-Hayk, MD Adel Alhazzani, MD, FRCPC, FAAN Ziad Alhumayyd, MBBS Hassan Alhussein, MD Ashhar Ali, DO Imran Ali, MD, FAAN Farwa Ali, MD Musab Ali, MD Syed Ali, MD Amza Ali, MD Syed Ali, MD Zakir Ali, MD Anwar Ali, MD Inshi Ali Mathew Alias, DO Malle Alilender, DO Asma Aljabbar, MD Bandar Nasser A Aljafen, MD




Iyad Alnahhas, MD Yousef Alnajar, MD Sara Alnajjar, MD Ammar Alobaidy, MD Nasser Alohaly, MBBS Ricardo Alonso, MD Cecilia Alonso Naser Daifallah Alotaibi, PhD Abdelkarim Al-qudah, MD Saad Alrajeh MB, FAAN Mohammad Alrajeh, MD Ali Alrefai, MD Raed Alroughani, MD Ahmad Al-Sabbagh, MD Saud Alsahli, MBBS Hamoud Alsahli, MD Roa Alsajjan, MBBS Ayman Al-Salaimeh Yasser Alsaleh, PhD Abdullah Al-Salti, MD, FRCPC Roger Alsassa, PhD Yousef Alsawwaf Sarab Alseoudi, MD Mohammed Alshaar, MD Mohammed AlShahrani Suhail Al-Shammri, FRCPC, FAAN Mahmoud Alshanqiti, MD Isa Al-Sharoqi MRCP, MD Fatemah Alshawaf, MD Ali Alshehri, MD Amer Alshekhlee, MD Omar Alsinaidi, MBBS Hamada Altalib, DO Juan Altamirano, MD Katharine Alter Carlos Altieri, MD Ayse Altintas, MD Mehmet Ufuk Aluclu, PhD Franklin Alvarez, MD Enrique Alvarez, MD, PhD Angelo Alves, MD, PhD Candida Alves Pinheiro, MD

Muhammad Alvi, MD Abdulaziz Alwehaibi, MD Hazem Aly, PhD Motasem Al-Yacoub, MD Dalal AlYouha, MD Peter Amann Amy Amara, MD, PhD Mauro Amaral PharmD Joan Amatniek, MD Maria Amato, PhD Anthony Amato Erastus Amayo, MD, FAAN Swapnil Ambulkar Lucia Ameghino, MD Abdolali Ameri Shahrabi Amy Amick, MD Hitha Amin, MD Kelly Aminian Rizvana Amir, MD Emre Amirak Fahd Amjad, MD Catherine Amlie-Lefond, MD Zakaria Ammach, MD Deidre Ammah, MD Diane Ammerman Katherine Amodeo, MD Gbola Amusa, MD, CFA Nidhiben Anadani, MBBS Maria Anagnostouli, MD Abhishek Anand, MD Rajiv Anand, MD Charenya Anandan, MD Amitha Ananth, MD Beau Ances, MD, PhD, MS Frederick Andermann, MD, FRCPC, FAAN Eva Andermann, MDCM, PhD, FCCMG Peter Andersen, MD Henning Andersen, MD Brian Andersen, MD, PhD Oluf Andersen, MD, PhD

203

REGISTRANTS

Ahmed Aljammaz Mohammed Al-Jumah, FRCP, MBBS, MD Maryam Alkandari, PhD Sami Alkasab, MD Mais Alkawaz, MD Ayham Alkhachroum, MD Mohamed AlKhaja Modhi Alkhaldi, MD Abdulrahman Alkhalifa MB, BCh, BAO Moayd Alkhalifah, MD Mona Alkhawajah, MD Hussien Alkully, MD Mohammed Alkuwaiti, MBBS Bashar Allaf Gilles Allali, MD, PhD Patrizia Allegra Ricardo Allegri, MD Rachel Allen, DO Anthony Allen, MD Baxter Allen, MD Zoe Allen Pedro Allende Omar Al-Louzi, MD Muhammad Al-Lozi Amal Al-Lozi Majed Alluqmani, MD Jagga Alluri, MD Fatima Al-Maadid Akshata Almad, PhD Klara Almakhanova, MD Mansour Almarhoon, MD Bayan Almarwani, MD Pedro Almeida Fraiman Mousa Almejally, MD Vanessa Almendro, PhD Jorge Almodovar-Suarez, MD Avraham Almozlino, MD, FAAN Ali Al-Mubarak, MD Mohammed Almuqbil, MD Mahmood Alnahass, MD


Thank You 2O17 Annual Meeting Supporters* AbbVie, Inc. ¡ Exhibit Guide ¡ Door Drop ¡ Exhibit Hall Passport ¡ Industry Therapeutic Update ACADIA Pharmaceuticals ¡ C140 Nonmotor Manifestations of Parkinson’s Disease II ¡ AANextra ¡ Door Drop ¡ Exhibit Guide ¡ Exhibit Hall Passport ¡ Industry Therapeutic Update Acorda Therapeutics ¡ Exhibit Guide The Allergan Foundation ¡ Enhanced Residents Leadership Program ¡ Medical Student Diversity Program Allergan Inc. ¡ Brain Health Fair Platinum Sponsor ¡ Diversity Leadership Program ¡ Palatucci Advocacy Leadership Forum ¡ Transforming Leaders Program ¡ Women in Leadership ¡ Women Leading in Neurology Alnylam Pharmacueticals ¡ Industry Therapeutic Update Amgen, Inc. ¡ Annual Meeting General Support ¡ Cell Charging Hub ¡ Hotel Key Cards & Sleeves ¡ Industry Therapeutic Update Arbor Pharmaceuticals, LLC ¡ Exhibit Hall Footprints ¡ Exhibit Hall Passport ¡ Industry Therapeutic Update

AveXis, Inc. ¡ 5k Run/1k Walk for Brain Research ¡ Cell Phone Charging Station ¡ Exhibit Guide ¡ Science Program Bayer HealthCare ¡ AANextra ¡ Exhibit Guide ¡ Exhibit Hall Passport ¡ Tabletop Graphics Biogen ¡ 5k Run/1k Walk for Brain Research ¡ AANextra ¡ Cell Charging Hub ¡ Cell Charging Skyway Lounge ¡ Door Drop Insert ¡ Exhibit Guide ¡ Exhibit Hall Digital Billboard ¡ Exhibit Hall Opening Reception ¡ Exhibit Hall Passport ¡ Exhibit Hall Pillar Marketing ¡ Industry Therapeutic Updates ¡ Presentation Stage ¡ Tabletop Graphics Celgene Corporation ¡ AANextra ¡ Door Drop Insert ¡ Exhibit Guide Centra Health ¡ Faculty and Trainee Night Coastal Health Alliance ¡ Faculty and Trainee Night CompHealth ¡ Faculty and Trainee Night Coram CVS Specialty Infusion Services ¡ Exhibit Guide Cox Health ¡ Faculty and Trainee Night

Duke Health ¡ Faculty and Trainee Night Eisai Inc. ¡ C29 Clinical Epilepsy I ¡ 5k Run/1k Walk for Brain Research ¡ AANextra ¡ Door Drop Insert ¡ Exhibit Hall Passport ¡ Exhibit Guide Electrical Geodesics Inc. (EGI) ¡ Exhibit Guide Eli Lilly and Company ¡ AANextra ¡ Door Drop ¡ Exhibit Hall Footprints ¡ Exhibit Hall Pillar Marketing ¡ Industry Therapeutic Updates EMD Serono ¡ 5k Run/1K Walk for Brain Research ¡ Door Drop Inserts ¡ Exhibit Hall Passport ¡ Exhibit Guide ¡ Presentation Stage Emerson Hospital ¡ Faculty and Trainee Night GE Healthcare ¡ Industry Therapeutic Update Geisinger Health System ¡ Faculty and Trainee Night Genentech ¡ AANextra ¡ Cell Charging Hub ¡ Door Drop Insert ¡ Exhibit Guide ¡ Exhibit Hall Footprints ¡ Exhibit Hall Pillar Marketing ¡ Industry Therapeutic Update ¡ Tabletop Graphics

Grifols USA ¡ C12 Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular and MuSK Myasthenia Hartford HealthCare ¡ Faculty and Trainee Night KabaFusion ¡ Exhibit Hall Passport Kaiser Permanente ¡ Faculty and Trainee Night KRONUS, Inc. ¡ C167 Autoimmune Neurology I: Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS ¡ Exhibit Guide Lundbeck LLC ¡ Enhanced Resident Leadership Program ¡ Transforming Leaders Program MedDay Pharmaceuticals ¡ Exhibit Guide Medtronic ¡ C30 Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders Merck & Co. ¡ C144 Approaching the Management of Common Sleep Disorders: Casebased Review for the Non-sleep Specialist ¡ C142 Alzheimer’s Dementia: Diagnosis and Treatment Merz Neurosciences ¡ C97 The Dystonias: Diagnosis, Treatment, and Update on Causes


The American Academy of Neurology (AAN) thanks the following companies, foundations, and organizations for their demonstrated vision, commitment, and strong support of programs which find answers and improve lives through neurologic education and research. MT Pharma America ¡ C69 Therapy of Neuromuscular Diesease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis ¡ AANextra ¡ Cell Charging Hub ¡ Door Drop Insert ¡ Exhibit Hall Passport ¡ Exhibit Hall Pillar Marketing ¡ Exhibit Guide ¡ Industry Therapeutic Update Neurocrine Biosciences ¡ AANextra ¡ Door Drop Insert ¡ Exhibit Hall Footprints ¡ Exhibit Hall Passport ¡ Industry Therapeutic Update Novartis Pharmaceuticals Corporation ¡ 5k Run/1K Walk for Brain Research ¡ AANextra ¡ Brain Health Fair Sponsor ¡ Door Drop Insert ¡ Exhibit Hall Park Benches ¡ Exhibit Guide ¡ Industry Therapeutic Update ¡ Mobile App Ochsner Health System ¡ Exhibit Guide Outcome Health ¡ Exhibit Hall Passport ¡ Office of the Future Gold Sponsorship Quest Diagnostics ¡ Exhibit Hall Passport

Sage Therapeutics ¡ 5k Run/1k Walk for Brain Research ¡ Door Drop Insert Sanofi Genzyme ¡ 5k Run/1k Walk for Brain Research ¡ AANextra ¡ Brain Health Fair Silver Sponsorship ¡ Door Drop Inserts ¡ Emerging Leaders Program ¡ Exhibit Hall Pillar Marketing ¡ Exhibit Guide ¡ Industry Therapeutic Update ¡ Palatucci Advocacy Leadership Forum ¡ Presentation Stage ¡ Resident Scholarship Fund ¡ Transforming Leaders Program ¡ Women Leading in Neurology SK biopharmaceuticals ¡ AANextra ¡ Headshot Lounge Southcoast Health ¡ Faculty and Trainee Night Strongbridge Biopharma ¡ C107 Unusual Diagnostic and Management of Cases in Neuromuscular Disease ¡ AANextra ¡ Cell Phone Charging Station Sunovion Pharmaceuticals Inc. ¡ 5k Run/1k Walk for Brain Research ¡ AANextra

¡ Brain Health Fair Silver Sponsorship ¡ Cell Phone Charging Station ¡ Cell Charging Area ¡ Cell Charging Skyway Lounge ¡ Door Drop Insert ¡ Exhibit Hall Footprints ¡ Exhibit Hall Networking Reception ¡ Exhibit Hall Passport ¡ Exhibit Hall Pillar Marketing ¡ Industry Therapeutic Update ¡ Office of the Future Silver Sponsorship ¡ Presentation Stage ¡ Tabletop Graphics ¡ Wifi Access on Shuttle Buses Supernus Pharmacueticals Inc. ¡ C131 Hot Topics in Headaches and Related Disorders I: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances ¡ 5k Run/1k Walk for Brain Research ¡ Brain Health Fair Gold Sponsorship ¡ Cell Charging Area ¡ Diversity Leadership Program ¡ Door Drop Insert ¡ Exhibit Hall Coffee Break ¡ Exhibit Guide ¡ Medical Student Diversity Program ¡ Resident Scholarship Fund ¡ Transforming Leaders Program

Teva CNS ¡ Door Drop Inserts ¡ Exhibit Guide ¡ Exhibit Hall Pillar Marketing ¡ Palatucci Advocacy Leadership Forum UCB, Inc. ¡ Door Drop Bag Sponsorship ¡ Exhibit Guide ¡ Exhibit Hall Passport ¡ Graphics at Exhibit Hall Entrance University of Utah Health Care ¡ Cell Phone Charging Lockers Upsher-Smith Laboratories, Inc. ¡ Door Drop Insert ¡ Exhibit Guide ¡ Exhibit Hall Passport Validus Pharmaceuticals LLC ¡ Exhibit Hall Passport Weatherby Health ¡ Faculty and Trainee Night Wolters Kluwer Health– Publisher of AAN Publications ¡ 5k Run/1k Walk for Brain Research ¡ Bookbags ¡ Brain Health Fair Bookbags ¡ Cell Phone Charging Locker ¡ Exhibit Hall Passport ¡ Wifi Access ¡ Water Bottles


Annual Meeting Registrants Daniel Anderson, DO Nicolaas Anderson, DO Wayne E. Anderson DO, MD, FAAN Haley Anderson, MD Aaron Anderson, MD Clark Anderson, MD Neil Anderson, MD Suzanne Anderson, MD Karen Anderson, MD Frank Anderson, MD Eric Anderson, MD, PhD Christopher Anderson, MD, PhD Dustin Anderson, MD, PhD Mariam Anderson, PhD Katy Anderson Deborah Anderson Julie Anderson Kay Anderson Candace Andersson, PhD Ligia Andrade, MD Danielle Andrade, MD Angeline Andrew, PhD Jinsy Andrews, MD Christos Andriopoulos MSc, MBA Parul Aneja, MD Francesca Angeletti, MBA Corrado Angelini, MD Suzanne Angell MA Renato Anghinah, MD, PhD Arayamparambil Anilkumar, MD Ifeyinwa Ani-Osheku, MBBS M Waseem Anjum, MD Isaac Annan, MD Pietro Annovazzi, MD Mustafa Ansari, MD David Anschel, MD Irina Anselm, MD Dana Anselmo Carl Ansevin, MD, FAAN Ronny Antelo, MD Ariel Antezana, MD

206

Gary Antezana Camacho, MD Paul Antony, PhD Layal Antoury Piero Antuono, MD Meldi Anuta, MD Yusuf Anwar, MD Brian Anziska, MD Hugo Aparicio, MD, MPH Brian Apatoff, MD, PhD Sabrina Apel, MD Liana Apostolova, MD, FAAN Stanley Appel, MD, FAAN Joan Appel PA, PA-C,CCRC Michelle Apperson, MD, PhD Thomas Aquilina, MD Ahmet Arac, MD Nilgun Arac, PhD Tomoko Arakaki, MD Ana Arango, MD Zsuzsanna Aranyi, MD, PhD Alexandra Araujo, MD, PhD Paula Araya, MD, PhD Steven Arbogast R. Lee Archer, MD Andrea Natalia Arcos Algaba Inbal Arditi, MD Bonaventura Ardito, MD Herminia Argente-Escrig, MD Charles Argoff, MD Gabriel Arismendi Feddy Aritonang, MD Deepak Arjundas, MD Dimitrios Arkilo, MD Steven Arkin, MD Karen Arkin, MD Jacob Arluck Carmel Armon, MD, FAAN Michelle Armstrong Melissa Armstrong Martinson Arnan, MD Barry Arnason, MD Sophie Arnaud Pras

2017 AAN Annual Meeting On-site Guide

Alexander Arnold, MD Douglas Arnold, MD Anna Arnsvik Sushanth Aroor Ashish Arora, MD Om Arora, MD, MBBS Eustaquio Arouca, MD Luis Arredondo MSc Isabel Arrillaga-Romany, MD, PhD Monica Arroyo, MD, MA Santiago Arroyo, MD, PhD Renato Arruda, MD Marco Arruda, MD, PhD Todd Arthur, MD Jonathan Artz, MD Harumi Asahi, PhD Senai Asefaw, MD Paul Ash, MD, PhD Lynn Ashby, MD Elizabeth Ashcraft PharmD Karen Hsiao Ashe, MD, PhD Eric Ashman, MD, FAAN Said Ashna Valerie Askanas, MD, PhD, FAAN Hasan Askari, MD Narguess Askari PharmD Rebecca Aslakson, DO Mitra Assadi Khansare, MD, FAAN Patrick Asselin Telma Assis, MD Fredrik Asztely, MD, PhD Saeed Ata, MD Pascal Atanga, MD Nazem Atassi, MD Kunakorn Atchaneeyasakul, MD Sudhir Athni Tejas Athni Rani Athreya, MD Jane Atkins, PhD Hatim Attar, MD Sanaz Attaripour, MD Kevin Attenhofer, MD




Armen Babigian, MD Shannon Babineau, MD Kristen Babinski, MD Suma Babu, MBBS, MD, MPH Malgorzata Bach, MD Christian Bacheler, MD Alejandra Bacile, MD Fernanda Bacin, PhD Adnan Badahdah, MD Mohamed Badawy, MBBS Neeraj Badjatia Monica Badve, MD Eun-Kee Bae, PhD Mathias Baehr, FRCP Joachim Baehring, MD William Baek, MD G Michael Baer, BS Joyce Baeta, MD Alex Baeta, PhD Sheila Baez-Torres, MD Susan Baggaley, NP Ally Baglin PharmD Mark Baglin Moogeh Baharnoori, MD, PhD, FRCPC Mona Bahouth, MD Laxman Bahroo, MD Yuansheng Bai, MD Xiang Bai, PhD Mark Bailey DO, PhD Mary Bailey, MD Meagan Bailey Jabari Bailey Ovidiu Bajenaru, MD, PhD Anna Bajer-Czajkowska, PhD Barbara Bajer-Kornek, MD Joseph Bajorek, MD, PhD Zahid Bajwa, MD Jessica Baker, MD Sara Baker Missy Baker Wendy Baker

David Baker Jacquie Baker Beverly Baker-Newsholme Rubina Bakerywala, MD Christos Bakirtzis, DO Ekaterina Bakradze, MD Nandini Bakshi, MD Raghunath Balakrishnan, MD Sudeep Balakrishnan, MD, MBBS Calaneet Balas Vamshi Krishna Sai Balasetti, MD Konstantin Balashov, MD, PhD, FAAN Laura Balcer, MD, MSCE, FAAN Fatma Balci, MD, PhD Erin Balcom Laura Baldassari, MD Anna Baldinotti, PhD Kelly Baldwin, MD Bhumika Balgobin, MD Taha Bali, MD Zerina Balic Rita Balice-Gordon, PhD Beverly Baliguas, MD Orlando Ballen, MD Robert Baloh Juergen Balthasar Christos Baltogiannis, DO Tijmen Balvers, MD Ahmed Bamaga, MD Mario Bana, MD Marta Banach, PhD Ramzi Banda, MD Srinivas Bandi, MD Tapas Banerjee, MD Vinit Banga, MBBS, MD Ghazal Banisadr, PhD Anna Bank Idowu Bankole, MD, FMCP Diana Banks, MD Poonam Bansal, MD Lata Bansal, MD

REGISTRANTS

Kenneth Attie, MD Ezzedine Attig, MD Jasvinder Atwal, PhD Kelvin Au, MD Yu Au, MD Adam Aubuchon, MD Natalie Aucutt-Walter, MD Sanford Auerbach, MD, FAAN Regine Augspach-Hofmann, MD Joshua August, MD Ann Augustine, MD Erika Fullwood Augustine, MD, FAAN Peggy Auinger MS Sheena Aurora Javier Avendano, MD Edward Avila, DO David Avila, MD Orly Avitzur, MD, FAAN KRISHNA AVTAR, MD Oluwole Awosika Patrick Ayache, PhD Selma Aybek, MD Ernesto Aycardi, MD Oluwasheyi Ayeni Gretchen Ayer MS Maranatha Ayodele, MD Omar Ayoub, MBBS Xavier Ayrignac Ana Ayroza Galvao Ribeir, MD Zahra Ayub, MD Angel Ayuga Martinez, PhD Ram Ayyar, MD, FAAN Muhammad Azeem, MD Ezat Azem Paula Azevedo, MD Christina Azevedo Amirreza Azimi Saeen, MD Adel Aziz, MD Ausim Azizi, MD, PhD Nassima Baba-Ahmed, MD Kellan Babbs

207


Annual Meeting Registrants Brenda Banwell, MD, FAAN George Baquis, MD, FAAN Ayelet Bar Dov PharmD Danny Bar Zohar Elizabeth Baraban, PhD Jorge Barahona, MD Tristan Barako, PhD Armando Barales Tallie Baram, MD, PhD Nobl Barazangi, MD, PhD Richard Barbano, MD, PhD Luigi Barbato, MD Peter Barber, PhD Cynthia Barber, PhD Elizabeth Barber, PhD Susan Barber Lindquist Vera Barbosa, MD Jerlene Barbosa, MD Antonio Barbosa del Olmo, MD Rodrigo Barbosa Thomaz, MD Shadi Barbu, MD Jason Barfield, MD Fernando Barinagarrementeria, MD, FAAN Nancy Barkan Paul Barkhaus, MD Frederik Barkhof, MD, PhD Elizabeth Barkoudah, MD Valeria Barletta, MD Vlad Barlog, PhD Ryan Barmore, MD Jay T. Barnes, MBA David Barnes, MD Michael Barnett Carolina Barnett Tapia, MD, PhD Richard Barohn, MD, FAAN Carly Baron Ralf Baron Daniel Barone, MD Alejandro Baroque II, MD Amit Bar-Or, MD, FRCPC Amrutlal Barot, MD

208

Nishidh Barot, MD Donald Barr, MD Lorraine Barr Donna Barragan Diana Barratt, MD, MPH Lori Barrentine PA, MS Jasmine Barrera MSPH Paula Barreras, MD Carlos Barreto, MD Juan Barreto-Montalvo, MD, PhD, FAAN Douglas Barrett, MD Kevin Barrett, MD Matthew Barrett, MD A. Barrett, MD, FAAN Scott Barrier Guillermo Barrios, MD Christian Barro, MD Fabio Barroso, MD Orlando Barsottini, MD, PhD J Bartleson, MD Luca Bartolini, MD Joshua Barton, MBBS, FRACP Christopher Barton, MD Brandon Barton, MD Jan Bartonik, MD Halina Bartosik-Psujek, MD, PhD Devra Baryshnik, MD Silvia Basaia Esra Basar Gursoy Salma Bashayeh, MD Hassaan Bashir, MBBS, MD Ferhad Bashir, MD Mahrukh Bashir, MD Rizwan Bashir, MD Rifaat Bashir, MD, FAAN Alexandra Basilakos, PhD Patricia Basile, MD Areeba Basit, MD Francine Bassett, NP Michael Basseyn, MD Ribal Bassil, MD

2017 AAN Annual Meeting On-site Guide

Rocio Bassons, MD Sagar Basu, MD Roshni Basu, PhD Tracy Batchelor, MD, MPH James Bateman, MD Ahmareen Baten, MD James Bathe, MD Emilie Batilliot Richard Batycky, PhD Patrick Bauer, MD Andrew Bauerschmidt, MD Robert Baumann, MD Barry Baumel, MD Nicole Baumer Megan Baumgardner Robert Baumhefner, MD, FAAN Vanessa Baute, MD Jesi Ellen Bautista, MD Katrina Bawden Antonios Bayas, MD Elham Bayat, MD Peggy Baylin PharmD Natalie Baynes RN Hernan Bayona, MD Majd Baz, MD Erica Bazerkanian, MBA Carl Bazil, MD, PhD, FAAN Brandon Beaber, MD Robert Beach, MD, PhD, FAAN Heidi Beadnall Jonathan Beary Olivier Beauchet, MD, PhD Ann-Marie Beaudoin, MD Michel Beaudry, MD Karla Becerril, PhD James Beck, PhD Veith Becker, MD Andrew Becker, MD Daniel Becker, MD Philip Becker, MD Zoe Becker Kyra Becker




Christian Benedict Lourdes Benes-Cases, MD Yvonne Benesova, MD Sarah M. Benish, MD, FAAN Sheldon Benjamin, MD, FAAN Margaux Bennett, PhD Jennifer Bennett, PhD Jennifer Bennett, PhD Susan Bennett PT, EdD, NCS Barbora Benova, MD Debbie Bensen-Kennedy, MD Gilbert Bensimon, MD, PhD Leslie Benson, MD Richard Benson, MD, PhD Rakesh Bera Roy Beran Andres Berardo, MD Kyriakos Berberian Kathryn Bercury Russell, PhD Alexander Berenblit, MD LeAnn Berens Thomas Berentsen, MD Olena Bereznyakova, MD Damian Berezovsky, MD Jacob Berger, MD Joseph Berger, MD, FAAN Peter Bergethon, MD Gregory K. Bergey, MD, FAAN Martin Berghoff, PhD Arnfin Bergmann, MD Lars Bergmann, PhD Amanda Bergner MS Joyce Bergstol RN Matthew Berk, MD Regina Berkovich, MD, PhD Peter Berkowitz, MBA Aaron Berkowitz, MD, PhD Peter Berlit, MD, FAAN Robert Berman, MD Brian Berman, MD, MS Stephen Berman, MD, PhD Sara Berman

Jennifer Berman Robert Bermel Camilo Bermudez Jacqueline Bernard, MD Carlos Bernardo Tauil, MD Corrado Bernasconi, MD, PhD James Bernat, MD, FAAN Zoe Berndt Natalie Berner Saunder Bernes, MD James Bernheimer, MD Irene Berni Anne Bernier, MD Jean Bernier, MD Evanthia Bernitsas, MD Miya Bernson-Leung, MD Carolyn Bernstein, MD Idanis Berrios Morales, MD Eric Berrut-Marechaud, MD Leanne Berry BA James Berry, MD, MPH Diane Berry RN John Bertelson Jimmy Berthaud, MD Antonio Bertolotto, MD Edward H. Bertram, MD, FAAN Amir Besharat, DO Sergiu Besliu, MD Aurore Besse Santiago Bestoso, MD Natalia Betances, MD John Betjemann Ricardo Bettinelli, MD Carolyn Bevan, MD Christopher Bever, MD, FAAN David Beversdorf, MD Said Beydoun, MD Amennai Beyeen, PhD Vanessa Beynon, MD Shivkumar Bhadola BA Seetha Bhagavan, PhD Krupesh Bhakta, DO

REGISTRANTS

Yesim Beckman, MD Peter Bede, MD, PhD Deborah Bedford, NP Gurdesh Bedi, MBBS, MD Richard Bedlack, MD, PhD Grayson Beecher, MD A. Ana Beesen, MD Bruce Beesley, MD Jamil Beg MSE, MBA Danny Bega, MD Susan Begelman Ettore Beghi, MD Jose Bejar, MD Paul Bejjani, MD Shibeshih Belachew, MD Samir Belagaje, MD Antonio Belenguer Benavides, MD Caitlin Bell, BS Alan Bell, MD Karen Bell, MD Michelle Bell, MD Isabelita Bella, MD Peter Bellafiore, MD Sushma Bellamkonda, MD Paolo Bellantonio, MD Vaijayantee Belle, MD Scott Belliston, DO Luis Bello-Espinosa, MD Anita Belman, MD Abdelrahman Beltagy, NP Dario Beltran, MD Janet Beltran, MD Karly Benamati Luca Benatti, PhD David Benavides, MD, PhD Evelyn Benavides, MD, PhD Selim Benbadis, MD Nathaniel Bendahan, MD Andreas Bender, MD Mariana Bendersky, MD Bernard Bendok Ralph Benedict, PhD

209


Annual Meeting Registrants Anisha Bhangav, MD Kesavamurthy Bhanu, MBBS, MD Pavan Bhargava, MD Muthu Bhaskaran, MD, PhD Annapoorna Bhat, MD, PhD Poonam Bhatia, MD Kailash Bhatia, MD, FAAN Jaydeep Bhatt, MD Nirav Bhatt Pratik Bhattacharya, MD Anup Bhattacharya, MD, MBBS Shamik Bhattacharyya Muhammad Bhatti, MD Danish Bhatti, MD Nilaya Bhawsar, DO Vikram Bhise, MD Shelby Biagi PharmD Matt Bianchi, MD, PhD Nabil Biary, MD Julien Biberon, PhD Jennifer Bickel James Bicksel, MD Martin Bielawski, MD Bibiana Bielekova, MD, PhD, FAAN Joanna Bielewicz, PhD Marek Bieniek, MD Julia Biernot, MD Alessandro Biffi Jeffrey Bigelow, MD Tanya Bilchik, MD Alejandro Bildosola, MD Lisa Bilek, PhD Suur Biliciler Santoshi Billakota Tara Biller, NP Jose Biller Lori Billinghurst, MD Michael Binzer, MD, PhD David Biondi DO, FAAN Andrew Biondo Damien Biotti, PhD Valerie Biousse

210

Levent Bir, MD Thomas Bird, MD, FAAN Erkingul Birday Laur Marius Birlea, MD Gary Birnbaum, MD Antje Bischof, MD Felix Bischof, MD Brett Bischof Keri Bischoff Alvino Bisecco, MD Nick Bishop, PhD Ayotunde Bisi, MBBS Stephanie Bissonnette, DO Siddhartha Biswas, MD Esther Bitanga, MD Filiz Bitirgen Johannes Bitter Frank Bittner Brian Bizoza, MD Carl Bjartmar, MD, PhD Paul Blachman, MD, FAAN Kyle Blackburn Kaitlyn Blackburn Derrick Blackmore, PhD Thomas Blaettler, MD Pamela Blake, MD Jaishri Blakeley Oliver Blanchard, MD Jorge Blanche, PhD Siani Blanchfield Ruth Bland, NP Ludovico Blasczyk, MD Kevin Blauth, PhD Patricio Blaya, MD Thomas Bleck, MD, FAAN Ian Bledsoe, MD Johannes Bleistein, MD Sana Bloch, MD, FAAN Andreas Blodau Bastiaan Bloem, MD, PhD Andrew Blondo Jessica Bloomfield BA

2017 AAN Annual Meeting On-site Guide

Andrew Blum, MD, PhD Robert Blum Gregory Blume, MD Sergiu Blumen, MD Andrew Blumenfeld Lauren Boak, PhD Kavya Bodapati John Bodensteiner, MD Karthik Bodhinathan, PhD Benedetta Bodini, PhD Cynthia Bodkin Tomas Boeckx, MD Amelia Boehme, PhD Christopher Boes, MD Bradley Boeve Michael Boffa, MD Sixto Bogantes Ledezma, MD Ulrich Bogdahn, MD Mike Boggild Jamie Bogle, PhD Ilya Bogorad, MD Tanya Bogoslovsky, MD, PhD Elliott Bogusz, MD Peter Bohlhoff-Martin Adrienne Boire Marc Boix Codony, MD georg bokel Geronimo Bolado, PhD Hector Bolanos Merida, MD, FAAN Francois Boller, MD, PhD, FAAN Aruna Bollineni, MD Stephanie Bolton, MD Borna Bonakdarpour, MD, FAAN Inmaculada Bonaventura Ibars, MD Brandon Bond, MD Kamila Bond Danielle Bongero Brill PharmD Dana Bongiovanni MPH Annette Bonnevie Deana Bonno, MD Ian Bonzani, PhD Andrea Boon




Theodore Bowen, MD Lauren Bowen, MD Aaron Bowen James Bower, MD, MSc Joe Bowers, MD Neli Boyanova, MD, MPH John Boyd, MD Edward Boyer, MD Stephen Boyer, PhD Matthew Boyko, MD Kevin Boylan, MD Laura Boylan, MD Jeffrey Boyle, MD, PhD Elizabeth Boyter Mary Boyum, NP Cavit Boz, PhD Carmen Bozic, MD Ivan Bozin, MD Alireza Bozorgi, MD Geir Braathen, MD, PhD Kathleen Brader Jennifer Bradford Ana Bradi, MD Walter Bradley, FRCP, MD, FAAN Michael Bradshaw, MD Elizabeth Bradshaw PA Paul Brady, MD Morgan Brady Rose Brady Colleen Brady Rafaela Braga, MD Pedro Braga-Neto, MD, PhD Sherri Braksick, MD Tiffany Braley Brittany Brand Melanie Brandabur, MD David Brandes, MD Ethan Brandler John Brandsema, MD Rachel Brandstadter Christian Brandt, MD Pierre Branger, PhD

Thomas Brannagan, MD, FAAN Chantale Branson, MD Jessica Braquet H. Brashear, MD Allison Brashear, MD, MBA, FAAN Melonie Brasher CNCT Kelly Braun, MD Stefan Braune, PhD Lana Braverman PharmD Pablo Bravo, MD Pavel Brazda Xandra Breakefield, PhD Alain Bredin, PhD Katherine Breedlove, PhD Day Breen, MD Noa Bregman, MD Ari Breiner, MD Paulo Breinis, MD Geert Brekelmans, MD, PhD K Brennan, MD, FAAN Ryan Brennan Robert Brenner, MD James Brenton, MD Kevin Brenzy, DO Adrien Bretagne Bruce Brew, MBBS, MD, FAAN Carolyn Ann Brewer, MD Robin Brey, MD, FAAN Margaret Brickley, NP Luis Brieva, PhD Filippo Brighina Halley Briglia, MD Vera Bril, MD Dennis Briley, MD Raquel Brillante Anna Brilliant Jon Brillman, MD Mitchell Brin, MD Vesna Brinar, MD Justine Brink, DO Jaime Brisendine PA Becky Bristol

211

REGISTRANTS

Victoria Boorman Brendon Boot, MD, MBBS Kevin Booth, MD John Boothby, MD Breta Boots, DO Aimee Borazanci, MD Grace Borchert Yvette Bordelon, MD, PhD Aaron Borders, PhD Letizia Borges Adeniyi Borire, MD Felippe Borlot, MD Babak Boroojerdi, MD, PhD, MBA Sebby Borriello Sally Borucki, MD Lyudmila Borun RN Anjali Bose Kolanu, MD Tim Bosinski PharmD, BCPS, MBA Thomas Bosley, MD, FAAN Alexandre Bossoni, MD Sevasti Bostantjopoulou-Kamb, MD Daniela Bota Stephan Botez, FRCP, MD Matthias Both, MD Manon Bouchard, FRCP, MD Hayet Boudjani, MD Latifa Boukarrou, MD Andrew Bouley, MD David Boulware Hanni Bouma, MD Nahla Boumahni, MD Karyn Boundy Mathieu Bourassa PharmD, RPh Dennis Bourdette David Bourke Richard Bourque Bertrand Bourre, MD Gamal Boutros, MD Dina Boutros, MD Todd Boutwell Riley Bove, MD


Annual Meeting Registrants Maria Lucia Brito Ferreira, PhD Carolyn Britton, MD Jeffrey Britton, MD, FAAN Josefine Britze, MD Simon Broadley, PhD Bruno Brochet, PhD Charles Brock, MD Robert Brocker, MD Staley Brod, MD Robbin Brodbeck, PhD James Brodie David Brody, MD, PhD Carlo Brogna, MD Waldemar Brola, PhD Mark Bromberg, MD, PhD, FAAN Steven Bromley, MD Kylie Bromley, PhD Lacey Bromley PT Yuri Bronstein, MD John Brooks, MD Benjamin Brooks, MD Jordan Brooks, MD Richard Brooks, MD Amy Brooks-Kayal, MD Thomas Brosch, MD Brian Brost Jordan Brown, BS Kevin Brown, DO E. Alexandra Brown, MD Joseph Brown, MD Robert Brown, MD, FAAN Janet Brown, NP LeighAnn Brown, NP, MS, APRNCNS, CC Daria Brown PharmD, BCPS Adam Brown, PhD Dean Brown, PhD Robert D. Brown, Jr., MD, FAAN Ethan Brown Amy Brown Victoria Brown Devin Brown

212

Christopher Brown Harrison Brown Nina Browner, MD Sara Brownstein Beau Bruce Anna Bruck, MD Wolfgang Brueck, MD Valerie Bruemmer, MD Jorg Bruening Lucie Bruijn, PhD Veralice Bruin, MD, PhD Audrey Brumback, MD, PhD Brianna Brun Bart Bruneel, MD Brian Brunelli, MD Liz Brunner Marla Bruns, MD, PhD Tyson Brust, MD Miroslaw Brys, MD, PhD Jessica Bryson PA Lawrence Brzozowski, MD Gabriel, BSteh, MD Christian, BSteh, MD Julia Bu Aaron Bubolz Ellen Bubrick, MD Bob Bucelli, MD, PhD Jeffrey R. Buchhalter, MD, FAAN Linda Buchwald, MD, FAAN Iwona Bucior, PhD Joshua Buck, MD, MHA Julia Bucklan, DO Richard Buckler, MD Sharon Buckler Thomas Buckley, PhD Joshua Budhu, MD Scott Budsberg PharmD Andrew Budson, MD Kumar Budur, MD Anna Budzianowska, MD Carolina Bueno Priscila Bueno, PhD

2017 AAN Annual Meeting On-site Guide

Jan Buermann Catherine Buettner, MD Christian Buettner Regine Buffels, MD Rhonda Buford Jacob Buhrow, MD Anita Buitenwerf, NP Krzysztof Bujarski Amjad Bukhari, MD Ronald Bukowy, MD Dilek Bulbul, MD Lisa Bulsara Uwe Bungard, MD Russell Buono, PhD Alonzo Burba, MD Emma Burbank, MD David Burdette, MD Daniel Burdick, MD Kevin Burfeind Marcos Burgos, PhD Facundo Burgos Ruiz, MD Joy Burke, MD James Burke Adam Burkey, MD David Burkholder, MD Mitchell Burnbaum, MD Margaret Burnett, MD Richard Burns, MD Matthew Burns, MD, PhD Kristie Burns MS Ramona Burns, NP, ARNP Julie Burns, NP, DNP Tamika Burrus, MD David Burtis, DO Edward Burton, MD, PhD Sander Bus, MD Herman Buschke, MD Dawn Buse, PhD Justin Bush Ittai Bushlin, MD, PhD Yelena Bushman Saif Bushnaq, MD




Christian Calero, MD Victor Calil da Silveira, MD Matt Calistri Elena Call, MD Brian Callaghan, MD Michael Callahan, PhD Juan Calle, MD Rodolfo Callejas-Rojas, MD Lien Callens Tracie Caller, MD, MPH Tara Calmes-Norgaard, NP Maria Elena Calzado Rivas, MD Ann Camac, MD Carlos Camara Lemarroy, MD Fabiola Camarena Cepeda, MD Walter Camargo Villarroel, MD Denise Cambier, MD David Camenga, MD Michelle Cameron Cindy Campbell, NP Toni Campbell Joseph Campellone, MD Mabel Campos, MD Maritza Campos WILLIAM CAMU Sibel Canbaz Kabay, MD, PhD Jorge Cancino, MD Bezeyim Candan PT, RN Awilda Candelario, MD Kristina Canlas, MD Joan Cannon PharmD Marc Cantillon, MD, FAAN Juan-Carlos Canton Vera, MD Gordon Cantor, MD Liliah Cantor, MD Fredric Cantor, MD, FAAN David Cantu, PhD Dan Capampangan, MD Lucia Capano, MD Joao Augusto Capelari, PhD Louis Caplan, MD David Capobianco, MD, FAAN

Patrick Capone, MD, PhD Nicoletta Caputi, PhD Domenico Caputo, MD Raphael Carandang, MD Olimpia Carbunar, MD Claudia Carcamo, MD Javier Cardenas, MD Cecilia Cardenas, PhD Simon Cardenas Robledo, MD Luzma Cardona, MD Sarah Cardoso CRC Juan Martin Cardozo Oliver, MD Miroslav Carek, MD Christophe Carel, PhD Victoria Carey Susan Carleton, MD Daniela Carlini, MD Alexander Carlson, BS Aaron Carlson, MD Chad Carlson, MD Alison Carlson, NP Brian Carlson, PhD Courtney Carlson Ginger Carlyle Lionel Carmant, MD David Carmel, MBA Ross Carne, MD Andre Carneiro, MD Sanda Carniciu, MD Francisco Carod-Artal, MD Christopher Carosella, MD Kyle Carpenter Arturo Carpio, MD Adriana Carra, PhD Claire Carrazco, DO Ana Sofia Carre Andrew Carrel, PhD Joseph Carrera, MD Pedro-Luis Carrera, MD, FRCPC Paulo Carrilho, MD Maria Carrillo, PhD Ignacio Carrillo-Nunez, MD

REGISTRANTS

Areej Bushnaq, MD Cheryl Bushnell Aisha Bushra, MBBS Neil A. Busis, MD, FAAN Katharina Busl, MD Stephanie Buss, MD James Buswinka, DO Russell Butler, MD Russell Butterfield, MD, PhD, BS Donna Butts RN,, NP Laurel Buxbaum Katherine Buzzard, MBBS, PhD Karen Byrd, NP Seenaiah Byreddy Paul Byrne, MD Melissa Byrne MSW Mark Cabatingan, PhD Norberto Luiz Cabral, PhD Oliver Cabrera, MD Christian Cabrera Kang, MD Fernando Caceres, PhD Bernardo Cacho Diaz, MD Diego Cadavid, MD, FAAN Sarah Cader,BSc MBBChir MRCP DPh Roger Cady, MD, FAHS Ryan Cady Marlon Caeira Johan Caekebeke Emily Caesar BA Jill Cafaro Anthony Caggiano, MD, PhD Jonathan Cahill, MD Dingfang Cai, MD Peter Calabresi Christopher Calahan, BS Miguel Calayag, MD Julio Calcano Perez, MD Christopher Calder, MD, PhD Marcelo Calderaro, MD Maria Calderon Rios, MD David Calderwood

213


Annual Meeting Registrants William Carroll, MBBS, MD, FRACP Lynn Carroll PharmD Robert Carruthers, MD Ana Cartagena, MD, FRCPC, CS Jonathan Carter, MD Alex Carter, MD, PhD Cindy Carter-Kappus Diego Carvalho, MD Rodrigo Carvalho, MD Fernanda Carvalho Poyraz, PhD Alan Carver, MD Patrizia Casaccia, MD, PhD Rosa Casademont Portell PharmD Joseph Casal-Dominguez Juan Casas, MD Gregory D. Cascino, MD, FAAN Terrence L. Cascino, MD, FAAN Eli Casdin, MBA Alex Casdin Richard Caselli, MD, FAAN Olivier Casez, PhD Courtney Casserly, MD Jacqueline Cassidy Carlos Castaneda, MD James Castellano, MD, PhD Jorge Castellanos, MD Pablo Castillo, MD Rosario Marieta Castillo Del Rio, MD Tamara Castillo Trivino, MD Carmen Castrillo-Viguera, MD Luiz Castro, MD Angel Castro, MD Felipe Castro, MD Diana Castro Wanda Castro Borrero, MD Eber Castro Correa, PhD Gustavo Castro Gonzalez, MD Louis Catalano, MD Jonathan Cauchi, MD Michelle Caunca Steven Cavalier, MD

214

Jose E. Cavazos, MD, PhD, FAAN Dustin Cavida David Cawthon, MD Jose Cea Munoz, MD Mathieu Ceccaldi, PhD Antonia Ceccarelli, MD Jesse Cedarbaum, MD, FAAN Clas-Goran Cederberg, MD Marketa Cee Nese Celebisoy, MD Jose Maria Cenarro Campos PharmD Mario Cerdan-Trevino, MD Mirela Cerghet, MD, PhD Camelia Cernea Andres Ceron, MD Raffaella Cerqua, MD Matteo Cervellati Yoon-Hee Cha, MD Jang-Ho Cha, MD, PhD Jacob Chacko, MD Monica Chacon, MD Noelia Chade, MD Gurleen Chadha Abderrahmane Chahidi DCFP Lana Chahine, MD Stella Chai, PhD Elijah Chaila MRCPI, CSCST Tia Chakraborty Samya Chakravorty, PhD Shilpa Chaku, DO Flavio Chalaupka, MD Scott Chambers, PhD Teodora Chamova, MD Myriam Chamsi, MD Amanda Chan, FRCP, MBBS Amy Chan, MD Lik Hang Chan, MD Diane Chan, MD, PhD Jacqueline Chan, MD, PhD, FAAN Fiona Chan Chiu Yee Leonard Chan

2017 AAN Annual Meeting On-site Guide

Sandy Chan William Chan Pratap Chand, MD Krishan Chandar, MBBS, MD, MB Justin Chandler, MD Tania Chandler, MD Arun Chandok, MD Bharatendu Chandra, MD Shivika Chandra, MD John Chandy Carlin Chang, MBBS Jose Chang, MD Judy Chang, MD Helen Chang, MD Victoria Chang, MD Tzu-Pu Chang, MD Ih Chang, PhD Chakorn Chansakul, MD Eve Chanson, MD Hsiao-Tuan Chao Catherine Chapman, MD William Chapman PharmD David Chapman, PhD Darla Chapman Sherita Chapman Amy Chappell, MD Brigitte Charbonneau, MD Nathalie Charbonnier Batt James Charles, MD, FAAN Jay Charleston, PhD Laurel Charlesworth, MD Bonnie Charpentier, PhD Leigh Charvete, PhD John Chase, MD Thomas Chase, MD Krai-Rith Chatamra, PhD Apratim Chatterjee, MD Seemant Chaturvedi, MD Tom Chau, MD Vann Chau, MD, FRCPC Shuchi Chaudhary, MD Burhan Chaudhry, MD




Frank Cheng, MBA Eric Cheng, MD, MS, FAAN Hsinlin Cheng, MD, PhD Nathan Cheng PharmD Wing Tai Cheng, PhD Marcello Cherchi, MD, PhD Rejo Cherian, MD Neil Cherian, MD Silviya Cherninkova-Gopina, MD Alexander Chernyak Howard Chertkow, MD David Chesak, MD William Cheshire Julie Cheu Shauna Cheung, MD Helen Cheung, MD Julee Cheung Mathilde Chevin M.Sc. Michael Chez, MD Sameer Chhibber, MD Chia-Chun Chiang, MD Carla Chicco, MD Hsin Chien, MD, PhD Yolanda Chik, MD Priyanka Chilakamarri, MD Richard Chin, MD Peter Chin, MD Jerome Chin, MD, PhD, FAAN Eva Chin Dennis Chinchilla-Weinstok, MD Rohit Chintamani Krishna Chinthapalli, MBBS Adriano Chio, MD, FAAN Louis Chiodo, PhD Nicole Chiota-McCollum, MD Christine Chiou Claudia Chiriboga, MD Jamal Chirri, DO Ritika Chitkara PA Tanuja Chitnis, MD, FAAN Shilpa Chitnis, MD, PhD, FAAN Michelle Chiu, MD

Shannon Chiu, MD Sung-Min Cho, DO Tracey Cho, MD Kyung Cho, MD Sungho Charles Cho, MD Joshua Chodosh, MD Meeryo Choe, MD Victor Choi, MD Jennifer Choi, MD Huimahn Choi, MD Hyoung Won Choi, MD Dennis Choi, MD, PhD Sudhansu Chokroverty, FRCP, MD, FAAN Catherine Chong, PhD Yoon Andrew Cho-Park, MD CM Ashley Chorath Claudia Chou, MD Denise Chou Sherry Chou Parichita Choudhury, MD Debasish Choudhury, MD, MBBS Lynn Chouhfeh, MD Nitish Chourasia, MD Felicia Chow, MD Tiffany Chow, MD, FAAN Kirk Christensen, PhD Kurt Christensen, PhD Mette Kirstine Christensen, PhD Angelene Christensen RN Michael Christiansen, MD Chadwick Christine, MD Leigh Christopher, PhD Kent Christopherson, PhD Alison Christy, MD, PhD Dafni Chroni Stacy Chu, MD Felicia Chu, MD Peiyun Chu, MD Yim Pui Chu, MD Chin-Chiang Chu, MD, PhD Renxin Chu, PhD

REGISTRANTS

Hunan Chaudhry, MD Vinay Chaudhry, MD, FAAN Nadeem Chaudhry Abhijit Chaudhuri DM, MD, PhD Sunil Chauhan, MD Rameshwar Chaurasia, MD Govind Chavada, MD, MRCP Marcelo Chaves, MD Margarita Chaves, MD Claudia Chaves, MD, FAAN Jeffrey Chavin, MD Pey Sze Patricia Che, MD Chun Fai Cheah, MD Priscilla Chee, MD Zahid Cheema, MD, FAAN Viorica Chelban Thomas Chemmanam FRACP, DM Jason Chen, BS Vicky Chen, BS Robert Chen, FRCP, MBBS, MD, MBBChir Marcus Chen, MBA Wei-Liang Chen, MD Anthony Chen, MD Adam Chen, MD Hsiong Chen, MD Rong Chen, MD Shaohua Chen, MD Chuling Chen, MD C. Chen, MD I-Hweii Chen, MD, PhD Shan Chen, MD, PhD Honglei Chen, MD, PhD Xi Chen, MD, PhD Sharon Chen, PhD Kai Chen, PhD Kevin Chen, PhD Benson Chen Hong Sheng Chen Baibing Chen Bing Yu Chen Derek Cheng, DO

215


Annual Meeting Registrants Cathy Chuang, MD Rosalind Chuang, MD Tzu-Ying Chuang, PhD Christine Chuck, MD Ugonma Chukwueke, MD Shubhangi Chumble, MD Keith Chun, MD Helena Chun Chin-Sang Chung, MD, PhD Sun Ju Chung, MD, PhD Sebastian Chung Miguel Chuquilin Arista, MD Watcharapong Chusri, MD Daniel Ciampi De Andrade, MD Olga Ciccarelli, MD, PhD, FRCP Samantha Cicero, PhD Courtney Cicero Andrew Cichowski, MD Isaac Ciechanover, MD Marlene Cinco, MD Comana Cioroiu, MD Judith Citroen, MD Johanna Claasen Daniel Claassen, MD Jan Claassen, MD, PhD Stacey Clardy, MD, PhD Kathleen Clarence-Smith, MD, PhD, FAAN Tyler Clark, MD Lukas Clark, MD David Clark, MD Derek Clark, MD Joni Clark, MD Nicole Clark, MD Ruth Clark, MD Matthew Clark MS Reed Clark, PhD Jennifer Clarke, MD Laura Clarke Damian Clarke-Bruce Lisa Clark-Imperial Jean-Pierre Claude, MD

216

Pierre Clavelou, PhD Carlos Santiago Claverie, MD Ashley Clayton MA David Clayton, MD Benjamin Claytor, MD Claire Clelland, MD, PhD Paula Clemens, MD Emilia Clement, MD Marinella Clerico, MD David Clifford, MD, FAAN Katherine Clifford Martha Cline, MD Gary Cline, PhD Elize Cline Matthew Coastes, MBA Lucy Cobbs Christine Coco Fernando Coelho, MD, PhD Timothy Coetzee, PhD Michael Coffee Christopher Coffey, PhD Samantha Coffino, MD Stanley Cohan, MD, PhD Nicolette Cohen, DO Jeffrey Cohen, MD, FAAN Jeffrey Cohen, MD Jason Cohen, MD Bruce H. Cohen, MD, FAAN Alexander Cohen, MD, PhD Rachel Cohen, NP Mathilde Cohen-Tannoudji Joao Coimbra, MD Yvonne Coiteux, NP Renato Colamarino, PhD Kimberly Cole Erin Coleman, MBBS Kelsey Coleman Pamela Coleman Dana Coleman Jessica Coleman David Collas, FRCP, MBBS Barry Collecutt, MD

2017 AAN Annual Meeting On-site Guide

Kalea Colletta Erica Colligan, MD Stuart Collins, PhD Julia Collison Howard Colman, MD, PhD Thomas Colman MS Patricia Colon-Garcia, MD Milagros Colon-Lopez, PhD Hector Colorado Sridevi Colten Julien Combaret Pierre Combremont, MD Carica Combrink Cynthia Comella, MD Giacomo Comi, MD Giancarlo Comi, PhD Henry Comiter, MD Naama Commander Christopher Commichau, MD Jacynthe Comtois, MD Lois Condie, PhD ABPP Francis Conidi DO,MS Maureen Conley Hannah Conn, BS Jill Conner MS, PhD Anne Connolly, MD Robert Conroy, DO Earl Consky, MD Miguel Constain, MD Viorelia Constantin, PhD Cris Constantinescu, MD, PhD, FRCP Theodore Conte, MD Maria Conti, MD Devon Conway, MD Jill Conway, MD, MA, MSCE Charlie Conway, PhD Robin Conwit, MD, FAAN Tara Cook, MD Stuart Cook, MD Glen Cook, MD Karin Cook MA




Gersonita Costa, MD Michael Costa MSc Beatriz Costa Roberto Costa Campos, PhD Lisa Costelloe, MD Joost Costerus, MD Evelyne Cote-Mantha, MD Angus Cottee, MBBS, FRACGP John Cotter Melissa Cottone David Cottrell MBChB,BSc, PhD, FRC James Couch, MD, PhD, FAAN David Coughlin, MD David Coulter, MD Timothy Counihan, MD Dana Coutts PA Eric Couture, PhD Robert Cowan, MD, FAAN Patricia Coyle, MD, FAAN Christina Coyle Rob Craggy Ian Crain, MD Liezel Cramer BBNSc Joyce Cramer, BS Allie Crandell PharmD, RPh Rui Cravo PharmD Bruce A. C. Cree, MD, PhD, MCR Jennifer Creed, MD, PhD Amy Crepeau, MD Ernesto Crespo, MD Marianela Elisa Crespo Arizmendi Juliette Crew Peter Crino, MD, PhD Diana Crisan, MD Emanuel Criscione David Crisp, MD Roxann Crisp Diana Cristalli, MD Massimiliano Cristofanilli, PhD Donatello Crochetta Carolyn Cronin, MD, PhD

Simon Cronin Didier Cros, MD Helen Cross Anne Cross David Croteau, MD Grace Crotty MBBChBAO Jason Crowell Jeff Crowther Teresa Crugnale Brian Crum, MD Jennifer Crum-Bailey Nick Crump Patricia Crumrine, MD, FAAN Kevin Crutchfield, MD Martha Cruz, DO Rosangel Cruz MA Marcelo Cruz, MD Leandro Cruz, MD Nadia Ruth Cruz, MD Daniel Cruz, PhD Salvador Cruz-Flores, MD, FAAN Tunde Csepany, MD Esther Cubo Delgado, MD, PhD Merit Cudkowicz Juan Cuebas, MD Ivan Cuesta Isabel, MD Yue Cui, PhD Mirjana Cukic, PhD Antonio Culebras, MD Jennifer Culkin RN Neil Culligan, MD Fiona Cullinan Bo Cumbo Christopher Cummings, MD Luis Cunha, MD Jodie Cunningham, MBA Ann Cunningham Ed Cunningham Edward Cupler, MD, FAAN Charles Curatalo, MD Maria Curbelo, MD Gioacchino Curiale, MD

REGISTRANTS

Calli Cook Elizabeth Coon Wade Cooper, DO Scott Cooper Frances Copeland, MD Kelly Copeland PharmD Alastair Corbett, MD Jean-Ronel Corbier, MD Ann Corbin DHSc David Corbin John Corboy, MD Sean Corcoran Christian Cordano, MD Cinzia Cordioli, MD Marta Cordoba, MD Joseph Corey, MD, PhD Jody Corey-Bloom, MD, PhD Vlad Coric, MD Jamie Cornali, NP Wayne Cornblath, MD Francisco Cornejo, MD Christian Cornelissen Nicole Cornett JD, MBA Paola Coronado, MD Fernando Coronetti, PhD Dioma Corporan, MD EDGAR CORREA, MD Ylmar Correa Neto, MD, PhD jorge correale, MD Ana Correia, MD Lauren Corry Jill Corson, NP Tansel Cortelekoglu, MD Melissa Cortez, DO Stefania Corti, MD, PhD Stefano Corvasce, MD Thomas Corya Carlos Cosentino, MD G. Rees Cosgrove Emily Coskun, MD H. Coslett, MD Camila Cosmo, MD, PhD

217


Annual Meeting Registrants Michael Curiel, MD Kathleen Curnow, PhD Candace Curry, MD Raquel Custodio Da Silveira, MD Jeremy Cutsforth-Gregory, MD Gary Cutter, PhD Matthew Cykowski Alexandra Czap, MD Barry M. Czeisler, MD, MS Soraya Da Silva, MD Ahmed Daak, MD, PhD Omar Dabbagh, MD, FAAN Alok Dabi, MD, MBBS Anelyssa D'Abreu, MD Edward Dabrowski, MD Brett Dabruzzo PharmD Vanessa Daccach Marques, PhD Yara Dadalti Fragoso, MD Kirk Daffner, MD, FAAN Carol Dagney, BS, BA Mohammad Magdy Dahab, MD Said Dahbour, MD Samer Dahdaleh Ahmad Daher, MD, PhD Frank Dahkle Nabila Dahodwala Youssef Dakka, MD, FAAN Marinos Dalakas, MD, FAAN Njall Dalberg, MD Ashley Dale, MD Marian Dale, MD Gina Dalferro Truslow MA Thomas Dallmann, MD Josep Dalmau, MD, PhD Joseph D'Alton, MD, FAAN Arif Dalvi, MD, MBA Farrah Daly, MD, MBA Antonio Damin, MD, PhD Oh Dan, MD Ilan Danan, MD Angela Dandan, MD Sudeepta Dandapat, MD

218

Jean-Francois Daneault, PhD Mustapha Danesi, FRCP, MBBS Harold Daniel, PhD Marissa Daniele Dayane Danieli, MD Kate Daniello, MD Bo Danielsson, MD Erica Dankiewicz Omar Danoun, MD Irena Danys, MD Mariza Daras, MD Richard Darby Nigar Dargah-Zada, MD Lisa Dark Rachel Darken, MD, PhD Leila Darki, MD Robert Daroff, MD, FAAN Shannon Darrah Basil Darras, MD Sirwan Darweesh, MD Ashis Das, MD Chandi Das, MD Rituparna Das, MD Rani Das, MD Gopal Dash Richard Dasheiff, MD Marin Daskalov, MD, PhD Akram Dastagir, MD Mohammad Dastjerdi, MD, PhD Sudhir Datar, MD Efim Dats, MD Neil Datta, MD Donald Daudt, PhD William Dauer, MD Alfredo Davalos-Balderas, MD Jay Dave, DO Prafull Dave, MD Nicole David, DO Kendra Davies PharmD Mariel Davila Martinez, MD, PhD Mike Davis, MBA Jared Davis, MD

2017 AAN Annual Meeting On-site Guide

Kathryn Davis, MD Arielle Davis, MD Debra Davis, MD Miryam Davis, MD Randall Davis, PhD Cecilia Davis-Hayes Sreenadha Davuluri, MD Andrew Dawson, MD David Dawson Gregory Day, MD Jason Day, MD John Day, MD, PhD Rebecca Day, PhD Lisa Day Praveen Dayalu, MD Ashok Dayananthan, MD Maria Dayaw, MD Jaap Jan De Boer, MD Lisa De Boer PharmD Stephen De Boisvilliers, PhD Gabriela De Bruin, MD Katrien De Bruyckere Carlos De Carvalho, MD Fabricio De Carvalho Gabriel de Erausquin, MD, PhD Gabriel de Freitas, MD, PhD Marcos De Freitas, MD, PhD Laura De Giglio, MD Umberto De Girolami, MD John De Groot, MD Jan Kristoper De Guzman, MD Adam De Havenon Sol De Jesus, MD Nina De Klippel, MD Dakar De La Cruz MANUEL DE LA MAZA, MD Gino De La Meilleure Gabriele De Luca, MD Heather De Luca Matteo De Marco, PhD Ermelinda De Meo, MD Mariane De Moraes Monteiro




Silvia Delgado, MD Jesus Delgado, MD Virginia Delgado Gil, MD Carlos Delgado Silva, MD Antonio Delgado-Escueta, MD, PhD, FAAN Christina Deligianni Amanda Deligtisch, MD Christopher Deline, MD Brenda Deliz-Roldan, MD Michele Deloizy, PhD Matthew DeLuca, MD Bart Demaerschalk, MD Katy Demery Ignacio Demey, MD, PhD Goksemin Demir, MD Caner Feyzi Demir Firdevs Gulsen Demir Seref Demirkaya, PhD Beatrice Denis, PhD Anand Deo, PhD Mita Deoras, MD Paul-Henri Depoortere, MD Jacqueline Deppen, NP Talal Derani Ian Derby, FRCP, MD Tobias Derfuss, MD Sandra Derghazarian, MD Norma Deri, PhD Paul Deringer, MD Wolfgang Derissen, MD Andrea Derlet Emmanouil Dermitzakis, PhD Steve DeRoos, MD Joy Derwenskus, DO Rebecca Derwin MPH Soaham Desai, MBBS, MD, DM Troy Desai, MD Nithya Desikan Claude Desnuelle, MD Jose DeSousa, MD, FAAN Christina DeSousa, MD, MPH

Bryan DeSouza, MD Lorna Desveaux Guenther Deuschl, MD, FAAN Michael Devereux, BS Sarala Devi, MD Michelle Devine, MD Renee DeVivo Keith DeVos, MD Georgius Dewanto, MD Jeffrey Dewey, MD Donn Dexter, MD Aaron Deykin, MD Miguel D'Haeseleer, MD Radhika Dhamija, MD Upinder Dhand, MD, FAAN Andrew Dhawan, MD Shaffina Dhume, PhD Anil Dhuna Giancarlo Di Battista, MD Juan Cruz Di Carlo, MD Rodica Di Lorenzo, MD Antonio Di Pasquo, MD Jason B. Diamond, MD, MPH walter diarbaquirli, MD Ricardo Diaz, MD Christina Diaz, MD Violeta Diaz, MD Paola Diaz, PhD Maria Diaz Lorente, MD Jose Diaz Perez, MD Ramon Diaz-Arrastia, MD, PhD, FAAN Camilo Diaz-Cruz, MD Hussein Dib, MD Salim Dib, MD Maria Dibner, MD Daniel DiCapua, MD Shannon DiCarlo, MD Herman Dick, MD Jeremy Dick, PhD Travis Dickendesher, PhD Bradford Dickerson, MD

REGISTRANTS

Tales De Oliveira Junior, MD Robert De Potter, MD, FAAN Inaki De Rezola Duilio Emiliano De Schutter, MD Jerome De Seze, MD Eduardo De Sousa, MD Reyes De Torres Chacon, MD Ana De Vera Darryl De Vivo, MD, FAAN Gert De Voer, PhD Charmaine De Wet MaryAnn Deak, MD Shannon Dean, MD Lisa M. DeAngelis, MD, FAAN Teresa (Tracy) DeAngelis, MD Anindita Deb, MD Julie DeBacker Arnel Debalucos, MD Carolyn Debeauport-Metivier, NP Anahita Deboo, MD Sarah Debray, MD Karen Debusk, NP, MSN Gina Deck, MD Danny Decoo Mailande Dedeaux PA Wissam Deeb, MD Aman Deep, MD Gilles Defer Spyridon Defteraios, DO Suleyman Degirmenci, MD, PharmD Elizabeth DeGrush, DO Claudio DeGusmao, MD Paula Deibel-Peterson RN, BSN, MBA Andres Deik Acosta Madiedo, MD Florian Deisenhammer, MD Fernando Del Moral Emilie Delannoy, PhD Jessica Deleon, MD Dirk Deleu, MD, PhD, FRCP, FAAN Martin Delf, MD

219


Annual Meeting Registrants Trisha Dickey, MD Carolyn Dickinson, NP David Dickoff, MD Rosamaria Didiano Nico Diederich, MD Andre Diel, MD Jose Danilo Diestro, MD Jorg Dietrich, MD, PhD Alexander Dietz, MD Dominik Dietz Melissa Diggin, NP Gaurav Dighe, MD Kathleen Digre, MD Sonam Dilwali, PhD Mazen Dimachkie, MD, FAAN Salvatore DiMauro, MD Alexandra Dimitrova, MD Farid Din, MBBS kirstin d'Incelli RD/LDN Joy Ding, MD Jing Ding, MD Marc Dinkin Eric Diot, MD Lorne Direnfeld, MD Michael Diringer Petra Dirks Lauren DiSalvo Michael DiSano, MD Joseph DiStefano Sofia DiStefano Dominique Dive Amy Dix PA Neel Dixit, MD Shanker Dixit, MD Janette Dixon, PhD Kamalia Djani, MD Aigul Djuldugulova, MD David, Do Karen, Doak PharmD Raymond, Doan Bryan, Dobbs Drini, Dobi, MD, PhD

220

Ruth, Dobson, PhD MRCP Eduardo, Doctorovich David W., Dodick, MD, FAAN Sarah, Dodwell, MD Nicholas, Doher, DO Leana, Doherty, MD James, Doherty, PhD Asif, Doja, MD Marjan, Dolatshahi, MD Mark, Dolev, MD Natalie, Domanico Ferid, Domi, PhD Courtney, Domigan, PhD Rose, Domingo-Horne, MD Joao, Domingos Luiz, Domingos Mendes Melg, PhD Ana Maria, Dominguez Mayoral, MD Sylke, Domke, MD Kimiko, Domoto-Reilly, MD Martin, Donadio, MD Deirdre, Donaldson, MD, PhD Vladimir, DoNATH, MD David, Dondis, MD Zhao, Dong, PhD Zhao, Dong, PhD Xianjun, Dong, PhD Neelesh, Dongre Sofia, Donica, MD Diane, Donley, MD Peter, Donofrio, MD Hector D'onofrio, MD Aubry, Donoghue Laura, Donovan, MD Joanne, Donovan, MD Daniel, Donovan, MD, PhD Katie, Donovan George, Dooneief, MD Babur, Dora, MD Severin, Dorfmuller-Kuchlin, MD Sanne, Dorhout Mees, PhD Alessandra, Dorigo, MD

2017 AAN Annual Meeting On-site Guide

James, Dorman, MD, FAAN Rainer, Dormann, MD Iulia, DOrneanu, DO Rachel,Dorsey E. Ray,Dorsey Ana Cristina,Dos Santos, MD Valmik,Doshi MS Paul,Dossa, PhD Erin,Doty, MD Michelle,Dougherty, MD Todd,Dougherty Christopher,Doughty Preston,Douglas, MD Javier,Doumic, MD Carin,Dove, MD Amanda,Dow, DO Phaedra,Dowell, MD Ewa,Dowling, PhD Nicola,Downes Brett,Downing Alexander,Doyle, MD Carly,Doyle Daniel Drachman, MD, FAAN Natasa Dragicevic, MD, PhD Christopher Draheim, PhD Jonathan Drake, MD Kendra Drake, MD Joseph Drazkowski Sarah Driessen Anna Driscoll Frank Drislane, MD Adam Drobnis, MD Aidan Droogan, FRCP,BSc, MBB Thomas Drouet, PhD John Drum PharmD Keri Drury Atlantic Dsouza, MD Caitlin D'Souza, DO Marcus D'Souza, MD Joseph D'Souza, PhD Cheng Du, MD Guangwei Du, MD, PhD




Hacer Durmus Tekce, PhD Mark Durso PharmD Uzoma Duru, MD Jonathan Duskin Aurelio Dutra, MD Livia Dutra Antonio, MD, PhD Carolyn Dutton B.Pharm Shamsher Dwivedee, MD Donald Dworek, DO Barbara Dworetzky, MD, FAAN Johannes Dworzak Jose Otavio Dworzecki Soares, PhD Michael Dwyer, MD, PhD Marisela Dy, MD Andrew Dyck, MD P. James Dyck Joseph Dye, PhD Heather Dyer, MD I Dyme, MD, PLLC Frances Dyro, MD, FAAN Damien Earl, MD, PhD John Earnheart, PhD Wendy Eastman, MD Silviya Eaton Janet Ebid, MD James Ebot Margarita Ebril-Lel, MD Kenneth Ecker PharmD Svetlana Eckert, MD Christine Eckhardt MS Dixie Ecklund RN Dale Edberg, PhD Mark Edery Ellen Edgar, MD Javon Edgecombe, MD Andrea Edling, PhD Brian Edlow Wendy Edlund, MD Bradley Edmonds Supakunya Edmonson, DO John Edwards, MD

Keith Edwards, MD, FAAN James Edwards, MD Michael Edwards, PhD Penelope Edwards-Conrad, MD Dawn Eeten PA Husnu Efendi PharmD, PhD Eric Eggenberger Pablo Eguia Del Rio, MD Debra Ehrlich, MD Jutta Eichelman, MD Katy Eichinger, PhD, PT, DPT, NCS Lawrence Eilender, MD Kenneth Einberg, MD Sylvia Eisele, MD, PhD Bertha Ekeh, MBBS, MD Anna Ekman, PhD Ozgul Ekmekci, MD Thomas Eko Purwata, MD, PhD, FAAN Victor Ekuta Sleiman El Jamal, MD Ahmad El Kouzi, MD Sherif El Seddawy PharmD Lubna El Sheikh Rima El-Abassi, MD Behzad Elahi, MD Rodger Elble, MD, PhD, FAAN Suzanne Elble MA Jason Eldrige Evdokia Eleftheriou, MD Rania Elenein, MD Fabio Elguezabal Mirret El-Hagrassy, MD Ahmed Elhusseiny, PhD Adrienne Elias Birte Elias-Hamp, MD Daniel Elicabe Toha, MD Isabel Elicer, MD Katz Eliezer, MD Muruvet Elkay, MD Rene Elkin, MD Jacob Elkins, MD

REGISTRANTS

Renaud Du Pasquier Robert Duarte, MD Fernando Duarte Caron, MD, PhD Sanjay Dube, MD Divyanshu Dubey, MD Richard M. Dubinsky, MD, MPH, FAAN Stephanie Dubow, DO Petra Duda, MD, PhD Martin Duddy, MD, FRCP Lindsay Dudeck, MD Stephen Dudek Nilofar Dudha, MD Karen Dudich, MD Jennifer Dudman RN Aud Nome Dueland, MD, PhD Alexandra Duffy, DO Amy Duhig, PhD Kevin Duhrkopf PharmD Poonam Dulai, MD Adriana Dulamea, PhD Jo Dulay Oana Dumitrascu, MD Sally Dunaway Young PT, DPT Erin Dunbar, MD David Duncan, MD Charles Duncan, PhD John Duncan John Dunlop, PhD Lauren Dunn, MD Timothy Dunn, MD Anastasie Dunn-Pirio, MD Sophie Dupont Callum Dupre, DO Nicolas Dupre, MD Sheena Dupuy BA Lissette Duque, MD Alejandra Duque Ramirez, MD Bryce Durafourt, MD Pascali Durand-Martel, MD Luca Durelli, MD Cynthia Durkin RN

221


Annual Meeting Registrants Aviva Ellenstein, MD, PhD Linnea Elliott BPS Jeffrey Elliott Steven Ellis, MD Ronald Ellis, MD, PhD, FAAN Mats Elm, MD Jordan Elm Tamer Elmahallawy, MD Wisam Elmalik, MD Ibrahim El-Menshawi, MD David Elmore Rasheda El-Nazer, MD Khalid El-Salem, MD, FAAN Marwah Elsehety Tamer Elserafi, PhD Nourhan Elshamma, MBBS Bakri Elsheikh, FRCP, MBBS Saad ElSherifi, PhD Jacques Stanley Elysee, MD Hoda Elzawahry, MD Kamel Elzawahry, MD, FAAN Ali Emami, MD Ronald Emerson Michael Emery, Jr., MBA Marian Emr Ufuk Emre, MD Temis Enamorado, MD Ahmed Enayetallah, MD, PhD Dag Encrantz, MD Steven Ender Jason Enders PharmD Amalia Ene, PhD Andrew Engel, MD W. Engel, MD, FAAN Ulrich Engelmann, MD John England, MD Kathy England, NP Sarah England, PhD Raymond Englander, MD Stephen English, MD Pernilla Englund John W. Engstrom, MD, FAAN

222

Guillermo Enriquez, MD Freddy Enriquez, MD Romeo Enriquez, MD Maria Enriquez Macias, PhD Amina Gargouri Ep Berrechid, PhD Mackenzie Epler Stacey Epps, MD Ronald Epstein Mefkure Eraksoy, MD Satish Eraly, MD, PhD Cyril Erameh, MBBS, FMCP Sevim Erdem-Ozdamar, MD Jessica Erfan PA-C Erik Eriksen, MD Steven Erlemeier, MD Erdal Ersin, MD Meltem Ersoz Soraya Ertefaie, PhD Deniz Erten-Lyons, MD Debuc Erwan, MD Maureen Erwin Romulo Esagunde, MD Cyrus Escabillas, MD Megan Esch, MD Diana Escolar, MD Luciano Escudero Herrera Abdolreza Esfahanizadeh, MD Siamac Esfandi, MD Jaime Eskenazi, MD Jonathan Eskenazi Markewitz, MD Alberto Espay, MD Gregory J. Esper, MD, MBA, FAAN Flint Espil, PhD Raymond Espinosa, MD Gabriela Espinoza, MD Geraldine Espiritu, MD Rosalina Espiritu-Picar, MD Basad Essa, MD Kate Essad Sandra Estrada, NP, RN Karol Estrada, PhD Danny Estupinan, MD

2017 AAN Annual Meeting On-site Guide

Prasanna Venkatesan Eswaradass, MD Jose Etcheverry, MD Debbie Etchison Mark Etherton Mill Etienne, MD, MPH, FAAN Roland Etti, FRCP, MBBS, MD Alan Ettinger, MD James Eubanks, PhD Marie Eugene, DO Grimm-Suess Eva, MD Maria Eleftheria Evangelopoulou, MD Nikos Evangelou, MD David A. Evans, MBA Ryan Evans, MD Karleyton Evans, MD Nicholas Everage, PhD Chris Everett, FRCP, MBBS, PhD Bjorn Evertsson, MD Virgilio Gerald Evidente, MD Chigolum Eze, MD Raymond Faber, MD Cibele Fabichak, PhD Oscar Fabre, DO Jessica Fabris Bryan Facca PharmD Stewart Factor DO, FAAN Giulia Fadda, MD Sarmed Fahad, MD Nida Faheem, MD Sheikh Faheem, MD Stanley Fahn, MD, FAAN Daniel Fain, MD, FAAN Leanne Fairley BJ Hon Michael Faithe PharmD Marytery Fajardo, MD Nikolaos Fakas, MD Malik Fakhar, MD Masoud Falah, MD Guido Falcone Mark Falone, MD




Alexander Fein Daniel Feinberg, MD Erin Feinstein, DO Robert Fekete, MD Zoltan Fekete, MD, PhD Jessica Feldman, MD Peter Feldman, PhD Karen Feliciano, NP Briseida Feliciano-Astacio, MD Vanessa Felipe, BS Ana Felix, MD Melissa Fellman, MD Warren Felton III, MD Nicole Feng BA Jenny Feng, MD Xuan Feng, PhD Alyssa Fenoglio Oyvind Fensgard, PhD Dawn Fenton Kaylan Fenton, NP, RN Lisa Ferayorni, MD Susanne Ferbus Gerald Ferencz, MD Richard Ferguson, MD, FAAN Damien Ferguson, MBBS Paul Ferguson, MD Maria Fernanda Mendes, MD Americo Fernandes, MD Maria Fernandes Jorge Fernandez, MD Ramiro Fernandez, MD Roberto Fernandez, MD, PhD Hubert Fernandez Oscar Fernandez Fernandez, MD, PhD Nicolas Fernandez Rua Santaf PharmD Arjuna Fernando, MD, MBBS, MRCP Maria Dolores Ferrandez, PhD Cynthia Ferrari PA Matias Ferraris

Elisabetta Ferraro, MD Pilar Maria Ferraro MS Isadora Ferreira Sergio Ferreira De Silva Claudia Cristina Ferreira Vasconcelos, PhD William Ferrell, MD Gerrard Ferrer, DO Ramon Ferro, MD John Ferro, MD, MS, FAAN Steven Feske Anteneh Feyissa, MD Ronald Fields, MD, MS James Fields Emmaculate Fields, NP Terry D. Fife, MD, FAAN Judith Figlo Maria Alejandra Figueredo, MD Karl Cristie Figuracion Mariella Filbin, MD, PhD Tatiana Filina, MD Alexandra Filippakis Luciane Filla, MD Christopher Filley, MD Edward Fine, MD, FAAN Anthony Fine Elizabeth Finger Autumn Fingerson PA Alan Fink, MD John Fink, MD Ezekiel Fink, MD David Fink Stacy Finkbeiner, PhD Alan Finkel, MD Richard Finkel, MD Sara Finkelstein, MD Jack Finkelstein, MD Sjoerd Finnema, PhD Glen Finney, MD Antara Finney-Stable Marcela Fiol, MD Miguel Fiol-Elias, MD

REGISTRANTS

Sami Fam, PhD Bolanle Famakin, MD Frances Fan, MD Schuber Fan, MD Mary-Jean Fanelli, MD Xiang Fang, MD, PhD Deirdre Fanning Lauren Fanty Michael Fara, MD, PhD George Farah Eric Farbman, MD Ulrich Farenkopf, MD Mary-Ann Fares Mauricio Franco Farez, MD Khosro Farhad, MD Amtul Farheen, MD, FAAN Fariba Farhidvash, MD Leonardo Faria, PhD Fernando Faria Andrade Figuei, MD Alirexa Faridar, MD Martin Farlow, MD Constantine Farmakidis, MD Nicole Farmer Lisa Farnett PharmD Salman Farooq, MD Imran Farooqui, MD Raihan Faroqui BA Michael Farris, MD Brittany Farro Alfonso Fasano, MD, PhD Rouzbeh Fateh, MD Jaleh Fatehi, MD Waseem Fathalla, MD R Faught, MD, FAAN Dell Faulkingham Monica Fay PharmD Pierre Fayad, MD, FAAN, FAHA Jenelle Feather Dominic Fee, MD, FAAN Shawna Feely Corey Fehnel, MD Kammy Lynn Fehrenbacher, PhD

223


Annual Meeting Registrants Cecilia Fiore, MD Franchesca Fiorito Torres, MD Luis Fiorotto, MD Hilary Firestone JD Pavlos Firinidis, MD Edward Firouztale, MD Kenneth Fischbeck, MD Falko Fischer, MD Beverly Fischer, MD, FAAN Jorge Fischer Jaume PharmD Stanley Fisher, MD Paul Fisher, MD Barbara Fisher, PhD Christopher Fisher Paul Fishman, MD, PhD Jesse Fishman PharmD Nahome Fisseha PharmD Urszula Fiszer, MD, PhD Heather Fitter, MD Kathryn Fitzgerald, PhD Keely Fitzgerald Mary Fitzpatrick Brian-Fred Fitzsimmons, MD Robin Fitzsimons, MBBS, PhD, FRACP Fatiha Fjeldskaar, PhD Mary Flaherty Kerin Flanagan, NP Eoin Flanagan Sheila Flemming Kelley Flesher Madhuri Fletcher, PhD Susan Flint MS Charles C. Flippen II, MD, FAAN Myrthe Flohil, MD Armando Flor, MD Julaine Florence PT Francisco Flores, MD Carlos Florez, MD Hana Florian, MD, PhD Gina Florida Mike Floyd

224

Thomas FlŸckiger Erin Flynn Brent Fogel, MD, PhD, FAAN Daniel Fok, MD Walter Folatti Nancy Foldvary-Schaefer John Foley, MD Dimitry Fomin, MD Johnson Fong Jose Felipe Fonseca Sialer, MD Paulo Fontoura, MD, PhD Sun-Hoo Foo, MD, FAAN, FACP Lisa Ford, MD Blair Ford, MD, FAAN Corey Ford, MD, PhD Thomas Ford BA Cathy Forest Kathy Foris, MD Rachel Forman, MD Jonathan Forman Andrea Formella Mireia Forner Andres PharmD Magnus Fornstedt Martin Forrest Olivier Fortin Ida Fortini, MD Lilian Petronella Fortuin Laura Foster, MD John Foster, MD Thomas Foster, MD Norman Foster, MD, FAAN Emma Foster, MD, MBBS Mary Ellen Foti, MD Anne Foundas, MD, FAAN Thomas Foutz, MD, PhD Martin Fowler DO, MS Susan Fox, MD Michael Fox, MD, PhD Edward Fox, MD, PhD, FAAN Robert Fox Susan Fox-Rosellini, MBA LaTeya Foxx

2017 AAN Annual Meeting On-site Guide

Maria Fracaro, MD Elizabeth Fracica Marco Aurelio Fraga Borges, MD Mazalit Fragis Mermelshtain PM Avram Fraint, MD Marcondes França Junior, MD, PhD Ada Francia, MD Laura Francis Roosevelt Francois, MD Samuel Frank, MD Diana Frank Lori Frank PharmD Diane Frank, PhD Ronald Franke, MD Gary Franklin Joseph Frasca, MBBS, FRAC Anthony Frattalone, MD David Frawley Judith Frayne, MD Carolyn Fredericks, MD Alice Fredrickson, MD Joseph Freeburg, MD Mark Freedman, MD Morris Freedman, MD, FAAN Cody Freeman, MD Alan Freeman, MD Marshall Freeman, MD William Freeman, MD, FAAN Roy Freeman Karen Frei, MD Walid Freij, MD David Freilich, PhD Catherine Freiman, PhD Miriam L. Freimer, MD Eric Fremed, MD Jacqueline French, MD, PhD, FAAN David French Robert Frere, MD, FAAN Ann Fricke, NP Jonathan Fridhandler, MD Ludmila Fridman, MD




Samuel Gable Al Gabor Hristu Gache, MD Kareem Gadelmola, MD Rajan Gadhia, MD Avi Gadoth, MD Blondell Gage, MD Marie-Sarah Gagne Brosseau, MD Alexis Gagnon, MD Marie-Eve Gagnon, MD William Gaillard Philippe Gailloud John Gaitanis, MD Helena Gala, NP Seth Gale, MD Bradley Galer, MD Gale Galese Kristin Galetta Steven Galetta Simonetta Galgani, MD Karin Galil, MD Smaranda Galis, MD Claire Gall, MBBS Krishna Mourya Galla Chris Gallagher Nickie Gallaher PharmD Antonio Gallo, MD Antonio Gallo, MD Segundo Gallo PharmD Gloria Galloway, MD Wendy Galpern, MD, PhD, FAAN Miriam Galvin, PhD Valentina Galvis, MD Charlene Gamaldo, MD Christy Gamble RN Eugenia Gamboa, MD Arnold Gammaitoni PharmD Daniel Gams Massi, MD Roopali Gandhi, PhD Aravind Ganesh, MD Geeta Ganesh, MD Julian Gangolli,BSc (Honors)

Gautam Ganguly, MD Karunesh Ganguly, MD, PhD Kimberly Gannon, MD, PhD Fay Gao, MD Mingyang Meah Gao, MD Yuan Gao, MD, PhD, MRCP Jiguo Gao Steve Garafalo, PhD Hugo Enrique Garay Calderon, MD Justin Garber, MBBS Todd Garber, MD Eduardo Garcia, MD, FAAN Leon Garcia - Martinez, PhD Clotilde Garcia Benitez, MD Estefania Garcia Molina, MD Juan Carlos Garcia Monco-Carra, MD Rayza Garcia Paredes, MD Fernando Garcia Perez, MD Rocio Garcia Santibanez, MD Guillermo Garcia-Ramos, MD Stephanie Garcia-Tarodo, MD Hannah Gardener ScD Kathy Gardner, MD Raquel Gardner, MD Robert Gardner, MD Andrew Gardner, NP Lidia Gardner, PhD, EMBA Ravi Garg, MD Neeta Garg, MD Rajesh Garg, MD Nina Garga, MD Ibon Garitaonandia, PhD Erich Garland, MD, FAAN Marie-Claire Garneau Elizabeth Garofalo, MD Colleen Garrett, PhD Jose Garrido, MD Emilio Garrido Sanabria, MD, PhD Teresa Gasalla, MD Dan Gasby Claudio Gasperini, MD

225

REGISTRANTS

Sebastian Fridman, MD Vera Fridman, MD Lawrence Fried, MD Andrew Friedberg, PhD Katie Friederich, MD Robert Friedland, MD, FAAN Laura Friedlander, MD Daniel Friedman, MD Alan Friedman, MD Gary Friedman, MD Jason Friedman, MD Deborah Friedman Harold Friend, MD, FAAN Timothy Fries, MD Francesca Frigerio, MD Rina Frisancho DO, MD, MPH Raymond Fritschy Joseph V. Fritz, PhD Steven Frucht, MD Manuel Fruns, MD Waldemar Fryze, MD, PhD Michael Fu Tom Fuchs Mario Fuentealba, MD Sully Fuentes Patarroyo, MD Leonardo Fugoso, MD Jong-Ling Fuh, MD Peter Fuhr, MD Reina Fuji, PhD Kenji Fujita, MD Albert Fullerton, MD Anders Funkquist, MD Clark Funnell, MD Karen Furie Julio Furlan, MD Howie Furst, MD Sarah Furtado, MD, PhD, FRCPC Mahoko Furujo, MD Nancy Futrell, MD, FAAN Tereza Gabelic, MD Mohamed Gaber Karissa Gable, MD


Annual Meeting Registrants Travis Gatesman Michele Gatheridge, MD Na Tosha N. Gatson, MD, PhD Maurizia Gatto, MD Emilia Gatto, MD Laura Gault, MD Susan Gauthier, DO Charlene Gaw Thomas Gawlick PharmD Khalid Gazala, MD Suzanne Gazda, MD Brittany Gazdag Sibel Gazioglu, MD, PhD Guannan Ge, MD Anjie Ge Zhaoming Ge Sophie Gebel, MD Klaus Gebel, MD Nikolaus Gebel Muhtesem Gedizlioglu, PhD Evan Gedzelman, MD Allen Gee, MD, PhD Adel Gehchan, MD Christopher Geiger, MD Juergen Geipel Christian Geis, MD Douglas Gelb, MD, PhD, FAAN Jeffrey Gelfand, MD Anna Gelfand, MD Amy Gelfand Rose Gelineau-Morel, MD Thomas Geller, MD Nestor Genco, MD Mary Genevieve, MD Ying Geng, MD Krasimir Genov, MD Koshy George, MBBS Benjamin George, MD Kristi George, MD Paul M. George, MD, PhD, MSE Edwin George, MD, PhD Jithin George

226

Ilena George Anthony Geraci, MD Bonnie Gerecke, MD Teresa Gerlock, BS Brad Gerow Carlos Gerra, MD Charles Gersbach, PhD Elizabeth Gerstner, MD Michael Geschwind, MD, PhD Michael Getzke Brad Geving, BS Alexander Gevorgyan, MD, PhD Mohammed Ghabra, MD Georges Ghacibeh, MD Mina Ghaly, MBBS Soufiane Ghannam Mehdi Ghasemi, MD Nacer Ghassoul James Ghattas Kimia Ghavami, MD Tariq Gheith, MD Angelo Ghezzi, MD Emanuele Ghione, MD Pahari Ghosh, MBBS, MD Partha Ghosh, MD Manjeera Ghosh Gino Gialdini, MD Athos Gianella-Borradori, MD Giorgio Giannattasio, MD, PhD Rolando Giannaula, MD Lucia Giannini,BSc Ermioni Giannouli, MD Ermioni Giannouli, MD Christopher Gibbons, MD Elena Gibson, MD Anne-Katrin Giese Louise Giesel, MD Barbara Giesser Michael Giglio, MD Jaleed Gilani Donald Gilbert, MD David Gilbert, MD

2017 AAN Annual Meeting On-site Guide

Robert Gilbert, MD Kasey Gildersleeve, MD Kathryn Giles, FRCP David Gill, DO Christine Gill, MD David Gill, MD Naurang Gill, MD Tariq Gill, MD Rebecca Gillani, MD, PhD Michel Gillard, PhD Elizabeth Gilles, MD Alan Gillett, PhD Sid Gilman, MD P.C. Gilvaz, MD Julio Gimenez, MD Ana Cristina Gimenez, MD Edward Ginns, MD, PhD Alan Ginsberg, MBA Matthew Ginsberg, MD Stanley Ginsburg, MD, FAAN Gustavo Giolito Bruno Giometto, MD Gavin Giovannoni, MD Elias Giraldo, MD David Girard, MD Daniele Girault, MD Gigi Girgis, MD Hira Girglani, PhD Tarun Girotra, MD Darren Gitelman, MD Juan Carlos Giugni, MD Fabrizio Giuliani, FRCP Dan Giurgiutiu, MD Christopher Giza Elias Gizaw, MD Martin Gizzi, MD, PhD, FAAN Andrzej Glabinski, PhD Jeanette Glad PharmD Matthew Gladman, MD Michael Glantz, MD, FAAN Robert Glanzman, MD Allan Glanzman PT




FAAN Myla Goldman, MD Jill Goldman MS, MPhil, CGC Robert Goldman, PhD Corey Goldsmith, MD Jerome Goldstein, MD Jessica Goldstein, MD Rachel Goldstein BA David Goldstein, PhD Joanna Goldstein Larry Goldstein Lawrence Goldstick, MD Krishna Goli, MD Olga Golub, MD Arvind Gomadam, MD Marcilio Gomes, MD Maria Gomes, MD Leo Gomes Juliana Gomez, MD Francisco Gomez, MD Hernan Gustavo Gomez, MD Francisco Gomez, MD Rene Gomez, MD, FAAN Christopher Gomez, MD, PharmD, PhD Luis Gomez Ramirez, MD Evelia Gomez Wong, MD Maria Teresa Gomez-Isla Rodrigo Goncalves Kleinpaul, PhD Teresella Gondolo, MD MURAT Gonen Pradeep Kumar Gonugunta, MD, MBBS Nicole Gonzales Oscar Gonzales Gamarra, MD Jesus Gonzalez, MD Maria Nina Gonzalez, MD Julio Gonzalez, MD Sergio Gonzalez Felix Gonzalez Monica Gonzalez Alarcon, MD Maria Gonzalez Duarte, MD

Ayoze Nauzet Gonzalez Hernandez, NP Luis Ernesto Gonzalez Sanchez, PhD Pedro Gonzalez-Alegre Victor Gonzalez-Montoya, MD Paloma Gonzalez-Perez, MD, PhD Guadalupe Gonzalez-Silveria Clifton Gooch, MD, FAAN Anna Goodheart, MD Douglas Goodin, MD J. Clay Goodman, MD, FAAN Andrew Goodman, MD, FAAN Kevin Goodno Mary Goodsett, MD, FAAN Alexandra Goodyear Sunali Goonesekera Mangala Gopal Srikumar Gopalakrishnan, MD, MBBS Murali Gopalakrishnan, PhD Sasikanth Gorantla, MD Barry Gordon, DO Marc Gordon, MD Laurie Gordon, MD Errol Gordon, MD Mark Gordon, MD, FAAN Barry Gordon, MD, PhD Allison Gordon David Gordon Mikalei Gordon Barbara Gordon Eliza Gordon-Lipkin, MD Philip Gorelick, MD Nikos Gorgoraptis, MD, PhD Mark Gorman, MD Elzbieta Gornisiewicz, MD Maria Gorno Tempini, MD, PhD Kenneth Gorson, MD Sankar Gorthi, MD Kimberly Goslin, MD Amartyadeb Goswami, MD

227

REGISTRANTS

Stella Glasmacher Jonathan Glass, MD Jon Glass, MD Braeme Glaun, MD Melanie Glenn, MD G. Gliebus, MD Sarah Glier BA Christopher Glisson, DO Marie Glisson Kimberly Glisson Daniel Glor, MD David Gloss, MD, FAAN Lauren Gluck, MD Steven Glusman Steven Glyman, MD Sharmilee Gnanapavan, MD, PhD Peter Goadsby, MD, PhD Stephan Goedee, MD Sandeep Goel, MD Susan Goelz, PhD Christopher Goetz, MD Brian Goetz PharmD Allene Goetz RN Jacqueline Gofshteyn, MD Martina Gogeissl Christoph Goger, MD Brian Goggins, MD Lodi Gogovska, MD Cyril Goizet Daniel Golan, MD Lawrence Golbe, MD Doria Gold, MD Carl Gold, MD Daniel Gold Mark Goldberg, MD Stephanie Goldberg, MD Amy Goldberger, PhD Tim Golden Debra Golden James Goldenberg, MD Adina Goldfarb Alport, MD Jennifer G. Goldman, MD, MS,


Annual Meeting Registrants Shweta Goswami, MD Jean Gottbreht Lauren Gotterer, DO Rebecca Gottesman, MD, PhD Daniel Gottlieb, MD David Gottlieb Lauren Gottlieb Rachel Gottlieb-Smith, MD Rainer Gotze, MD Guy Goudreau, MD Olivier Gout, PhD Stephen Goutman, MD Amelie Govare, MD Raghav Govindarajan, MD David Gow, MD Namita Goyal, MD Jaya Goyal, PhD Phyllis Grable-Esposito, MD Tara Grabowsky, MD Fernando Gracia Daniel Graf, MD William Graf, MD, FAAN Jonathan Graff-Radford, MD Neill Graff-Radford, MD Brett Graham, MD Glenn Graham, MD, PhD, FAAN Laura Graham MPH Dennis Graham Elias Granadillo, MD Tobias Granberg, MD, PhD Arthur Grant, PhD, MD, HD Rama Grantab Jonathan Grashow Antonios Gratsas Donna Graves, MD Tracey Graves, MD, MRCP, PhD Jennifer Graves, MD, PhD Lenora Gray, MD, FAAN Orla Gray, MD, FRCP Elena Grebenciucova, MD Mark Green, MD Jody Green, MD

228

Phillip Green, MD, FAAN Eric Green Jason Green J. Greenamyre, MD, PhD Benjamin Greenberg, MD Jeffrey Greenberg, MD Michal Greenberg-Abrahami Adam Greene John Greenfield, MD, PhD Ariele Greenfield Beverly Greenspan, MD, PhD David Greer, MD, FAAN Annette Grefe, MD Nicholas Gregg, MD Ashley Gregg, NP Michael Greicius, MD Bart Grelinger, MD, FAAN Daryl Gress, MD Himmat Grewal, MBBS, MD Amrit Grewal, MD Raji Grewal, MD Susan Grice C-TAGME Franz Grieszmayer, MD Craigan Griffin, MD Kimberly Griffin Rhonda Griffin RN Neil Griffith, MD James Griffith, MD Patrick Griffith, MD, FAAN Nancy Griffith, PhD Robert C. Griggs, MD, FAAN Nikolaos Grigoriadis, MD Marie Grill, MD Luigi Maria Edoardo Grimaldi, MD Sean Grimm, MD Kate Grimsrud, MD Anna Grisold, MD Wolfgang Grisold, MD Maria Grisold, MD Jeffrey Grodi Wayne Grody, MD, PhD James Grogan, MD

2017 AAN Annual Meeting On-site Guide

Gary Gronseth, MD Kirk Grosel, MD Kenneth Gross, MD Jeffrey Gross, MD Mitchell Gross, MD Paul Gross, MD, FAAN Robert A. Gross, MD, PhD, FAAN Silvia Grossi, PhD Murray Grossman, MD, FAAN Megan Grosso PA, PT Katrin Gross-Paju, MD, PhD Christoph Grothe, MD Carrie Grouse, MD Angela Gruber, PhD Ross Gruber, PhD Waltraud Gruenbauer, PhD Zoran Grujic, MD Marketa Grunermelova, MD Christopher Grunseich, MD Rebbeca Grysiewicz, DO Andrew Grzybowski, PhD Eugene Gu, MD Jiaping Gu, PhD Luis Guada, MD Joseph Guadagno MBChB,BSc(Hons), MR Gary Gualberto, MD Yuzhou Guan, PhD Juan Guapo Mendoza, MD Charles Guardia, MD Michele Guarnaccia, MD Robert Guber Guido Guberman BA&Sc Mark Gudesblatt, MD Aashrai Gudlavalleti Zain Guduru, MD Antoine Gueguen, MD Alla Guekht, MD Xavier Guell, MD Jenny Guerre, MD Manolete Guerrero, MD Rosana Erica Guerreros, MD




Surinder Gupta, MD, DM Pradip Gupta, MD, FAAN Suneel Gupta, PhD Jeff Guptill Michael Gurevich, MD Aaron Gusdon, MD Michael Guskey PharmD Jon Gustafson, MD Elan Guterman, MD James Gutierrez, MD Amparo Gutierrez, MD Camilo Gutierrez, MD Mario Gutierrez Saenz, MD Josef Gutman, MD Ludwig Gutmann, MD Laurie Gutmann, MD, FAAN Padmaja Gutti, MD Huriye Hayat Guven, MD Amy Guzik Rebeca Guzman Joseph Guzman RN Kelly Gwathmey Katrina Gwinn, MD Bryan Gwyn PharmD Samyeol Ha, MD Jennifer Haagensen Bret Haake, MD Jeff Haas MARIO HABEK, MD Laurence Haber, MD Michael Haboubi, DO Vladimir Hachinski, MD, DSc, FAAN Yael Hacohen, MBBS Paul Haczynskyj Naim Haddad, MD Michelle Hadden, MD Nawal Hadhoum, PhD Abdallah Hadj Tahar, FRCP, MD, PhD GEORGIOS HADJIGEORGIOU, MD Aristides Hadjinicolaou, MD

Carl-Albrecht Haensch, MD Dieter Haering Shaheryar Hafeez, MD David Hafler, MD Jeffrey Hagedorn, MD Frank Hagenow Shalom Haggiag, MD Aya Haggiagi, MD Christopher Hahn, MD Nazar Haidri, MD George Haig PharmD Meagan Hainlen, MD Brian Hainline, MD Clotilde Hainline, MD Jeffrey Hainsworth, DO Vernita Hairston-Mitchell, MD Rula Hajj-Ali Ann Hake, MD Ihab Hakim PharmD Ryan Hakimi, DO Tanja Hakkarainen Anne Hald Nihar Ranjan Haldar, MD Sulev Haldre, PhD David Hale, MD Lyndsey Hale, MD, MPH Chad Hales, MD, PhD E. Haley, MD, FAAN Mario Javier Halfon, MD Jonathan Halford, MD Christopher Halfpenny, PhD, FRCP Jacob Hall, MD Deborah Hall, MD, PhD Steven Hall PharmD, RPh, BS Mary Hall, PhD Lesley-Ann Hall Habib Hallak, PhD Mark Hallett, MD, FAAN John Halperin Rachel Halpern, PhD Karen Halstead, MBA Simona Haluskova, MD

REGISTRANTS

Carlos Guevara, MD Carlos Guevara Oliva, MD Michael Guger, MD Seid Gugssa Michael Guido, MD Amanda Guidon, MD Andrew Guidry, MD Monica Guillory PharmD Laurent Guilloton, PhD Samy Guirguis, MD Nuno Guitian Oliveira, PhD Sergio Daniel Guizzo, MD Arunodaya Gujjar, MBBS, DM, FRCP Yogesh Gujrati, MD Sibel Guler Murat GŸltekin, MD Rohit Gummi Haluk Gumus Padma Gunaratne, MD Margaret Gunarsons Aswin-Kumar Gunasekar MS, MBA Harsha Gunasekara, MD Ruwani Gunawardane, MD Tuncay Gunduz, MD Thorunn Gunnarsdottir Andrea Gunnells, NP Cary Gunther, MD, PhD Yanjun Guo, MD Yanjun Guo, MD, PhD Amy Guo, PhD Qin Amy Guo Praveen Gupta, MBBS Raksha Gupta, MBBS Pushkar Gupta, MBBS, MD Deepak Gupta, MD Sahil Gupta, MD Aneeta Gupta, MD Isha Gupta, MD Suresh Gupta, MD Vidhu Gupta, MD

229


Annual Meeting Registrants Mark Halvorsen Catherine Ham, MD Anai Hamasaki, MD Chris Hamblett, PhD Abdallah Hamdallah, MD Hamid Hamdi, MD Ali Hamedani, MD Natasha Hameed, MD Bilal Hameed, MD Johanna Hamel Basem Hamid, MD Robert Hamill, MD Katherine Hamilton, MD Robert Hamilton, PhD Emily Hamlyn, NP Julie Hammack Louise Hammerich Nancy Hammond, MD Matthew Hammond, PhD Tyler Hammond Khaled Hammoud, MD Samuel Hamner, PhD Melanie Hampton, NP, RN, CNS Mohsen Hamza, MD Jee-young Han, MD Steve Han, MD, PhD Jian Han, PhD Fei Han Tyler Hanak, BS, CNIM, PhD Maureen Handoko, MD Kay Hanley, NP Daniel Hanley John Hannam, MD Peter Hannon, MD Anas Hannoun Jennifer Hanowell, DO Brian Hanrahan, MD Bernard Hanseeuw, MD, PhD Brett Hansen, MD Calvin Hansen, MD Johnni Hansen, PhD Carina Hansen

230

Ryan Hanson, MD Leah Hanson, PhD Seth Haplea, MD Ihtsham Haq, MD Christopher Haqq, MD, PhD Ayesha Haque Makoto Hara, MD Yadollah Harati, MD Paula Hardeman PA Cynthia L. Harden, MD Orla Hardiman Huntley Hardison, MD Martin Hardmeier, MD Asaff Harel, MD Joseph Harmon, DO Matthew Harms, MD Lutz Harms, PhD Julia Harp Byrne Harper, FRCP, MD Emily Harrington, MD, PhD Kristie Harrington, NP Sally Harris, MD Amy Harris Justin Harris Daniel Harrison Daniel Harrison Antoinette Harrison John Hart, MD David Hart, MD, FAAN Edward Hart, MD, FAAN Cara Harth, MD, FAAN Adam Hartman, MD Benjamin Hartmann Hans-Peter Hartung Mona Lie Hartung Diane Harvey, PhD Shabih Hasan, MD Shabbir Hasan, MD Tasneem Hasan, MD Shemonti Hasan Masakazu Hase, PhD Lobat Hashemi ScD

2017 AAN Annual Meeting On-site Guide

Richard Haspel, MD, PhD Ameer Hassan, DO Ayman Hassan, MD Bahaa Hassan, MD Ahmed Hassan, MD Ali Hassan, MD Houry Hassanpour-Kalam-Rou, PhD Christopher Hassett Steven Hata, MD Neda Hatami Jaime Hatcher-Martin Celestin Hategeka, MD, MSc Jacquie Hauer, MD Walter Haupt, MD Diogo Haussen, MD Marco Hautalahti, PhD Evis Havari Msc Joachim Havla, MD Eva Havrdova, MD Kathleen Hawker, MD Christopher Hawkes, MD,BSc, FRCP Trevor Hawkins, MD Angela Hawkins RN Jason Hawley, MD Rollin Hawley, MD Chester Haworth, MD Eman Hawy, MD Ghazala Hayat, MD Bronagh Hayden Timothy Hayes, MD, PhD Beth Ann Haynes, MD Mary-Kathryn Hazel Majed Hbahbih, DO Wei He, MD Jamie Heath, MD Kaitlynne Heath Waits Katharine Heatwole, MD Julien Hebert, MD Michael Hecker, PhD Mohammad Heder, MD




Dominique Heon, MD Marylene Hepp, MD Alejandro Heras Chehan Herath, BS Nihal Herath, MD, FAASM Laura Herbelin Heinz-Peter Herbst, MD Diego Herbstein, MD Geoffrey Herkes, PhD, FRACP, MBBS Aline Herlopian, MD Susan Herman, MD Martin Herman, MD Dirk Hermann, MD, PhD Andras Hermann, PhD Sarah Hermanson Rosana Herminia Scola, PhD Eric Hernandez, MD Larisa Hernandez, MD Paulo Hernandez, MD Elena Hernandez, PhD norma hernandez oramas, NP Zulma Hernandez-Peraza, MD Robert Herndon, MD Elena Herranz, PhD Anne Herrick Rachelle Herring, MD William Herring, MD, PhD David Herrmann, MD Steven Hersch, MD, PhD Bonnie Hersh, MD Carrie Hersh Linda Hershey, MD, PhD, FAAN Leonard Hershkowitz, MD, FAAN Steven Herskovitz, MD, FAAN Roman Herzig, PhD Andrew Herzog, MD, MSc, FAAN Donna Hesari, MD Christopher Hess, MD Dorte Hesse Diane Hesselbrock, MD Amy Hessler, DO

Amber Hetrick, MD Lauren Heusinkveld Lawrence Hewitt, PhD Geoffrey Heyer, MD Nadine Heyworth Meghan Hickey, MD Lisa Hickey Gonzalo Hidalgo, MD Sarah Hierholzer Cristina Hierro Abad Sayumi Higashi, PhD Lenora Higginbotham Nick Higgins Shawn Higuchi, MD Stefan Hilbers Andrea Hildebrand Raymond Hill, MD, FAAN Chloe Hill, MD Hazel Hill, PhD Bryan Hill Sierra Hill Megan Hille CMP, CAE Machteld Hillen, MD Argye Hillis, MD William Hills Beat Hiltbrunner, MD Martin Himmelmann, MD Judith Hinchey, MD Andrew Hindman Sidney Hinds, MD Cynthia Hingtgen, MD, PhD Holly Hinson, MD Jason Hinzman, PhD Petra Hipp, PhD Michio Hirano, MD Scott Hirsch, MD Lawrence Hirsch, MD, FAAN Roberto Hirsch, MD, PhD, FAAN Fuki Hisama, MD, FAAN Yoshimi Hisamoto, MD Emi Hitomi John Hixson, MD

REGISTRANTS

Stephanie Hedoux Bjoern Hedstroem, MD Frederic Heerinckx PharmD William Heetderks, MD Sheetal Hegde Janka Hegedus, FRCP, MD, PhD Anneli Hegestam, PhD Michael Hehir, MD Wolfgang Heide, MD, FEAN Felicita Heidler, MD Terttu Heikinheimo-Connell, MD Kenneth Heilman, MD Terry Heiman-Patterson, MD Irvin Heinrichs, MD Olivier Heinzlef, MD Yuvraj Heir, MD Daragh Heitzman, MD Ingo Helbig Gisela Held, MD Laura Heller PharmD Katherine Heller, PhD Amy Hellman, MD Mark Hellman, MD Kerstin Hellwig, MD Lauryn Hemminger Christopher Hemond, MD John Hemphill, MD Claire Henchcliffe, MD, PhD Mike Hencke Victor Henderson, MD, FAAN William Henderson FACMPE Eric Henderson PT, MPT Patricia Henegan Henning Henningsen, MD Julia Henriksen, MD Camila Henriques De Aquino, MD Carole Henry Fred Henry MS MPH Roland Henry, PhD John Henson Faycal Hentati, PhD Jacqueline Henze

231


Annual Meeting Registrants John Harold Hiyadan, MD Alexander Hladek Petr Hlustik, PhD Bryan Ho, MD Doreen Ho, MD Pei-Ran Ho, MD ANDREW HO, MD Joyce Ho, MD Gary Ho, MD, PhD Khang-Cheng Ho, MD, PhD Thomas Hoang, MD Timothy Hoban, MD Jeremy Hobart, PhD Daniel Hoch, MD, PhD, FAAN Helen Hochstetler PharmD Sara Hocker, MD Sue Hodgkinson Jonathan Hodgson Timea Hodics, MD Matthew Hoerth Barbara Hoese Caitlin Hof Stuart Hoffman, DO Olaf Hoffmann, MD Frank Hoffmann, MD Michael Hoffmann, MD, FCP, FAAN,FAHA Robert Hogan, MD Jacqueline Hogan Anna D. Hohler, MD, FAAN Jason Hoitt David Hojnacki, MD Kristen Hokenson, PhD Samantha Holden, MD William Holder Megan Holec Victoria Holiday, MD Neil Holland, MBBS, FAAN Daniel Holland Larry Hollenbeck, MD, FAAN Melinda Hollingsworth Rick Hollis

232

Mary Holmay, PhD, RN Tomas Holmlund, MD Todd Holmquist, MD Katie Holroyd, MD Stanley Holstein, MD, FAAN William Holt, DO Jeffrey Holt, PhD Steven Holtz, MD David Holtzman, MD Richard Holub, MD Adrien Holzgreve Mark Homonoff, MD Fong Kwong Hon, MBBS, MBChB Jade Hon, MD Siqi Hong, MD Kira Hongell, MD Josephe Archie Honorat, MD, PhD Daniel Hood, MD Zehra Hooda, DO Juzar Hooker, MD Maryann Hooker, MD, FAAN Omotola Hope Sarah Hopkins, MD Katrin Hoppe, MD Holli Horak Dana Horakova, MD Andreas Horn, PhD Gretchen Horner Sam Horng, MD, PhD William Hornyak Steven Horowitz, MD, FAAN Sean Horrigan Andreas Horst, MD Henrik Horster, MD Erika Horta, MD Lindsay Horton, MD David Horvilleur Jonathan P. Hosey, MD, FAAN Catherine Hosley, MD Islam Hosni Michael Hossack, MD Christophe Hotermans, MD, PhD

2017 AAN Annual Meeting On-site Guide

Jyh-Gong Hou, MD, PhD Alexander Houck Parul Houston, MD James Howard, MD, FAAN Michael Howell, MD Thomas Howell Lisa Hoyte, MD, PhD Michaela Hrdlickova RN MD Kinan Hreib, MD Mesropian Hripsime, MD Julia Hsiao Ging-Yuek Hsiung, MD Larry Hsu, PhD Ann Hsu, PhD, PharmD Sherry Hu, MD Ye Hu, MD Wei Hu, MD, PhD Ningyan Hu MS Amy Hua, DO Le Hua, MD Andres Hualpa PA, CMA Chun Chin Huang, MD Josephine Huang, MD Yonglu Huang, MD, PhD Zhigao Huang, MD, PhD DeRen Huang, MD, PhD Alisen Huang MS Kevin Huang Menggui Huang, PhD Ming-Yi Huang, PhD Jessie Huang Jean Hubble, MD Sven Huber, MD Michael Hubschen Laurie Huckabee Daniel Huddleston, MD Tod Hudson, PhD Stella Maris Huespi, MD Kenneth Huff, MD Sara Huffer, MD Emmanuelle Hugentobler, MD Haley Huggins




David Hwang, MD Byungkwan Hwang, MD, PhD Janielle Hyde, MD Robert Hyde, PhD Petya Hykkelbjerg, MD Megan Hyland, MD Bradley Hyman, MD, PhD Mitchell Hymowitz Craig Hyser, MD Jose Iacozzilli, MD Andreea Iancu, MD, PhD Chinazom Ibegbu, MD Abdullahi Ibrahim, MBBS Elmoatazbellah Ibrahim, MD Faisal Ibrahim, MD Gharib Ibrahim, MD Bashair Ibrahim, MD Rebecca Ichord, MD Titto Thundiyil Idicula, MBBS, MD, PhD Fethi Idiman, MD, PhD Egemen Idiman, PhD Katsutoshi Ido PharmD, PhD Mohamad Idris MB BChir MA MRCP(UK) Oscar Iguzquiza, MD Takahiro Iizuka, MD Yukihiko Iizuka, PhD Masamichi Ikawa, MD, PhD Ken Ikeda, MD, PhD Atsushi Ikeda, PhD Milos Ikonomovic, MD Alessandro Iliceto Hristelina Ilieva, MD Kachikwu Illoh, MD Steven Illsley Chike Ilorah, MD Dan Imamoto Jaime Imitola, MD Kevin Immanuel Marlowe Indo, MD Allan Ingenito, MD

Sarah Ingersoll MBA, PHN Nicholas Ingham, MBBS Scott Innis Salvatore Insana, PhD Jihad Inshasi, MD, MBBS, FAAN Edny Inui, PhD Anna Iones, MD Javed Iqbal, MBBS, FCPS Deniz Irem Eliud Irizarry, MD Michael Irizarry Ceyla Irkec, MD Khadija Irshad, MD Obehioya Irumudomon, MD Anna Irwin, MD Sangeetha Poongunam Isaac, MBBS Yakov Isakov, DO Entela Isaraj, MD Yevgeniy Isayev, MD Koto Ishida, MD Mohammed Islam, MD Florian Islinger, MD Khaled Ismail PharmD Noriko Isobe, MD, PhD Davelene Israel-Hanniford, PhD Erik Istre, MD Yasunori Ito Andrei Ivashynka, MD Autumn Ivy, MD, PhD Stanley Iyadurai, MD, PhD Alagoma Iyagba, MD Guillermo Izquierdo Ayuso, MD Yuishin Izumi, MD, PhD Anthony Izzo, DO Bahman Jabbari, MD, FAAN Carlayne E. Jackson, MD, FAAN Jeffrey Jackson, MD Anthony Jackson, MD Kenneth Jackson PharmD Kenneth Jackson Zoey Jackson

REGISTRANTS

Isaac Hughes Hons B.Sc. Stella Hughes, MD Mary Hughes, MD Peter Hughes, MD Maureen Hughes, MD Bruce Hughes, MD, FAAN Linnea Hughes PA Tom Hughes, PhD James Hughes Cinda Hugos PT Helena Huhmar, MD Kerry Hulsing, MD Mohammad Junaid Humayun, MD Jennifer Hung, MBBS Albert Hung, MD, PhD Ann Hunt, DO Ian Hunt MSc Patrick Huott, MD Christina Hupman, MD Raymond Maria Mathie Hupperts Prof Ahm Huq, MD, PhD, MBBS Elizabeth Hur, PhD Aatif Husain, MD Mohammad Husain, MD Arif Husain Marijke Huskens, MD David Huss, MD Georg-Peter Huss, MD Syed Hussain, MD Yessar Hussain, MD Susan Hussman Nicole Hutchcraft, NP Michael Hutchinson, MD, PhD Sharlisa Hutson, MD Francis Huttinger, MD George Hutton, MD Hang Huynh, MD Alexandria Huynh, PhD Tridu Huynh Helle Hvilsted-Nielsen, MD Yun Tae Hwang, MBBS

233


Annual Meeting Registrants Alexandra Jacob MS miguel jacobo, MD Marianne Jacobs, DO Alan Jacobs, MD Claire Jacobs, MD, PhD Bram Jacobs, MD, PhD Ryan Jacobson, MD Nuri Jacoby, MD Ashutosh Jadhav David Jaeger, MD, PhD Michael Jaffee, MD, FAAN Amanda Jagolino, MD Juan Jose Jaime, MD Sejal Jain, MD Aanchal Jain, MD Sandip Jain, MD Sanjay Jain, MD Abhi Jain PT Shashi Kumar Jaiswal, MD Shyam Jaiswal, MD, MBBS Nina Jaitly, MD Johannes Jakobsen, MD, DMSci Hamza Jalal, MD Divya Jalota, DO Nasheed Jamal, MD Sheheryar Jamali Jim James, MD Lauren James Evan Jameyfield Dara Jamieson Roland Dominic Jamora, MD Rabia Jamy, MD Crystal Janani, MD Paul Janda DO, JD Kali Janes, PhD Ronak Jani, MD Agnes Jani-Acsadi, MD, FAAN Mark Janicki, MD Joseph Jankovic, MD, FAAN Janet Jankowiak, MD Jyoti Jankowski PharmD Ali Jannati, MD, PhD

234

John Janosik PharmD Erik Janssen, MD Francis Janton, MD Todd Janus, MD, PhD, FAAN Leonardo Janus Kremer, MD Gudrun Japp, MD Daniel Jaraj, MD, PhD Hugh Jarnagin Modestas Jarutis, MD Richard Jarvis Mahi Jasinarachchi, FRCP, MBBS Yasir Jassam, MD Anabel Jaureguiberry, MD Pradeep Javarayee, MD Muhammad Javed, MBBS, FCPS Bushra Javed, MD Adil Javed, MD, PhD Laszlo Javor, MD Omar Jawdat, MD Laura Jawidzik, MD Malgorzata Jaworska, MD Cheryl Jay, MD, FAAN Lakshman Jayagopal, MD Annapurni Jayam-Trouth, MBBS, MD, FAAN Divya Jayaraman, PhD Jakub Jedynak, PhD Douglas Jeffery, MD, PhD Lara Jehi Lauren Jendraszek Susy Jeng, MD Stephen Jenkins, MD Peter Jenkins Danna Jennings, MD William Jens, DO David Jensen, BS Frances Jensen, MD Judd Jensen, MD Henrik Jensen, MD, PhD Lori Jensen Cretella, MD Dieter Jeromin, MD Andreas Jeromin, PhD

2017 AAN Annual Meeting On-site Guide

Holger Jespersen, MD Nicola Jessop Shafali Jeste, MD John Jestico, MBBS, MD,BSc Anil Jha, MD Lokesh Jha Kai Ming Jhang Mehul Jhaveri PharmD Jonathan Ji, MD Jing Ji, MD Jeffrey Jian Dongmei Jiang, MD, PhD TingTing Rachel Jiang, NP Xiaoyu Jiang, PhD Gregory Jicha, MD, PhD Neekita Jikaria, BS Devanand Jillapalli, MD Dinesh Jillella, MD Soraya Jimenez, MD Joohi Jimenez Shahed, MD Peter Jin, MD Onanong Jitkritsadakul, MD Sungyang Jo, MD Barbara Jobst, MD Angeline Jocson, MD Elizabeth Joe, MD Jalyoung Joe, MD Anne Berit Joentvedt, MD Siw Johannesen, MD Rune Johansson, MD Jenny Johansson Denny John, MD Kuruvilla John, MD Sayona John, MD Molly John, MD Donald Johns, MD Christina Johns Jason Johns Jami Johnsen, MD Ann Johnson BA, C-TAGME Brooke Johnson, DO Kristin Johnson, DO




Kristen Joseph MA Charles Joseph, MD Jeffrey Joseph, MD, PhD S. Josephson, MD Shivang Joshi, MD Manher Joshi, MD Abhay Joshi, PhD Raed Joundi, MD, PhD Tudor Jovin Ralph E. Jozefowicz, MD, FAAN Yo-El Ju Burk Jubelt, MD, FAAN Cory Jubenville, MD Vern Juel Jeffery Juergens, PhD Adam Juersivich, MD Eric Juettler, MD, PhD Mark Juhn, DO Sergio Juica, PhD Parunyou Julayanont, MD Herve Jullien de Pommerol Jibreel Jumare, MBBS Larry Junck, MD Young Hee Jung, MD Youngsin Jung, MD, PhD Adalia Jun-O'Connell, MD Sara Jurado, PhD Caroline Just, MD Marie-France Jutras, MD Mee Jeong Ka Samer Kaba, MD Taylor Kabacinski, DO Jane Kabanoff RN Mohammad Ashish Kabir, MD Imen Kacem, MD Ahmad Kaddurah, MD Jafar Kafaie, MD, PhD Yoshifumi Kagamiishi, PhD Pegah Kahaliardabili, MD Anna Kahari Ericsson, MD Timo Kahles, MD Maninder Kahlon, MD

Sandeep Kahlon, MD Kenneth Kahn, MD Pinar Kahraman Koytak, MD Emine Kahriman, MD Mustafa Kahriman, MD Oksana Kaidanovich-Beilin, PhD Damacio Ramon Kaimen Maciel, PhD Marwa Kaisey Anna-Lotta Kaivorinne, MD, PhD Yasushi Kajii, PhD Manisha Kak, MD Algirdas Kakarieka Michelle Kaku, MD Laura Kalayjian, MD Nilufer Kale Icen Alicja Kalinowska-Lyszczarz, PhD Sonia Kalirao, MD Yogeshwar Kalkonde Faidra Kalligerou, MD Boris Kallmann, MD Bernadette Kalman, MD, PhD Haris Kamal, MD Vikram Kamath, MD Tetsumasa Kamei, MD David Kaminsky, PhD Ozden Kamisli, MD, PhD Brad Kamitaki Sohail Kamrudin Mohammed Kananeh, MD Masato Kanazawa, MD Nathan Kanazawa Takashi Kanda, MD, PhD Geetha Kandimala, MD Padmaja Kandula, MD Tejaswi Kandula Schae Kane Min Kang, MD Un Kang, MD, FAAN Peter Kang Mahdi Kanjo, MD RIe Kanki, MD, PhD

REGISTRANTS

Paul Johnson, MD Nicholas E. Johnson, MD Megan Johnson NBA Reed Johnson Asa Johnson Courtney Johnson, PhD Jacqueline Johnson, PhD Linda Johnson RN Jessica Johnson RNP Elliot Johnson Keith Johnson Ervin Johnson III, MD, PhD Lori Johnston Kern Jolibois MS Surindar Jolly, MD Nicholas Jonas, MD Alan Jonason, PhD Amy Jones, MD Rebecca Jones, MD Elaine C. Jones, MD, FAAN Lyell K. Jones, MD, FAAN Margaret Jones, MD Robert Jones, MD David Jones, MD Kimberly Jones, MD Dylan Jones MPH, MS Cynthia Jones, PhD Daryl Jones, PhD Daniel Jones, PhD Michelle Jones-London, PhD Sze Chin Jong, MD Ho-Yann Jong, MD Daniel Jons, MD Gloria Joo BA Julia Joo Justin Jordan, MD Morgan Jordan Scott Jordan Maurino Jorge, PhD Kyle Jorgensen, MD Mary Jorgensen Gustavo Jose, PhD

235


Annual Meeting Registrants Gokul Kannan Sujatha Kannan Prasad Kanneganti, MD Ronald Kanner, MD Andres Kanner Petr Kanovsky, PhD Trishna Kantamneni, MD Kejal Kantarci, MD Orhun Kantarci rakesh kantaria PharmD Jenna Kanter, MD Kiran Kanth, MD Daniel Kantor, MD, FAAN Ema Kantorova, MD Justin Kao Karen Kao Vasiliki Kapitzoglou, MD Tamara Kaplan, MD Shaheen Kaplan PharmD Johanne Kaplan, PhD Adam Kapler Tanya Kapoor, DO Nidhi Kapoor, MD Anil Kapoor, MD, MBBS Niren Kapoor, MD, PhD Ludwig Kappos, MD Wolfgang Kaps Raj Kapur Rana Karabudak, PhD Georgios Karachalios Hasan Huseyin Karadeli, MD Clementine Karageorgiou, MD Elissaios Karageorgiou, MD Melissa Karagoz Ioannis Karakis, MD, PhD Basak Karakurum Goksel, MD Chafic Karam, MD Hans Karbe, MD Christoph Karch, MD, PhD Shahnawaz Karim, MBBS, MD Jessica Karl Hamdi Necdet Karli, PhD

236

Goeril Karlsson Yuval Karmon, MD Arnon Karni, MD Vikram Karnik, MD Barbara Karp, MD Anna Karpenko, MD Mark Karvosky Mithat Kasap Edward Kasarskis, MD, PhD Richard Kasdan, MD Bhavani Kashyap, MBBS, PhD Joseph Kass, MD, FAAN Darine Kassar, MD Eric Kassel PharmD Iveta Kastnerova, MD Maria Kataki, MD, PhD Lynn Kataria, MD Sarosh Katrak, FRCP, MD Constance Katsafanas, DO Zoe Katsarou, MD Jorge Kattah Douglas Katz, MD Brian Katz, MD Amos Katz, MD Ilana Katz Sand, MD Irene L. Katzan, MD Hans Katzberg, MD Olga Katzelnik Regina Katzenschlager, MD Ute Kauermann, MD Daniel Kaufer, MD Marcelo Kauffman, MD David Kaufman, DO Joel M. Kaufman, MD, FAAN David Kaufman, MD, FAAN Ronald Kaufman PharmD Petra Kaufmann, MD, FAAN Jeffrey Kaufmann Horacio Kaufmann Gurmeen Kaur Ulrich Kausch, MD Corrina Kaut

2017 AAN Annual Meeting On-site Guide

Claudia Kawas Noriko Kawashima, MD Tomoya Kawazoe, MD, PhD Aneta Kaweczynska-Lason, MD, PhD Atrac Kay, MD Heidi Kay RN Jonathan Kay Amy Kaye, PhD Lesley Kaye D Kayed, MD, FAAN Edith Kayode-Iyasere, MD Douglas Kazutoshi Sato, PhD Kelly Kearns, PhD Mark Keegan, MD Kevin Keenan, MD Erin Keith Kristin Keith John Kelemen, MD, FAAN Howard Kelfer, MD Seth Keller, MD Bill Keller Jake Keller Mark Kellett, MD Brendan Kelley, MD Gordon Kelley, MD Adam Kelly, MD Brian Kelly, MD Michael Kelly, MD, FAAN Klaus Kempkes, MD Arzu Kempkes-Toros Benoit Kenda Joelle Kendrick Sarah Kendroud Peter Kennedy, MD, PhD Tiffany Kennedy Deanne Kennedy Zachary Kennedy Kathleen Kennelly, MD, PhD, FAAN Phillip Kenner Christopher Kenney, MD Kimbra Kenney, MD




Sami Khella, MD, FAAN Pravin Khemani, MD Suresh Khemani Davender Khera, MD Babar Khokhar, MD Reza Mohammad Khorooshi, PhD Shaweta Khosa, MBBS Shahram Khoshbin, MD Samia Khoury, FRCP, MD, FAAN Somphanh Khousakoun Ramesh Khurana, MD, FAAN Vikram Khurana, MD, PhD Hiroyuki Kida Spomenka Kidemet Piskac, MD Emy Kikuchi Camilla Kilbane, MD William Kilgo, MD Shannon Kilgore, MD, FAAN Paul Killen Ronald Killiany, PhD Lance Kim, DO Grace Kim, MD David Kim, MD Eric Kim, MD Hyun Ah Kim, MD Inhyup Kim, MD Jisoon Kim, MD Kyung-Wha Kim, MD Minji Kim, MD Nina Kim, MD Onjin Kim, MD Edward Kim, MD Jang Sung Kim, MD Diana Kim, MD Jaeho Kim, MD Joontae Kim, MD, PhD Sang Beom Kim, MD, PhD Jee Young Kim, MD, PhD Jean Kim Eun Kyung Kim Hyunjoong Kim Sang Woo Kim

Tae-Yeon Kim Tara Kimbason, MD W. Taylor Kimberly, MD, PhD Daniel Kimple, MD Jun Kimura Maria Kinali, MBBS, MD Kraig Kinchen, MD David King, FRCP, MD Richard King, MD, PhD, FAAN Maggie King, PhD Wendy King John King William Kingston, FRCP, MD Revere Kinkel, MD, FAAN Masako Kinoshita, MD Maximo Kiok, MD, FAAN Ria Kioupritzi, PhD Jonathan Kipnis, PhD Lucas Kipp, MD Ruth Kirkeby, MD Sally Kirkpatrick, MD Angelia Kirkpatrick, MD, MPH Batool Kirmani, MD Jawad Kirmani, MD Douglas Kirsch Matthew Kirschen, MD, PhD Yaz Kisanuki, MD Brett Kissela, MD, FAAN Ilya Kister, MD Yoshihiro kitagawa Yuki Kitazaki, MD Michael Kitchell, MD Francis I. Kittredge, Jr., MD, FAAN Pia Kivisakk Webb, MD, PhD Parameswaran Kizhakkedathu Malika, MD, MBBS James Klaas, MD Kelsey Klaas, MD Karen Klahr Miller Lori Klaman, PhD Antoinette Klapwijk, MD Jan Klatt

237

REGISTRANTS

Mike Kenston Edgar Kenton, MD, FAAN Tapani Keranen, MD Nino Kerashvili, MD Kevin Kerber Geoffrey Kerchner, MD, PhD Cecile Kerloeguen Drew Kern, MD Lawrence Kerson, MD, FAAN Andrew Kertesz, MD, FAAN Tigran Kesayan, MD Sanjeev Keshary, MD Remi Kessler Kiandokht Keyhanian, MD Janet Keys-Brown, MBBS Antoine Keyser, MD, PhD Charlotte Keywood, MBBS Sany Khabbaz, MD Fatemeh Khadjevand, MD, MPH Khalid Khalid, MBBS Ehtesham Khalid, MBBS Fariha Khalid, MD Saleem Khamisani, MD Shaida Khan, DO Fareed Khan, MBBS Nadeem Khan, MD Jaffar Khan, MD, FAAN Omar Khan, MD Ikram Khan, MD Muhib Khan, MD Raza Khan, MD Maria Khan, MD Mohammed Khan, PhD Navid Khan Nisha Khanna Abbas Kharal, MD Swati Khare Rakesh Khatri, MD Ismail Khatri, MD, MBBS, FAAN Pooja Khatri Ayaz Khawaja, MD Zeshaun Khawaja, MD


Annual Meeting Registrants Eric Klawiter, MD Mark Klee PharmD Anno Kleider, MD Anne Kleiman, DO Bradley Klein, MD Brad Klein, MD Christopher Klein, MD Hannah Klein, MD, PhD Joshua Klein, MD, PhD Susan Klein, MD, PhD Emily Klein, NP Jessica Klein Christine Klein Dawn Kleindorfer Patricia Klementowski Isaiah Kletenik, MD Sylvia Klineova, MD Henrik Klitgaard, PhD Stephan Klohe, MD Luisa Klotz, MD Benzi Kluger, MD, FAAN Joseph Knapik, MD, FAAN Volker Knappertz, MD, PhD Laurie Knepper, MD Mark Knobel, MD, PhD David Knocke Janice Knoefel, MD David Knopman, MD, FAAN Philipp Knorn, MD Eduardo Knorre, MD Nadine Knowles Robert Knowlton, MD Anthony Knox, MD, PhD Sean Knox Irene Knuesel, PhD Melissa Ko, MD David Ko, MD John Ko PharmD Robert Kobelja, MD Jari Kobylka, PhD Vedat Kocak, MD, PhD Ayse Kocaman, PhD

238

Belgin Kocer Patrick Koch Naira Kocharian, MD Lisa Kockeritz, PhD Boguslawa Koczon-Jaremko, MD Thomas Kodankandath, MD Wolfgang Koehler, MD Peter Koehler, MD, PhD, FAAN Tracy Koehler, PhD Tyler Koehn, MD Monica Koehn, MD Diederik Koelman Harold Koendgen, MD Arnulf Koeppen, MD, FAAN Raid Kofahi, MD Cory Kogelschatz, MD Alejandro Kohler, MD Matias Kohler, PhD Supriya Kohli, MBBS Henry Koiti Sato, MD Anne Koivisto, MD Suleiman Kojan, MD, FAAN Raghuram Kolanu, MD, MBBS Noah Kolb, MD Hadar Kolb, MD Stephen Kolb, MD, PhD Seth Kolkin, MD Sai Kolla, MD Herbert Kollross-Reisenbauer, MD Leslie Koltes, NP Arkady Koltun, MD, PhD Kiyonobu Komai, MD, PhD Steven Komjathy, MD Eva Konakova, MD Spyridon Konitsiotis, MD Jenna Konkel PharmD Richard Konkol, MD, PhD Takuya Konno, MD, PhD Patricia Konstant Arkadiy Konyukhov, MD Benjamin Koo, MD Brian Koo, MD

2017 AAN Annual Meeting On-site Guide

Catherine Koola MPH Maria Kootsikas PharmD Barbara Koppel, MD, FAAN Aart Koppenaal, MD Igor Koralnik, MD Pearce Korb, MD Schaun Korff, PhD Julie Korich, PhD Dina Kornblau, MD Joshua Kornbluth, MD Becca Kornfeld Jeffrey Kornitzer, MD Minna Korolainen Nicholas Koroneos Walter Koroshetz Steven Kosa, MD Peter Kosa, PhD Hitoshi Koshiya Kurien Koshy, MBBS, MD Jessyca Koslyk, MD Anna Kostera-Pruszczyk, MD, PhD Sandra Kostyk, MD, PhD Suresh Kotagal, MD, FAAN Prakash Kotagal, MD, MBBS Devdutt Kotekar, MD Sanjeev Kothare Ravish Kothari, MD Simple Kothari, MD Katya Kotschet, MBBS Mohamad Koubeissi, MD, FAAN Irene Koulinska, MD Lucia Kovacikova RN, MD Sukanthi Kovvuru, MD Hisatomo Kowa, MD, PhD Andreas Kowalik, MD Feliks Koyfman, MD Feliks Koyfman Randy Kozel, MD Mark Kozinn, MD, FAAN Wojciech Kozubski, PhD Jeff Kraakevik, MD Thomas Kraemer, MBBS, FRACP




Natalie Kukulka Walter Kukull, PhD, FAAN Roger Kula, MD, FAAN Alina Kulakowska, MD, PhD Kandan Kulandaivel, MBBS, MD Catherine Kulick Kedariprasad Kulkarni, MD Sarah Kulke, MD Alexander Kulla, PhD Jennifer Kullmann, MD Philipp Kulozik, PhD Inessa Kulyk Anupama Kumar, MBBS Ashok Kumar, MD Gyanendra Kumar, MD Shekhar Kumar, MD Rajeev Kumar, MD, FRCPC Navdeep Kumar, MD, MBBS Rajnish Kumar, MD, MBBS Sanjay Kumar, MD, MBBS SUDHIR KUMAR, MD, MBBS Neeraj Kumar Pradeep Kumbham Aliza Kumpinsky, MD Dursun Emre Kumral Doris Kung, DO Nathan Kung, MD Nathan Kung Hari Prasad Kunhi Veedu, MD Nancy Kuntz Gaston Kuperman Christopher Kurahashi, MD Kateryna Kurako, MD Jerome Kurent, MD, FAAN Christeena Kurian, MD Alan Kurland, MD Philip Kurle, MD Can Ebru Kurt, MD Murat Kurtuncu, MD Robert Kurtzke, MD Nuwan Kurukulasuriya, PhD Dulanji Kuruppu, MD

Anne Kurver Daniel Kurz, MD Arielle Kurzweil, MD David Kushner, MD, FAAN Jeffrey Kutcher Gunihal Kutlu, PhD Hanna-Maija Kuusisto, MD Johan Kuyler, FRCP Justin Kwan, MD Tinna Kwan RN Priscilla Kwan Ingrid Kwee, MD Eric Kyler Konstantinos Kylintireas, MD Steven Kymes, PhD Paulina Kyriakopoulos, MD Alice La Danny La Fontaine, MBBS Theresa LaBarte, DO Pierre Labauge, MD vincenzo labella, MD, PhD Andres Labiano Fontcuberta, MD Shannon LaBoy Dmitriy Labunskiy, MD Daniel Lachance, MD, FAAN Dariusz Lacheta, MD Elijah Lackey, MD Daniel Lackland, PhD Zdravko Lackovic, MD, PhD David Lacomis, MD, FAAN Kevin Lacroix, FRCP, MD Francisco Lacruz Bescos, MD, PhD Joseph Lacy, MD Harshad Ladha, MD Kathrin LaFaver, MD Kristina Lafaye, MD Annik Laflamme Jeanne Lafortune, MD W. LaFrance, MD Richard Lafrance, MD, FAAN Andres Lafuente Alonso, PhD John Lagios, MD

239

REGISTRANTS

Dimitri Krainc, MD, PhD Jeffrey Kralstein Carl Kramer, MD Christopher Kramer Christian Krarup, FRCP, MD Daniel Krashin, MD Ruediger Kratz, MD, FAAN Joerg Kraus, MD Erik Krause, DO Martin Krauss, MD Magdalena Krbot Skoric, PhD Megan Krench, PhD Kiren Kresa-Reahl, MD Alexander Kretzschmar, MD Jean Francois Krider Rainer Kriegelsteiner Stephen Krieger, MD, FAAN Nagesh Krish, MD Balaji Krishnaiah Vaishnav Krishnan, MD, PhD Kseniia Kriukova Kelly Krogh, PhD Mette Krogsaa Richard Krolewski, MD, PhD Kassi Kronfeld, MD Robert M. Kropp, MD, FAAN Harald Kropshofer Shana Krstevska, MD Lauren Krupp Richard Krysiak Ewa Krzystanek, PhD Yumi Kubo Danute Kucinskiene, MD, PhD Megan Kuechle Daniel Kueh, PhD Robert Kuhelj, PhD Jens Kuhle, MD, PhD Gregory Kuhlman, MD Benedicta Kuhnler, MD Elske Kuipers Kathy Kujawa, MD, PhD Pavnit Kukreja PharmD


Annual Meeting Registrants James Lah, MD, PhD Asok Lahiri, MD Stella Lai, MD Tim Lai, MD George Lai, MD Florence Lai, MD Eugene Lai, MD, PhD Sue Lai, PhD Sharon Lai Jose Miguel Lainez, PhD Benjamin Laitman, PhD Sushil Lakhani, MD Arun Lakhanpal, MD Arpita Lakhotia, MD Lynsey Lakin, NP Amrita Amanda Lakraj, MD Sonia Lal, MD Patrice Lalive d'Epinay, PhD Michelle Lally, MD Patrice Laloux, MD, PhD, FAAN Cedric Laloyaux, PhD Eric Lalumiere, MD Yau On Lam, MBBS Erek Lam, MD Alice Lam Jack Lam Rene Lamar, MD Dronacharya Lamichhane, MD Shannon Lancaster, MD Eric Lancaster, MD, PhD Hunter Land Edwin Landaker, MD Daniel Landau, MD Lamberto Landete, PhD Mark Landrio, MD Paula Landriscina, MD Ali Landry PMP Douglas Landsman, PhD Roger Lane, MD Michael Lane, MD Tabathya Lane, NP Gareth Lane

240

Michelle Laneuville, MD Todd Lang Anthony Lang carolyn lange PharmD Kimberly Langenbach, PhD Frederick Langendorf, MD Annette Langer-Gould, MD, PhD Douglas Langford, MD Madeline Langley Abe Langseth, PhD Stefan Lanker, PhD Astrid Lankow, MD Benjamin Lanning MPH Katherine Lanning Nathalie Lanoie, MD Peter Lansbury, PhD Douglas Lanska Sebastian Lanternier, MD Christian Lanz, MD Roberta Lanzillo, MD Samuel Lapalme-Remis, MD David Lapides Yves Lapierre, FRCP, MD Emmanuelle Lapointe, MD Joseph LaPorta Suzette LaRoche Alice Laroni, MD Kerri LaRovere, MD Daniel Larriviere, MD Niccole Larsen, PhD Douglas Larsen David Larson Dewey Larson Roger Larson Tracey Lasak-Myall PharmD Stephanie Lash, MD, FAAN Erin Lasher Jacobstein Dave Lashmet, MD Chrstoph Lassek, MD Jutta Lassmann, MD Estelle Latendresse, MD John Latham, PhD

2017 AAN Annual Meeting On-site Guide

Valentin Laticevschi, MD Gene Latorre, MD, FAAN Norman Latov, MD, PhD K. H. Vincent Lau German Laufer, MD Ruple Laughlin, MD Chris Laurel Vanina Laurent-Ledru Antonio Laurenza, MD, FAAN Guy Laureys, MD Amy Laverdiere Monica Lavian, DO Catherine LaVigne, MD Keri LaVigne-Langenstein, MD Myriam Lavoie Luigi Lavorgna, MD Mark Lawden, FRCP, MBBS, PhD Kenneth Laxer, MD, FAAN Lori Layton Liana Laza, MD Ronald Lazar, PhD, FAAN Joash Lazarus, MD Scott Le, DO Scheherazade Le, MD Christine Le, MD Lamvy Le Rodney Leacock Michael Leahy, MD Natalia Leal, MD Rita De Cassia Leal, MD Fernanda Leal, MD, MSc Luis Andre Leal Ferman, MD Jens Leander Megan Leary, MD Audrey Leasure Katherine Leaver, MD Victoria Leavitt, PhD Christine Lebrun Frenay, PhD Jeanette Lechner-Scott, PhD Nathalie Leclerc PharmD Angela LeDay PharmD, PhD Adena Leder, DO




Fawn Leigh, MD Richard Leigh, MD Richard Leigh-Pemberton, MD Enrique Leira, MD, FAAN Thomas Leist, MD, PhD, FAAN Megan Leitch, MD Paulo Leite, MD Guilherme Leite, MD Cristian Leiva, MD Carlos Leiva, MD, PhD Caroline Lemieux, PhD Richard Lemons, MD Tunde Lengyel PharmD Kelsey Lenihan Laura Lennihan, MD, FAAN Letizia Leocani, MD Teresa Leon, MD, PhD Monica Isabel Leon, PhD Luciana Vanesa Leon Cejas, MD Juan Carlos Leon Hernandez, PhD Hubert Leonard, MD, PhD Matthew Leoni, MD David Leppert Elizabeth Leroux, MD David Lesch, MD Daniel Lesley, MD Devin Leslie, DO Ryan Leslie PharmD Harold Lesser, MD, PhD Karine Letourneau, MD Thomas Leung, MD Jay Levenson Joseph Leveque, MD James Leverenz, MD, FAAN Myriam Levesque-Roy, MD Marjory Levey, PhD Lara Levi Andrew Levin, MD Kerry H. Levin, MD, FAAN Morris Levin, MD Karen Levin, MD Michael Levin, MD, FAAN

Seth Levin Aidan Levine BA Todd Levine, MD Manuela Levitt Maxwell Levy, MD Ariel Levy, MD Michael Levy, MD, PhD, FAAN Igor Levy-Reis, MD Jim Lewin PharmD Richard Lewis, MD Steven L. Lewis, MD, FAAN Jeffrey Lewis, MD, PhD Travis Lewis, MD, PhD Matthew Lewis MPA Richard Lewis Cristian Leyton, MD, PhD Marie-Claude L'Heureux, PhD Leonard Li, FRCP, MBBS Lucia Li, MBBS Clarence Li, MD Terrence Li, MD John-Michael Li, MD Hongyan Li, MD, PhD Maureen Li, MD, PhD Yuebing Li, MD, PhD Yi Li, MD, PhD Honglan Li, MD, PhD Jun Li, MD, PhD, FAAN Tom Li PharmD JieQiong Li, PhD Xiaobing Li, PhD Ziliang Li, PhD Xuan Li Shannon Liang, MD Grace Liang, MD Jinjun Liang, MD Allison Liang Albert Liangtonotandra Wars, MD Y. Joyce Liao, MD, PhD Yi-Chu Liao, MD, PhD Nicholas Liaw, MD, PhD David Libell, MD

241

REGISTRANTS

Jason Ledesma Angelica Lee, DO Kim En Lee, FRCP, MBBS Chi Yan Lee, MBBS Yuan Lee, MBBS Chaewon Lee, MD Ian Lee, MD David Lee, MD Eudocia Lee, MD Hyomin Lee, MD Amy Lee, MD Leslie Lee, MD, FAAN Peter Lee, MD, PhD Ming-Jen Lee, MD, PhD I-Hui Lee, MD, PhD Yi-Chung Lee, MD, PhD Zeeihn Lee, MD, PhD Benjamin Lee, MD, PhD Ellen Lee PharmD Hane Lee, PhD Andrew Lee, PhD Dolim Lee, PhD Lily Lee, PhD Andrea Lee Jacqueline Lee Kai Yin Lee Soon Lee Moon Jeong Lee Rebekah Lee Maureen Leehey, MD, FAAN Beth Leeman-Markowski, MD, MA Michael Leffler-McCabe, MD Emily Lefler, PharmD Bruce LeForce, MD, FAAN Alan Legatt, MD, PhD Tanya Lehky, MD Laura Lehman, MD James Lehrich, MD, FAAN Lenora Lehwald, MD Richard Leider Dana Leifer, MD, FAAN Peter Leigh, FRCP, MBBS, PhD


Annual Meeting Registrants Stephanie Licata, PhD Samuel Lichtman-Mikol Nicole Licking, DO Jennifer Liebenthal, MD Frank Lieberman, MD David Lieberman, MD, PhD Eric Liebler Jill Liebman, DO Maryana Liedke, DO Assuncion Liem, MD Teerin Liewluck, MD Hugo Lijtmaer, MD David Likosky, MD, FAAN Anne Marie Likwaicheung Wei Lim, MBBS, MD, PhD Chern Lim, MD Shi Lim, MD Siew Na Lim, MD An An Lim, PhD Chai Lim, PhD Gabriel Lima, MD Gaurang Limachia Krista Lim-Hing, MD Chen Lin, MD Jason Lin, MD Kathie Lin, MD Helen Lin, MD Lu Lin, MD, PhD Hsin-Pin Lin, MD, PhD Mark Lin, MD, PhD, FAAN David Lin Chun-Jen Lin Jia Lin Ramiro Linares, MD Nicolas Lindau, MD Marc Linden, MD Carly Linder Kristen Lindgren, MD, PhD Anouk Lindley, MBA Margot Lindner Markus Lindroos, MD Chris Lindsay

242

Perttu Lindsberg, MD Eva Lindstrom, MD, PhD Yumin Link, MD, PhD Francisca Linn, MD Heather Linn, MD Jenny Linnoila, MD, PhD Celia Linton Christopher Liong Eric Liotta, MD Melissa Lipford, MD David Lipps, MD Richard Lipton, MD, FAAN Anne Lipton, MD, PhD David Lira, MD Robert Lisak, MD, FAAN Jerome Lisk, MD Lubomir LISY, PhD Brian Litt Ann Little, MD Allison Little PharmD Mark Litton, PhD Anna Litvak, MD Irene Litvan, MD, FAAN Janete Litwiniak, MD Mike Liu, DO Natarie Liu, MD Yin Allison Liu, MD Suzanne Liu, MD Jerry Liu, MD Jiangping Liu, MD Lynn Liu, MD Wei Liu, MD Ran Liu, MD Wei-Qiao Liu, MD Lei Liu, MD, PhD Dawei Liu, PhD Enchi Liu, PhD Shifang Liu, PhD Ganqiang Liu, PhD David Liu Grant Liu Henry Liu

2017 AAN Annual Meeting On-site Guide

Terrie Livingston PharmD Jana Lizrova, MD Miguel Angel Llaneza, PhD Yicela Llinas, MD Rafael Llinas, MD, FAAN Gloria Maria Llorens, PhD Alexandra Lloyd-Smith, MD Warren Lo, MD Albert Lo, MD, PhD Mina Lobbous, MD Lorri Lobeck, MD Julie Locklear PharmD Tobias Loddenkemper, MD Elizabeth Loder Jeffrey Loeb, MD, PhD Veronika Logovinsky, MD, PhD Giancarlo Logroscino, MD, PhD, FAAN Matthias Lohle, MD Ingrid Loma-Miller, MD Scott London, MD Zachary London Diana Londono, MD Daniel Long, DO Lucretia Long Erin Longbrake, MD, PhD Frank Longo, MD, PhD W. T. Longstreth, MD, FAAN Aaron Loochtan, DO Alexandra Loomis BA Caitlin Loomis, MD Ralf Loos, MD Iscia Lopes-Cendes, MD, PhD Ricardo Lopez, DO J. Lopez, MD, FAAN Alfonso Lopez, MD Ana Lopez, MD Oscar Lopez, MD Michael Lopez, MD, PhD Pablo Lopez, PhD Juan Carlos Lopez Cormenzana, PhD




Sylvia Lucas, MD, PhD Tameka Lucas PharmD Claudia F. Lucchinetti, MD, FAAN Uladzimir Luchanok, MD Sarah Luchansky, PhD Daniel Luciano, MD Carlos Luciano, MD, FAAN Amanda Luciano PharmD David Ludolph, PhD Zoltan Ludwig Matthew Luedke, MD Geraldine Luetic, PhD Mara Lugassy, MD Kate Lui, MBBS For-Shing Lui, MD Collin Luk, MD, PhD Joshua Lukas, MD Aleksandra Luksza Diego Luna, MD Abhishek Lunagariya Line Sofie Lunde Larsen, MD Brian Lundstrom, MD, PhD Codrin Lungu, MD Lan Luo, MD Jin Luo, MD, PhD, FAAN Tudor Lupescu, MD, PhD Francisco Luque, MD, PhD, FAAN Giacomo Lus, MD Jennifer Luth Nijee Luthra, MD, PhD Alexandria Lutley, MD Danielle Lux, MBBS Saverio Luzzi, MD LinAng Lv Ina Ly, MD Cindy Ly, MD, PhD Tia Ly PharmD Sheri Lydick Michael Lyerly, MD Sharon Lynch, MD Timothy Lynch, PhD David Lynch

George Lyons, MD Kelly Lyons, PhD Dan Lyons, PhD Jennifer Lyons Yelena Lyustikman MSc Alice Ma, MBBS Li Rong Ma, MD Chaoran Ma, MD Sherry Ma, MD, PhD QILIN MA, PhD Ali Maamar-Tayeb, MD Eric Maas, MD Matthew Maas, MD Ricardo Mabanta, MD Patrick Mabray, MD, PhD Corina Maria Socorro Macalintal, MD Vincent Macalintal, MD Regina Macalintal-Canlas, MD Peter Macaskill Holly MacCallum, MD James MacDonald, MD Kevin MacDonald Richard Macdonell, MD, FAAN Alexander MacDougall, MD Larissa Macedo Duarte Machado, MD Flavia Machado, MD Lais Machado De Oliveira, MD Daniel Machemer, PhD Ernane Maciel, MD Carolina Maciel Ryan MacIsaac, MD Ruth MacIver Kenneth Mack, MD, PhD Dave Mack Diane Mackie RN Glenn Mackin, FRCP, MD, FAAN Eric Macklin, PhD Gregg MacLean, MD Blaine MacNeil Elise Madar

REGISTRANTS

Carlos Lopez Gomez, PhD Pino Lopez Mendez, PhD Margarita Lopez Roa Maria Lopez-Bresnahan, MD Eduardo Lopez-Portillo, MD Marco Lopez-Vizcarra, MD Mary Lor Nikki Lorenz Luis Felipe Lorâ&#x20AC;&#x2122;a Rosado, MD Sherrill Loring, MD David Loring, PhD Samantha LoRusso, MD Itay Lotan,MD Mitesh Lotia, MD Anton Lotman, MD Ira Lott Timothy Lotze, MD Jau-Shin Lou, MD, PhD, FAAN Sara Loud MBA, MSEE Barry Louden, MD Patricia Loudis, MD Lucy Loughnan Jane Louie, MD May Louie, MD Jay Louik Elan Louis, MD, FAAN Kathy Love RN Amy Lovett Racke, PhD Phillip Low, MD, FAAN Max Lowden, MD Jessica Lowe, MD Carolina Lowe PharmD Stephanie Lowenhaupt RN Linda Lowes, PhD Jyh-Haur Lu, MD Angela Lu, MD Ming Lu, PhD Zhengqi Lu, PhD Stuart Lubarsky, MD Gabriele Luber, MD Fred Lublin, MD, FAAN Michal Lubomski, MBBS

243


Annual Meeting Registrants Leslie Madden, MBA Patrick Madden, MD John Madden, PhD Ramesh Madhavan, MD Mohan Madhusudanan, MD Chinedu Maduakor, MD Yasuhiro Maeda, MD Chantal Maertens Daniel Mafla, MD Matthew Maga, PhD Gerson Magalhaes, MD Luis Magalhaes, MD, PhD Razaz Mageid Steffen Mager Pietro Maggi, MD, PhD Carlos Alberto Magirius Peixoto, PhD Rick Magun, MD Melinda Magyari, PhD Don Mahad, MD, PhD, FRCP Ziad Mahadeen, MD Supriya Mahajan, MD Abhimanyu Mahajan, MD Darshan Mahajan, MD Shalini Mahajan, MD Kedar Mahajan, MD, PhD Erica Mahany Mandat Maharaj, FRCP, MBBS, MD Atul Maheshwari Ibrahim Mahjneh, MD Sadiqa Mahmood BDS Ayesha Mahmood, MD Naznin Mahmood, MD Tariq Mahmood, MD Riaz Mahmood RN Sidrah Mahmud, MD Kyle Mahoney, MD Mark Mahowald Advait Mahulikar, MD Zabeend Mahuwala, MD Elisabeth Maillart, MD

244

Davide Maimone, MD Eric Maina, MBBS Juan Maiques, MD Katherina Mair, MD Wolfgang Mair, MD Baijayanta Maiti, MD, PhD Adrien Maitrot, MD Nazanin Majd, MD Masoud Majed, MD Mohammed Majeed, MD Jennifer Majersik, MD M. Junaid Majid Hon.,BSc. Shahram Majidi, MD Aniel Majjhoo, MD Akintomiwa Makanjuola, MBBS Naila Makhani, MD Seraj Makkawi, FRCP, MBBS Yamane Makke, MD Richard Malamut, MD Rachna Malani, MD George Malatinszky Irene Malaty, MD Shailesh Male, MBBS, MD Edoardo Malfatti, MD, PhD Ram Malhotra, MBBS, MD Manoj Malhotra, MD Raman Malhotra, MD, FAAN Ashish Malhotra, MD, MBBS Preeti Malik, MBBS Asma Malik, MD Muhammad Taimur Malik, MD Saeeda Malik, MD Fady Malik, MD, PhD Beatrice Malka Tisserand Roneil Malkani, MD Elfrida Malkin, MD Marc Malkoff, MD, FAAN Eric Mallack, MD Ruthvik Mallad Robert Mallery, MD Nelson Mallillin, MD Giulia Mallucci, MD

2017 AAN Annual Meeting On-site Guide

Stephan Malm, MD Emily Malm, NP Bassam Malo, MD Kelly Malone Ann-Sophie Maltais-Duchesne, MD Neil Maluste, MD William Malzone, MD, FAAN Mansoureh Mamarabadi, MD Andrew Mammen, MD, PhD Aubrey Manack Adams, PhD Natalie Manalo, MD Maria Linda Manalo Riccardo Manca Neeraj Manchanda, MD Eric Manchon, MD Delia Mancoci, MD, PharmD Marcela Mancuso, PhD Ajith Mandadi, MD, MBBS Karuna Mandava, MD David Mandelbaum, MD, PhD, FAAN Alan Mandell, MD Pujyitha Mandiga Raul Mandler, MD, FAAN Jayawant Mandrekar, PhD Matthew Maneen, PhD Lawrence Maness, PhD Girish Mangalick, MD Venkatachalam Mangeshkumar, FRCP, MD, FAAN Leonardo Mangieri, MD Teresa Mangin, MD Ram Mani, MD Ranjit Mani, MD Iyswarya Mani Bhaskar, MD Tap Maniar, MD Manuel Manita, MD Ami Mankodi, MD Mandeep Mann, MD Christine Mann Robert Mannel




Donald Marks, MD William Marks, MD, FAAN Blanca Marky, MD, FAAN John Marler, MD Monika Marona, PhD M. Sean Marquez, FRCP, MBBS, MD Joachim Marr, MD, PhD Christina Marra, MD Ruth-Ann Marrie, MD, PhD Caitlin Marron Jonathan Marrow, MBBS Jennifer Marsella, MD Michael Marsh, MD Elisabeth Marsh, MD Rita Marshall, MD Randolph S. Marshall, MD, FAAN Frederick Marshall, MD William Marshall, MD Veronique Martel, MD Anne Martel RN Justin Martello, MD Klaus Marten Jeffrey Martens Madhusudhana Marthati, MD, MBBS Jan Martin, MD Carola Martin, MD Kelin Martin, MD Wayne Martin, MD Joseph Martin, MD, PhD, FAAN Dana Martin PharmD Lee Martin, PhD Melinda Martin, PhD Joanne Martin Filippo Giovanni Martinelli Boneschi, MD Hector Martinez, MD, PhD Natalie Martinez Meritxell Martinez Ferri, MD Adriano Martinez Reyes, MD Jorge Martinez-Cerrato, MD

Jennifer Martinez-Thompson, MD Christopher Martino, DO Anthony Martino, MD Davide Martino, MD, PhD Linda Martino Sheryl Martin-Schild, MD, PhD Maria Martucci, MD Lionel Martul Paul Maruff, PhD Erika Marulanda-Londono Mercedes Maruscak Maya Marzouk Neil Masangkay, MD Matthias Maschke, MD Florencia Masciottra, MD Joseph Masdeu, MD, PhD, FAAN Angelika Masero Cinzia Masini, MD Kiran Maski Eliezer Masliah, MD Hesham Masoud Shamin Masrour, MD Michele Mass, MD Jason Massa, DO Maxime Massarotto, MD Janice Massey, MD Regina Massey Jennifer Massey Josee Masson-roy, MD Alina Masters-Israilov, MD Dimitra Mastrantoni Muhammad Masud, MBBS, MD Ruturaj Masvekar, PhD Marina Mata, MD Elie Matar, MBBS Walid Matar, MBBS Sopio Mataradze, MD Farrah Mateen, MD, PhD, FAAN Zuzana Matejcikova Valentin Mateos Marcos, MD Vesselina Mateva, MD Jean Matheson, MD

245

REGISTRANTS

Jody Manners, MD Glenn Mannheim, MD Tracey Mannion Georgios Manousakis, MD Joao Mansano De Oliveira Hebah Mansour, MD Megan Mantica, MD Tobias Mantl, MD Sneha Mantri, MD William Mantyh, MD Bharti Manwani, MD, PhD Giovanna Manzano Soe Mar, MD Nicholas Maragakis, MD John Maraganore Thibaut Marais Stefania Maraka, MD Josefina Maranzano, MD Rohit Marawar, MD Tessa Marburger, MD Norina Marcello, MD Todd Marcero Dominic Marchese Carole Marcillat Brian Marcus, MD Joseph Marcus, MD Sherry Marcus Linda Marden, MD, FAAN Kenneth Marek, MD Miroslav Mares, MD Jan Mares, MD Alejandro Marfil, MD Zoltan Mari, MD Elisabeth Mari, PhD Yuri Maricich, MD Iris Vanessa Marin Collazo, MD Sandro Marini, MD Ann Marini, MD, PhD Isaac Marin-Valencia Victor Mark, MD Samuel Markind, MD Michael Markowski DO, FAAN


Annual Meeting Registrants Subin Mathew, MD Gracykutty Mathew, MD Thomas Mathew, MD, MBBS Paul Mathew Katherine Mathews, MD Tobias Sejbaek Mathiesen, MD Rajeev Mathur, MD Mayank Mathur, MD Vishakhadatta Mathur Kumaraswamy, MD Jordi Matias-Guiu Antem, MD Jorge Matias-Guiu Guia, MD Peter Mativo, MD Rustambek Matmurodov, PhD Joseph Matsumoto Andre Matta, MD Paul Matteis Brandy Matthews, MD, FAAN Geoffrey Matthews Kirsten Matthiesen PharmD Miriam Mattoscio, MD, PhD David Mattson, MD, PhD, FAAN Michelle Mauermann, MD, FAAN Andre Maues De Paula, MD, PhD MB Maughan RN Petteri Maunu, MD Carine Maurer, MD, PhD Catherine Maurice, FRCP, MD Timothy Maus Melissa Mausolf, MD Jerome Mawet, MD Jordan Mayberry, MD Sara Mayer, MD Stephan Mayer, MD Lori Mayer RN Suzana Mayer Tchomtchoua, PhD Fernando Mayor Basto, MD William Mays, MD MaryAnn Mays, MD Douglas Mayson, MD Edward Mazdzer, MD Amir Mazhari, MD

246

Gordon Mazibrada, MD Robert Mazo, MD Maria Antonietta Mazzola, MD Carmen Mazzola, MD Peter McAllister Lindsay McAlpine Robert McBurney, PhD Paul McCabe, MD Dominick McCabe Karen McCain Joseph McCall, MD Donald McCarren DO, FAAN Matthew McCarthy, MD Allan McCarthy, MD Lucas McCarthy, MD Micheline McCarthy, MD, PhD, FAAN Joseph McCarty, MD Stella McCaughey, PhD Cheryl McCauley PharmD Michael McCauley Irene McClain Jeffrey McClean, MD, FAAN Mercedes McClean, PhD Karen McClendon, PhD William McClintock, MD Pamela McCombe Matthew McConnell, MD Brice McConnell, MD, PhD Kayla McConvey, MD Ramona McCormick Donald McCorquodale, MD, PhD Michael McCrea, PhD Peter McCroskery, MD Jane McCrossen Louise McCullough, MD, PhD Dana McDermott, DO Melissa McDonald, MD Fiona McDougall, PhD Jose McFaline Figueroa, MD, PhD Nikolaus McFarland, MD, PhD Michael McGlynn PharmD

2017 AAN Annual Meeting On-site Guide

Judith McGonagle, NP Rose McGowan Alexander McGown, PhD Tresa McGranahan, MD, PhD Robert McGrath, FRCP Emer McGrath, MD, PhD Denise McGrath Christopher McGuigan, MD Stephen McGuire, MD, FAAN Jennifer McGuire Joseph McGuire Courtney McIlduff, MD Mark McInerney Edward McInerny PA Steven McIntire, MD, PhD Mary Anne McIntyre Marilyn McKasson, MD Jake McKay, MD Marc McKay Charlie Mckechnie Eric McKee Ann McKee Roger McKelvey, FRCP, MD Geoffrey McKendry Stephen McKenzie, FRCP, MD Marna McKenzie, MD Andrew McKeon Jennifer McKinney, MD Mac McLaughlin, MD Samantha McLea, NP Colin McLeod, MD Robert McMahon, MD, FAAN Barbara McManus, MD Robert McMichael, MD Carolyn McMicken Paul McMonagle, MD, FRCP Nuala McNicholas, MBBS Norman McNulty, MD David McOmber Katherine McPherson RN Elizabeth McQuade, MD Niamh McSweeney, MD




Nydia Melendez-Brugueras, MD David Melikian PharmD Gayane Melikyan, MD, PhD Maurizio Melis, MD Michelle Mellion, MD Calvin Melmed, FRCP, MD, FAAN Kara Melmed, MD Mariana Melo, MD Agustin Melo Carrillo, MD, PhD Raima Memon, MBBS Adeel Memon, MD Anza Memon, MD Margarita Menapace Dale Menard, MD Shay Menascu, MD Jerry Mendell, MD, FAAN Erica Mendelsohn Stuart Mendelson, MD, FAAN Irene Mendes, MD Shannon Mendes Alejandro Mendez, MD Joe Mendez, MD Montserrat Mendez, MD Mario Mendez, MD, PhD Paola Mendez Gomez, MD Adriana Mendez Sanchez, MD J Richard Mendius, MD Nuno Mendonca, MD Jason Mendoza, PhD Xiangyi Meng, PhD Derek Menkedick, DO Daniel Menkes, MD, FAAN Barry Menna, DO Katja Menneking Murali Krishna Menon, MD, MBBS Katerina Mensikova, MD Karin Mente, MD Alexander Menze, MD Giovanni Meola, MD Ivan Mercader, MD Melissa Mercado, MD Bethann Mercanti

Iqbal Merchant, MBBS, MD Shabbir Hussain Merchant, MD Kian Merchant-Borna Matthew Mercuri, MD Lawrence Meredith, MD Jose G. Merino, MD, MPhil, FAAN Kelsey Merison, MD Vanessa Merker Alexander Merkler, MD Lisa Merlin, MD, FAAN Stephen Mernoff, MD, FAAN Aristide Merola, MD, PhD Charlotte Merrill, PhD Barbara Merriman, DO Martin Merschhemke Oliver Merse Sandra Mertz William Merva, MD Alla Mesh, MD Patrick Meshaka Boulenouar Mesraoua, MD, FAAN Steven Messe, MD M. Mesulam, MD, FAAN Nicholas Metrus, MD Hussein Metwally, PhD Luanne Metz, FRCP, MD Lawrence Metz, MD, FAAN David Metzer RN Ryan Metzger, PhD Abby Metzler, MD Marco Meucci, MD William Meurer, MD Jenny Meyer, MD Ana-Claire Meyer, MD Catherine Meyer RN Hailey Meyer Briana Meyer Rebecca Meyerson, MD Jesse Mez MS Kelly Meza Capcha Naomi Mezaki, MD Michelle Mezei, MD

247

REGISTRANTS

Kathryn McVicar, MD William McVicar, PhD Jennifer McVige, MD Kimford Meador Maureen Mealy RN Jose Eustasio Meca Lallana, MD Laszlo Mechtler Milton Medeiros, MD Stephen Medeiros Marietta Medel, MD Steve Medhurst, PhD Jennie Medin Juan Marcelo Medina, MD Milagros Medina, MD Luis Medina, PhD Jose Miguel Medrano, MD Melissa Mee PharmD Austin Meeker, MD Gregg Meekins, MD, FAAN Matthias Meergans, MD, PhD Katrin Meffert, MD Jonathan Megerian, MD, PhD Sanket Meghpara Sandhya Mehla, MD Yash Mehndiratta, MD Anahit Mehrabyan, MD Dev Mehta, DO Tapan Mehta, MBBS, MD Lahar Mehta, MD Mona Mehta, MD Niyati Mehta, MD Jagjivan Mehta, MD Shyamal Mehta, MD, PhD Sunil Mehta PharmD Devangi Mehta, PhD Jyotsna Mehta Jessica Meir, MD Jeremy Meisel, MD Nicte Mejia Luis Mejico, MD, FAAN Jan Mejnartowicz, MD, PhD Michel Melanson, MD


Annual Meeting Registrants Noha Mhjob, MD Maryam Mian, MD Nidaullah Mian, MD Amanda Michael, MD Lang Michael, MD Kristine Michael Nara Michaelson Slawomir Michalak, PhD Elliot Michel, MD Federico Micheli, MD Hani Midani, MD Lefkos Middleton, MD Michelle Mielke, PhD Susanna Mierau, MD, PhD Raffaella Migliaccio, MD, PhD Mitchell Miglis, MD Laurence Mignon, PhD Cornelia Mihai, MD, FAAN Titus Vasile Mihai, PhD Dragos Mihaila, MD Mohamad Mikati, MD Margarita Mikhaylova, DO Daniel Mikol, MD, PhD Nicholas Milano, MD Rosalyn Miles, MD Cristina Milesi, PhD Francisca Millan Zamora, MD Eliza Miller, MD Aaron E. Miller, MD, FAAN Bradford Miller, MD Hugh Miller, MD Laura Miller, MD Timothy Miller, MD Robert Miller, MD, FAAN Julie Miller, MD, PhD John Miller, MD, PhD, FAAN Paul Miller MS Catherine Miller PharmD Randy Miller RN Colleen Miller Sarah Miller Dena Miller

248

Tammi Miller Daniella Miller Rebecca Miller Wai Wai Miller Robin Miller John Millichap, MD Tracey Milligan, MD Reversa Mills, MD Brittany Mills PharmD Margherita Milone Eli Miloslavsky Mark Milstein, MD Ju-Hong Min, MD Chris Min, MD, PhD Yair Mina, MD Shannon Mindt RN Mia Minen, MD Xue Ming, MD, PhD Michael Minieka, MD Aarathi Minisandram MS Jonathan Mink, MD, PhD Nancy Minshew, MD, FAAN Mark Mintz, MD, FAAN Scott Mintzer, MD Svjetlana Miocinovic, MD, PhD Saad Mir, MD Massimiliano Mirabella, MD Pablo Miralda, MD Caroline Miranda, MD Gustavo Miranda Loria, MD Augusto Miravalle, MD, FAAN Neha Mirchandani, MD Shahim Mirdavood Mohammad, PhD Anat Mirelman, PhD, PT Ario Mirian Slobodan Miric, MD Alex Mirzoev, MD Jusuf Misbach, MD, FAAN Bliss Mishler Bikash Kumar Mishra, MD Shrikant Mishra, MD, FAAN

2017 AAN Annual Meeting On-site Guide

Dhanashri Miskin, MD Lotika Misra, MD Edward Mistler, DO Niraj Mistry, MD Reena Mistry PharmD Hetal Mistry Karl Misulis, MD, PhD, FAAN Ann Mitchell, MD Terence Mitchell, PhD Mesfin Mitike, MD Kristin Mitrovich, MD Dimos Dimitrios Mitsikostas, MD, PhD Hiroshi Mitsumoto, MD, FAAN Shivam Mittal, MD Shilpi Mittal, MD Ashlea Mittelstaedt Toji Miyagawa, MD, PhD Laura Miyares Janis Miyasaki, MD, MEd, FRCPC, FAAN Eli Mizrahi, MD, FAAN Heidi Moawad, MD Rob Moccia, MD, PhD Andrea Mocigemba, MD Ellen Modell, MD Jack Modell, MD nishit Modi, PhD Jeremy Moeller, MD Jeffrey Mogelof, MD, FAAN Cristina Moglia, MD, PhD Yasir Osman Mohamed, MD Ibrahim Mohamed PharmD Ghaieb Mohame Nadeem-Asim Mohammad Haider Mohammed, MD Mariya Mohammed Negar Moheb, MD Nimish Mohile, MD Nabil Mohsen, MD Koby Mok, PhD Sepideh Mokhtari, MD




Moses Moorthy, MD Rana Moosavi, MD Fabiano Moraes, MD Ester Moral, PhD Augusto Morales, MD Mircea Morariu, MD Karla Mora-Rodriguez, MD Rami Morcos, FRCP, MD, FAAN Zeyad Morcos, MD Roland More, MD Francois Moreau, MD Thibault Moreau, PhD Thais Moreira, PhD, PharmD Vanessa Fernanda Moreira Ferreira Osvaldo Jose Moreira Nascimento, PhD Gabriel Moreno, MD Margarita Moreno, MD Walter Morgan, MD Bethanie Morgan, MD Christopher Morgan, MD John Morgan, MD, PhD Joel Morgenlander, MD Eva Morgenstern, MD Alex Mori Hiroki Mori, PhD Gerald Moriarty, MD, FAAN Keith Morneau Martha Morrell, MD, FAAN John Morren, MD John C. Morris, MD, FAAN Jane Morris, MD Harold Morris, MD, FAAN Gaby Morris Peter Morrison, MD Elizabeth Morrison-Banks, MD Mark Morrow, MD, FAAN Sarah Morrow, MD Gregg Morrow PharmD Melanie Morrow Paula Morrow Dominique Mortel, MD

Veronica Morton RN Electra Mosca, MD Constantine Moschonas, MD Brian Moseley, MD Howard Moses, MD, FAAN Heather Moses, PhD hanieh moshayedi, MD Anthony Mosley, MD Brandon Moss, MD Heather Moss, MD, PhD Mark Moster, MD, FAAN Rajeev Motiwala, MD Jeremias Motte, MD Rizkalla Mouchati, MD Arlete Moura, PhD Lidia Maria Moura Heather Moury, DO Yahya Mousali, MD Charbel Moussa, MD, PhD Asma Moussaoui, MD Marie-Catherine Mousseau, PhD Mariam Mouti, MD Justin Mowchun, MD Ellen Mowry Antonio Moya, MD Stacy Moye RN,, NP Jason Moyer, PhD Tahseen Mozaffar, MD Susan Mozzicato, MD Davit Mrelashvili, MD Maciej Mrugala, MD Marisol Mubarak, MD Huiam Mubarak Adnan Mubaraki, MD Alexandra Muccilli, MD Chandra Sekhar Reddy Muddireddy, MD Jannis Mueller, MD Erika Mueller, MD Felix Mueller, MD Matthias Mueller, MD, MSc Soeren Mueller, PhD

REGISTRANTS

Amir Molaie Jennifer Rose Molano, MD, FAAN Joyce Molengraft RN Eric Molho, MD, FAAN Luis Enrique Molina Carreon, MD Luis Alberto Molina Martin, MD Robert Molinari, PhD Teresia Moller, PhD Patrick Moloney, MBBS Paul Molyneux, MD, FRCP Aigul Momunaliyeva, MD Thomas Monaghan, MBBS Jorge Moncayo, MD James Monckton, PhD Gabriela Mondino Catherine Monigan Michelle Monje, MD, PhD Jean Monsalvo, MD Pasquale Montagna, MD Jocelyn Montalvo, MD Arturo Montano Amanallah Montazeripouragha Anne-Sophie Monte, MD Carlos Monte, MD Cecilia Monteiro, MD Teshamae Monteith, MD David Monteith, PhD Maxime Montembeault Priscilla Monterrey, MD Jacqueline Montes Jose Montes-Rivera, MD Annie Montmarquette Lauren Moo, MD Jennifer Moodie, MD Miriella Moodley, MD Amanda Mook, DO Justin Moon, MD J Moore, MD Dana Moore, PhD Helena Moore Margaret Moores, MD Bhagwan Moorjani, MD, FAAN

249


Annual Meeting Registrants Thomas Mueller, PhD Kinan Muhammed Arabinda Mukherjee, MD, DM Devi Mukherjee, PhD Maxim Mulder, MD Stefanie Karin Muller, MD Heiko Muller, MD Caitlin Mulligan, MD Paul Mullin, MD Sarah Mulukutla, MD Kassandra Munger Heidi Munger Clary, MD Bhoopathy Munirathinam, MD, MBBS Kenneth Munnerlyn, MD Mario Munoz, MD David Munoz, MD Shanan Munoz, MD Daniel Munoz, MD Laura Munoz-Arcos, MD Frederick Munschauer, MD, FAAN Srikanth Muppidi Letitia Muresan, FRCP, MD Natalia Murinova, MD Matthew Murnane, MD Olwen Murphy, MD Robert Murphy, MD M Murphy, MD Desmond Murphy PharmD Ladonna Murphy PharmD Elyse Murphy RN Jacqueline Murphy Ellen Murphy Niamh Murphy Evan Murray, MD David Murray, PhD Eileen Murray Dallan Murray Jagarlapudi Murthy, MBBS, MD, FAAN Santosh Murthy, MD Kolar Murthy, MD, FAAN

250

Pavan Murty, MD Ramasamy Murugan, MD, MBBS Kimberly Muscara Alessandra Musella, PhD Gail Musen, PhD Mohamed Mustafa PharmD Rafid Mustafa Adekunle Mustapha, MD, MBBS Maria Muste, MD Adham Musthak Eduardo Mutarelli, MD, PhD, FAAN Tatsuro Mutoh, MD, PhD Maria Muxfeldt, MD Gail Myburgh Marcin Mycko, MD, PhD Melissa Myers Darius Nabavi, MD David Nacionales, DO Dimitrios Nacopoulos, MD Elie Naddaf, MD Janel Nadeau, MD Yannick Nadeau, MD Stephen Nadeau, MD, FAAN elaine nadeau PharmD Bernardo Nadelman, PhD Krzysztof Nadgrodkiewicz, PhD Divya Nadkarni, MD Sathiji Nageshwaran, MBBS Lavanya Nagineni, MD Kimberly Nagle-Seidel Seema Nagpal, MD Praneeta Nagraj, MD, PharmD, RPh Adam Nagy, MD Shirley Nah Fatta Nahab, MD Stephanie Nahas Anil Nair, MD Sreekumaran Nair, MD Radhakrishnan Nair, MD, MBBS Robert Naismith Umer Najib, MD Faranak Najibi, MD

2017 AAN Annual Meeting On-site Guide

Souhel Najjar, MD Tsutomu Nakada, MD, PhD, FAAN Kazuma Nakagawa, MD, FAAN Beau Nakamoto, MD, PhD, MBA, FAAN Taizen Nakase, MD, PhD Mohammad Nakawah, MD Shravani Nalla, MD Navi Nallasamy, MBBS Jooyeon Nam, MD Kanako Namekawa, MD Veeresh Kumar Nanjangud Shivamurth, MBBS Reena Nanjireddy, MD Shashidhara Nanjundaswamy, MD Sarah Naoshy James Napier, MD Julie Napieralski, PhD Amy Naquin-Chappel, MD Imama Naqvi, MD Sunil Narayan, FRCP, MBBS, MD, PhD Ashok Narayan, MBBS, MD Ram Narayan, MD Udayan Narayan, MD, MBBS Kannan Narayana, MBBS, MD Randhi Narayana, MBBS, MD Pushpa Narayanaswami, MBBS, MD, FAAN Dean Naritoku, MD, FAAN Reshma Narula, MD Sona Narula, MD Isabel Narvaez Correa, MD Felipe Nascimento Alejandro Nasimbera, MD Syed Nasir, MD John Nasrallah, MD Sahar Nassiri B. Nataraju, MD Karen Nater-Pineiro, MD Uma Nath, FRCP, MBBS, MD Avindra Nath




Sajjan Nemani, MD, FAAN Ahmed Nemr, PhD Rodolfo Nerety Cassie Nesbitt, FRCP, MBBS Gerardo Netz, PhD Matthew Neu Ole Neubauer, MD Astrid Neubauer Andrea Neundorf, MD Ira Neustadt, MD Kathryn Nevel, MD Vanessa Nevins Naomi Nevler, MD Pamela New, MD Jeff New PharmD Nancy Newman, MD Daniel Newman, MD Lawrence Newman, MD, FAAN John Newman, PhD Heather Newman Jonathan Newmark, MD, FAAN Scott Newsome Braeden Newton Thomas Neylan Ping-wing Ng, FRCP, MBBS Kok Pin Ng, MBBS Wei Ping Kay Ng, MBBS Lai Han Betty Ng, MBBS Wing Kwan Noelle Ng, MBBS, MbChb Nicole Ng, MD Marcus Ng, MD Elizabeth Ng, MD, FAAP Jennifer Ng Vincci Ngan, MD Ly Ngo, MD Jennifer Nguyen, MD Madeline Nguyen, MD Thanh Nguyen, MD Trung Nguyen, MD, PhD Ha Nguyen Viet-Huong Nguyen PharmD

Sandy Nguyen, PhD Suzanne Nguyen RN Jimmy Nguyen Natalie Nguyen Mai Nguyen-Huynh, MD Muhammad Niazi, MD Flavia Niccolini, PhD Kathryn Nichol, PhD Richard Nicholas, FRCP, PhD Jennifer Nichols, MD Katharine Nicholson, MD Kyle Nicholson PharmD Molly Nickerson, PhD Tyler Nickle Joseph Nicolas, MD Johny Nicolas, MD Stefan Nicolau, MD Charles Nicoli Allen Nielsen, MD Lotte Nielsen Richard Nieman, FRCP, MD Nicki Niemann, MD Conrad Nievera, MD Adam Andrzey Niezgoda, PhD Masaaki Niino, MD Esmaeil Nikfekr, MD, PhD, FRCP Jon Nilsen, PhD Melissa Nirenberg, MD, PhD, FAAN Akihisa Nishimura Laura Nist, MD Ricardo Nitrini, MD Matthias Nitschke, MD Alexander Niyazov PharmD Jean Bertin Nkendjuo James Noble, MD Romy Nocera, PhD Evan Noch Katherine Noe, MD, PhD Michael Noetzel Pedro Nofal, MD Tom Noff, MD

REGISTRANTS

Audrey Nath Ajay Nathan Barnett Nathan Cody Nathan Douglas Nathanson, MD Sharon Nations, MD Andrew Natonson, MD Sami Natour Markus Naumann, MD Digvijaya Navalkele, MD Kasun Navarathna Claudio Navarrete, PhD Carlos Navarrete Maldonado, MD Allison Navis, MD Sagarika Nayak, MD Ramesh Nayak, PhD Lakshmi Nayak Shakti Nayar, MD Maria Naylor, PhD Sonia Nayyar, MD Ankit Nayyar, MD Manmohan Nayyar, MD, FAAN Tara Nazareth Bernadette Nazario-Lopez, MD Ryan Nazemian, MD Khurram Nazir, MBBS Bijen Nazliel, MD Maureen Neary Zuzana Nedelska, MD, PhD Krassen Nedeltchev, PhD Robert Neel, MD Shyama Prasad Neelakandan, MD Anil Neelakantan, MD Edward Neely, MD Ahmed Negida Laura Negrotto, PhD Gereon Nelles, PhD Aaron Nelson, MD Matthew Nelson PharmD Sally Nelson, PhD Cheryl Nelson RN Charlotte Nelson

251


Annual Meeting Registrants Jorge Nogales, MD Luciano Nogueira, PhD Nilson Nogueira Mendes Neto, MD Martin Nogues, MD, PhD Anna Marie Nolido, MD Aaron Noll, MD Peggy Nolty Georgios Nomikos, MD, PhD Lois Nora, MD, FAAN Kristi Nord, MD Douglas Nordli Sara Nordman Jared Noroozi, MD John Norris, FRCP, MD James Norton, PhD Adeline Not, PhD Marie-Ange Noue, PhD Amre Nouh, MD Bardia Nourbakhsh, MD Kasid Nouri, MD Peter Novak, MD Alicia Novak, PhD Roberta Novakovic Nelson Novarro, DO Paul Novello, MD Jimmy Novero, MD Przemyslaw Nowacki, PhD Kamilia Nozile-Firth, MD Juergen Nuessner, MD Ruaa Nughays, MD Viviana Nunez, MD Alberto Nunez Virginia Nunez Karen Nunez-Wallace, MD Chloe Nunneley Bakhtier Nurmukhamedov, MD Tami Nussbaum, MD Japhari Nyassinde, MD Barbara Nye, MD Steven Nye, PhD Haakon Nygaard, MD, PhD Paul Nyquist, MD, FAAN

252

Anne Louise Oaklander, MD, PhD, FAAN John Oas, MD Ahmed Obeidat, MD, PhD David Ober, MD Dragana Obradovic, MD, PhD Barbara OBrien, MD Barbara OBrien, MD Hope O'Brien, MD Anthony O'Brien, MD Christopher O'Brien, MD, FAAN Margaret O'Brien MRCPI, PhD Dennis O'Brien PA Fanny O'Brien, PhD Terence O'Brien Cassandra Ocampo, MD Cumara O'Carroll Christelle Ochin Karen O'Connell, MD John O'Connell, MD Barbara O'Connell, MD Michael O'Connell Antoinette O'Connor, MD Allan O'Connor Francis O'Connor Fred Odago, MD Yazmin Odia, MD Luke O'Donnell, MD Steve O'Donnell Frederike Oertel Ole Oesterberg Erin O'Ferrall, MD Michelle Offit M.S. MS Katsuhisa Ogata, MD, PhD Annette Ogbru PharmD Yomi Ogun, MD Haroun Ogun, MD Muminot Ogunmuyiwa, NP Ahyuda Oh DDS, MBA, DrPH Chad Oh, MD Seong-il Oh, MD Charles Oh, MD

2017 AAN Annual Meeting On-site Guide

Jiwon Oh Robert O'Hara, MD, FAAN Denise O'Hara, NP Maurice Ohayon, MD, DSC, PhD Gunnel Ohlsson Oluwadamilola Ojo, MD Erin Okazaki, MD Dennis OKeefe, MD Daniel Okobi, PhD Emeka Okonji, MD Obi Okonkwo-Onuigbo, MD Kome Okposo PharmD Georg Okroy Caitlin Oksienik, MD Darin Okuda, MD, FAAN Michael Okun Elias Olafsson, MD, PhD Marieta Olaivar, MD Weredes Olango Michael Oldham, MD, MPH Jessie Oldham MS Edgar Olivas, MD Henrique Oliveira, MD Guilherme Oliveira PharmD Nicholas Olney, MD Segun Oloyede, MBBS, MWACP Abby Olsen Sandra F. Olson, MD, FAAN Sam Olum, MD Cathy Oly PA Ouali Omani, MBA Larsson Omberg, PhD Olubunmi Omojowolo, MD Adekola Omokunmi, MBBS Antonio Omuro, MD Olukayode Onasanya, MD William Ondo, MD Mary O'Neal, MD Welton O'Neal PharmD Gilmore O'Neill, MD, MB, MRCPI Nina Onem Abimbola Onikoro MBS




Jill Ostrem, MD Denis Ostrovskiy, MD Carlos Otero, MD Orna O'Toole Tunde Otulana, MD Alexander Ou, MD Derek Ou Russell Ouellette,BSc Griselda Oujo, MD Bruce I. Ovbiagele, MD, MSc, FAAN Opeyemi Owa Mohammad Owais, MD James Owens, MD, PhD Laura Owlett Lukman Owolabi, MBBS, PhD, MB Mayowa Owolabi, MD Marcelo Oyarce, PhD Temitayo Oyegbile, MD, PhD Sarka Oygarden, MD George Oyler, MD, PhD Serkan Ozakbas, MD Arif Kemal Ozalp PharmD, PhD Shelly Ozark, MD Iklim Ozdemir Haktanir, MD Laurie Ozelius, PhD Handan Ozisik Karaman, MD Reha Oytum Ozkanoglu Mehmet Ozmenoglu, MD Mark Ozog, PhD Musa Ozturk, MD Serefnur Ozturk, MD Ayhan Ozturk, MD, PhD Paivi Paavola, MD Anna Pace, MD Maria Pacha, DO Lisa Pachinger Alison Pack, MD Katrina Pack, MD Russell Packard, MD, FAAN Claudia Padilla, MD Jennifer Padilla Martinez

Sabrina Paganoni, MD, PhD Diana Page, NP Nora Pagel, MD Guillaume Pagnier Rainer Paine, MD, PhD Anderson Paiva, MD Asif Paker, MD, MPH Julia Pakpoor, MBBS John Palaccios Natalia Palacios, PhD Adriana Palade, MD Frank Palermo, MD Gaurang Palikh, MD Michael Palm, MD Jose-Alberto Palma, MD, PhD Vala Palmadottir, MD Joseph Palumbo, MD Vijay Pampana, MD Janne Pamsgaard,BSc Xiaoping Pan, PhD Jennifer Panagoulias Renzo Pancorvo, MD Avidesh Panday, MD Ajay Pandey, MD Krupa Pandey, MD Massimo Pandolfo, MD, FAAN Anup Panduranga, MD Vishal Pandya, MD Dipakkumar Pandya, MD Neil Pandya, MD Vanil Pandya Shree Pandya PT Cristina Panea, MD, PhD Pritpal Panesar PharmD Min Hee Pang MS Heather Panic, PhD Bobby Panikulam, MBBS, DM NEUROLOGY F Walter Panis, MD Sharjeel Panjwani, MD Alexander Pantelyat Fatima Pantiu

REGISTRANTS

Ligia Onofrei Daniel Ontaneda Berfin Onur Gerald Onwuegbuzie, MD Chidelu Onyeani-Nwosu San Oo, MBBS, MD Hwai Yin Ooi, MD Lauren Oommen, DO Kalarickal Oommen, MD, FAAN Jens Opalka, MD Kristine O'Phelan Sabrina Oporto, MD Edgar Oppenheimer, MD Maral Ordabayeva Terry O'Regan Eleanor Orehek, MD Erin O'Reilly Sheila Oren, MD, MBA Ryan Orie PA Karen Orjuela Mario Orlando Yulia Orlova, MD, PhD Joseph Oropilla, MD John Orr, DO Hector Orrego, MD Marcos Ortega, MD Santiago Ortega-Gutierrez, MD Melanie Ortiz, BS Jorge Ortiz-Garcia, MD Brian Ortmeier, PhD Jonathan Orwitz, MD, FAAN Frank Oser, MD Sarah O'Shea, MD Olajumoke Oshinaike, MD Michael Oshinsky, PhD Bjorn Oskarsson, MD, FAAN Maryam Oskoui, MD, FAAN Gamaleldin Osman, MD Tahir Osman, MD Juan Pablo Ospina, MD Henry Osso-Rivera, MD Joel Oster, MD

253


Annual Meeting Registrants Linda Pao, MD Andrea Paolillo, MD Stephanie Paolini, MD Dimitra Papadimitriou, MD Dimitrios Papadopoulos, MD, PhD Panayiota Papadopoulos, PhD Stelios Papadopoulos, PhD Athina Papadopoulou, MD Nikolaos Papamitsakis, MD Spyridon Papapetropoulos, MD, PhD Caroline Papeix, MD Maria Grazia Papini James Pappas, MD Eric Pappert, MD Ray Paprocky Guillermo Paradiso, MD, PhD Boguslaw Paradowski, PhD Alexander Parajeles, DO Maria Dolores Paramo Camino, MD Leila Parand, MD Melvin Parasram MS Matteo Pardini, MD Jorge Pardo, MD Carlos Pardo-Villamizar Roberto Paredes, MD Paras Parekh Sophie Parent BPharm, MSc Prachi Parikh, MD Neal Parikh, MD Simy Parikh Bill Paris, MBA Joseph Parisi, MD Jung Yeon Park, MD Katherine Park, MD Byung Park, MD Danny Park, MD Edwin Park, MD Soo-Hyun Park, MD Sung-Min Park, MD, PhD Sungmee Park

254

John Parker, MD Alicia Parker, MD Stephen Parker, MD, FAAN Andrea Parks, MD Natalie Parks, MD Fatma Yesim Parman, MD Andrea Parpart Beverly Parson Annie Partisano Ruby Parveen, MD Ville Parviainen, MD Nicholas Parziale, MD Asmo Pasanen Robert Paschall, DO Robert Pascuzzi, MD Marie Pasinski Noemi Pasquarelli, MD Giovanni Passiatore, PhD Marco Passini, PhD Alejandra Pastore, MD Usha Pasupuleti, BS Devakinanda Pasupuleti, MD Monika Patacq Sapijanskas, PhD Bhavana Patel, DO Jayesh Patel, DO Anjali Patel, DO Donika Patel, DO Harsh Patel, MBBS Rifali Patel, MBBS Urvish Patel, MBBS Smit Patel, MBBS, MPH Birenkumar Patel, MD Neil Patel, MD Neil Patel, MD Payal Patel, MD Roshni Patel, MD Viren Patel, MD Pratit Patel, MD Anup Patel, MD Himanshu Patel, MD Kevin Patel, MD Neepa Patel, MD

2017 AAN Annual Meeting On-site Guide

Roshan Patel, MD Shnehal Patel, MD Sandhya Patel, MD Hema Patel, MD, FAAN Chirag Patel, MD, PhD Nital Patel Minal Patel Rahul Patel Khyati Patel, NP Nikki Patel PharmD Payal Patel PharmD Teresa Patel PharmD Ankit Patel, PhD Hemali Patel, PhD Kiran Patil, MD Anuja Patil, MD, DM Neurology Kiran Patil Riddhi Patira, MD Rajiv Patni, MD Gillian Paton, MD Ryan Patrick, MD David Patry, FRCP, MD Gary Pattee, MD Bernard Patten, MD, FAAN Addie Patterson, DO Marc Patterson, MD Frederick Patterson, MD Shanna Patterson, MD Kristina Patterson, MD, PhD Bridget Patterson-Marshall, MD Eddie Patton, MD Justin Paturel,BSc, MSc William Pau MS Friedemann Paul, MD Lisa Paul, NP Jordan Paulson, MD Henry Paulson, MD, PhD, FAAN Sean Pauzauskie, MD Julia Pavelka, NP, APRN - BC Pantelis Pavlakis, MD, PhD Jan Pavlik, MD Milena Pavlova




Marta Penas-Prados Stanley Penc, MD, PhD Michael Pender, MD, PhD Aparna Pendurthi, MD Teng Peng, BS Xiangmin Peng, MD Xiaolan Peng Todd Penizotto Page Pennell Dana Penney, PhD Ellen Penney Amanda Pennington, MD, PhD Patricia Penovich, MD, FAAN Catherine Pepin Joanna Pera, MD P. Dana Peralta, MD Antonio Pereira Gomes Neto, MD Matheus Peres Claudia Perez, MD Angel Perez, MD David Perez, MD Amy Perez, NP Natalia Cristina Perez, PhD Frank Perez, PhD Enmanuel Perez, PhD Jennifer Perez WOI Coraly Perez Bajandas PharmD Cristina Perez Lago, MD Rafael Perez Noguera, MD Sahyli Perez Parra, MD Alfredo Perez-Canabal, MD Efrain Perez-Vargas, MD Margaret Pericak-Vance, PhD Adriana Perilla, MD Lilena Perisse Jonathan Perk, MD, PhD Joel Perlmutter, MD, FAAN Michael Perloff, MD, PhD Sherry Perlov, MD Carlos Perrello, MD Matthieu Perrenoud, MD Stephen Perrett, PhD

Randy Perrin Amy Perrin Ross, NP, RN, MSN, CNRN Christopher Perrone, MD Carlton Perry, MD, PA George Perry, PhD Jorge Pesantes, MD Jorge Pesquera, MD Douglas Pet Nils Peters, MD Katherine Peters, MD, PhD John Peters Ronald C. Petersen, PhD, MD, FAAN Astrid Petersen, PhD Nils Petersen Nicholas Peterson Kate Petheram MBChB, MRCP Gil Petitnicolas, PhD Rodica Petrea, MD Nicolae Petrescu, MD Jennifer Petrillo, PhD Rada Petrinjac-Nenadic, MD Ognen Petroff, MD, FAAN Melita Petrossian, MD Daniela Petrova, PhD, MBBS, MRCP Nikolaos Petsas, MD Russell Petter, PhD Jacqueline Pettersen, FRCP, MD John Pettinato, DO Juan Pettinichi, PhD Sandra Petty, PhD, FRACP, MBBS Caroline Peyronnard, MD Frederick Pfeiffer, MD Ronald Pfeiffer, MD, FAAN Norman Pflaster, MD Thong Pham, MD Tammy Pham Jennifer Phaneuf BN Phanyarat Phankhian, MD Maria Philip, MD Boulu Philippe Denis

255

REGISTRANTS

Jelena Pavlovic, MD, PhD Srinivas Pavuluri, MD Siddharama Pawate, MD Natalie Pawlak Marc Pawlitzki Richard Payne, MD Jeremy Payne, MD, PhD Jenniffer Paz, MD M. Mateo Paz Soldan, MD, PhD Ilker Pazarcioglu, MD Ladislav Pazdera, MD Robert Peach, PhD Phillip Pearl, MD, FAAN Richard Pearl, MD, FAAN Donald Pearl Eric Pearlman, MD, PhD Owen Pearson MB Bch, FRCP Dawn Pearson, MD Guerry Peavy, PhD Allan Thimsen Pedersen, MD Robert Pedersen, MD Bernard Pedespan, PhD Timothy A. Pedley, MD, FAAN Noorie Pednekar, MD Elizabeth Pedowitz, MD Carlos Pedraza, PhD Marzena Pedrini, PhD Jose Luiz Pedroso, MD, PhD Carrie Peek, MD Lindsay Peglar, MD Davut Pehlivan, MD Lisa Peicott Omer Peksen, MD Victoria Pelak Barbara Pelgrims, PhD Jonathan Pelikan, MD David Pellerin, MD, MSc Jean Pelletier, MD Daniel Pelletier, MD Paula Pelliza Amanda Peltier, MD Paivi Peltola


Annual Meeting Registrants Lauren Phillips, BS Joel Phillips, DO Yanny Phillips DO, PhD Justin Phillips, MD J. Theodore Phillips, MD, PhD, FAAN Amy Phillips PharmD Glenn Phillips, PhD Roderick Phillips, PhD Flavia Piazza, PhD Hernan Picard, MD Francoise Picarel, PhD Philippe Picaut PharmD Linda Piccinini, PhD Ezequiel Piccione, MD Shanthi Pichai Michael Pichler, MD Pilar Pichon, MD Allyson Pickard, MD Meg Pickard Lesley Pickford, PhD Mary Ann Picone, MD Robert Pierce, DO Jontel Pierce, MD Aimee Pierce, MD Mark Pierce MSc Alexandre Pieri, MD Serge Pierre-Louis, MD Michael Pietak, MD Andrei Pikalov Jagan Pillai, MBBS, PhD, MD Rammohan Pillai, MD, MBBS Jyoti Pillai, MD, MBBS, MR Frank Pimental Jesus Pina-Garza, MD Arnold Angelo Pineda, MD Lana Pinkhasov Lecio Pinto, MD Erik Pioro, MD, DPhil Luiza Piovesana, MD Mauro Roberto Piovezan, MD Joy Pipes

256

Amanda Piquet, MD Paulo Piquioni, MD Paula Pire Garcâ&#x20AC;&#x2122;a, MD Roxana Piris, PhD Noor Pirzada, MD, FAAN Ramdas Pisharody Maria Cecilia Pita, MD Nataria Pitiyanuvath, MD Verne Pitman PharmD Izabela Pitta, MD Sophie Pittion Vouyovitch, PhD Jennifer Pitts, MD Eric Pitts, MD Polyana Piza, MD Radim Piza, MD Sarah Planchon, PhD Michael Plaschke, MD Meril Platzer, MD Tatiana Plavina, PhD Alyson Plecash, MD Sandra Pleiser, PhD Milvia Pleitez, MD Perrin Pleninger, MD Conrad Plimpton MS Maureen Ploen PA Scott Plotkin, MD Ewa Pniak, MD Kieren Po, MBBS Saahith Pochiraju, BS Karan Poddar, MD Dieter Poehlau, MD Walter Poellmann, MD Werner Poewe, PhD Suyog Pol, PhD Juan Polanco, MD Robert Polans Shikha Polega PharmD Laurence Poliquin-Lasnier, MD Marios Politis Michael Pollack, MD Scott Pomeroy, MD, PhD Marcus Ponce De Leon, MD, FAAN

2017 AAN Annual Meeting On-site Guide

Ann Poncelet Michael Poon, MD, MBBS Veronica Popescu, MD, PhD Ljiljana Popovic BA Valentina Poretto, MD Peter Portegies, MD, PhD Alejandro Portela, MD Catherine Porter, MD Neil Porter, MD Lekiesha Porter John Porter, PhD Alyx Porter Claudine Portha, PhD Ruben Portier, MD Steven Portman, MD Fabio Porto, MD Jose Posas Anke Post, MD, PhD Joseph Post, PhD Michele Potashman, PhD Srinivasa Potluri, MD Sonja Potrebic, MD, PhD, FAAN Daniel Potts, MD, FAAN Justin Potuzak, PhD Pavel Potuznik, MD Frederic Potvin-Gingras, MD Michael Pourfar Rahman Pourmand, MD Guillermo Povedano, MD Alice Powell, MBBS Clydette Powell, MD Craig Powell, MD, PhD, FAAN Sarah Powers, NP Scott Powers, PhD Christine Pozniak Carlo Pozzilli, MD Aparna Prabhu, MD, MRCP Nisha Pradeep, DO Suraj Pradhan, PhD Neal Prakash, MD, PhD Neha Prakash Monika Prasad, MD




Mathew Pulicken, MD, MHS Irene Pulido Valdeolivas, MD Uma Pulipaka, MD, MBBS Seth Pullman, MD, FAAN Stefan M. Pulst, MD, FAAN Melissa Pulver Bloch, MD Svetlana Pundik Archana Puri Jennifer Purks Frank Pusey, MD Gunasundari Pushparasah, MD, MRCP Deepti Putcha, PhD Steve Putra, MD Indah Putri Swapna Putta, MD Araya Puwanant, MD Yelena Pyatkevich, MD Yebsun Pyon CPA Hebah Qashqari, MD Peiqing Qian, MD Lan Qin, MD, PhD Cuie Qiu, MD Jianhua Qiu, MD, PhD Cuc Quach PharmD Zhi Xuan Quak, MBBS, MRCP (UK) Schenley Que, MD Henry Querfurth, MD, PhD Mary Quiceno, MD, FAAN Adam Quick, MD Megan Quimby MS, CCC-SLP Colin Quinn, MD Gerardo Quinones Carlos Quintana, MD Juan Jose Quintana, MD Yeni Quintana, NP Michael Quiqueran-Beaujeu Nydia Quiroga, MD Delia Quiros Benedicte Quivron Ghazala Quraishi, MD Muddasir Qureshi, MD

Irfan Qureshi, MD Mohtashim Qureshi, MD Adnan Qureshi Gil Rabinovici, MD Adrian Rabinowicz, MD, FAAN Alejandro Rabinstein, MD Alex Rabodzey, PhD Brad Racette Caroline Racine Belkoura, PhD Michael Racke, MD Angela Rackley, MD Juan Racosta, MD Marta Radaelli, MD Kris Radcliffe, MD, PhD Sureshkumar Radhakrishnan, MD Fatai Radji, MD Shana Radomski Ivan Raets, MD James Ragland, MD Frank Ragone, PhD Vijayalakhmi Ragoor, MD Nagaveni Ragothaman, MD Simhachalam Raguthu, MD Elaine Rahal Fathima Gani Rahamathullah, PhD Yashar Rahimpour MS Mohammed Rahman, DO Shareena Rahman, MD Khawaja Rahman, MD Muhammad Rahman, MD Charles Rahming, MD Samhitha Rai, MD Pooja Raibagkar William Raino, MD Shruti Raja, MD Suraj Rajan, MD Ranjithkumar Rajendran, MD Alaleh Raji, MD Sanjay Rakhade, MD, PhD, MBBS Aiga Rakhesh, MBBS Goran Rakocevic, MD, FAAN Lovelle Ralls ARNP

257

REGISTRANTS

Madan Prasad, MD, MBBS Sashank Prasad Ilaria Prato Chenna Preetham, MD Marisa Prelack, MD Enrico Premi, MD Keerthivaas Premkumar Silvia Presas Rodriguez, MD Lise Prescott, MD Daniel Press Peter Pressman, MD Judith Prestifilippo, MD David Preston, MD, FAAN Paolo Preziosa, MD Donald Price, MD Raymond Price Adrian Priesol, MD Csilla Priest MSc Jessica Priest PharmD Maria Prieto Eibl, MD Katerina Prikrylova, MD Eric Prince, MD David Prince, MD Patricia Pring-Akerblom, PhD Tamara Pringsheim Devin Prior, MD Vera Prisacari, BS Halina Pritula, MD John Probasco, MD Ellyse Probst-Simmons Calin Prodan, MD Alessandra Protti, MD Laurel Provencher, PhD Amy Pruitt, MD Stanley Prusiner, MD, FAAN Harald Pruss, MD Boris Przytulski Kristy Pucylowski PharmD Bettina Puffer, MD John Pugh, MD, PhD Violeta Pukaite, MD John Pula, MD


Annual Meeting Registrants Jeffrey Ralph Nandhagopal Ramachandiran, MBBS, DM, FAAN, FRCP Tarakad Ramachandran, FRCP, MBBS, MD, FAAN Arun Ramachandran, MD Guhan Ramamurthy, MBBS, MD Venkat Ramani, MD, FAAN Balakrishnan Ramasamy, MD, MBBS Shankar Ramaswamy, MD Geetha Ramaswamy, MD, PhD Marc Ramby, BS Wyssem Ramdani, MD Ritesh Ramdhani, MD Mark Rametta, DO Nima Ramezan-Arab, MD, FAAN Francisco Eduardo Ramirez, MD Eder Ramirez, MD Paula Ramirez, PhD Verena Ramirez Campos, MD Sergio Ram’rez Garc’a, MD Adolfo Ramirez Zamora, MD Liliana Ramirez-Gomez, MD Denia Ramirez-Montealegre, MD, MPH, PhD Joanna Ramiro, MD Gail Melissa Ramiro Kottil Rammohan, MD Maria Cristina Ramo Tello, MD Vesper Ramos, MD Gustavo Ramos, MD Ines Ramos, PhD Ciro Ramos Estebanez, MD, PhD Mary Ramsey, MD Vicki Ramsey-Williams, MD, PhD Muhammad Ramzan, MD Sandeep Rana, MD Mandeep Rana, MD, MBBS Daniel Randa, MD Jaskaren Randhawa, MD, MBBS Stanley Rane, PhD

258

Manu Rangachari, PhD Ricardo Rangel Guerra, MD, FACP, FAAN Shabbir Rangwala, MBBS Surabhi Ranjan, MD Kelsey Rankin BA Anthony Ranno PharmD Gerhard Ransmayr, PhD Mary Ransom, MD Annemarei Ranta, MD, PhD, FRAC Terhi Rantamaki-Hakkinen, MD, PhD Shishir Rao, MD Anitha Rao, MD Neal Rao, MD Kimberly Rao, NP Samuel Rapoport, MD, PhD, FAAN Renee Rapp Tanaporn Rasameesoraj, MD Katya Rascovsky, PhD Mehmood Rashid, MD Basem Rashwan Fabrizio Rasi, MD, FAAN Michaela Raskova Peter Vestergaard Rasmussen, PhD Maimona Rasoully, NP, FNP-BC Tara Rastgardani Komal Rastogi, MD John Ratchford, MD Subhendu Rath, MBBS Timothy Rathbun, DO Geetanjali Rathore, MD Jaivir Rathore, MD Jeffrey Ratliff, MD Watcharasarn Rattananan, MD Elena Ratti, MD Gerd Rauch, MD Sebastian Rauek, MD Yasmeen Rauf, MBBS Shaista Rauf, MD Bhrugav Raval, MBBS Sandhya Ravikumar, MD

2017 AAN Annual Meeting On-site Guide

Pravin Ravishanker John Ravits, MD, FAAN Sapna Rawal, FRCP, MD Melissa Rayhill, MD Jordan Raynor, MD Elizabeth Raynor, MD Jenelle Raynowska Ahmad Raza, MBBS Sushil Razdan, MD, DM Sara Razmjou Marina Reade, NP Margie Ream, MD, PhD Carol Reames-Trotter Nicole Reams, MD David Reardon Gabriela Rebelo Jason Reckner Jeanine Reczek, MD Tianle Redanz, PhD Stephen Reddel Rajashekar Reddi, MD Robert Reddig, MD Sujan Teegala Reddy, MD Amit Reddy Anthony Reder, MD Ian Redmond DM, FRCP Janice Redmond, MD Douglas Redosh, MD Daniel Ree, MD Brady Reece Robert Reed, MD Sheridan Reed Michael Reed, PhD Scott Reedie Paul Rees, MBBS, MBA Paul Reese, MD James Reese, MD, MPH Luc Regal, MD Keren Regev, MD Alyssa Rehm, MD Stephen Reich, MD Daniel Reich, MD, PhD




David Rezendes Michael Reznik, MD Zahra Rezvani, MD, PhD Naji Riachi, MD John Ribaudo, MD Joana Ribeiro, MD Cristiane Ribeiro De Almeida A, PhD Irapua Ricarte, MD Manjula Ricciardi, FRCP Patricia Riccio, MD Cory Rice, MD Marcus Rice, MD, FAAN Kelli Rice, NP Benn Richards BA Jason Richards, MD John Richards Perry Richardson, MD Rita Richardson, MD Jordan Richardson John Richert, MD, FAAN Nancy Richert, MD, PhD Megan Richie, MD Angela Richmond, PhD Stephan Richter, MD Richard Richter Evan Riddle, PhD Steven Rider, MD Mohammad Ridha, FRCP, MBBS Larry Ridings, MD Erich Riederer, MD Rosario Maria Riel-Romero, MD, FAAN Scott Ries Zeno Righetti, MD David Riley, MD Ashley Riley, MD Patty Riley RN Claire Riley Sean Riminton, MBBS, PhD Kathryn Rimmer, MD Francesca Rinaldi, MD

Wilson Rincon Parra, MD Jeffrey Rind, MD, PhD Steve Ring, MD Steven P. Ringel, MD, FAAN Jon Riolo, PhD Olga Rios, MD Gregory Rippon Jorge Risco, MD Barry Jay Riskin, MD Peter Riskind, MD, PhD Gail Risse, PhD Pamela Rist, PhD Elissa Ritt MAS Eva Ritzl, MD Alda Rivara Castro, MD Victor Rivas, MD Yaron River, MD KAREN RIVERA, MD Ivia Rivera Agosto, MD Alberto Rivero, MD James Riviello, MD Jihad Rizkallah, MD Dominick Rizzi, MD Matthew Rizzo, MD, FAAN Maria Rizzo PA Paul Rizzoli, MD, FAAN E. Roach, MD, FAAN Laurie Robak Daphne Robakis, MD Matthew Robbins, MD Michael Robbins, MD Nathaniel Robbins, MD Kathryn Roberts, MD Leslie Roberts, MD Rosebud Roberts, MD Kirk Roberts, MD Jetter Robertson DO, MD Edgar Robertson, MD Matthew Robertson, MD Wendy Robertson, MD, FAAN Kimberly Robeson, MD Albert Robichaud, PhD

REGISTRANTS

Loes Reichman, MD Valerie Reid, MD Lucienne Reid-Duncan, MD Daniel Reiff Jaimee Reiley PharmD Amanda Reimer, MD Dacy Reimer, NP Regine Reimers, DO Stephen Reingold, PhD Ricardo Reisin, MD Birgitt Reisinger-Voglmayr Stephanie Reiter Sandra Reiter-Campeau Konrad Rejdak, PhD Maja Relja, MD Noel Reloj, MD, PSC Rahul Remanan, MBBS Greg Remigio, PhD Zheng Ren, PhD Carla Renata Aparecida Vie, MD Swetha Renati Susanne Renaud, MD Nadia Renckens Beatrice Rendenbach-Mueller, PhD Mary Rensel, MD Pavle Repovic, MD, PhD Karin Rerat, MD Maria Bernadete Resende, MD Melissa Rethana, MD Reinhard Reuss, MD Anna Revellat, MD Fredy Revilla, MD, FAAN Saul Reyes, MD Kristina Reyes PharmD Maria Teresa Reyes Alvarez, MD Dannaly Reyes-Baerga, MD Yolanda Reyes-Iglesias, MD Adam Reynolds, MD Wesley Reynolds, MD Patrick Reynolds Flรกvio Rezende Costa, MD Juliana Rezende Dutra, MD

259


Annual Meeting Registrants Osama Robin Elalamy, FRCP, MD Carl Robinson, MD Maisha T. Robinson, MD, MS Randy Robinson, PhD Rebecca Robinson Jessica Robinson Papp, MD, FAAN Ana Robles, MD, FAAN Maria Assunta Rocca, MD Walter Rocca, MD, MPH Emanuela Roccato, MD Katherine Roche Susana Roche, PhD Lance Rodan, MD Marcelo Rodrigues, MD Bernardo Rodrigues, MD, PhD Marcia Rodrigues, MD, PhD Marta Rodrigues Da Costa Rafael Rodriguez, MD Rodrigo Rodriguez, MD Diana Rodriguez, MD Ramon Rodriguez, MD, FAAN Jeronimo Rodriguez, MD, FAAN Christian Rodriguez Jorge Rodriguez, PhD Alejandro Rodriguez, PhD Abiezer Rodriguez Centeno, MD Adrian Rodriguez Hernandez Margarita Rodriguez Lens MSci Ildefonso Rodriguez-Leyva, MD, FAAN Federico Rodriguez-Porcel, MD David Roeltgen, MD, FAAN Erika Roers Nora Roesch, MD David Rog, MD, FRCP Nancy Rogacki, PhD Michael Rogawski, MD, PhD Nicole Rogers, MD Jennifer Roggenbuck MS, CGC Kathryn Rogotzke FNP Lisa-Sophie Rohner Luisa Rojas, MD

260

Julio Rojas, MD, PhD Jitka Rokytova, MD Rafal Rola, PhD Jessica Roland, PhD Henrik Rolsted M.Sc. Gustavo Roman, MD, FAAN Samantha Roman Alissa Romano, DO Jose Romano, MD Lucas Romano, MD Gary Romano, MD, PhD Jacob Romano PharmD James Romanowsky, MD Meghan Romba, MD Michael Rome, PhD Andrew Romeo, MD Jerome Romero Dario Ronchi, PhD Lingling Rong, MD Pezhman Roohani, MD Melissa Rooney, MD Timothy Rooney Katrin Roos, MD Raymond Roos, MD, FAAN Karen Roos Ashley Roque, MD Gleysson Rosa, MD, RN Luis Rosales, DO Xiomara Rosales, MD Raymond Anthony Rosales, MD Silvio Rosales, MD Julieta Rosales, MD Jonathan Rosand Iwona Rosciszewska -Zukows, PhD Michael Rose, FRCP, MBBS, MD John Rose, MD Lee Rose RN Katie Rosell Noah Rosen, MD Howard Rosen Philip Rosenbaum, BS Roger N. Rosenberg, MD, FAAN

2017 AAN Annual Meeting On-site Guide

Jay Rosenberg, MD, FAAN Gilead Rosenberg, MD, MSc Peter Rosenberger, MD, FAAN Michael Rosenbloom, MD, FAAN Nicole Rosendale, MD Michael Rosenfeld, MD Jeffrey Rosenfeld, MD, PhD, FAAN Thorsten Rosenkranz, MD Johanna Rosenthal, MD Adriana Rosero-Enriquez, MD Yelena Roshchina DO, MD Christian Rosker PharmD N. Paul Rosman Ina Rosnizeck, MD Stephen Ross, BS Marjorie Ross, MD Mark Ross, MD, FAAN M. Elizabet Ross, MD, PhD Leonardo Rosello, MD Stefano Rossetti, MD Kyle Rossi, MD Horacio Rossi, MD Natalia S. Rost, MD, FAAN Mohamad Rostami, MD, PhD, FAAN Robert Rosti MSc. DHEd Serge Roth, MD Heidi Roth, MD, FAAN William Roth Julie Roth Stephanie Rothman, DO Alissa Rothman Joel Rothman John Rothrock, MD Biliana Rotse, PhD Dalia Rotstein, MD Francisco Rotta, MD Guy A. Rouleau, MD, PhD Elizabeth Rountree, MBA Stephen Roush PharmD Alessandra Rovescalli, PhD Maria Roveta, MD




Ilene Ruhoy, MD, PhD Andrea Ruiz BGS Marta Ruiz Lopez Juan Luis Ruiz Pena, MD Lokesh Rukmangadachar, MBBS, MD Sean Ruland, DO Melissa Rumple, NP Tatjana Rundek, MD, PhD Heloisa Helena Ruocco, PhD Lesli Rusche-Skolarus James Russell DO, FAAN Michael Russell, MD, PhD, DrMe Andrew Russman, DO Andrew Russo, BS Louis Russo, MD, FAAN Alice Rutatangwa, DO Jonathan Rutchik, MD, MPH, FAAN Doungporn Ruthirago, MD Seward Rutkove, MD Jori Ruuskanen, MD Petr Ruzicka, MD Keith Ryan BA Aisling Ryan MB, PhD, FRCPI Conor Ryan, MD Hewitt Ryan, MD Richard Ryan Sophia Ryan Eva Rybak PharmD Erik Rydin, MD Angela Rydinsky Danuta Ryglewicz, MD, PhD Wi-Sun Ryu, MD, PhD Ali Saad, MD Fahed Saada, MD Leila Saadatpour, MD Altaf Saadi Henna Saarialho-Kahila, MD Barbara Saba, MD Guido Sabatella, MD Ali Saber Tehrani, MD

Somayyeh Sabet, MD Priyanka Sabharwal, MD, MBBS Civele Maria Sabido David Thomas Sabin, MD, FAAN Valeriy Sabodash, MD Mark Sabra, MD Amin Sabra, MD Emmanuel Saby, MD Francesco Sacca, MD Daniel Sacchetti, DO Ralph L. Sacco, MD, MS, FAHA, FAAN Noor Sachdev, MD Harmeet Sachdev, MD, FAAN Monisha Sachdev Kapil Sachdeva, MD Stephen Sachs, MD, FAAN Ned Sacktor, MD Horacio Enrique Sacristan, MD Shankar Sadasivan, PhD Rajesh Sadasivuni, MD Zahra Sadat-Hossieny Marjan Sadeghi PharmD Kamal Sadjadpour, MD, FAAN Mary Sadler, NP Carl Sadowsky, MD, FAAN Ghazaleh Sadri-Vakili, PhD Mostafa Sadry, MD Neema Sadry Umair Saeed, MD Ali Saeed, MD Arash Safaei, PhD Joseph E. Safdieh, MD, FAAN Omar Safi, MD Jessica Sagen BA Vishwanath Sagi, MD Shankar Saha, MBBS, MD Kamala Saha Kinshuk Sahaya, MD Farhad Sahebkar-Moghaddam, MD Zeynep Sahin, MD Mustafa Sahin, MD, PhD

261

REGISTRANTS

Fiona Rowland Louis Roy, FRCP, MD Bhaskar Roy, MD Reshmi Roy, MD Gulmohor Roy, MD Trishit Roy, MD Vincent Roy MSc Shumita Roy, PhD Walter Royal, MD Aprile Royal Todd Rozen, MD Eduard Rozner, MD Csilla Rozsa, MD Arminda Maria Ruano Hernandez, MD Jacob Rube, MD Helene Rubeiz, MD Elayna Rubens, MD Hernando Rubiano, MD Bruce Rubin, MD, FAAN Michael Rubin, MD, MA Daniel Rubin, MD, PhD Glenna Rubin RN Devon Rubin Ivana Rubino Clio Rubinos, MD Roman Rubio, MD Silvina Rubiolo, MD Janet Rucker, MD Klaus-Peter Rude Iakov Rudenko, MD, PhD Marvin Ruderman, MD, FAAN Stacy Rudnicki, MD Despina Rudolf, MD Sarah Rudolph, NP Monika Rudzinska Ă? Bar PharmD Aurelie Ruet, MD Emily Ruether, MD Ilana Ruff, MD Dustin Ruff Pascal Rufi, MD Marcelo Rugiero, MD


Annual Meeting Registrants Bogachan Sahin, MD, PhD Kristen Sahler, MD Nina Sahlin, MD Leonard Sahn, MD Ramandeep Sahni, MD Pradeep Sahota, MD, FAAN Areen Said, MBBS, MD Marianne Said, MD Rana R. Said, MD Sarita Said Said, MD Vasu Saini, MD Marie-Helene Saint-Hilaire, MD, FRCPC, FAAN Yuji Saitoh, MD, PhD Kalyan Chekravarthy Sajja, MBBS Sarada Sakamuri, MD Paraskevi Sakka, DO Ai Sakonju, MD Ken Sakushima, MD, PhD Mohammad Salajegheh, MD, FAAN Fawzy Salama, MD Karim Salame, MD Johnny Salameh, MD Leslie Saland, MD Arash Salardini, MBBS Rachel Marie Salas, MD Gerardo Carmelo Salazar, MD Yasir Saleem, MD Mohammad Saleem Setareh Salehi Omran, MD Constanza Salera, PhD Efrain Salgado, MD Mireille Saliba Joel Salinas Salomi Salins, MD, MBBS, MD Janet Salisbury, NP Irma Saliu PharmD Kristin Salottolo MPH Laura Saltonstall, MD Catherine Salussolia, MD, PhD Meenakshi Sundaram

262

Salvadeeswaran, MBBS, MD David Salvatore, DO Rachel Salzman DVM Maria Sam, MD, FAAN Frederick Samaha, MD, FAAN Edgar Samaniego Verena Samara, MD Michael Samaras, PhD Ranmal Samarasinghe, MD, PhD Johnny Prudentius An Samijn, MD Behrang Saminejad, MD Lawrence Samkoff, MD, FAAN Radhika Sampat, DO Ajay Sampat Stephen Samples, MD Jacinda Sampson, MD, PhD Rohini Samudralwar, MD Vijay Samuel, MD Devprakash Samuel, MD Sophie Samuel PharmD Martin Samuels Pyay San Marta San Luciano Sirisha Sanamandra, MBBS Ricardo Sanchez, DO Leopoldo Sanchez, MD Ana Sanchez, MD Benjamin Sanchez, PhD Pedro S‡nchez L—pez, PhD Pablo Sanchez Lozano, MD Isabel S‡nchez Magro, PhD David S‡nchez Matienzo, PhD Olga Sanchez Solino, MD Julian Sanchez-Bautista Maria Sanchez-Quintero, PhD Marie Sanchirico, PhD Joaquin Sancho Gomez PharmD Magnhild Sandberg-Wollheim, MD, PhD Friedhelm Sandbrink, MD Rupert Sandbrink, MD, PhD Howard Sander, MD, FAAN

2017 AAN Annual Meeting On-site Guide

Amy Sanders, MD, FAAN Eric Sanders, MBA Katrien Sanders, MD Keith Sanders, MD, FAAN Alan Sanderson, MD Julyne Sandes Pernilla Sandgren, MD Yuksel Sandikci, MD Claire Sandoe Alfred Sandrock, MD, PhD Stefano Sandrone Paola Sandroni, MD, PhD, FAAN Sherry Sandy, MBBS Francesca Sangalli, MD Navdeep Sangha, MD Dipen Sangurdekar, PhD Mohammed Sanjak, PhD, PT June Sanson Rodrigo Santamarina, PhD Alexandra Santana Almansa Lenay Santana-Gould, MD Sherry Santiago Castro, MD Carla Santiago Martinez MS Rocio Santibanez, MD Veronica Santini Bianca Santomasso, MD Maria Santos, MD Hector Santos, MD Carmen Santos, MD Andre Santos, MD, PhD Ayanna Santos Laura Santoso Sourav Santra, PhD Giuseppe Santuccio, MD Mariana Sanvitale Clifford Saper, MD, PhD David Saperstein, MD Francine Saperstein MS, HCAD Biggya Sapkota, MBBS Bishnu Sapkota, MD Mario Saporta, MD, PhD, FAAN Gustavo Saposnik, MD




Steve Scarbrough RN, MBA Cora Scarlet RN Stephen Scelsa, MD Bernd Schade, MD Jan Schadrack, MD Sara Schaefer, MD Barbara Schaeffler Barbara Schaeuble, MD, PhD Randall Schapiro, MD, FAAN Frauke Schapmann Eugene Scharf, MD Jeremiah Scharf, MD, PhD Douglas Scharre, MD Randall Schatzman, PhD Robyn Schecter, PhD Zach Scheiner, PhD Elke Schel Matthew Schelke Robert Schell, MD Peter Schellinger, MD Carlos Schenck Christian Schenk, MD Patricia Schepman, PhD, MS, PharmD Ann Scher, PhD Steven Scherer Jacqueline Scherpenisse, MD Clemens Scherzer, MD Richard Scheyer, MD David Schiff Emmanuelle Schindler, MD, PhD Matthew Schindler, MD, PhD Markus Schirmer, PhD Ingo Schirotzek, MD Regina Schlaeger, MD Helen Schleimer, MD Antonio Schlesinger, MD Emily Lane Schlitz Fortenberry, MD Marc Schlosberg, MD Evan Schloss, MD Jeremy Schmahmann Sonja Schmid

Sabine Schmidt, MD Elena Schmidt, MD John Schmidt, MD Stephan Schmidt, MD Pete Schmidt, MD Holger Schmidt, MD, Prof. Dr. Bernd Schmidt, MD, PhD Hollie Schmidt MS Peter Schmidt, PhD Christiane Schmied, PhD Christian Schmiegelt Andreas Schmitt, MD Frank Schmitz, MD Christian Schnaas, MBA Logan Schneider, MD Adam Schneider, MD Alexander Schneider, MD Eugene Schneider, MD Susan Schneider Williams Fred Schnell, PhD Kerri Schoedel Ellen Schoen, NP Ben Schoenbachler, MD Ellen Schoenberger RPh Niels Schoenmaker, PhD Vinicius Schoeps, MD Marius Scholtz, MD Eric Schon, PhD Michael Schonberger DO, MBA Ronald Schondorf, MD, PhD Katlijn Schotsmans, MD Katrina Schrader MA, CCRP Marcus Schramm Jennifer Schreiber, BS, CPPM cert Teri Schreiner Chad Schroer Ryan Schubert Stephan Schuele Lori A. Schuh, MD, FAAN Hans-Michael Schult, MD Thomas Schulten, MD David Schultz, FRCP, MBBS, FRACP

263

REGISTRANTS

Sandhya Sapra, PhD Frank Saracco PharmD Taylor Saraceno,BSc Stayko Sarafov, PhD Sasmit Sarangi, MBBS, MD Shirly Sarfati BA Ma. Socorro Sarfati, MD Erdem Sarikaya, MD Rani Sarkis, MD, MSc Anand Sarma, MD Amrou Sarraj, MD Harini Sarva, MD Ahsan Sarwani, FRCP, MBBS Aliya Sarwar, MD Tomislav Sasko, MD Mananya Satayaprasert, MD Aimee Sato, MD Neda Sattarnezhad, MD Shekhar Sattiraju, MBA Benjamin Saunders, MD Rachel Saunders-Pullman Timothy Saurer, PhD Tim Sautner, MBA Benjamin Savage, DO Belinda Savage-Edwards, MD Rodolfo Savica, MD, PhD, MSc Anthony Savino, MD Daniel Savitt, DO Filippo Savoldi, MD Feray Savrun, DO Lina Savsek Constantinos Savva Paul Sax, MD Anand Saxena, MD, MBBS Ritu Saxena, PhD Deanna Saylor, MD, MHS Mouaz Sbei, MD Saleh Sbeiti, MD Joseph Scamardo, MD Thomas Scandura, NP Luis Scarabelot, MBBS Susan Scarberry, MD


Annual Meeting Registrants Hans Schulz, MD Andreas Schulz, MD Courtney Schusse, MD Nathaniel Schuster, MD Erica Schuyler, MD Stefan Schwab, MD Roland Schwab, MD Matthias Schwab, PhD Lee Schwamm, MD Horst Schwan, MD John Schwankhaus, MD Robin Schwartz, MD Tamara Schwartz, MD Kenny Schwartz, MD Neil Schwartz, MD, PhD Nicholas Schwartz Marianne Schwarz, MD Anisha Schwarz, MD Heidi B. Schwarz, MD, FAAN Stefan Schwarz, MD Michael Schwarzschild, MD, PhD Todd Schwedt Ty Schwertfeger, MD Julia Schwientek Guilherme Sciascia Do Olival, MD Angela Scicutella, MD, PhD Marla Scofield Daniel Scoles, PhD Erika Scott BMSc Courtney Scott, FRCP, MD Thomas Scott, MD Timothy Seabrook, PhD Eric Seachrist, MD Meagan Seay, DO Russell Seay PharmD Joseph Sebastian, MD Guillaume Sebire, MD, PhD Jennifer Seda, MD Tricia See ScM Lauren Seeberger, MD, FAAN Pierrette Seeldrayers John Seeley, MD

264

William Seeley Christopher Seet, MBBS Sasa Sega Jazbec, MD J Bradley Segal BA, BS Olga Segal, MD Elsa Segaut Sandeep Sehgal, MD, MBBS Tad Seifert, MD Manuel Seijo-Martinez, MD Martin Seiler, MD Nicolas Seiller, PhD Syndi Seinfeld, DO James Sejvar Krithiga Sekar, MD, PhD Harmehr Sekhon B.Sc., M.Sc. Candida Richard Selbst, MD Daniel Selchen, MD Victoria Selesnick Christa Seligman, NP Yury Seliverstov, MD, PhD Johann Sellner, MD Krzysztof Selmaj, MD, PhD Arul Selvan, MBBS, MD, DM, FREP Megan Selvitelli, MD Linda Selwa, MD, FAAN James Selwa, MD, MBA Sergio Semeraro Jordy, PhD Adnane Semlali, DO Ugur Sener, MD Thomas Senf, MD Elizabeth Seng, PhD Tanya Sengupta Joshua Seno Maria Leonor Sequeira, MD Fatema Serajee, MBBS Natalia Serdiuk, MD, PhD Stephen M. Sergay MB BCh, FAAN Abbas Serhan, MD Zakhar Serkin, MD Jose Antonio Serra Carneiro, MD Carmen Serrano, MD, FAAN

2017 AAN Annual Meeting On-site Guide

Alberto Serrano-Pozo, MD, PhD Chad Service Sudha Seshadri, MD, FAAN Kallol Set, MD David Setboun Kapil Sethi, FRCP, MD Ranjit Sethi, MD Prahlad Kumar Sethi, MD, FAAN Nitin Sethi, MD, MBBS, FAAN Suroto Setijorumekso, MD, PhD, FAAN Michelle Settle, PhD Matthew Sexson Laura Seynaeve, MD Syed Shabbir, MD Anna Shadman,BSc Neelofer Shafi, MD Laura Shafner MSc Vishal Shah, MBBS Akshay Shah, MBBS, MD Kavit Shah, MD Syed Shah, MD Binit Shah, MD Dhara Shah, MD Reena Shah, MD Swati Shah, MD Syed Shah, MD Nidhi Shah, MD Dhenuka Shah, MD Aashit Shah, MD, FAAN Sunit Kumar Shah, MD, MBBS Jesal Shah MS Arya Shah Dhara Shah PharmD Nimish Shah PharmD Fereydoun Shahrokhi, MD, FAAN Aziz Shaibani, MD, FAAN Nawal Shaikh, MBBS, MD Abdul Shaikh, MD Lydia Shajenko, MD, PhD Susan Shake MS Hussam Shaker, MD




Zubeda Sheikh, MD Sarah Sheikh, MD, BM Bch, MSc, MRCP Muhammed Sheikh, MD, MBBS Lila Sheikhi, MD Yilin Shek, MD Shashank Shekhar, MD, MSc Amit Shelat DO, FACP Renee Shellhaas Edlira Shemsi, MD Lihong Shen, MD Ding Guo Shen, MD Mary Elizabeth Reed Shenk MHSA Joel Shenker, MD, PhD Martin Shenkman PC Anant Shenoy, MD Carol Sherako William Sheremata, FRCP, MD, FAAN Alexander Sherman ABD Maushmi Sheth, MD Kevin Sheth, MD, FAAN Raj Sheth Wen Shi, PhD Perry Shieh, MD, PhD Ludy Shih Jerry Shih Hyung Shim, MD Jean Shimazaki, MD Keiko Shimohata, MD Takayoshi Shimohata, MD, PhD, FAAN Cheolsu Shin, MD Kyong Jin Shin, MD Lauren Shin, MD Hitoshi Shinotoh, MD, PhD Paul Shipkin, MD Afsaneh Shirani, MD Minta Shirley, NP, CNP Ka Lock Shiu, FRCP, MBBS,MRCP M M Arun Shivaraman, MBBS, MD,, NP, D M Rosita Shivdat-Nanhoe, MD Sara Shnider, PhD John Shoffner, MD

Mikio Shoji, MD Glenn Short PharmD Eslam Shosha, MD Wei-Li Shou Ira Shoulson, MD, FAAN Stephen Shrewsbury, MBBS Arpan Shrivastava Natasha Shroff, BS Dinesh Shroff, MD, MBBS Alexander Shtilbans, MD, PhD Anukrati Shukla, MBBS Vijeta Shukla, MD Chirag Shukla, MD, FAAN Aishwarya Shukla Kenneth Shulman, DO Julie Shulman, MD Lisa M. Shulman, MD, FAAN Joshua Shulman, MD, PhD Katherine Shulman, NP Jennifer Shum, MD Pauline Shum Derrick Shumate, DO Michael E. Shy, MD Xiaohong Si, MD Siavoche Siassi MPH, MBA Francesca Siclari, MD Nancy Sicotte, MD Omar Siddiqi Teepu Siddique, MBBS, MD, FAAN Mustafa Siddiqui DO, MD, FAAN Junaid Siddiqui, MD Ursela Siddiqui, MD Sitwat Siddiqui Andrew Siderowf, MD William Siders, PhD Tatiana Sidorenko Chad Siegall Irwin Siegel, MD James Siegler Kurt Sieloff, MD Eric Siemers Susan Sifers, MD Karl-Otto Sigel, MD Bruce Sigsbee, MD, FAAN

265

REGISTRANTS

Maryam Shakir Daniel Shalev, MD Lauren Sham, MD Ejaz Shamim, MD, MBA, MS Aamir Shamim Choudry Fadi Shammas, MD Lakshmi Shankar, MD Nandita Shankar, MD Sai Shankar, PhD Srinivas Shankara, PhD Vicki Shanker, MD Mahmoud Shaqfeh, MD Vera Sharashidze, MD Safiullah Shareef, MD Susan Sharifi, MD Tara Sharma, DO Priya Sharma, DO Kartikeya Sharma, MBBS Sushma Sharma, MBBS, MD, DM, DNB Bhavana Sharma, MD Malveeka Sharma, MD Akanksha Sharma, MD Sanjay Sharma, MD Vibhash Sharma, MD Neil Sharma, MD Rohitash Sharma, MD, MBBS Nutan Sharma, MD, PhD, FAAN Pooja Sharma Basil Sharrack, MD, PhD, FRCP, FAAN Michael Shaw, BS Abdel Hakim Shawki, MD, FAAN Mikhail Shchepinov, PhD Molly Shea Deborah Sheahan Amgad Shebl, MD, MBBS Joshua Sheehan Stephanie Sheffield, MD Jeremy Shefner, MD, PhD Mohamed Shehab-Eldin, MD Ali Sheharyar, MBBS, MD Sohail Sheikh, MBA Syema Sheikh, MD


Annual Meeting Registrants Gudrun Rosa Sigurdardottir, MD Marvin Sih, MD Vincenzo Silani, MD Elizabeth Silayuv, PhD Michael Silber Donald Silberberg, MD, FAAN Shai Silberberg, PhD Elizabeth Silbermann Stephen Silberstein, MD, FAAN Jussi Sillanpää Pedro Silva, MD Elza Silva, MD, PhD Carlos Eduardo Silva M. Catarina Silva, PhD Robert Silva, PhD Diego Silva Jose Silva Cuellar, MD Diosely Silveira, MD, PhD Maya Silver BA Brent Silver David Silverberg, MD Stuart Silverman, MD, FAAN Andrew Silverman Scott Silverman Nicholas Silvestri, MD Rosalia Silvestri-Hobson, MD Mateus Simabukuro, MD Kristina Simacek MA Mark Simaga, MD Yohannes Simeneh, MD Steven Simensky, MD, PhD Laura Simionescu, MD Caio Vinicius Simioni, MD Richard Simmons, MD Zachary Simmons, MD, FAAN Andrea Simmons, NP Daniel Simmons Magdolna Simo, MD Marta Simone, MD Marialaura Simonetto, MD Manuel Javier Simon-Talero Horga, MD Kristina Simonyan, MD, PhD Ericka Simpson, MD David Simpson, MD, FAAN

266

Philipp Simschitz, MD Tanya Simuni, MD Vladimiro Sinay, MD David Sinclair, MD Christian Sindic Barry Singer, MD Carlos Singer, MD Harvey Singer, MD, FAAN Wolfgang Singer Simran Singh, DO Parduman Singh, MBBS Mohinder Singh, MBBS, MD Neeraj Singh, MD Amrinder Singh, MD Dharampreet Singh, MD Mini Singh, MD Deepinder Singh, MD Tarvinder Singh, MD Anuradha Singh, MD Baljinder Singh, MD Ravinder Singh, MD Shaily Singh, MD Sanjay Singh, MD, FAAN Anil Singh, MD, MBBS Avinash Singh, MD, MBBS Karun Singh, PhD Mamta Singh Vineeta Singh Divya Singhal, MD Aneesh Singhal, MD Anil Singhal, MD Sonia Singhvi J. Singleton, MD Andrew Singleton Nisha Sinha, MD Swapan Sinha, MD Manish Sinha, MD, MBBS Rahul Sinha, MD, MPH Saurabh Sinha, MD, PhD Dong in Sinn, MD Amy Sinor-Anderson, PhD Daniel Sinsimer, PhD Martina Sintzel, PhD Sue Faye Siow, MBBS

2017 AAN Annual Meeting On-site Guide

Yunus Sipal Georgi Sirakov, PhD Pooja SirDeshpande, MBBS Michael Sirdofsky, MD Abdelazim Sirelkhatim, MBBS, MD, FAAN David Sirken, DO Ashok Sirsat, MD Joseph I. Sirven, MD, FAAN Lila Sirven Villaros Daniella Sisniega Lucian Sitwell, MD Jenny Siv, MD Aksel Siva, PhD Mark Sivak, MD Chitra Sivasankar, MD Lalitha Sivaswamy, MD Kasia Siwek Simona Skerjanec, MD Demetrios Skias, MD Philip Skidd, MD Vladimir Skljarevski Franck Skobieranda, MD Martin Skoda Brett E. Skolnick, PhD Monica Skordilis, MD Christian Skulina, MD Monika Skutova, MD Irina Skylar-Scot Isabella Slaby Jeremy Slater, MD Jaroslaw Slawek, PhD Mark Slee, MBBS, PhD David Sletten, MBA J. Scott Sloka, MD, PhD Julia Slotwinski MSc Agnieszka Slowik, PhD Juan Small, MD Steven Small, MD, PhD, FAAN Christopher Smelick, MD Keith Smetak Joanne Smikle, PhD Dawn Smilek, MD, PhD James Smirniotopoulos Suzanne Smith,BSc(Hons)MSc




Piotr Sobolewski, PhD Eufemio Sobrevega, MD Leonor Sobrevega, MD Achinoam Socher, MD Frank Soergaard, MD Gad Soffer, MBA Derrick Soh, MBBS Peter Soh, MD Michael Soileau, MD Merja Soilu-H nninen, MD Lauri Soinne, MD, PhD Jorge Daniel Ma Anto Solana Silveira, MD Valerie Soland, MD Marylou Solbrig, MD Nina Solenski, MD Betty Soliven, MD Ulla Sollenberg, PhD Benjamin Solomon, MD Diane Solomon, MD Seymour Solomon, MD, FAAN Gail Solomon, MD, FAAN Andrew Solomon Guillermo Solorzano, MD Payam Soltanzadeh, MD Teesta Soman, MD, MBBS Suresh Somani, MD, MBBS Anna Somerto, MD Kenneth Sommerville, MD, FAAN R Sommerville Kishori Somyreddy, MD Aziz Sonawalla, MD Ali Sonbaa Lisbeth Sonderskov Jun Sone, MD, PhD Nancy Song, MD Sarah Song, MD Shlee Song, MD Suying Song, MD Hong Ki Song, MD, PhD Helen Song MS HyunJin Song, BS Yang Song, PhD Madhu Soni, MD

Shruti Sonni, MD Aleena Soomro, MBBS Bashir Ahmed Soomro, MBBS, FCPS Sopio Sopromadze, MD Per Schmidt Sorensen, MD Per Solberg Sorensen, MD, PhD, FAAN Farzaneh Sorond, MD, PhD Veronica Sosa, MD Maria del Milagro Sosa, MD Hugo Sotelo, MD Ma. Felicidad Soto, MD Oscar Soto, MD, PhD Javier Sotoca Fernandez, MD Nizar Souayah, MD, FAAN Frederique Souchon, FRCP Lamprini Soufleri, MD William Souillard-Mandar Masters Fereshteh Soumekh, MD Alessandro Sousa, MD Livia Sousa, MD Andrew Southerland, MD Andrezza Souza, MD Andre Souza, MD Michael Sowell, MD Aysun Soysal, MD Marco Soza, MD Rebecca Spain Magnus Spangsberg Boesen, PhD Steven Sparagana, MD Susan Sparks, MD, PhD Jennifer Sparks, NP,, NP-C Steven Sparr, MD Rossella Spataro, MD, PhD Marianna Spatola, MD, PhD Christopher Spears, MD Roderick C. Spears, MD sean spears Sarah Spence, MD, PhD Karen Spencer, MD, MD, MS, MPH Danielle Spengler, MD Dylan Sperling BA Judith Spies, MBBS, PhD Lorraine Spikol, MD

267

REGISTRANTS

Ryan Smith, DO Brien Smith, MD, FAAN Jeff Smith, FRCP, MD Andrew Smith, MD Stacy Smith, MD A. Gordon Smith, MD, FAAN Andrew Smith, MD Daniel B. Smith, MD, FAAN Marsha Smith, MD Cheryl Smith, MD Derek Smith, MD Jonathan Smith, MD Kara Smith, MD Kristen Smith, MD Stanya Smith, MD Bryan Smith, MD Richard Smith, MD Don Smith, MD, FAAN Dennis Smith, MD, FAAN Wade Smith, MD, PhD Bonnie Smith Megan Smith, NP Sarah Smith, NP, CRNP Michael Smith, PhD Terence Smith, PhD Debbie Smith, PhD Michael Smith, PhD Eric Smith Pete Smith Amy Smith-Rewse Bart Smits, MD, PhD Joost Smolders, MD, PhD Kyle Smoot, MD Duncan Smyth, MD Joan Smyth, PhD Elizabeth Smyth O. Snead, MD, FAAN Gilbert Snider, MD B. Joy Snider, MD, PhD David Snyder, MD Daniel Snyder, PhD Heather Snyder, PhD Yuen So, MD, PhD Elson So


Annual Meeting Registrants Salvatore Spina, MD, PhD Meredith Spindler, MD Casey Spinelli Warren Spinner, DO Paul Spira MB, BS, MD A Spitzer, MD Alfred Sebastian Spitzer, MD Kristi Spitzmueller PharmD Luciano Sposato, MD Mellanie Springer, MD Susan Springer Douglas Sproule, MD Gizelle Spurgeon, MD Charles Spurlock, PhD David Squillacote, MD Trevor Squire, DO Arvind Sreedharan Anirudh Sreekrishnan Sugandhi Sridharan, MD, MBBS Ragini Srinivasan, MD Shraddha Srinivasan, MD Avathvadi Srinivasan, MD, FAAN Jayashri Srinivasan, MD, PhD, MRCP, FAAN Subramaniam Sriram, MD Ratika Srivastava, MD Sanjeev Srivastava, MD Erik St. Louis, MD William Stacey Jessica Stachyra, DO Christopher Stack, MD Kristin Stacy C-TAGME Mark Stacy, MD, FAAN Bianca Stadler Nathan Staff, MD, PhD Eddie Stage BA Justin Stahl, MD Randall Stahly, DO Julia Staisch MS David Stamler, MD Melanie Standridge PharmD Emily Stanford James Stankiewicz Bruno Stankoff, PhD

268

Serge Stankovic, MD, PhD Michael Stanley AB Tom Stanton MS Richard Stark FRACP, MBBS James Stark, MD Aleksandra Stark-Laudate, MD Jamie Starks, MD Amaal Starling, MD Gary Starling, PhD Geoffrey Starr, MD Jeffrey Statland, MD Cezary Statuch Kara Stavros, MD Lynn Stazzone, NP Kristen Steenerson Ben Steer BBus Maria Stefanidou, MD Sabrina Stefanizzi Debuc, PhD Anca Stefanoiu Hons. B. Sc. David Stefanoni MSHSA Kamil Stefanowski, MD Anna Stefansdottir, MD Steve Steffensen, MD Laura Stein, MD Alexis Steinberg, MD Judith Steinberg, MD Lon Steinberg, MD David Steiner, MD Israel Steiner Joshua Steinerman, MD Ines Steinich, MD Victoria Steinkoenig APN Rick Stell Bianca Stelten, MD Fernando Stelzer, MD, PhD Danielle Stember, MD Brigitte Stemper, MD Lucas Stenzel, MD Monica Stephan, MD Christopher Stephen, MD, MB, ChB, MRCP Brian Stephens, MD Claude Steriade, MD Barney Stern, MD, FAAN

2017 AAN Annual Meeting On-site Guide

Lawrence Stern, MD, FAAN John Stern, MD, FAAN Robert Stern, PhD Eliezer Sternberg, MD David Sternman, MD Ivana Stetkarova, PhD Glen Stevens DO, PhD, FAAN Olivier Stevens, MD James C. Stevens, MD, FAAN Emily Stevenson, PhD Birute Stewart, MD Sarah Stewart, MD Martin Sticha David Stiles, PhD Edward Stim, MD Amro Stino, MD Derek Stitt, MD Michael Stitzer, MD Claire Stockhausen PA Katharina Stoeck, MD Florian Stoegbauer, MD Mathew Stokes, MD Daniela Stokmaier, PhD Sharon Stoll, DO Seth Stoller, MD Katherine Stoltz, MD Joshua Stone, MD William Stone, MD, FAAN David Stone, MD, PhD Andrea Stoner, DO Muriel Stoppe James Storey, MD, FAAN Tyler Story, PhD Daryl Story Pavel Stourac, MD Natividad Stover Patricia St-Pierre Benjamin Strain Jacob Strand Elizabeth Straub Denise Strauss Coral Stredny, MD Jonathan Streifler, MD Leopold Streletz, MD, FAAN




Jayashree Sundararajan, MD Soujanya Sunkaraneni MS Taofiki Sunmonu, MD Songkit Supakornnumporn Melanie Leigh Supnet, MD Melanie Leigh Supnet, MD Nicole Sur, MD Yazan Suradi, MD Praveen Surana, MD, MBBS S.S. Surenthiran, FRCP, MBBS Niraja Suresh, MD Laura Surillo Dahdah, MD Sajid Suriya, MD Tiffany Surles PharmD Nirmal Surya, MD, DNB Handoyo Suryo, MD Frandy Susatia, MD Jon Sussman, FRCP, MBBS, PhD Leena Suthar Harry Sutherland-Foggio Thomas Sutula, MD, PhD Mario Suva Sirorat Suwannachote, MD Masahiko Suzuki, MD Claus Bo Svendsen, MD, PhD Anton Svetlanov DO, PhD Kara Swafford, MD Thirukan Swaminathan, MD, PhD, MBBS Nikil Swamy, MD Barbara Swartz, MD, PhD, FAAN Kathleen Sweadner, PhD Joan Sweeney, MD Michael Sweeney, MD Patrick Sweeney, MD, FACP, FAAN Erica Sweet, DO Margaret Sweet, FRCP, MD Andrea Swenson, MD Michael Swerdlow, MD Jennifer Swiecki PharmD Thomas R. Swift, MD, FAAN Emily Swinkin, MD David Swope, MD Dionne Swor, DO

Stephanie Syc-Mazurek, PhD Syed Feisal Syed Farooq, MD Andrew Sylvester, MD Andrea Synowiec, DO Olga Syritsyna, MD Antal Szabo, MD Jozsef Attila Szasz, PhD Aimee Szewka, MD Jarmila Szilasiova, MD Miklos Szolics, MD, PhD Christina Szperka, MD Scott Szymanski, MBA Mohammad Tabaeizadeh Fesharak, MD Elham Tabarsi PharmD Grace Tabatabai BA Samer Tabbal, MD Susan Taboada, NP Daisy Tabuena, MD Kirk Tacka, PhD Bjorn Tackenberg, MD Ehsan Tadayon, MD Tezeta Tadesse, PhD Aleksey Tadevosyan Prasannna Tadi, MD Souhila Tadjer, PhD Christine Taeter, MD George Tagaris, MD Elsayed Tageldin, MD Foad Taghdiri, MD Chao Tai, FRCP, MB, FRCP Charles Tai, MD Makiko Taira, MD, PhD Callie Takahashi BA Ryosuke Takahashi, MD Sachiko Takahashi, MD,BSc Koji Takahashi, PhD Hiroki Takano, MD Koji Takei MS Jean-Noel Talabardon Sheila Talbott, MD, PhD Bradford Talcott, MD, PhD, FAAN Roger Tam, PhD Janet Tamai, DO

REGISTRANTS

Christoph Stretz, MD Tamara Strohm, MD Jeffrey Strommen Lisa Stropp Roy Strowd, MD Michael Strupp, MD, FANA, FEAN Tamela Stuchiner MA Chad Stuckey, MD Leanne Stunkel, MD Yvonne Sturm Amber Stutz, MD Olaf Stuve, MD, PhD Ning Su, MD Wendy Su, PhD Jose Suarez, MD Fabio Suarez, MD Gerson Suarez-Cedeno, MD Vanchilingam Subbiah, MD, MBBS Adnan Subei, DO Poovillam Subramaniam, MD, FAAN Laurent Suchet Lewis Sudarsky, MD Michelle Sudyn MS Jens Suero Lora, MD Wolfgang Suess, MD Laura Anouk Suess Paulus Sugianto, MD Bum Chun Suh, MD Torsten Suhnel, MD Enra Suiic Mehmedika, PhD Ana Suller Marti, MD Sarah Sullivan, DO Lawrence Sullivan, MD Kelly Sullivan, PhD Shumaila Sultan, MD Ai Sumida, MD Belinda Summerville Charlotte Sumner Linquan Sun, MD Hong Sun, MD, PhD Yan Sun, PhD Fang Sun, PhD, BM Bob Sun

269


Annual Meeting Registrants Serife Tamam, MD, PhD Yusuf Tamam, MD, PhD Sharon Tamir Tze Hian Tan B.SC (Pharm) (Hons) Chi Hsien Tan, MBBS Kay-Sin Tan, MBBS, MRCP, FRCP Kenny Tan, MD Michael Tan, MD Kevin Tan, MD Leon Tan, MD Lin Tan Merrick Tan Masami Tanaka, MD, FAAN Yutaka Tanaka, MD, FAAN Keiko Tanaka, MD, PhD Yuji Tanaka, MD, PhD Diana Tanase, MD, PhD Rup Tandan, MD, FRCP, FAAN Elise Tandberg, MD, PhD Nilufer Taner, MD, PhD Melissa Taney, PhD Chih-Wei Tang, MD Weihua Tang, PhD Ruth Tangonan RN David Tang-Wai, MD, FRCPC Caroline Tanner, MD, PhD, FAAN Sarah Tanveer B.Sc Fernando Taraciuk Nael Tarakji, MD Rajiv Tarigopula MS Nauman Tariq, MD Usama Tariq Mohamed Tarkhan, MD Caitlin Tarlton, MD Ivaylo Tarnev, PhD Ivaylo Tarnev, PhD Alexander Tarnutzer, MD Christopher Tarolli, MD Daniel Tarsy, MD Carmela Tartaglia Tomo Tarui, MD Adriana Tarulla, MD Edwin Tasch, MD Nebahat Tasdemir, MD

270

Nudrat Tasneem, MBBS William Tatum Stephen Taubenfeld, MD, PhD Shahamat Tauhid, MD Blanche Tavernier PharmD Dario Tavolini, PhD Abdullah Tawakul, MD Tania Tayah, MD Haythum Tayeb, MD Martin Taylor DO, PhD Travis Taylor, MD Carolyn Taylor, MD Kirk Taylor, MD Mary Taylor, MD Melanie Taylor, MD Lynne Taylor, MD, FAAN Abigail Taylor PA Lori Taylor, PhD Anatalia Nina Tayo, MD Dmitry Tchapyjnikov Matt Teague BA Mehmet Tecellioglu, MD Matthew Techy BA Gioacchino Tedeschi, PhD Hennan Teixeira Manoel Teixeira, PhD Evan Templeton, MD Silvia Tenembaum, MD Nadia Tenenbaum, MD Edmond Teng, MD, PhD Connie Tengah, MD Cynthia Tenhoopen, NP Stewart Tepper Bastiaan Ter Meulen, MD Pichet Termsarasab Kyle Terpak PharmD Santo Terranova, DO Laura Tervonen, MD Murat Terzi, MD Claudia Testa, MD, PhD Fernando Testai, MD, PhD Laurien Teunissen, MD, PhD Paul Teychenne, MBBS, FAAN Megan Teynor ScD

2017 AAN Annual Meeting On-site Guide

Ali Tfaily, NP, PhD, RN Gaby Thai, MD Pariwat Thaisetthawatkul, MD, FAAN Nimish Thakore, MD Manisha Thakore-James, MD Mona Thakre, MBBS, MD Kiran Thakur, MD Avner Thaler, MD, PhD Thananan Thammongkolchai, MD Baburaj Thankappan, MD Emily Tharp Sujata Thawani, MD Simon Thebault, MD Brett Theeler, MD Cindy Theigs RPh Oliver Theis, MD Moyinulhaq Thekkumpurath, MD, MBBS Linda Then Yee Yen, MD William Theodore, MD, FAAN Paul Theron Marc Therrien, MD Corey Thibeault, PhD Cornelius Thiels Robert Thies, MD John Thipphawong, MD Parthasarathy Thirumala, MD, FAAN Win Min Thit, MBBS, MD thomas thomaidis, DO Alyssa Thomas BA Karen Thomas, DO Madhavi Thomas, MD, FAAN Melinda Thomas, MBA Neil Thomas, MD Anila Thomas, MD Gary Thomas, MD Reji Thomas, MD Robert Thomas, MD K Florian Thomas, MD, MA, PhD, FAAN Lisa Thomas Eleanor Thomas Meagan Thomas




Kelly Tisovic, MD David Titelbaum, MD Victoria Titoff, DO Igor Titoff DO, MA Maarten Titulaer, MD, PhD Harmanpreet Tiwana, MD Nantaporn Tiyapun, MD Girianto Tjandrawidjaja, MD Veronica Analia Tkachuk, MD Hal Tobias, MD, FAAN W. Oliver Tobin MB BCh, BAO, PhD Kimberly Tobon, DO Alejandro Tobon, MD Candice Todd, MD Peter Todd, MD, PhD Anissia Todd Donald Todman, MD, MBBS, FAAN Win Toe, MD Vahid Tohidi, MD, PhD Stacey Tokar, MD Ivie Tokunboh BA Dwain Tolbert, PhD Benjamin Tolchin, MD Haley Toledano, NP Michel Toledano Walter Toledo, MD Guillermo Toledo Sotomayor, MD Bharat Tolia, MD, MBA, FAAN Trent Tollefson, MD Gianina Toller, PhD Anthony Tolley Eugene Tolomeo, MD Henna Tolvanen-Mahjneh, MD Mohamed Tom, MD Marie Tomasi, MD Temel Tombul Kinga Tomczak, MD, PhD Davorka Tomic Stuart Tomko, MD Olivia Tong, MD Gary Tong, MD, PhD Yi Tong Martijn Tonk, MD Toomas Toomsoo, DO

Raffi Henry Topakian, PhD Sena Topcu, MD Jordan Topel, MD, FAAN Qaiser Toqeer, MD Mary Beth Toran, MD Carlos Jose Manuel Tordesillas Lia, DO Josh Torgovnick, MD Laura Tormoehlen, MD Carlo Tornatore, MD Leticia Tornes, MD Camilo Toro, MD Jaime Toro, MD, FAAN Gabriel Torrealba Acosta, MD Angelo Torrente, MD Diego Torres-Russotto, MD Michael Torrey Jaime Torrington Carla Tortorella, MD William Tosches, MD, FAAN Virginia Tosney-Trask Fabio Toso, MD Rocco Totaro, MD Julia Toub, MD Tiffany Townsend, MD, CM, FRCPC Adam Townsend John Townsend III, MD, FAAN Louisa Townson, PhD Martin Traber, MD Sebastiano Traccis, MD Robert Trainor, MD Louis Tramontozzi, MD Jennifer Tran BA Lisa Tran BA Conny Tran, BS Vi Tran, BS Jessica Tran, BSPH Catherine Tran Fatima Traore, MD Ute Traugott, MD, FAAN Doris Trauner, MD Bryan Traynor, MD Constantina Treaba, MD, PhD Lauren Treat, MD

271

REGISTRANTS

Zach Thomas PharmD, FCCM Aliki Thomas, PhD Fiona Thomas Rebecca Thompson, MD Alan Thompson, MD, FRCP, FAAN Jill Thompson, NP Judith Thompson PharmD Alejandro Thomson, MD Alfredo Thomson, MD Jesse Thon Jason Thonhoff, MD, PhD Chandana Thorat Anja Thormann, MD James Thornton, MD Samuel Thorpe, PhD Susanne Horso Thorsdal Eric Thouvenot, PhD Zachary Threlkeld, MD Bjoern-Holger Thuemler, MD Cleopatra Thurman, DO Matthew Thurtell JT Tibung, MD, MBA Nicola Ticozzi, MD, PhD Felipe Tienken, MBA Thuy An Tienor, MD Gretchen Tietjen, MD Tonu Tiimus, MD Christine Till, PhD Jan-Mendelt Tillema John Tillett, MBBS Ann Tilton, MD, FAAN John Tilton Shilpa Tilwalli, MD Lynne Timmermans Jeroen Tinbergen, MD Richard Tindall, MD, FAAN Wu Ting Jie Ting, PhD Ron Tintner, MD Vanessa Tiongson, MD Jose Miguel Tirapegui, MD David Tirschwell, MD, FAAN Ezgi Tiryaki, MD Jonathan Tisdell, MD


Annual Meeting Registrants Elaine Treichel PharmD Simona Treidler, MD Maria Elena Trejo, MD Matthew Tremblay, MD Helen Tremlett, PhD, BPharm William Trescher, MD Edwin Trevathan, MD, FAAN Javier Triana, MD Jennifer Triemstra, PhD Gabriela Trifan, MD Bhavesh Trikamji, MD Brian Trimble, MD, MPH Gemma Trinder,BSc Bo Trinh PharmD Richa Tripathi, MD Gautam Tripathi, MD Anurag Trivedi, MD Bhargava Trivedi, MD Jaya Trivedi, MD, FAAN Sara Trivino, PhD Lukasz Troinski, MD Maria Trojano, PhD Thomas Tropea, DO Victoria Trott PA LynnMarie Trotti Marci Troxell, DO Todd Truesdale Karen Truitt, DO Brian Trummer, MD, PhD Melanie Truong, DO Daniel Truong, MD, FAAN Mina Tsagkournisakis, MD Po-Heng Tsai, MD Richard Tsai, MD Nina Tsakadze, MD, PhD Jack Tsao, MD, DPhil, FAAN Weichia Tsao Dominic Ming Yin Tse MBCHB Evgeny Tsimerinov, MD, PhD, FAAN Amy Tso, MD Lap Kiu Tsoi, MBBS Spyridon Tsoutsouras Elena Tsoy MSc

272

Tammy Tsuchida, MD, PhD Kikumi Tsuda Andrey Tsvetkov, PhD Alan Tuchman, MD, FAAN Howard Tucker, MD Mitzi Tucker John Tuddenham BA Madina Tugizova MA, BS John Tulloch, MD, FAAN Subhash Tummala, MD Brian Tumminello PharmD William Tung, MD, MPH Tanya Turan, MD, FAAN Omer Faruk Turan Pierpaolo Turcano, MD Giorgio Turella, MD Anya Turetsky, MD Nilda Turgut, MD Matthias Turk, MD Katherine Turk Peter Turkeltaub, MD, PhD Cigdem Turkmen PharmD Recai Turkoglu, MD, PhD Garth Turner, MD Diderick Turpijn, MD Luis Tusen, MD Mark H. Tuszynski, MD, PhD, FAAN Melih Tutuncu, MD, PhD Erdem Tuzun, MD, PhD Steven Tversky, DO David Tworek MS, MBA Paul Twydell, DO Kenneth Tyler Charles Tyshkov, MD Ergun Uc, MD Ali Ulvi Uca, MD Julie Uchitel Bjarne Udd, MD, Prof Sean Udow Akihiro Ueda, MD, PhD Mihaela Ugarcovici MS Reinaldo Ugrinovich, MD Nnamdi Uhegwu, MD Tomas Uher, MD

2017 AAN Annual Meeting On-site Guide

Erik Uhlmann, MD Bernard Uitdehaag, MD, PhD Ryan Uitti, MD, FAAN Christina Ulane, MD, PhD Robin Ulep, MD Carol Ulloa, MD Chizoba Umeh, MD Yoshie Umemura, MD Karadan Ummer, MD Roople Unia, MD Cherukara Unni, MD, MBBS Ruby Upadhyay, MD Parth Upadhyaya Timothy Upchurch, MD Kristin Ura PharmD Edward Urban, MD Robert Ure, MD Bernardo Uribe, MD Eduard Urich, PhD David Urion, MD, FAAN Melanie Ursell, MD Renata Ursu, PhD Gary Usher, MD Uzma Usman, MD Ben Utecht Basim Uthman, MD, FACIP, FAAN Erica Utigard, DO Jessica Utt PA Ursula Utz, PhD Ezinne Uvere MPH Marta Vachova, MD Martin Vadala, PhD Aparna Vaddiparti, MD Vaishnavi Vaidyanathan Gabriel Vainstein, MD Lana Vainsteine, MD Sanjeev Vaishnavi, MD, PhD Geetanjali Vajapey, MD Ravi Vakani, MD Nojan Valadi, MD Sergio Valdes-Ferrer, MD, PhD Alisha Valdez PharmD Felix Valdez L, MD Francisco Valdivia, MD




Juliana VanderPluym, MD Joshua VanDerWerf, MD Manuela Vaneckova, PhD Kavin Vanikieti, MD Dana Vanino, DO Susan VanMeter, MD Robert Vann, PhD Ludo Vanopdenbosch, MD, FAAN Rena Vanzo MS Okeanis Vaou, MD Annick Varachaud, MD Panayiotis Varelas, MD, PhD Stefan Varga, PharmD Irene Vargas Alejandro Vargas, MD Bert B. Vargas, MD, FAAN Ruben Vargas, MD Alfredo Vargas, MD Wendy Vargas, MD Tania Vargas, MD Nicolas Vargas Zea MSc, MBA Daniel Vargas-Mendez, MD Chandra Vargeese, PhD Robert Varipapa, MD Karl Varkey MSc Kubilay Varli, MD Siddhartha Varma, MD Amitaabh Varma, MD, MBBS Marija Vasiljevic Eliana Vasquez Pabel Vasquez Valenzuela, MD Somanath Vasudeva, MD, MBBS Laura Vaters, NP Leslie Vaughan RPh Anthony Vaughn, MBA Bradley Vaughn, MD Anthony Vaughn, MD Caila Vaughn, PhD Barry Vaught, MD Jessica Vaz MRCP Marisel Vazquez, MD Rocio Vazquez Do Campo Lionel Vazquez-Figueroa, MD Jennifer Vecere, NP

Sivaram Vedantam, PhD Aravindhan Veerapandiyan, MD Karthika Veerapaneni, MD Venkat Veerappan, MD Catherine Veilleux Isaac Veinbergs, PhD Daniel Vela-Duarte, MD Ana Luisa Velasco, MD Elidenia Velasquez, MD Jasmin Velasquez Graziano DPM Jan Veldink, MD, PhD Karina Velez Jimrnez, MD Bryson Velletri Arvl Selvan Vellorelenin, MD Eric Veloso Soumya Vemuri MS Jose Andres Venegas Jaymes Venema, MD Praveen Venkatachalam, MD Chethan Venkatasubba Rao Arun Venkatesan, MD, PhD Mangala Venkatesh, MD Yedatore Venkatesh, MD, FAAN Anand Venkatraman, MD Guha Venkatraman, MD Annalena Venneri, MD, PhD Vincent Vente Johannah Venturini Elisabetta Verdun di Cantogno, PhD Loreto Vergara Ingrid E.C. Verhaart, PhD Wilhelmus Ignatius M Verhagen, PhD Leonard Verhagen Metman, MD, PhD Lonneke Verhoeff, MD Marc Verin, MD, PhD Ryan Verity Rehan Verjee Sonam Verma, MD Mamta Verma, MD Ashok Verma, MD, FAAN Amit Verma, MD, MBBS RAJESH VERMA, MD, MBBS Ajay Verma, MD, PhD

273

REGISTRANTS

Cristina Valencia Sanchez, MD Elizabeth Valente Gianluca Valenza Reuben Valenzuela, MD Jaquelin Valicek, MD Martin Valis, MD, PhD Gustavo Valitutti, MD Steven Valliere PharmD Claudia Vallin, DO Orlando Vallone Juan Antonio Valverde Espinoza, DO Johan van Beek, MD Christine Van Broeckhoven, PhD Anne Van Cott, MD, FAAN Diederik Van De Beek, MD, PhD Ilja van de Staak, MD Janneke Van De Vlekkert, MD Leonard Van den Berg, MD, PhD Tobi Van den Bossche, MD Marjon Van Der Meulen, MD Ronald Van Der Rol Jeroen Van Dillen, MD Daniel Van Engel, MD Peter Van Ess PharmD, PhD Bjorn van Geel, MD, PhD Tracey Van Kempen, PhD Ana Maria Van Koningsloo Rinske van Koningsveld, PhD Amber Van Laar, MD Tim Van Langenhove, MD, PhD Sara Van Mossevelde, MD Melany van Oostrom, MBA Wendy Van Overveld, PhD Kenou van Rijckevorsel, MD Carson Van Sanford, MD Ivo van Schaik, MD, PhD David Van Slooten, MD Renee Van Stavern, MD Gregory Van Stavern Amanda Van Straten, MD Jeffery Vance, MD, PhD Joshua Vandeburgh Jeanne Vander Zanden PharmD, BCPP


Annual Meeting Registrants Patrick Vermersch, PhD Jennifer Vermilion Steven Vernino, MD, PhD, FAAN Aad Verrips, MD, PhD Mark Versavel, MD, PhD, MBA Michael Vertino, MD Michael Vesali, MD Paul Vespa Santiago Vetere, MD Aurelien Viaccoz, MD Belen Viaggio, MD Barbara G. Vickrey, MD, MPH, FAAN Jesse Victor, MD Ivan Vidal, MD Carlos Guillermo Videla, MD Aleksandar Videnovic, MD, MSc, FAAN Thomas R. Vidic, MD, FAAN Luciano Vieira, MD Soniza Vieira Alves Leon, MD Megan Vignos, PhD Cristina Viguera, BS Swathi Vijayaraghavan, MD Maria Jose Vila Dupla, MD Luis Villa, MD Kenneth Villa, MD Marta Villa Jorge Villacura, MD Martin Daniel Villagra, MD Pablo Villagra Cocco, MD Julio Cesar Villalobos, MD Raissa Villanueva, MD Osvaldo Villaver, MD Juan Villazon, MD Michael Vinahl, MD Angela Vincent, FRCP, MBBS, MSc Francois Vingerhoets, MD Erick Viorritto, MD, MPH Oscar Virgilio, MBA BAcc BAdm Tuhin Virmani, MD, PhD Megan Viscovich PA, CMA Hubert Frederik Visee, MD Anastasia Vishnevetsky John Visser, MD

274

John Vissing, MD Natarajan Visvanathan, MD, DM Paolo Vitali, FRCP, MD, PhD Ottavio Vitolo, MD, MMSc Padmaja Vittal, MD, MS Carolina Vivar, MD Pedro Vivar Cruz, MD Francisco Jose Vivar Gonzalez PharmD Carlos Viviani, MD Anton Vladic, PhD Mihaela Vlaicu Khac Huy Vo PharmD Ivana Vodopivec, MD, PhD Kevin Voelker, PhD Barbara Voetsch, MD, PhD Julio Vogel Barbara Vogler, MD Heinrich Vogt, MD P. Emanuela Voinescu, MD, PhD Antanina Voit Vladimira Vojtova PharmD, MD Ana Volkmann, MD Timothy Vollmer, MD, FAAN Brandi Vollmer MPH Gabriel Volman, MD H.-Christian von Budingen, MD Gisele von Buren PharmD Christiane von der Eltz Felipe Von Glehn Silva, MD, PhD, MSc Christian Von Hehn, MD, PhD Florian Von Raison Sebastian Von Rosenstiel, MD, PhD Aida Von Schirach PharmD Nuttawan Vongveeranonchai, MD Jean Vonsy DVM, PhD, MRCVS Nirali Vora, MD Sylvia Voreck, MD Yakov Vorobeychik, MD Pieter Vos, MD, PhD Kellen Voss, PhD Scott Vota, DO Carlos Vrech, MD

2017 AAN Annual Meeting On-site Guide

Kim Yen Thi Vu LMSW Anh-Thu Vu, MD Duc Vu, MD Mithila Vullaganti, MD Mai Vuong, MD Aditya Vuppala, MD Ashish Vyas, MD Neeta Vyas, NP Mikhail Vydrin, MD Josef Vytlacil, MD Michal Vytopil, MD Andrew Waclawik, MD, FAAN Subodh Wadhwa, MD Anish Wadhwa, MD Muhammad Faisal Wadiwala, MBBS, FCPS Jason Wafalosky Aaron Wagen, MBBS Sheetal Wagle, MD Binod Wagle, MD Aparna Wagle-Shukla, MD Steffen Wagner, MD Torsten Wagner, MD Joanne Wagner, PhD, PT Kolawole Wahab, MD Mark Waheed, DO Gerald Wahl, MD Brian Wainger, MD, PhD Mark Wainwright, MD, PhD Ben Wakerley, PhD, MRCP Tobias Walbert, MD, PhD Allison Walczyk, NP, RN Nils Waldmann, MD Brendan Waldoch Kristin Waldron, MD David Walk, MD Jonathan Walker, MBBS Ian Walker, MD Harrison Walker, MD Sian Walker, MD Melissa Walker, MD, PhD Cindy Walker MS Bryan Walker Cheryl Wall, NP, CNP




Windy Wang PharmD, MBA Jingwen Wang, PhD Lihua Wang, PhD Lijuan Wang, PhD Daguang Wang, PhD David Wang, PhD Michael Wang Mushtaq Wani, MD Joseph Wapenski, MD Jayne Ward, DO Michael Ward DVM Tiffany Ward, MD Thomas Ward Emma Waring MSci Peter Warinner, MD Tanya Warwick, MD Mohammad Wasay, FRCP, MBBS, MD, FAAN Hena Waseem, MD Andrea Wasilewski, MD Sanchea Wasyliw, MD Elizabeth Waterhouse Brandon Waters, MD Janet Waters, MD Cheryl Waters, MD, FAAN Michael Waters, MD, PhD, FAAN Tim Waters Laura Watne MS RD Emily Watson, MD David Watson, MD James Watson, MD William Watson, MD Crystal Watson MS Colin Watson, PhD C Watson Paul Watts, FRCP, MBBS, PhD Julia Watts Emmanuelle Waubant Ewa Way, MD Vincent Way Gregg Waylander, NP Natalie Weathered, MD Allison Weathers, MD, FAAN Joshua Weaver, MD

Dallas Webb Andrew Webb Philip Webber, PhD Daniel Weber, DO Stewart Weber, MD Martin Weber, MD Joerg Reinhold Weber, PhD Georgina Weber RN Gill Webster, PhD Lawrence Wechsler, MD, FAAN Gisbert Weckbecker, PhD Chee Keong Wee, MBBS, MD Nate Weedin PharmD, MBA Nabil Wees, MD Arkadiusz Weglewski, PhD Shao-Hwa Wei, DO Jerry Wei, MD Alex Wei Christine Wei Karen Weidenheim, MD Spencer Weig, MD Conrad Weihl, MD, PhD Jeffrey Weinberg Howard Weiner, MD Mira Weiner Brian Weinshenker Jessica Weinstein, MD Bianca Weinstock-Guttman, MD Scott Weintraub, MBA Raphaella Weiser, MD David Weisher, MD Daniel Weisholtz, MD Emma Weiskopf, MD Anne Weiss, DO Michael Weiss, MD Jamie Weiss, PhD Ted Weissfeld, MD Robert Welch PharmD Mary Welch Jason Weller, MD Alexandra Weller Michael Weller Andreas Wellmer, MD Rebecca Wells

REGISTRANTS

Anastacia Wall PA Thomas Wallace, PhD Asya Wallach, MD Mitch Wallin, MD, MD, MPH Brooke Walls, MD Erik Wallstroem Lori Walmsley Ronan Walsh MB, BCh, BAO, MPH, M Michael Walsh, MBBS, FRACP Richard Walsh, MD Alison Walsh, MD Francis Walsh, MD Christopher Walsh, MD, PhD Ryan R. Walsh, MD, PhD, FAAN Jessica Walter, MD Hannah Walters, MD Royce Waltrip, MD Yu Wan, MD, PhD Ruchi Wanchoo, MD Narine Wandrey, BS David Wang, DO Alan Wang, MD Bing Wei Wang, MD Cynthia Wang, MD Jeffrey Wang, MD Nancy Wang, MD Angela Wang, MD Katherine Wang, MD Annabel Wang, MD Charles Wang, MD David Z. Wang DO, FAAN, FAHA Dong Wang, MD Yunxia Wang, MD Jiawei Wang, MD Li Wang, MD Jing Wang, MD Ruihao Wang, MD Leo Wang, MD, PhD Hua Wang, MD, PhD Deli Wang, MD, PhD Shanshan Wang, MD, PhD Tao Wang Kathy Wang

275


Annual Meeting Registrants Patrick Wen, MD Marie Wencel CCRP Vidar Wendel-Hansen, MD, PhD Linda Wendell, MD Bernd Wendtland, MD Gregory Went, PhD Vicky Wenzlawsh Camilla Werke, MD Lineu Werneck, MD, PhD John Werner, MD Corinne Werquin PharmD Carol Werther MS, RD Sarah Wesley, MD Thomas Wessel, MD, PhD Karen Wesselhoeft, NP Colin West, MD, PhD Billy West, PhD Timothy West Lyle Weston, MD Andrew J. Westwood, MD Jennifer Wethe, PhD Christine Wettmarshausen, MD Thurman Wheeler, MD David Wheeler, MD, PhD, FAAN Daniel White, MBBS Kathryn White Carly Whitehead, DO Ruth Whitham, MD, FAAN Christopher Whiting, DO James Whitlock, MD Martha Whitmore Kristi Whitmyre David Whitney, MD Steven Whitworth, PhD Andrzej Wiak, PhD Leah Wibecan MPH Matthew Wicklund, MD, FAAN Mary Widmeyer, MD Katherine Widnell, MD, PhD Michelle Widolff, PhD Rainer Wiegand, MD, FAAN Martin Wiehl Heinz Wiendl, MD Jill Wiener, MD

276

Janice Wiesman, MD Linda Wietecha RN, MS Jagath Wijesekera, FRCP, MD, MBBS Colin Wilbur, MD Miguel Wilken, MD Simon Wilkinson Barbara Willekens, MD Carol Willems, MD Roman Willi, PhD Eugene Williams, MBA Vernon Williams, MD Jeri Williams, MD Korwyn Williams, MD, PhD Benjamin Williams, MD, PhD Judy Williams Betsy Williams, PhD James Williams, PhD Matt Williams Justin Williams Craig Williamson, MD Mary Willis, MD Paul Willis, MD Jonathan Willmer, FRCP, MD Anne Marie Wills, MD Crystal Wilmot, NP Nathaniel Wilson BA Martin Wilson, FRCP, DM Annise Wilson, MD Michael Wilson, MD Christina Wilson, MD Andrew Wilson, MD, MBA Nancy Wilson Sara Winchester, MD Jorge Luiz Winckler, PhD Charlotte Wincott, PhD Toni Winder, MD, FRCP Thomas Winder, PhD, FACMG Joshua Winegar, BS Sarah Wing, MD Ryan Winger, PhD Dean Wingerchuk, MD Gerhard Winkler, MD Paul Winner DO, FAAN

2017 AAN Annual Meeting On-site Guide

Yang Winnie Hanna Winogrodzki, MD, PhD Elaine Wirrell, MD Anna Maria Wirth MSc Natalie Witek, MD Elke Witte, MD Mike Witte Brigitte Wittmann, MD Leslie Witton, MD Anna Wojcicka-Mitchell, MD Valerie Wojna, MD Christian Wolf, MD Sheldon Wolf, MD, FAAN Gil Wolfe, MD Jimmy Wolfe, MD Adam Wolff, MD Andrew Wolff, MD Brian Wolff, MD Jerry Wolinsky, MD, FAAN David Wolk, MD Jonas Wolpher David Wong, MBBS Ho Ming June Wong MBChB Bonnie Wong, MD Brian Wong, MD Ericka Wong, MD Melvin Wong, MD Schiffon Wong Ka-Ho Wong, BS Jamie Wong, PhD Lily Wong-Kisiel, MD Marc Wonneberger Dipl Andrew Woo, MD, PhD Kai Woo Daniel Woo Jeong Woo Cho Kevin Wood, MD Cheryl Wood, NP Julie Wood, PhD Kathryne Wood Ian Woodcock, MBBS Jonathan Woodcock, MD Jonathan Woodhouse PsyD Karin Woodman, MD




Haiyan Xu, MD, PhD Wei Xu, MD, PhD Cen Xu, PhD Yun Xu, PhD Lin Xu, PhD, MS Roy Yaari Oron Yacobi-Zeevi, PhD, DVM Helena Yacoub Ravi YADAV, MBBS, MD, DM Vijayshree Yadav, MD Kristine Yaffe Nagib Yahmad, MD, FRCP(C) Aleksandra Yakhkind Fabio Yamamoto, MD Noriyuki Yamamoto, PhD Mitsugu Yamanaka, PhD Hiroshi Yamashita, PhD Olivia Yambem, MD Peter Yan, MD Justin Yancey, MD Gonzalo Yanez, MD, FAAN Hyun-Sik Yang, MD Haichen Yang, MD Irene Yang, MD Michael Yang, MD Laurice Yang, MD Keyi Yang, MD, PhD Jeff Yang Charles Yanofsky, MD, FAAN Claire Yanta, MD Patrina Yao, MD Faith Yao, PhD Siew Mei Yap, MBBS Lina Ya'qoub, MD Ravi Yarlagadda, MD Kalyan Yarraguntla Mohammad Yaseen, MD Jay Yasen, MD Dileep Yavagal, MD VILDAN AYSE YAYLA, PhD Xiaolan Ye, PhD Melvin Yee, MD E. Ann Yeh, MD Crystal Yeo, MD, PhD

Isaac Yepez, MD Vahide Deniz Yerdelen Oleg Yerokhin, MD Sushma Yerram, MD Jill Yersak, PhD Anusha Yeshokumar, MD Michael Yeung, MD Yun Wo Katie Yin, MBBS Jie Yin, MD Wei Yin, PhD Victor Ylagan, MD Tahir Kurtulus Yoldas, MD, PhD Makoto Yoneda, MD, PhD Jinhyuk Yoo, MD William Yorns, DO Micah Yost, DO Katherine Youmans-Kidder, PhD Erica Youn, MD Jina Youn MS Clover Youn West, DO Michael Young, DO Taylor Young MA Terence Young, MBBS Eufrosina Young, MD Robyn Young, MD Richard Young, MD, FAAN William Young, MD, FAAN David Young, MD, PhD Meredith Young, PhD Drew Young Drew Young Marcus Yountz, MD Muhammad Ismail Khal Yousaf, MBBS Tariq Yousef, MD Doaa Youseif, MD Leena Youssefian, MD Sarah Youssof, MD Asad Yousuf, MD Fawad Yousuf, MD Amy Yu BA Xin Xin Yu, MD Melissa Yu, MD Jun Yu, MD

REGISTRANTS

Bryan Woodruff, MD Reid Woods, BS Doris Woodson, BS Abra Woolard, NP John Wooten, MD Lila Worden David Wormser, PhD Bradford Worrall, MD Nicola worsforl Damian Wren, FRCP, MBBS, MD Clinton Wright, MD Paul Wright, MD, FAAN R. Wright, MD, MB, ChB, FRACP Christina Wright PharmD Zbigniew Wszolek, MD, FAAN Matthew Wu, BS Allan Wu, MD Annie Wu, MD Joyce Wu, MD Jr-Wei Wu, MD Suying Wu, MD Xuqing Wu, MD Xuan Wu, MD, PhD Jiayi Wu MS Hui Wu Ying Wu, PhD Fan Wu, PhD Jens Wuerfel, MD Rachel Wurzman, PhD Ann Wyborny Kathryn Wyman-Chick PsyD James Wymer, MD, PhD, FAAN Daniel Wynn, MD Jill Wyrwa Sokrat Xhaxho, MD Zongqi Xia, MD, PhD Zhen Xiao, PhD Yi Xie, MD Daojun Xie, MD Ting Xie, PhD Natalia Ximenes, MD Wajiha Nasser Ximenes, MD Li Xiong, MD, PhD Lei Xu, MD

277


Annual Meeting Registrants Wengui Yu, MD, PhD Shengyuan Yu, PhD Chungping Yu, PhD Derek Yuan, MD Jun Yuan, MD Chad Yucus, MD Fenny Yudiarto, MD, PhD Sue Yueh PharmD April Yuki, MD Christopher Yun, BS Ethan Yun, DO Anita Yun Jang Yun, PhD Nadia Yusuf, MD Aram Zabeti, MD Neta Zach, PhD Melanie Zacker, PhD Kathleen Zackowski, PhD Cindy Zadikoff, MD Saman Zafar, MD Mauro Zaffaroni, MD Dario Zagar, MD Piergiuseppe Zagnoni, MD, FAAN Craig Zaidman, MD Marshall Zaitlen, MD Lauren Zajac MS Joseph Zajicek Yahia Zakaria Mohammad MBBCh, PhD Monica Zaki, DO Iram Zaman, DO Lab Zambon, DO Maria Zambrano, MD Eduardo Zamora, MD Maria Zamora, MD Arelys Zamora Edward Zamrini, MD Jorge Zamudio Scott Zamvil, MD, PhD Gisela Zanga, MD Shayna Zanker Maryamnaz Zaribaf Amy Zarrin, MD, PhD Lina Zaslavsky, MD

278

Mayana Zatz, MD, PhD Sarah Zauber, MD Kristina Zawaly, PhDc, MSc, BS Ifrah Zawar, MBBS, MD Tania Zayas Torres, MD Karin Zebenholzer, PhD Nassim Zecavati, MD Chiara Zecca, MD Phyllis Zee, MD, PhD Aaron Zelikovich Robert Zeller, MD Guillermo Zeppa, MD Ronald Zerofsky, MD Theresa Zesiewicz, MD, FAAN Burcu Zeydan, MD Fei-Fei Zhai, MD Stephanie Zhang, BS Qian Zhang, MD Chunxiao Zhang, MD Li Zhang, MD Lynn Zhang, MD Eileen Zhang, MD Qiang Zhang, MD, PhD Frank Zhang, MD, PhD Fang Zhang MHA Pan Zhang MS, CFA Ying Zhang Min Zhang, PhD Sheng Zhang, PhD Chelsea Zhang Lixin Zhang-Auberson, MD, PhD Jun Zhao, MD Gang Zhao, PhD Jian Zhao, PhD Wei Zheng, MD Karen Zhou, MD Melissa Zhou Nancy Zhou, NP Dong Zhou, PhD Lana Zhovtis Ryerson, MD He Zhu, MD Bing Zhu, MD Qingyan Zhu, MD Laura Zhu, PhD

2017 AAN Annual Meeting On-site Guide

Min Zhu, PhD Yanan Zhu, PhD Ping Zhuang, PhD Almagul Zhusupova, MD Adil Zia, MD Wendy Ziai, MD Marina Ziehn, PhD Glynnis Zieman, MD Adam Ziemann, MD, PhD Tjalf Ziemssen, MD Panagiotis Zikos, MD Giovanni Bosco Zimatore, MD Sabrina Zimmerman,BSc Andrew Zimmerman, MD, FAAN Carla Zingariello, DO Vera Zingler Alberto Zinnerman, PhD Marcello Ziosi, PhD Gary Zirpoli, PhD Charlotte Zisman, MD Robert Zivadinov, MD, PhD, FAAN Justin Zivin, MD, PhD, FAAN Sasha Zivkovic, MD, PhD Irina Zlamanets, MD Charles Zollinger, MD, FAAN Ilya Zolotnik, MD Yasar Zorlu, MD Ioannis Zoukos, MD James Zu, MD Salman Zubair, MD Irati Zubizarreta Nafarrat, MD Stephan Zuchner Emily Zucker Mark Zuckerman, MD Daniel Zuin, PhD Ana Lucia Zuma de Rosso, PhD Leslie Zuniga, MD Jonathan Zurawski, MD Tadas Zuromskis, MD Cornelis Petrus Zwanikken, PhD Richard Zweifler, MD Jessica Zwerling, MD Jocelyn Zwicker, MD Casimir Zygmunt PharmD


Thank You 2017 Industry Roundtable Members* The American Academy of Neurology and the Industry Roundtable collaborate on opportunities to support neurology and serve patients with neurologic disease.

$50,000

$40,000

$25,000

$10,000

ACORDA Therapeutics IPSEN Biopharmaceuticals, Inc.

Eisai Inc. GE Healthcare Medtronic Merck & Co.

Alnylam Pharmaceuticals Arbor Pharmaceuticals AveXis, Inc. Axovant Sciences LivaNova PLC Neurocrine Biosciences

*Commitments as of March 10, 2017


SEE YOU NEXT YEAR LOS ANGELES

APRIL 21–27, 2018


1275 1273 1271 1269

Office of the Future Headshots

1265 1263 1261 1259 1257

1253

1249 1247 1245

1241 1239 1235

1229 1227 1225 1223 1221

Association Neighborhood

Tech Area 1274 1272 1270

1264 1260 1258 1256

1252

1248 1246 1244

1175

1165 1163 1161 1159 1157

1153

1149 1147 1145

1171

1240 1238 1236 1234

1228

1224 1222 1220 1218

1129

1125 1123 1121 1119

Technology Pavilion

Presentation Stage

1174 1172 1170 1168

1164 1162 1160

1075 1073

1065 1063 1061 1059 1057 1055 1053 1051

1069

1156 1154 1152 1150

Charging Hub

1140 1138 1136 1134

1128 1126 1124 1122 1120 1118 1116

1112

1041 1039 1037 1035

1029 1027 1025 1023 1021 1019 1017

1013 1011

Career Fair

981 994

889

895 894 892

Meal Services

984 885

791

969

974

Charging Hub

785

795 793

975

1064 1062 1060 1058 1056 1054 1052 965 963 961

957

955 953

971

858

771

779

945

927

Charging Hub

853

875 873 871

1028 1026 1024 1022 1020 1018 1016

745

751

917

924 922

916

911

825 823 818 816 Publications Row 838

1010 1008 1006 907 906

811

807

836 834

741 739 737 735

721

729

801

1012

715

740 738 736 734

685

559

573

591

925 923 921

547

523

585

501

513

535

To Posters 489

493

483

467

473

426

445

454

409

401

439

417 383

379 377 375 373

369

367

339

337 335

First Time Exhibitors

283

MS1

378 376 374 279 277 275 274

MS2

MS5

MS7

MS3

MS6

MS8

Charging Hub

336 334

241 239 237 235

272 270 268

177 175 173 171 169

MS4

240 238

234

139

137 135

229

324 322

310 308

225 223

209

224 127

201 Charging Hub

Charging Hub

125

116 147

164

MS16

MS9

338

244

260

301

311 329

MS10

MS11

MS12

MS13

145

128

124

112 110

106 104

148 146 144

Exhibit Hall BC

MS14

052B

052A

051

MS15

050

2017 AAN Annual Meeting Exhibit Hall Map

Up

Up


2O17 On-site Guide

COME SEE WHAT’S NEW IN BOOTH #473.

e t i s On ide Gu

• Booth Descriptions • Daily Passports • Office of the Future

  Bo

 • 017 8, 2 2–2 il 2 Apr

}} Annual Meeting Information }} Exhibits

n sto

AMERICAN ACADEMY OF NEUROLOGY

©2017 EMD Serono, Inc.

All rights reserved.

US/REB/0217/0037e

Printed in USA

03/17


2O17 On-site Guide

COME SEE WHAT’S NEW IN BOOTH #473.

e t i s On ide Gu

• Booth Descriptions • Daily Passports • Office of the Future

  Bo

 • 017 8, 2 2–2 il 2 Apr

}} Annual Meeting Information }} Exhibits

n sto

AMERICAN ACADEMY OF NEUROLOGY

©2017 EMD Serono, Inc.

All rights reserved.

US/REB/0217/0037e

Printed in USA

03/17

2017 Annual Meeting On-site Guide  

Your guide to navigating the Annual Meeting, including program schedule, Exhibitor Listing, information on award recipients, and more.

Read more
Read more
Similar to
Popular now
Just for you